1	Cumulative	JJ	O	cumulative	amod	2	SENT_1	[p1l46t81r570b165],
2	Effect	NN	O	effect	_	0	SENT_1	[p1l609t82r879b164],
3	of	IN	O	of	_	0	SENT_1	[p1l918t82r1006b164],
4	Risk	NN	O	risk	nn	5	SENT_1	[p1l1042t81r1251b164],
5	Alleles	NNS	O	allele	prep_of	2	SENT_1	[p1l1290t81r1597b164],
6	in	IN	O	in	_	0	SENT_1	[p1l1640t89r1726b163],
7	CFH	NNP	O	CFH	prep_in	5	SENT_1	[p1l1767t84r2011b177],
8	,	,	O	,	_	0	SENT_1	[p1l1767t84r2011b177],
9	ARMS2	NN	O	arms2	prep_in	5	SENT_1	[p1l40t200r440b294],
10	,	,	O	,	_	0	SENT_1	[p1l40t200r440b294],
11	and	CC	O	and	_	0	SENT_1	[p1l485t198r644b280],
12	VEGFA	NNP	O	VEGFA	prep_in	5	SENT_1	[p1l679t200r1048b300],
13	on	IN	O	on	_	0	SENT_1	[p1l1087t231r1197b280],
14	the	DT	O	the	det	18	SENT_1	[p1l1237t198r1376b280],
15	Response	NN	O	response	amod	18	SENT_1	[p1l1416t202r1839b301],
16	to	TO	O	to	_	0	SENT_1	[p1l1881t220r1966b280],
17	Ranibizumab	NNP	O	Ranibizumab	prep_to	15	SENT_1	[p1l44t315r630b397],
18	Treatment	NN	O	treatment	prep_on	12	SENT_1	[p1l671t319r1150b397],
19	in	IN	O	in	_	0	SENT_1	[p1l1189t323r1275b396],
20	Age	NNP	O	Age	prep_in	18	SENT_1	[p1l1314t315r1835b418],
21	—	CD	NUMBER	—	num	20	SENT_1	[p1l1314t315r1835b418],
22	related	JJ	O	related	amod	24	SENT_1	[p1l1314t315r1835b418],
23	Macular	NNP	ORGANIZATION	Macular	nn	24	SENT_1	[p1l44t431r415b513],
24	Degeneration	NNP	ORGANIZATION	Degeneration	dep	2	SENT_1	[p1l453t436r1058b534],

1	Dzenita	NNP	PERSON	Dzenita	nn	2	SENT_2	[p1l43t659r178b697],
2	Smailhodzic	NNP	PERSON	Smailhodzic	_	0	SENT_2	[p1l194t657r408b699],
3	,	,	O	,	_	0	SENT_2	[p1l194t657r408b699],
4	MD	NNP	O	MD	nn	8	SENT_2	[p1l427t651r529b699],
5	,1	CD	NUMBER	,1	num	8	SENT_2	[p1l427t651r529b699],
6	Philipp	NNP	PERSON	Philipp	nn	8	SENT_2	[p1l550t657r666b701],
7	S.	NNP	PERSON	S.	nn	8	SENT_2	[p1l683t659r715b692],
8	Muether	NNP	PERSON	Muether	appos	2	SENT_2	[p1l735t657r894b699],
9	,	,	O	,	_	0	SENT_2	[p1l735t657r894b699],
10	MD	NNP	O	MD	nn	13	SENT_2	[p1l913t651r1019b699],
11	,2	CD	NUMBER	,2	num	13	SENT_2	[p1l913t651r1019b699],
12	John	NNP	PERSON	John	nn	13	SENT_2	[p1l1032t657r1114b698],
13	Chen	NNP	PERSON	Chen	appos	8	SENT_2	[p1l1130t657r1234b699],
14	,	,	O	,	_	0	SENT_2	[p1l1130t657r1234b699],
15	MD	NNP	O	MD	nn	18	SENT_2	[p1l1254t651r1359b698],
16	,3	CD	NUMBER	,3	num	18	SENT_2	[p1l1254t651r1359b698],
17	Angela	NNP	PERSON	Angela	nn	18	SENT_2	[p1l1376t657r1499b701],
18	Kwestro	NNP	PERSON	Kwestro	appos	8	SENT_2	[p1l1514t659r1667b699],
19	,	,	O	,	_	0	SENT_2	[p1l1514t659r1667b699],
20	MD	NNP	O	MD	nn	24	SENT_2	[p1l1687t651r1788b699],
21	,1	CD	NUMBER	,1	num	24	SENT_2	[p1l1687t651r1788b699],
22	Alice	NNP	PERSON	Alice	nn	24	SENT_2	[p1l43t707r131b742],
23	Yang	NNP	PERSON	Yang	nn	24	SENT_2	[p1l148t709r236b751],
24	Zhang	NNP	PERSON	Zhang	appos	8	SENT_2	[p1l250t707r367b751],
25	,	,	O	,	_	0	SENT_2	[p1l250t707r367b751],
26	MD	NNP	O	MD	nn	29	SENT_2	[p1l387t701r491b749],
27	,3	CD	NUMBER	,3	num	29	SENT_2	[p1l387t701r491b749],
28	Amer	NNP	PERSON	Amer	nn	29	SENT_2	[p1l508t709r608b742],
29	Omar	NNP	PERSON	Omar	appos	8	SENT_2	[p1l624t709r738b749],
30	,	,	O	,	_	0	SENT_2	[p1l624t709r738b749],
31	MD	NNP	O	MD	appos	8	SENT_2	[p1l758t701r862b748],
32	,3	CD	NUMBER	,3	num	31	SENT_2	[p1l758t701r862b748],
33	Iohannes	NNP	PERSON	Iohannes	nn	38	SENT_2	[p1l877t707r1034b748],
34	P.	NNP	PERSON	P.	nn	38	SENT_2	[p1l1052t709r1087b742],
35	H.	NNP	PERSON	H.	nn	38	SENT_2	[p1l1108t709r1153b742],
36	Van	NNP	PERSON	Van	nn	38	SENT_2	[p1l1173t709r1247b743],
37	de	IN	PERSON	de	amod	38	SENT_2	[p1l1262t707r1299b742],
38	Ven	NNP	PERSON	Ven	dep	31	SENT_2	[p1l1316t709r1397b749],
39	,	,	O	,	_	0	SENT_2	[p1l1316t709r1397b749],
40	MD	NNP	O	MD	nn	44	SENT_2	[p1l1417t701r1519b748],
41	,1	CD	NUMBER	,1	num	44	SENT_2	[p1l1417t701r1519b748],
42	Jan	NNP	DATE	Jan	nn	44	SENT_2	[p1l1536t709r1598b748],
43	E.	NNP	O	E.	nn	44	SENT_2	[p1l1614t709r1651b742],
44	E	NNP	O	E	appos	8	SENT_2	[p1l1673t709r1698b742],
45	.	.	O	.	_	0	SENT_2	[p1l1705t736r1710b742],

1	Keunen	NNP	PERSON	Keunen	dep	45	SENT_3	[p1l1731t709r1876b748],
2	,	,	O	,	_	0	SENT_3	[p1l1731t709r1876b748],
3	MD	NNP	O	MD	appos	1	SENT_3	[p1l1896t709r1980b749],
4	,	,	O	,	_	0	SENT_3	[p1l1896t709r1980b749],
5	PhD	NNP	O	PhD	nn	8	SENT_3	[p1l2001t701r2106b748],
6	,1	CD	NUMBER	,1	num	8	SENT_3	[p1l2001t701r2106b748],
7	Bernd	NNP	PERSON	Bernd	nn	8	SENT_3	[p1l44t757r148b792],
8	Kirchhof	NNP	PERSON	Kirchhof	appos	1	SENT_3	[p1l163t757r321b801],
9	,	,	O	,	_	0	SENT_3	[p1l163t757r321b801],
10	MD	NNP	O	MD	appos	1	SENT_3	[p1l341t759r425b799],
11	,	,	O	,	_	0	SENT_3	[p1l341t759r425b799],
12	PhD	NNP	O	PhD	nn	16	SENT_3	[p1l446t751r555b798],
13	,2	CD	NUMBER	,2	num	16	SENT_3	[p1l446t751r555b798],
14	Carel	NNP	PERSON	Carel	nn	16	SENT_3	[p1l573t757r669b792],
15	B.	NNP	PERSON	B.	nn	16	SENT_3	[p1l686t759r723b792],
16	Hoyng	NNP	PERSON	Hoyng	appos	1	SENT_3	[p1l744t759r871b801],
17	,	,	O	,	_	0	SENT_3	[p1l744t759r871b801],
18	MD	NNP	O	MD	appos	1	SENT_3	[p1l891t759r975b799],
19	,	,	O	,	_	0	SENT_3	[p1l891t759r975b799],
20	PhD	NNP	O	PhD	nn	24	SENT_3	[p1l996t751r1101b799],
21	,1	CD	NUMBER	,1	num	24	SENT_3	[p1l996t751r1101b799],
22	B.	NNP	NUMBER	B.	nn	24	SENT_3	[p1l1123t759r1160b792],
23	Jeroen	NNP	PERSON	Jeroen	nn	24	SENT_3	[p1l1177t759r1290b798],
24	Klevering	NNP	PERSON	Klevering	appos	1	SENT_3	[p1l1306t757r1479b801],
25	,	,	O	,	_	0	SENT_3	[p1l1306t757r1479b801],
26	MD	NNP	O	MD	appos	1	SENT_3	[p1l1499t759r1583b799],
27	,	,	O	,	_	0	SENT_3	[p1l1499t759r1583b799],
28	PhD	NNP	O	PhD	nn	32	SENT_3	[p1l1604t751r1709b799],
29	,1	CD	NUMBER	,1	num	32	SENT_3	[p1l1604t751r1709b799],
30	Robert	NNP	PERSON	Robert	nn	32	SENT_3	[p1l44t807r158b842],
31	K.	NNP	PERSON	K.	nn	32	SENT_3	[p1l173t809r214b842],
32	Koenekoop	NNP	PERSON	Koenekoop	appos	1	SENT_3	[p1l235t807r436b851],
33	,	,	O	,	_	0	SENT_3	[p1l235t807r436b851],
34	MD	NNP	O	MD	appos	1	SENT_3	[p1l455t809r540b849],
35	,	,	O	,	_	0	SENT_3	[p1l455t809r540b849],
36	PhD	NNP	O	PhD	appos	1	SENT_3	[p1l561t801r669b849],
37	,3	CD	NUMBER	,3	num	36	SENT_3	[p1l561t801r669b849],
38	Sascha	NNP	PERSON	Sascha	nn	45	SENT_3	[p1l688t807r804b842],
39	Fauser	NNP	PERSON	Fauser	nn	45	SENT_3	[p1l820t809r947b849],
40	,	,	O	,	_	0	SENT_3	[p1l820t809r947b849],
41	MD	NNP	O	MD	appos	45	SENT_3	[p1l967t809r1051b849],
42	,	,	O	,	_	0	SENT_3	[p1l967t809r1051b849],
43	PhD	NNP	O	PhD	appos	45	SENT_3	[p1l1072t801r1181b848],
44	,2	CD	NUMBER	,2	num	45	SENT_3	[p1l1072t801r1181b848],
45	Anneke	NNP	O	Anneke	_	0	SENT_3	[p1l1198t807r1332b842],
46	I	PRP	O	I	dep	45	SENT_3	[p1l1350t809r1363b842],
47	.	.	O	.	_	0	SENT_3	[p1l1369t836r1374b842],

1	den	NN	O	den	_	0	SENT_4	[p1l1395t807r1455b842],
2	Hollander	NNP	PERSON	Hollander	dep	1	SENT_4	[p1l1471t807r1654b849],
3	,	,	O	,	_	0	SENT_4	[p1l1471t807r1654b849],
4	PhD1	NN	O	phd1	nn	5	SENT_4	[p1l1675t801r1799b842],
5	’	NN	O	’	appos	2	SENT_4	[p1l1675t801r1799b842],
6	4	CD	NUMBER	4	dep	1	SENT_4	[p1l1675t801r1799b842],

1	Purpose	NN	O	purpose	_	0	SENT_5	[p1l93t911r269b949],
2	:	:	O	:	_	0	SENT_5	[p1l93t911r269b949],
3	Intravitreal	JJ	O	intravitreal	amod	5	SENT_5	[p1l315t911r503b942],
4	ranibizumab	NN	O	ranibizumab	nn	5	SENT_5	[p1l518t911r743b942],
5	injections	NNS	O	injection	nsubj	10	SENT_5	[p1l756t911r929b950],
6	currently	RB	DATE	currently	advmod	10	SENT_5	[p1l941t911r1102b950],
7	are	VBP	O	be	cop	10	SENT_5	[p1l1113t919r1170b942],
8	the	DT	O	the	det	10	SENT_5	[p1l1180t911r1238b942],
9	standard	JJ	O	standard	amod	10	SENT_5	[p1l1249t911r1411b942],
10	treatment	NN	O	treatment	dep	1	SENT_5	[p1l1423t913r1601b942],
11	for	IN	O	for	_	0	SENT_5	[p1l1612t911r1662b942],
12	neovascular	JJ	O	neovascular	amod	14	SENT_5	[p1l1674t911r1896b942],
13	age	NN	O	age	nn	14	SENT_5	[p1l1907t911r2116b950],
14	—	NN	O	—	prep_for	10	SENT_5	[p1l1907t911r2116b950],
15	related	JJ	O	related	amod	17	SENT_5	[p1l1907t911r2116b950],
16	macular	JJ	O	macular	amod	17	SENT_5	[p1l46t956r192b988],
17	degeneration	NN	O	degeneration	dep	14	SENT_5	[p1l208t956r449b996],
18	(	CD	NUMBER	(	num	19	SENT_5	[p1l468t956r588b995],
19	AMD	NNP	O	AMD	dep	17	SENT_5	[p1l468t956r588b995],
20	)	CD	NUMBER	)	num	19	SENT_5	[p1l468t956r588b995],
21	.	.	O	.	_	0	SENT_5	[p1l468t956r588b995],

1	However	RB	O	however	advmod	11	SENT_6	[p1l609t956r780b993],
2	,	,	O	,	_	0	SENT_6	[p1l609t956r780b993],
3	a	DT	O	a	det	5	SENT_6	[p1l799t964r819b988],
4	broad	JJ	O	broad	amod	5	SENT_6	[p1l837t956r941b988],
5	range	NN	O	range	nsubjpass	11	SENT_6	[p1l961t964r1063b996],
6	of	IN	O	of	_	0	SENT_6	[p1l1080t956r1115b988],
7	response	NN	O	response	nn	8	SENT_6	[p1l1132t964r1301b995],
8	rates	NNS	O	rate	prep_of	5	SENT_6	[p1l1318t958r1408b988],
9	have	VBP	O	have	aux	11	SENT_6	[p1l1426t956r1511b988],
10	been	VBN	O	be	auxpass	11	SENT_6	[p1l1529t956r1617b988],
11	observed	VBN	O	observe	_	0	SENT_6	[p1l1635t956r1816b993],
12	,	,	O	,	_	0	SENT_6	[p1l1635t956r1816b993],
13	the	DT	O	the	det	14	SENT_6	[p1l1834t956r1891b988],
14	reasons	NNS	O	reason	dobj	11	SENT_6	[p1l1909t964r2053b988],
15	for	IN	O	for	_	0	SENT_6	[p1l2069t956r2119b988],
16	which	WDT	O	which	nsubjpass	19	SENT_6	[p1l44t1002r150b1033],
17	are	VBP	O	be	auxpass	19	SENT_6	[p1l172t1010r229b1033],
18	poorly	RB	O	poorly	advmod	19	SENT_6	[p1l250t1002r364b1041],
19	understood	VBN	O	understand	prepc_for	14	SENT_6	[p1l384t1002r604b1033],
20	.	.	O	.	_	0	SENT_6	[p1l384t1002r604b1033],

1	This	DT	O	this	det	3	SENT_7	[p1l625t1002r701b1033],
2	pharmacogenetic	JJ	O	pharmacogenetic	amod	3	SENT_7	[p1l723t1002r1044b1041],
3	study	NN	O	study	nsubj	4	SENT_7	[p1l1065t1002r1166b1041],
4	evaluated	VBD	O	evaluate	_	0	SENT_7	[p1l1186t1002r1362b1033],
5	the	DT	O	the	det	6	SENT_7	[p1l1383t1002r1441b1033],
6	impact	NN	O	impact	dobj	4	SENT_7	[p1l1462t1002r1586b1041],
7	of	IN	O	of	_	0	SENT_7	[p1l1606t1002r1642b1033],
8	high-risk	JJ	O	high-risk	amod	9	SENT_7	[p1l1662t1002r1820b1041],
9	alleles	NNS	O	allele	prep_of	6	SENT_7	[p1l1840t1002r1953b1033],
10	in	IN	O	in	_	0	SENT_7	[p1l1975t1002r2002b1032],
11	CFH	NNP	O	CFH	prep_in	9	SENT_7	[p1l2024t1001r2116b1038],
12	,	,	O	,	_	0	SENT_7	[p1l2024t1001r2116b1038],
13	ARMS2	NN	O	arms2	nn	24	SENT_7	[p1l41t1047r194b1084],
14	,	,	O	,	_	0	SENT_7	[p1l41t1047r194b1084],
15	VEGFA	NN	LOCATION	vegfa	dep	24	SENT_7	[p1l215t1047r354b1084],
16	,	,	O	,	_	0	SENT_7	[p1l215t1047r354b1084],
17	vascular	JJ	O	vascular	amod	24	SENT_7	[p1l372t1048r527b1079],
18	endothelial	JJ	O	endothelial	amod	24	SENT_7	[p1l542t1048r741b1079],
19	growth	NN	O	growth	nn	24	SENT_7	[p1l759t1048r885b1087],
20	factor	NN	O	factor	nn	24	SENT_7	[p1l901t1047r1009b1079],
21	(	CD	NUMBER	(	num	24	SENT_7	[p1l1025t1047r1150b1087],
22	VEGH	NN	O	vegh	nn	24	SENT_7	[p1l1025t1047r1150b1087],
23	receptor	NN	O	receptor	nn	24	SENT_7	[p1l1168t1049r1322b1087],
24	KDR	NN	O	kdr	conj_and	6	SENT_7	[p1l1336t1048r1430b1084],
25	,	,	O	,	_	0	SENT_7	[p1l1336t1048r1430b1084],
26	and	CC	O	and	_	0	SENT_7	[p1l1449t1048r1515b1079],
27	genes	NNS	O	gene	conj_and	6	SENT_7	[p1l1533t1055r1643b1087],
28	involved	VBN	O	involve	conj_and	28	SENT_7	[p1l1661t1048r1810b1079],
29	in	IN	O	in	_	0	SENT_7	[p1l1829t1048r1857b1078],
30	angiogenesis	NN	O	angiogenesis	nn	32	SENT_7	[p1l1875t1048r2117b1087],
31	(	NN	O	(	nn	32	SENT_7	[p1l45t1093r164b1132],
32	LRP5	NN	O	lrp5	prep_in	28	SENT_7	[p1l45t1093r164b1132],
33	,	,	O	,	_	0	SENT_7	[p1l45t1093r164b1132],
34	FZD4	NN	O	fzd4	nn	35	SENT_7	[p1l186t1093r297b1132],
35	)	NN	O	)	appos	32	SENT_7	[p1l186t1093r297b1132],
36	on	IN	O	on	_	0	SENT_7	[p1l319t1101r362b1125],
37	the	DT	O	the	det	38	SENT_7	[p1l383t1093r441b1125],
38	response	NN	O	response	prep_on	35	SENT_7	[p1l463t1101r632b1132],
39	to	TO	O	to	_	0	SENT_7	[p1l651t1095r687b1125],
40	ranibizumab	NN	O	ranibizumab	nn	41	SENT_7	[p1l709t1093r934b1125],
41	treatment	NN	O	treatment	prep_to	28	SENT_7	[p1l954t1095r1132b1125],
42	and	CC	O	and	_	0	SENT_7	[p1l1153t1093r1219b1125],
43	on	IN	O	on	_	0	SENT_7	[p1l1242t1101r1285b1125],
44	the	DT	O	the	det	45	SENT_7	[p1l1307t1093r1364b1125],
45	age	NN	O	age	prep_on	28	SENT_7	[p1l1385t1101r1452b1133],
46	of	IN	O	of	_	0	SENT_7	[p1l1472t1093r1508b1125],
47	treatment	NN	O	treatment	nn	48	SENT_7	[p1l1526t1095r1704b1125],
48	onset	NN	O	onset	prep_of	45	SENT_7	[p1l1725t1095r1836b1125],
49	.	.	O	.	_	0	SENT_7	[p1l1725t1095r1836b1125],

1	In	IN	O	in	_	0	SENT_8	[p1l1861t1093r1889b1124],
2	contrast	NN	O	contrast	prep_in	10	SENT_8	[p1l1911t1095r2062b1125],
3	to	TO	O	to	_	0	SENT_8	[p1l2082t1095r2117b1125],
4	previous	JJ	O	previous	amod	5	SENT_8	[p1l46t1139r201b1178],
5	studies	NNS	O	study	prep_to	2	SENT_8	[p1l216t1139r357b1175],
6	,	,	O	,	_	0	SENT_8	[p1l216t1139r357b1175],
7	the	DT	O	the	det	8	SENT_8	[p1l373t1139r431b1170],
8	data	NNS	O	datum	nsubjpass	10	SENT_8	[p1l445t1139r526b1170],
9	were	VBD	O	be	auxpass	10	SENT_8	[p1l539t1147r628b1170],
10	stratified	VBN	O	stratify	_	0	SENT_8	[p1l642t1139r800b1170],
11	according	VBG	O	accord	_	0	SENT_8	[p1l816t1139r998b1178],
12	to	TO	O	to	prepc_according_to	10	SENT_8	[p1l1013t1141r1049b1170],
13	the	DT	O	the	det	14	SENT_8	[p1l1063t1139r1121b1170],
14	number	NN	O	number	pobj	10	SENT_8	[p1l1136t1139r1277b1170],
15	of	IN	O	of	_	0	SENT_8	[p1l1290t1139r1326b1170],
16	high-risk	JJ	O	high-risk	amod	17	SENT_8	[p1l1340t1139r1499b1178],
17	alleles	NNS	O	allele	prep_of	14	SENT_8	[p1l1513t1139r1626b1170],
18	to	TO	O	to	aux	19	SENT_8	[p1l1639t1141r1675b1170],
19	enable	VB	O	enable	xcomp	10	SENT_8	[p1l1690t1139r1812b1170],
20	the	DT	O	the	det	21	SENT_8	[p1l1826t1139r1883b1170],
21	study	NN	O	study	dobj	19	SENT_8	[p1l1898t1139r1999b1178],
22	of	IN	O	of	_	0	SENT_8	[p1l2013t1139r2048b1170],
23	the	DT	O	the	det	25	SENT_8	[p1l2060t1139r2118b1170],
24	combined	JJ	O	combined	amod	25	SENT_8	[p1l45t1185r227b1216],
25	effects	NNS	O	effect	prep_of	21	SENT_8	[p1l244t1185r368b1216],
26	of	IN	O	of	_	0	SENT_8	[p1l384t1185r419b1216],
27	these	DT	O	these	det	28	SENT_8	[p1l433t1185r534b1216],
28	genotypes	NNS	O	genotype	prep_of	25	SENT_8	[p1l550t1187r743b1224],
29	on	IN	O	on	_	0	SENT_8	[p1l759t1193r802b1216],
30	the	DT	O	the	det	32	SENT_8	[p1l819t1185r876b1216],
31	treatment	NN	O	treatment	nn	32	SENT_8	[p1l891t1187r1069b1216],
32	response	NN	O	response	prep_on	19	SENT_8	[p1l1086t1193r1265b1224],
33	.	.	O	.	_	0	SENT_8	[p1l1086t1193r1265b1224],

1	Design	NN	O	design	_	0	SENT_9	[p1l93t1230r242b1269],
2	:	:	O	:	_	0	SENT_9	[p1l93t1230r242b1269],
3	Case	NNP	O	Case	nn	5	SENT_9	[p1l286t1230r379b1261],
4	series	NN	O	series	nn	5	SENT_9	[p1l395t1230r503b1261],
5	study	NN	O	study	dep	1	SENT_9	[p1l519t1230r629b1269],
6	.	.	O	.	_	0	SENT_9	[p1l519t1230r629b1269],

1	Participants	NNS	O	participant	_	0	SENT_10	[p1l93t1275r344b1313],
2	:	:	O	:	_	0	SENT_10	[p1l93t1275r344b1313],
3	A	DT	O	a	det	4	SENT_10	[p1l386t1275r414b1306],
4	cohort	NN	O	cohort	dep	1	SENT_10	[p1l429t1275r547b1306],
5	of	IN	O	of	_	0	SENT_10	[p1l563t1275r598b1306],
6	420	CD	NUMBER	420	num	7	SENT_10	[p1l613t1275r680b1306],
7	eyes	NNS	O	eye	prep_of	4	SENT_10	[p1l696t1283r780b1314],
8	of	IN	O	of	_	0	SENT_10	[p1l797t1275r832b1306],
9	397	CD	NUMBER	397	num	12	SENT_10	[p1l846t1276r913b1306],
10	neovascular	JJ	O	neovascular	amod	12	SENT_10	[p1l931t1275r1154b1306],
11	AMD	NN	ORGANIZATION	amd	nn	12	SENT_10	[p1l1167t1275r1258b1306],
12	patients	NNS	O	patient	prep_of	7	SENT_10	[p1l1276t1275r1431b1314],
13	.	.	O	.	_	0	SENT_10	[p1l1276t1275r1431b1314],

1	Methods	NNS	O	method	_	0	SENT_11	[p1l93t1321r278b1352],
2	:	:	O	:	_	0	SENT_11	[p1l93t1321r278b1352],
3	The	DT	O	the	det	4	SENT_11	[p1l321t1321r390b1352],
4	change	NN	O	change	dep	1	SENT_11	[p1l414t1321r550b1360],
5	in	IN	O	in	_	0	SENT_11	[p1l576t1321r603b1351],
6	visual	JJ	O	visual	amod	7	SENT_11	[p1l629t1321r732b1352],
7	acuity	NN	O	acuity	prep_in	4	SENT_11	[p1l758t1321r868b1360],
8	(	CD	NUMBER	(	num	10	SENT_11	[p1l893t1320r963b1360],
9	VA	NN	O	va	nn	10	SENT_11	[p1l893t1320r963b1360],
10	)	NN	O	)	dep	4	SENT_11	[p1l893t1320r963b1360],
11	between	IN	O	between	_	0	SENT_11	[p1l990t1321r1145b1352],
12	baseline	NN	O	baseline	prep_between	10	SENT_11	[p1l1173t1321r1324b1352],
13	and	CC	O	and	_	0	SENT_11	[p1l1349t1321r1415b1352],
14	after	IN	O	after	mark	19	SENT_11	[p1l1442t1320r1525b1352],
15	3	CD	NUMBER	3	num	17	SENT_11	[p1l1548t1321r1569b1352],
16	ranibizumab	NN	O	ranibizumab	nn	17	SENT_11	[p1l1595t1321r1820b1352],
17	injections	NNS	O	injection	nsubjpass	19	SENT_11	[p1l1847t1321r2020b1360],
18	was	VBD	O	be	auxpass	19	SENT_11	[p1l2045t1328r2118b1352],
19	calculated	VBN	O	calculate	conj_and	10	SENT_11	[p1l45t1366r243b1398],
20	.	.	O	.	_	0	SENT_11	[p1l45t1366r243b1398],

1	Genotyping	NN	O	genotyping	nsubjpass	22	SENT_12	[p1l259t1366r471b1406],
2	of	IN	O	of	_	0	SENT_12	[p1l487t1366r522b1398],
3	single	JJ	O	single	amod	5	SENT_12	[p1l534t1366r641b1406],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_12	[p1l656t1366r846b1398],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_12	[p1l861t1366r1144b1406],
6	in	IN	O	in	_	0	SENT_12	[p1l1159t1366r1187b1397],
7	the	DT	O	the	det	16	SENT_12	[p1l1201t1366r1258b1398],
8	CFH	NNP	O	CFH	nn	16	SENT_12	[p1l1272t1366r1363b1403],
9	,	,	O	,	_	0	SENT_12	[p1l1272t1366r1363b1403],
10	ARMS2	NN	O	arms2	dep	16	SENT_12	[p1l1376t1366r1529b1403],
11	,	,	O	,	_	0	SENT_12	[p1l1376t1366r1529b1403],
12	VEGFA	NN	LOCATION	vegfa	dep	16	SENT_12	[p1l1547t1366r1686b1403],
13	,	,	O	,	_	0	SENT_12	[p1l1547t1366r1686b1403],
14	KDR	NN	O	kdr	dep	16	SENT_12	[p1l1701t1366r1795b1403],
15	,	,	O	,	_	0	SENT_12	[p1l1701t1366r1795b1403],
16	LPR5	NN	O	lpr5	prep_in	5	SENT_12	[p1l1810t1366r1920b1403],
17	,	,	O	,	_	0	SENT_12	[p1l1810t1366r1920b1403],
18	and	CC	O	and	_	0	SENT_12	[p1l1936t1366r2003b1398],
19	FZD4	NN	O	fzd4	nn	20	SENT_12	[p1l2017t1366r2117b1397],
20	genes	NNS	O	gene	prep_in	5	SENT_12	[p1l44t1420r155b1451],
21	was	VBD	O	be	auxpass	22	SENT_12	[p1l170t1420r243b1443],
22	performed	VBN	O	perform	_	0	SENT_12	[p1l261t1412r460b1451],
23	.	.	O	.	_	0	SENT_12	[p1l261t1412r460b1451],

1	Associations	NNS	O	association	nsubjpass	3	SENT_13	[p1l477t1412r713b1443],
2	were	VBD	O	be	auxpass	3	SENT_13	[p1l729t1420r818b1443],
3	assessed	VBN	O	assess	_	0	SENT_13	[p1l834t1412r1005b1443],
4	using	VBG	O	use	xcomp	3	SENT_13	[p1l1024t1412r1119b1451],
5	linear	JJ	O	linear	amod	7	SENT_13	[p1l1138t1412r1236b1443],
6	mixed	JJ	O	mixed	amod	7	SENT_13	[p1l1252t1412r1361b1443],
7	models	NNS	O	model	dobj	4	SENT_13	[p1l1380t1412r1522b1443],
8	.	.	O	.	_	0	SENT_13	[p1l1380t1412r1522b1443],

1	Main	NNP	O	Main	nn	3	SENT_14	[p1l93t1458r189b1489],
2	Outcome	NNP	O	Outcome	nn	3	SENT_14	[p1l213t1457r393b1489],
3	Measures	NNS	O	measure	_	0	SENT_14	[p1l415t1458r620b1489],
4	:	:	O	:	_	0	SENT_14	[p1l415t1458r620b1489],
5	The	DT	O	the	det	7	SENT_14	[p1l663t1458r731b1489],
6	VA	NN	ORGANIZATION	va	nn	7	SENT_14	[p1l753t1458r806b1488],
7	change	NN	O	change	dep	3	SENT_14	[p1l827t1458r962b1497],
8	after	IN	O	after	_	0	SENT_14	[p1l985t1457r1068b1489],
9	3	CD	NUMBER	3	num	11	SENT_14	[p1l1089t1458r1110b1489],
10	ranibizumab	NN	O	ranibizumab	nn	11	SENT_14	[p1l1134t1458r1359b1489],
11	injections	NNS	O	injection	prep_after	7	SENT_14	[p1l1384t1458r1557b1497],
12	and	CC	O	and	_	0	SENT_14	[p1l1579t1458r1646b1489],
13	the	DT	O	the	det	14	SENT_14	[p1l1669t1458r1727b1489],
14	age	NN	O	age	dep	3	SENT_14	[p1l1749t1465r1816b1497],
15	of	IN	O	of	_	0	SENT_14	[p1l1839t1457r1874b1489],
16	neovascular	JJ	O	neovascular	amod	18	SENT_14	[p1l1897t1458r2119b1489],
17	disease	NN	O	disease	nn	18	SENT_14	[p1l44t1504r185b1535],
18	onset	NN	O	onset	prep_of	14	SENT_14	[p1l201t1506r312b1535],
19	.	.	O	.	_	0	SENT_14	[p1l201t1506r312b1535],

1	Results	NNS	O	result	_	0	SENT_15	[p1l93t1550r253b1581],
2	:	:	O	:	_	0	SENT_15	[p1l93t1550r253b1581],
3	After	IN	O	after	_	0	SENT_15	[p1l295t1550r384b1581],
4	ranibizumab	NN	O	ranibizumab	nn	5	SENT_15	[p1l396t1550r621b1581],
5	treatment	NN	O	treatment	prep_after	18	SENT_15	[p1l632t1552r819b1586],
6	,	,	O	,	_	0	SENT_15	[p1l632t1552r819b1586],
7	AMD	NN	ORGANIZATION	amd	nn	8	SENT_15	[p1l831t1550r923b1580],
8	patients	NNS	O	patient	nsubj	18	SENT_15	[p1l936t1550r1082b1589],
9	without	IN	O	without	_	0	SENT_15	[p1l1093t1550r1229b1581],
10	risk	NN	O	risk	nn	11	SENT_15	[p1l1241t1550r1304b1581],
11	alleles	NNS	O	allele	prep_without	8	SENT_15	[p1l1315t1550r1429b1581],
12	in	IN	O	in	_	0	SENT_15	[p1l1442t1550r1469b1580],
13	the	DT	O	the	det	14	SENT_15	[p1l1481t1550r1539b1581],
14	CFH	NNP	O	CFH	prep_in	11	SENT_15	[p1l1551t1549r1634b1581],
15	and	CC	O	and	_	0	SENT_15	[p1l1645t1550r1711b1581],
16	ARMS2	NN	O	arms2	nn	17	SENT_15	[p1l1721t1549r1865b1581],
17	genes	NNS	O	gene	conj_and	14	SENT_15	[p1l1877t1558r1987b1589],
18	(	VBP	O	(	dep	1	SENT_15	[p1l1999t1549r2117b1589],
19	4.8	CD	PERCENT	4.8	num	20	SENT_15	[p1l1999t1549r2117b1589],
20	%	NN	PERCENT	%	dobj	18	SENT_15	[p1l1999t1549r2117b1589],
21	)	CD	NUMBER	)	nsubj	22	SENT_15	[p1l1999t1549r2117b1589],
22	demonstrated	VBD	O	demonstrate	rcmod	20	SENT_15	[p1l45t1596r301b1627],
23	a	DT	O	a	det	26	SENT_15	[p1l325t1603r345b1627],
24	mean	JJ	O	mean	amod	26	SENT_15	[p1l368t1603r467b1627],
25	VA	NN	O	va	nn	26	SENT_15	[p1l489t1596r542b1626],
26	improvement	NN	O	improvement	nsubj	55	SENT_15	[p1l564t1596r805b1635],
27	of	IN	O	of	_	0	SENT_15	[p1l827t1595r863b1627],
28	10	CD	NUMBER	10	num	37	SENT_15	[p1l886t1596r927b1627],
29	Early	JJ	O	early	amod	37	SENT_15	[p1l952t1596r1040b1635],
30	Treatment	NN	O	treatment	nn	37	SENT_15	[p1l1060t1596r1249b1627],
31	Diabetic	NNP	O	Diabetic	nn	37	SENT_15	[p1l1273t1596r1422b1627],
32	Retinopathy	NNP	O	Retinopathy	nn	37	SENT_15	[p1l1446t1596r1667b1635],
33	Study	NNP	O	Study	nn	37	SENT_15	[p1l1689t1595r1796b1635],
34	(	CD	NUMBER	(	num	37	SENT_15	[p1l1818t1595r1970b1635],
35	ETDRS	NNP	O	ETDRS	nn	37	SENT_15	[p1l1818t1595r1970b1635],
36	)	CD	NUMBER	)	num	37	SENT_15	[p1l1818t1595r1970b1635],
37	letters	NNS	O	letter	prep_of	26	SENT_15	[p1l1995t1596r2115b1632],
38	,	,	O	,	_	0	SENT_15	[p1l1995t1596r2115b1632],
39	whereas	IN	O	whereas	mark	44	SENT_15	[p1l44t1641r199b1672],
40	no	DT	O	no	det	42	SENT_15	[p1l218t1649r262b1672],
41	VA	NN	O	va	nn	42	SENT_15	[p1l279t1641r332b1672],
42	improvement	NN	O	improvement	nsubjpass	44	SENT_15	[p1l350t1641r591b1680],
43	was	VBD	O	be	auxpass	44	SENT_15	[p1l609t1649r682b1672],
44	observed	VBN	O	observe	dep	37	SENT_15	[p1l701t1641r870b1672],
45	in	IN	O	in	_	0	SENT_15	[p1l892t1641r919b1672],
46	AMD	NNP	ORGANIZATION	AMD	nn	47	SENT_15	[p1l937t1641r1029b1672],
47	patients	NNS	O	patient	prep_in	44	SENT_15	[p1l1049t1641r1194b1680],
48	with	IN	O	with	_	0	SENT_15	[p1l1212t1641r1286b1672],
49	4	CD	NUMBER	4	num	50	SENT_15	[p1l1305t1642r1326b1672],
50	CFH	NN	O	cfh	prep_with	44	SENT_15	[p1l1345t1641r1428b1672],
51	and	CC	O	and	_	0	SENT_15	[p1l1445t1641r1512b1672],
52	ARMS2	NN	O	arms2	nn	54	SENT_15	[p1l1528t1641r1672b1672],
53	risk	NN	O	risk	nn	54	SENT_15	[p1l1691t1641r1755b1672],
54	alleles	NNS	O	allele	conj_and	50	SENT_15	[p1l1772t1641r1886b1672],
55	(	VBP	O	(	ccomp	22	SENT_15	[p1l1904t1641r2021b1680],
56	6.9	CD	PERCENT	6.9	num	57	SENT_15	[p1l1904t1641r2021b1680],
57	%	NN	PERCENT	%	dobj	55	SENT_15	[p1l1904t1641r2021b1680],
58	;	:	O	;	_	0	SENT_15	[p1l1904t1641r2021b1680],
59	P	NN	O	p	dep	57	SENT_15	[p1l2041t1641r2068b1672],
60	=	JJ	O	=	amod	62	SENT_15	[p1l2089t1653r2114b1663],
61	0.014	CD	NUMBER	0.014	tmod	60	SENT_15	[p1l45t1686r167b1726],
62	)	NN	O	)	dep	59	SENT_15	[p1l45t1686r167b1726],
63	.	.	O	.	_	0	SENT_15	[p1l45t1686r167b1726],

1	Patients	NNS	O	patient	nsubj	12	SENT_16	[p1l184t1687r332b1718],
2	with	IN	O	with	_	0	SENT_16	[p1l345t1687r419b1717],
3	4	CD	NUMBER	4	num	5	SENT_16	[p1l434t1687r455b1717],
4	high-risk	JJ	O	high-risk	amod	5	SENT_16	[p1l470t1687r629b1726],
5	alleles	NNS	O	allele	prep_with	1	SENT_16	[p1l642t1687r756b1718],
6	in	IN	O	in	_	0	SENT_16	[p1l771t1687r798b1717],
7	CFH	NNP	O	CFH	prep_in	5	SENT_16	[p1l814t1686r897b1718],
8	and	CC	O	and	_	0	SENT_16	[p1l910t1687r976b1718],
9	ARMS2	NN	O	arms2	prep_in	5	SENT_16	[p1l988t1686r1132b1718],
10	were	VBD	O	be	cop	12	SENT_16	[p1l1145t1695r1234b1718],
11	5.2	CD	DURATION	5.2	num	12	SENT_16	[p1l1248t1687r1302b1718],
12	years	NNS	NUMBER	year	_	0	SENT_16	[p1l1316t1695r1415b1726],
13	younger	JJR	O	younger	attr	12	SENT_16	[p1l1428t1695r1579b1726],
14	than	IN	O	than	_	0	SENT_16	[p1l1591t1687r1670b1718],
15	patients	NNS	O	patient	prep_than	13	SENT_16	[p1l1687t1687r1832b1726],
16	with	IN	O	with	_	0	SENT_16	[p1l1846t1687r1920b1718],
17	1	CD	NUMBER	1	num	21	SENT_16	[p1l1937t1687r1949b1717],
18	or	CC	O	or	_	0	SENT_16	[p1l1970t1695r2007b1718],
19	2	CD	NUMBER	2	num	21	SENT_16	[p1l2019t1687r2039b1717],
20	risk	NN	O	risk	nn	21	SENT_16	[p1l2055t1687r2118b1718],
21	alleles	NNS	O	allele	prep_with	15	SENT_16	[p1l44t1733r167b1769],
22	,	,	O	,	_	0	SENT_16	[p1l44t1733r167b1769],
23	respectively	RB	O	respectively	advmod	21	SENT_16	[p1l185t1733r405b1772],
24	(	CD	PERCENT	(	number	25	SENT_16	[p1l419t1732r559b1772],
25	63.5	CD	PERCENT	63.5	num	26	SENT_16	[p1l419t1732r559b1772],
26	%	NN	PERCENT	%	dep	21	SENT_16	[p1l419t1732r559b1772],
27	;	:	O	;	_	0	SENT_16	[p1l419t1732r559b1772],
28	P	NN	O	p	dep	29	SENT_16	[p1l575t1732r783b1772],
29	<	JJR	O	<	dep	26	SENT_16	[p1l575t1732r783b1772],
30	0.0001	CD	NUMBER	0.0001	num	31	SENT_16	[p1l575t1732r783b1772],
31	)	NN	O	)	dep	29	SENT_16	[p1l575t1732r783b1772],
32	.	.	O	.	_	0	SENT_16	[p1l575t1732r783b1772],

1	The	DT	O	the	det	3	SENT_17	[p1l798t1733r867b1764],
2	mean	NN	O	mean	nn	3	SENT_17	[p1l882t1740r981b1764],
3	age	NN	O	age	nsubj	30	SENT_17	[p1l997t1740r1063b1772],
4	at	IN	O	at	_	0	SENT_17	[p1l1078t1734r1111b1764],
5	which	WDT	O	which	rel	11	SENT_17	[p1l1125t1733r1231b1764],
6	the	DT	O	the	det	9	SENT_17	[p1l1246t1733r1304b1764],
7	first	JJ	ORDINAL	first	amod	9	SENT_17	[p1l1317t1732r1385b1764],
8	ranibizumab	NN	O	ranibizumab	nn	9	SENT_17	[p1l1401t1733r1625b1764],
9	treatment	NN	O	treatment	nsubjpass	11	SENT_17	[p1l1639t1734r1817b1764],
10	was	VBD	O	be	auxpass	11	SENT_17	[p1l1831t1740r1904b1764],
11	carried	VBN	O	carry	rcmod	3	SENT_17	[p1l1919t1733r2043b1764],
12	out	RP	O	out	prt	11	SENT_17	[p1l2059t1734r2117b1764],
13	among	IN	O	among	_	0	SENT_17	[p1l44t1786r170b1818],
14	AMD	NNP	ORGANIZATION	AMD	nn	15	SENT_17	[p1l185t1778r276b1809],
15	patients	NNS	O	patient	prep_among	11	SENT_17	[p1l293t1778r439b1817],
16	with	IN	O	with	_	0	SENT_17	[p1l454t1778r528b1809],
17	all	DT	O	all	det	20	SENT_17	[p1l545t1778r582b1810],
18	6	CD	NUMBER	6	num	20	SENT_17	[p1l599t1779r619b1810],
19	risk	NN	O	risk	nn	20	SENT_17	[p1l636t1778r699b1810],
20	alleles	NNS	O	allele	prep_with	11	SENT_17	[p1l714t1778r827b1810],
21	in	IN	O	in	_	0	SENT_17	[p1l844t1778r871b1809],
22	CFH	NNP	O	CFH	prep_in	20	SENT_17	[p1l888t1778r979b1815],
23	,	,	O	,	_	0	SENT_17	[p1l888t1778r979b1815],
24	ARMS2	NN	O	arms2	prep_in	20	SENT_17	[p1l993t1778r1147b1815],
25	,	,	O	,	_	0	SENT_17	[p1l993t1778r1147b1815],
26	and	CC	O	and	_	0	SENT_17	[p1l1164t1778r1231b1810],
27	VEGFA	NNP	O	VEGFA	prep_in	20	SENT_17	[p1l1250t1778r1378b1810],
28	was	VBD	O	be	cop	30	SENT_17	[p1l1394t1786r1468b1810],
29	65.9	CD	DURATION	65.9	num	30	SENT_17	[p1l1483t1779r1561b1810],
30	years	NNS	NUMBER	year	_	0	SENT_17	[p1l1576t1786r1675b1818],
31	(	RB	O	(	advmod	33	SENT_17	[p1l1691t1778r1774b1817],
32	2	CD	PERCENT	2	num	33	SENT_17	[p1l1691t1778r1774b1817],
33	%	NN	PERCENT	%	attr	30	SENT_17	[p1l1691t1778r1774b1817],
34	)	CD	NUMBER	)	dep	33	SENT_17	[p1l1691t1778r1774b1817],
35	versus	CC	O	versus	_	0	SENT_17	[p1l1789t1786r1910b1810],
36	75.3	CD	DURATION	75.3	num	37	SENT_17	[p1l1926t1779r2003b1809],
37	years	NNS	NUMBER	year	conj_versus	33	SENT_17	[p1l2019t1786r2117b1818],
38	in	IN	O	in	_	0	SENT_17	[p1l46t1824r73b1854],
39	patients	NNS	O	patient	prep_in	37	SENT_17	[p1l92t1824r237b1863],
40	with	IN	O	with	_	0	SENT_17	[p1l253t1824r327b1855],
41	o	NN	O	o	prep_with	39	SENT_17	[p1l345t1824r365b1855],
42	or	CC	O	or	_	0	SENT_17	[p1l381t1832r418b1855],
43	1	CD	NUMBER	1	num	46	SENT_17	[p1l435t1824r447b1854],
44	high-risk	JJ	O	high-risk	amod	46	SENT_17	[p1l471t1824r630b1863],
45	allele	NN	O	allele	nn	46	SENT_17	[p1l645t1824r738b1855],
46	(	NN	O	(	conj_or	33	SENT_17	[p1l754t1823r871b1863],
47	8.8	CD	PERCENT	8.8	number	48	SENT_17	[p1l754t1823r871b1863],
48	%	NN	PERCENT	%	amod	46	SENT_17	[p1l754t1823r871b1863],
49	;	:	O	;	_	0	SENT_17	[p1l754t1823r871b1863],
50	P	NN	O	p	dep	46	SENT_17	[p1l888t1824r915b1854],
51	=	JJ	O	=	amod	53	SENT_17	[p1l934t1836r959b1846],
52	0.001	CD	NUMBER	0.001	tmod	51	SENT_17	[p1l979t1823r1101b1863],
53	)	NN	O	)	dep	50	SENT_17	[p1l979t1823r1101b1863],
54	.	.	O	.	_	0	SENT_17	[p1l979t1823r1101b1863],

1	After	IN	O	after	_	0	SENT_18	[p1l1117t1824r1207b1855],
2	ranibizumab	NN	O	ranibizumab	nn	3	SENT_18	[p1l1222t1824r1447b1855],
3	treatment	NN	O	treatment	prep_after	10	SENT_18	[p1l1463t1826r1650b1861],
4	,	,	O	,	_	0	SENT_18	[p1l1463t1826r1650b1861],
5	patients	NNS	O	patient	nsubj	10	SENT_18	[p1l1669t1824r1815b1863],
6	with	IN	O	with	_	0	SENT_18	[p1l1830t1824r1904b1855],
7	6	CD	NUMBER	6	num	9	SENT_18	[p1l1922t1824r1942b1855],
8	high-risk	JJ	O	high-risk	amod	9	SENT_18	[p1l1960t1824r2119b1863],
9	alleles	NNS	O	allele	prep_with	5	SENT_18	[p1l44t1870r158b1900],
10	demonstrated	VBD	O	demonstrate	_	0	SENT_18	[p1l174t1870r430b1900],
11	a	DT	O	a	det	14	SENT_18	[p1l448t1877r469b1900],
12	mean	JJ	O	mean	amod	14	SENT_18	[p1l485t1877r584b1900],
13	VA	NNP	O	VA	nn	14	SENT_18	[p1l600t1870r653b1900],
14	loss	NN	O	loss	nsubj	19	SENT_18	[p1l669t1870r740b1900],
15	of	IN	O	of	_	0	SENT_18	[p1l757t1869r792b1900],
16	10	CD	NUMBER	10	num	18	SENT_18	[p1l809t1870r850b1900],
17	ETDRS	NN	O	etdr	nn	18	SENT_18	[p1l869t1869r999b1900],
18	letters	NNS	O	letter	prep_of	14	SENT_18	[p1l1016t1870r1128b1900],
19	(	VBP	O	(	ccomp	10	SENT_18	[p1l1144t1869r1362b1908],
20	P	NN	O	p	dobj	19	SENT_18	[p1l1144t1869r1362b1908],
21	<	VBG	O	<	partmod	20	SENT_18	[p1l1144t1869r1362b1908],
22	0.0001	CD	NUMBER	0.0001	num	23	SENT_18	[p1l1144t1869r1362b1908],
23	)	NN	O	)	dobj	21	SENT_18	[p1l1144t1869r1362b1908],
24	.	.	O	.	_	0	SENT_18	[p1l1144t1869r1362b1908],

1	Conclusions	NNS	O	conclusion	_	0	SENT_19	[p1l94t1914r348b1946],
2	:	:	O	:	_	0	SENT_19	[p1l94t1914r348b1946],
3	This	DT	O	this	det	4	SENT_19	[p1l391t1914r467b1946],
4	study	NN	O	study	nsubj	5	SENT_19	[p1l480t1914r581b1954],
5	evaluated	VBD	O	evaluate	dep	1	SENT_19	[p1l593t1914r770b1946],
6	the	DT	O	the	det	10	SENT_19	[p1l783t1914r841b1945],
7	largest	JJS	O	largest	amod	10	SENT_19	[p1l855t1914r977b1954],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_19	[p1l991t1914r1312b1954],
9	AMD	NNP	ORGANIZATION	AMD	nn	10	SENT_19	[p1l1323t1914r1415b1945],
10	cohort	NN	O	cohort	dobj	5	SENT_19	[p1l1428t1914r1546b1946],
11	reported	VBD	O	report	rcmod	10	SENT_19	[p1l1560t1914r1714b1953],
12	to	TO	O	to	_	0	SENT_19	[p1l1727t1916r1763b1946],
13	date	NN	O	date	prep_to	11	SENT_19	[p1l1776t1914r1866b1946],
14	.	.	O	.	_	0	SENT_19	[p1l1776t1914r1866b1946],

1	A	DT	O	a	det	3	SENT_20	[p1l1879t1914r1907b1945],
2	cumulative	JJ	O	cumulative	amod	3	SENT_20	[p1l1918t1914r2118b1946],
3	effect	NN	O	effect	nsubj	14	SENT_20	[p1l44t1960r147b1991],
4	of	IN	O	of	_	0	SENT_20	[p1l164t1960r199b1991],
5	high-risk	JJ	O	high-risk	amod	6	SENT_20	[p1l215t1960r374b1999],
6	alleles	NNS	O	allele	prep_of	3	SENT_20	[p1l390t1960r503b1991],
7	in	IN	O	in	_	0	SENT_20	[p1l521t1960r548b1991],
8	CFH	NNP	O	CFH	prep_in	6	SENT_20	[p1l566t1959r657b1996],
9	,	,	O	,	_	0	SENT_20	[p1l566t1959r657b1996],
10	ARMS2	NN	O	arms2	prep_in	6	SENT_20	[p1l673t1959r826b1997],
11	,	,	O	,	_	0	SENT_20	[p1l673t1959r826b1997],
12	and	CC	O	and	_	0	SENT_20	[p1l845t1960r911b1991],
13	VEGFA	NNP	O	VEGFA	prep_in	6	SENT_20	[p1l931t1959r1060b1991],
14	seems	VBZ	O	seem	_	0	SENT_20	[p1l1078t1968r1197b1991],
15	to	TO	O	to	aux	17	SENT_20	[p1l1213t1962r1248b1991],
16	be	VB	O	be	auxpass	17	SENT_20	[p1l1266t1960r1310b1991],
17	associated	VBN	O	associate	xcomp	14	SENT_20	[p1l1327t1960r1525b1991],
18	with	IN	O	with	_	0	SENT_20	[p1l1542t1960r1616b1991],
19	a	DT	O	a	det	21	SENT_20	[p1l1634t1968r1655b1991],
20	younger	JJR	O	younger	amod	21	SENT_20	[p1l1670t1968r1821b1999],
21	age	NN	O	age	prep_with	17	SENT_20	[p1l1837t1968r1903b1999],
22	of	IN	O	of	_	0	SENT_20	[p1l1919t1960r1955b1991],
23	onset	NN	O	onset	prep_of	21	SENT_20	[p1l1970t1962r2071b1991],
24	in	IN	O	in	_	0	SENT_20	[p1l2089t1960r2116b1991],
25	combination	NN	O	combination	prep_in	23	SENT_20	[p1l45t2006r272b2037],
26	with	IN	O	with	_	0	SENT_20	[p1l289t2006r363b2037],
27	poor	JJ	O	poor	amod	29	SENT_20	[p1l381t2014r466b2045],
28	response	NN	O	response	nn	29	SENT_20	[p1l481t2014r650b2045],
29	rates	NNS	O	rate	prep_with	17	SENT_20	[p1l667t2008r757b2037],
30	to	TO	O	to	_	0	SENT_20	[p1l772t2008r807b2037],
31	ranibizumab	JJ	O	ranibizumab	amod	32	SENT_20	[p1l825t2006r1050b2037],
32	treatment	NN	O	treatment	prep_to	17	SENT_20	[p1l1065t2008r1252b2037],
33	.	.	O	.	_	0	SENT_20	[p1l1065t2008r1252b2037],

1	Financial	NNP	O	Financial	nn	2	SENT_21	[p1l93t2051r273b2082],
2	DiscIosure	NNP	O	DiscIosure	nsubj	12	SENT_21	[p1l282t2051r548b2089],
3	(	CD	NUMBER	(	num	4	SENT_21	[p1l282t2051r548b2089],
4	s	NNS	O	s	dep	2	SENT_21	[p1l282t2051r548b2089],
5	)	CD	NUMBER	)	dep	2	SENT_21	[p1l282t2051r548b2089],
6	:	:	O	:	_	0	SENT_21	[p1l282t2051r548b2089],
7	The	DT	O	the	det	8	SENT_21	[p1l591t2051r659b2082],
8	author	NN	O	author	dep	5	SENT_21	[p1l671t2051r830b2090],
9	(	CD	NUMBER	(	num	10	SENT_21	[p1l671t2051r830b2090],
10	s	NNS	O	s	dep	8	SENT_21	[p1l671t2051r830b2090],
11	)	CD	NUMBER	)	dep	8	SENT_21	[p1l671t2051r830b2090],
12	have	VBP	O	have	_	0	SENT_21	[p1l844t2051r930b2082],
13	no	DT	O	no	det	17	SENT_21	[p1l943t2059r986b2082],
14	proprietary	NN	O	proprietary	nn	17	SENT_21	[p1l1000t2051r1200b2090],
15	or	CC	O	or	_	0	SENT_21	[p1l1211t2059r1248b2082],
16	commercial	JJ	O	commercial	conj_or	14	SENT_21	[p1l1259t2051r1472b2082],
17	interest	NN	O	interest	dobj	12	SENT_21	[p1l1487t2051r1621b2082],
18	in	IN	O	in	_	0	SENT_21	[p1l1635t2051r1662b2082],
19	any	DT	O	any	det	20	SENT_21	[p1l1676t2059r1740b2090],
20	materials	NNS	O	material	prep_in	17	SENT_21	[p1l1753t2051r1918b2082],
21	discussed	VBN	O	discuss	partmod	20	SENT_21	[p1l1931t2051r2116b2082],
22	in	IN	O	in	_	0	SENT_21	[p1l46t2097r73b2127],
23	this	DT	O	this	det	24	SENT_21	[p1l90t2097r155b2128],
24	article	NN	O	article	prep_in	21	SENT_21	[p1l171t2097r291b2128],
25	.	.	O	.	_	0	SENT_21	[p1l171t2097r291b2128],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_22	[p1l316t2096r599b2136],
2	2012	CD	DATE	2012	num	1	SENT_22	[p1l611t2097r1003b2134],
3	;	:	O	;	_	0	SENT_22	[p1l611t2097r1003b2134],
4	119:2304	CD	DURATION	119:2304	num	5	SENT_22	[p1l611t2097r1003b2134],
5	-2311	CD	DURATION	-2311	dep	1	SENT_22	[p1l611t2097r1003b2134],
6	©	CD	NUMBER	©	num	7	SENT_22	[p1l1023t2096r1055b2128],
7	2012	CD	DATE	2012	dep	5	SENT_22	[p1l1069t2097r1161b2128],
8	by	IN	O	by	_	0	SENT_22	[p1l1176t2097r1222b2136],
9	the	DT	O	the	det	11	SENT_22	[p1l1236t2097r1292b2128],
10	American	NNP	ORGANIZATION	American	nn	11	SENT_22	[p1l1305t2097r1481b2128],
11	Academy	NNP	ORGANIZATION	Academy	prep_by	7	SENT_22	[p1l1495t2097r1672b2136],
12	of	IN	ORGANIZATION	of	_	0	SENT_22	[p1l1686t2097r1725b2128],
13	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	prep_of	11	SENT_22	[p1l1737t2096r2025b2136],
14	.	.	O	.	_	0	SENT_22	[p1l1737t2096r2025b2136],

1	Age	NNP	O	Age	nsubj	12	SENT_23	[p1l6t2322r427b2403],
2	—	RB	O	—	advmod	12	SENT_23	[p1l6t2322r427b2403],
3	related	JJ	O	related	amod	5	SENT_23	[p1l6t2322r427b2403],
4	macular	JJ	O	macular	amod	5	SENT_23	[p1l474t2322r762b2385],
5	degeneration	NN	O	degeneration	nsubj	12	SENT_23	[p1l809t2322r1268b2403],
6	(	CD	NUMBER	(	num	7	SENT_23	[p1l1319t2322r1579b2399],
7	AMD	NNP	O	AMD	dep	5	SENT_23	[p1l1319t2322r1579b2399],
8	)	CD	NUMBER	)	num	7	SENT_23	[p1l1319t2322r1579b2399],
9	is	VBZ	O	be	cop	12	SENT_23	[p1l1630t2322r1685b2385],
10	the	DT	O	the	det	12	SENT_23	[p1l1735t2322r1841b2385],
11	leading	VBG	O	lead	amod	12	SENT_23	[p1l1890t2322r2150b2403],
12	cause	NN	O	cause	_	0	SENT_23	[p1l7t2443r202b2485],
13	of	IN	O	of	_	0	SENT_23	[p1l234t2423r311b2485],
14	blindness	NN	O	blindness	prep_of	12	SENT_23	[p1l333t2423r668b2485],
15	in	IN	O	in	_	0	SENT_23	[p1l700t2423r768b2484],
16	the	DT	O	the	det	17	SENT_23	[p1l797t2423r904b2485],
17	West	NNP	O	West	prep_in	14	SENT_23	[p1l933t2411r1166b2497],
18	}	CD	NUMBER	}	num	17	SENT_23	[p1l933t2411r1166b2497],
19	with	IN	O	with	_	0	SENT_23	[p1l1202t2423r1359b2485],
20	the	DT	O	the	det	22	SENT_23	[p1l1388t2423r1494b2485],
21	neovascular	JJ	O	neovascular	amod	22	SENT_23	[p1l1525t2423r1951b2485],
22	form	NN	O	form	prep_with	12	SENT_23	[p1l1980t2423r2153b2485],
23	responsible	JJ	O	responsible	amod	22	SENT_23	[p1l6t2524r411b2604],
24	for	IN	O	for	_	0	SENT_23	[p1l451t2524r554b2586],
25	80	CD	PERCENT	80	num	26	SENT_23	[p1l595t2524r749b2586],
26	%	NN	PERCENT	%	prep_for	23	SENT_23	[p1l595t2524r749b2586],
27	of	IN	O	of	_	0	SENT_23	[p1l794t2524r871b2586],
28	severe	JJ	O	severe	amod	30	SENT_23	[p1l907t2543r1129b2586],
29	vision	NN	O	vision	nn	30	SENT_23	[p1l1169t2524r1386b2586],
30	loss	NN	O	loss	prep_of	26	SENT_23	[p1l1425t2512r1665b2586],
31	.	.	O	.	_	0	SENT_23	[p1l1425t2512r1665b2586],

1	”	NN	O	”	nn	3	SENT_24	[p1l1425t2512r1665b2586],
2	Neovascular	JJ	O	neovascular	amod	3	SENT_24	[p1l1706t2524r2153b2586],
3	AMD	NN	O	amd	nsubjpass	5	SENT_24	[p1l6t2627r211b2688],
4	is	VBZ	O	be	auxpass	5	SENT_24	[p1l276t2626r331b2689],
5	characterized	VBN	O	characterize	_	0	SENT_24	[p1l397t2626r871b2689],
6	by	IN	O	by	_	0	SENT_24	[p1l932t2626r1020b2708],
7	choroidal	JJ	O	choroidal	amod	8	SENT_24	[p1l1085t2626r1419b2689],
8	neovascularization	NN	O	neovascularization	agent	5	SENT_24	[p1l1483t2626r2151b2689],
9	(	CD	NUMBER	(	num	11	SENT_24	[p1l9t2729r271b2806],
10	CNV	NN	ORGANIZATION	cnv	nn	11	SENT_24	[p1l9t2729r271b2806],
11	)	NN	O	)	tmod	5	SENT_24	[p1l9t2729r271b2806],
12	,	,	O	,	_	0	SENT_24	[p1l9t2729r271b2806],
13	an	DT	O	a	det	14	SENT_24	[p1l308t2748r388b2791],
14	outgrowth	NN	O	outgrowth	appos	11	SENT_24	[p1l420t2728r784b2810],
15	of	IN	O	of	_	0	SENT_24	[p1l816t2728r893b2791],
16	blood	NN	O	blood	nn	17	SENT_24	[p1l916t2728r1120b2791],
17	Vessels	NNS	O	vessel	prep_of	14	SENT_24	[p1l1150t2728r1399b2791],
18	that	WDT	O	that	nsubj	19	SENT_24	[p1l1432t2728r1565b2791],
19	invade	VBP	O	invade	rcmod	14	SENT_24	[p1l1595t2728r1830b2791],
20	the	DT	O	the	det	24	SENT_24	[p1l1861t2728r1968b2791],
21	subretinal	JJ	O	subretinal	amod	24	SENT_24	[p1l2002t2728r2148b2791, p1l6t2828r232b2891],
22	and	CC	O	and	_	0	SENT_24	[p1l269t2828r395b2891],
23	intraretinal	JJ	O	intraretinal	conj_and	21	SENT_24	[p1l429t2828r819b2891],
24	spaces	NNS	O	space	dobj	19	SENT_24	[p1l857t2848r1104b2910],
25	,	,	O	,	_	0	SENT_24	[p1l857t2848r1104b2910],
26	causing	VBG	O	cause	partmod	24	SENT_24	[p1l1144t2828r1423b2910],
27	exudation	NN	O	exudation	dobj	26	SENT_24	[p1l1462t2828r1846b2903],
28	,	,	O	,	_	0	SENT_24	[p1l1462t2828r1846b2903],
29	hemorrhage	NN	O	hemorrhage	dobj	26	SENT_24	[p1l1886t2828r2149b2891, p1l6t2930r231b3012],
30	,	,	O	,	_	0	SENT_24	[p1l1886t2828r2149b2891, p1l6t2930r231b3012],
31	and	CC	O	and	_	0	SENT_24	[p1l288t2930r417b2993],
32	subsequent	JJ	O	subsequent	amod	35	SENT_24	[p1l471t2930r880b3012],
33	rapid	JJ	O	rapid	amod	35	SENT_24	[p1l930t2930r1121b3012],
34	Visual	JJ	O	visual	amod	35	SENT_24	[p1l1172t2930r1391b2993],
35	decline	NN	O	decline	conj_and	27	SENT_24	[p1l1445t2930r1730b2993],
36	.	.	O	.	_	0	SENT_24	[p1l1445t2930r1730b2993],

1	Important	JJ	O	important	amod	2	SENT_25	[p1l1786t2932r2152b3012],
2	triggers	NNS	O	trigger	nsubj	12	SENT_25	[p1l6t3032r288b3114],
3	for	IN	O	for	_	0	SENT_25	[p1l333t3032r440b3095],
4	angiogenesis	NN	O	angiogenesis	nn	7	SENT_25	[p1l483t3032r959b3114],
5	and	CC	O	and	_	0	SENT_25	[p1l1006t3032r1135b3095],
6	vascular	JJ	O	vascular	conj_and	4	SENT_25	[p1l1177t3032r1487b3095],
7	permeability	NN	O	permeability	prep_for	2	SENT_25	[p1l1527t3032r1997b3114],
8	are	VBP	O	be	cop	12	SENT_25	[p1l2043t3052r2151b3095],
9	Vascular	JJ	O	vascular	amod	12	SENT_25	[p1l7t3135r316b3198],
10	endothelial	JJ	O	endothelial	amod	12	SENT_25	[p1l371t3135r783b3197],
11	growth	NN	O	growth	nn	12	SENT_25	[p1l840t3135r1100b3216],
12	factor	NN	O	factor	_	0	SENT_25	[p1l1156t3135r1372b3197],
13	(	CD	NUMBER	(	num	15	SENT_25	[p1l1429t3135r1824b3212],
14	VEGF	NN	O	vegf	nn	15	SENT_25	[p1l1429t3135r1824b3212],
15	)	NN	O	)	attr	12	SENT_25	[p1l1429t3135r1824b3212],
16	.	.	O	.	_	0	SENT_25	[p1l1429t3135r1824b3212],

1	—	NN	O	—	_	0	SENT_26	[p1l1429t3135r1824b3212],
2	.	.	O	.	_	0	SENT_26	[p1l1429t3135r1824b3212],

1	A	DT	O	a	amod	8	SENT_27	[p1l1429t3135r1824b3212],
2	and	CC	O	and	dep	5	SENT_27	[p1l1881t3135r2011b3197],
3	its	PRP$	O	its	poss	5	SENT_27	[p1l2066t3135r2149b3197],
4	receptor	NN	O	receptor	nn	5	SENT_27	[p1l6t3246r311b3318],
5	VEGFR	NN	O	vegfr	dep	1	SENT_27	[p1l341t3237r716b3300],
6	—	NN	O	—	dep	5	SENT_27	[p1l341t3237r716b3300],
7	2	CD	NUMBER	2	num	6	SENT_27	[p1l341t3237r716b3300],
8	(	NN	O	(	_	0	SENT_27	[p1l751t3237r926b3314],
9	also	RB	O	also	advmod	10	SENT_27	[p1l751t3237r926b3314],
10	known	VBN	O	know	partmod	8	SENT_27	[p1l957t3237r1206b3300],
11	as	IN	O	as	_	0	SENT_27	[p1l1239t3256r1309b3299],
12	kinase	NN	O	kinase	nn	13	SENT_27	[p1l1341t3237r1577b3299],
13	insert	NN	O	insert	prep_as	10	SENT_27	[p1l1609t3237r1815b3299],
14	domaincontaining	JJ	O	domaincontaining	amod	17	SENT_27	[p1l1846t3237r2149b3299, p1l7t3339r397b3419],
15	receptor/fetal	JJ	O	receptor/fetal	amod	17	SENT_27	[p1l439t3338r914b3419],
16	liver	NN	O	liver	nn	17	SENT_27	[p1l955t3338r1118b3401],
17	kinase	NN	O	kinase	dep	25	SENT_27	[p1l1156t3339r1383b3401],
18	[	CD	NUMBER	[	num	19	SENT_27	[p1l1430t3327r1974b3415],
19	KDR/Flk	NN	O	kdr/flk	dep	17	SENT_27	[p1l1430t3327r1974b3415],
20	-1	CD	NUMBER	-1	num	21	SENT_27	[p1l1430t3327r1974b3415],
21	]	CD	NUMBER	]	dep	19	SENT_27	[p1l1430t3327r1974b3415],
22	)	NN	O	)	dep	25	SENT_27	[p1l1430t3327r1974b3415],
23	.4	CD	NUMBER	.4	num	22	SENT_27	[p1l1430t3327r1974b3415],
24	The	DT	O	the	det	25	SENT_27	[p1l2015t3338r2151b3401],
25	identiﬁcation	NN	O	identiﬁcation	dep	10	SENT_27	[p1l7t3441r476b3504],
26	of	IN	O	of	_	0	SENT_27	[p1l507t3441r584b3504],
27	VEGF	NN	O	vegf	prep_of	25	SENT_27	[p1l607t3441r839b3504],
28	as	IN	O	as	_	0	SENT_27	[p1l870t3460r938b3504],
29	an	DT	O	a	det	31	SENT_27	[p1l972t3460r1052b3504],
30	important	JJ	O	important	amod	31	SENT_27	[p1l1081t3441r1428b3522],
31	factor	NN	O	factor	prep_as	10	SENT_27	[p1l1457t3441r1664b3504],
32	in	IN	O	in	_	0	SENT_27	[p1l1692t3441r1759b3503],
33	the	DT	O	the	det	34	SENT_27	[p1l1789t3441r1895b3504],
34	patho2	NN	O	patho2	prep_in	31	SENT_27	[p1l1924t3441r2149b3522, p1l8t3656r198b3733],

1	©	RB	O	©	dep	2	SENT_28	[p1l329t3683r373b3727],
2	2012	CD	DATE	2012	_	0	SENT_28	[p1l398t3683r519b3727],
3	by	IN	O	by	dep	2	SENT_28	[p1l542t3683r603b3740],
4	the	DT	O	the	det	6	SENT_28	[p1l626t3683r701b3727],
5	American	NNP	ORGANIZATION	American	nn	6	SENT_28	[p1l723t3683r969b3727],
6	Academy	NNP	ORGANIZATION	Academy	pobj	3	SENT_28	[p1l991t3683r1229b3740],
7	of	IN	ORGANIZATION	of	_	0	SENT_28	[p1l1253t3683r1307b3727],
8	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	prep_of	6	SENT_28	[p1l1326t3683r1716b3740],

1	Published	VBN	O	publish	_	0	SENT_29	[p1l328t3748r574b3792],
2	by	IN	O	by	_	0	SENT_29	[p1l595t3748r657b3804],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_29	[p1l679t3748r884b3792],
4	Inc.	NNP	ORGANIZATION	Inc.	prep_by	1	SENT_29	[p1l905t3749r996b3792],
5	.	.	O	.	_	0	SENT_29	[p1l905t3749r996b3792],

1	genesis	NN	O	genesis	dep	100	SENT_30	[p2l8t152r265b232],
2	of	IN	O	of	dep	100	SENT_30	[p2l296t152r373b214],
3	neovascular	JJ	O	neovascular	dep	100	SENT_30	[p2l395t152r821b214],
4	AMD	NNP	ORGANIZATION	AMD	dep	100	SENT_30	[p2l847t153r1051b213],
5	has	VBZ	O	have	dep	100	SENT_30	[p2l1080t152r1195b214],
6	led	VBN	O	lead	dep	100	SENT_30	[p2l1226t152r1333b214],
7	to	TO	O	to	dep	100	SENT_30	[p2l1360t161r1426b214],
8	the	DT	O	the	dep	100	SENT_30	[p2l1455t152r1561b214],
9	development	NN	O	development	dep	100	SENT_30	[p2l1590t152r2050b232],
10	of	IN	O	of	dep	100	SENT_30	[p2l2078t152r2154b214],
11	anti-VEGF	JJ	O	anti-vegf	dep	100	SENT_30	[p2l8t253r402b315],
12	therapy	NN	O	therapy	dep	100	SENT_30	[p2l424t253r688b333],
13	aimed	VBN	O	aim	dep	100	SENT_30	[p2l714t253r928b315],
14	to	TO	O	to	dep	100	SENT_30	[p2l950t262r1016b315],
15	neutralize	VB	O	neutralize	dep	100	SENT_30	[p2l1040t253r1389b315],
16	VEGF-A	NN	O	vegf-a	dep	100	SENT_30	[p2l1412t253r1737b315],
17	activity	NN	O	activity	dep	100	SENT_30	[p2l1762t241r2146b333],
18	.5	CD	NUMBER	.5	dep	100	SENT_30	[p2l1762t241r2146b333],
19	‘	NN	O	‘	dep	100	SENT_30	[p2l1762t241r2146b333],
20	7	CD	NUMBER	7	dep	100	SENT_30	[p2l1762t241r2146b333],
21	Previously	RB	O	previously	dep	100	SENT_30	[p2l6t353r386b433],
22	available	JJ	O	available	dep	100	SENT_30	[p2l414t353r732b415],
23	treatments	NNS	O	treatment	dep	100	SENT_30	[p2l758t362r1126b415],
24	for	IN	O	for	dep	100	SENT_30	[p2l1155t353r1258b415],
25	neovascular	JJ	O	neovascular	dep	100	SENT_30	[p2l1282t353r1708b415],
26	AMD	NNP	ORGANIZATION	AMD	dep	100	SENT_30	[p2l1732t354r1957b426],
27	,	,	O	,	_	0	SENT_30	[p2l1732t354r1957b426],
28	such	JJ	O	such	dep	100	SENT_30	[p2l1990t353r2148b415],
29	as	IN	O	as	dep	100	SENT_30	[p2l8t473r76b515],
30	laser	NN	O	laser	dep	100	SENT_30	[p2l113t453r281b515],
31	photocoagulation	NN	O	photocoagulation	dep	100	SENT_30	[p2l312t453r931b534],
32	and	CC	O	and	dep	100	SENT_30	[p2l967t453r1093b515],
33	photodynamic	JJ	O	photodynamic	dep	100	SENT_30	[p2l1125t453r1633b534],
34	therapy	NN	O	therapy	dep	100	SENT_30	[p2l1669t453r1954b534],
35	,	,	O	,	_	0	SENT_30	[p2l1669t453r1954b534],
36	generally	RB	O	generally	dep	100	SENT_30	[p2l1992t473r2145b534, p2l7t554r207b635],
37	did	VBD	O	do	dep	100	SENT_30	[p2l231t554r342b616],
38	not	RB	O	not	dep	100	SENT_30	[p2l364t563r477b616],
39	result	VB	O	result	dep	100	SENT_30	[p2l497t554r695b616],
40	in	IN	O	in	dep	100	SENT_30	[p2l715t554r783b615],
41	visual	JJ	O	visual	dep	100	SENT_30	[p2l805t554r1016b616],
42	improvement	NN	O	improvement	dep	100	SENT_30	[p2l1038t554r1513b634],
43	in	IN	O	in	dep	100	SENT_30	[p2l1534t554r1601b615],
44	most	JJS	O	most	dep	100	SENT_30	[p2l1623t563r1796b616],
45	patients	NNS	O	patient	dep	100	SENT_30	[p2l1816t542r2146b634],
46	.8	CD	NUMBER	.8	dep	100	SENT_30	[p2l1816t542r2146b634],
47	Ranibizumab	NNP	O	Ranibizumab	dep	100	SENT_30	[p2l114t655r586b717],
48	(	CD	NUMBER	(	dep	100	SENT_30	[p2l643t655r996b732],
49	Lueentis	NNP	PERSON	Lueentis	dep	100	SENT_30	[p2l643t655r996b732],
50	;	:	O	;	_	0	SENT_30	[p2l643t655r996b732],
51	Novartis	NNP	ORGANIZATION	Novartis	dep	100	SENT_30	[p2l1051t655r1376b729],
52	,	,	O	,	_	0	SENT_30	[p2l1051t655r1376b729],
53	Basel	NNP	LOCATION	Basel	dep	100	SENT_30	[p2l1431t655r1646b729],
54	,	,	O	,	_	0	SENT_30	[p2l1431t655r1646b729],
55	Switzerland	NNP	LOCATION	Switzerland	dep	100	SENT_30	[p2l1704t655r2145b729],
56	,	,	O	,	_	0	SENT_30	[p2l1704t655r2145b729],
57	and	CC	O	and	dep	100	SENT_30	[p2l8t755r134b817],
58	Genentech	NNP	ORGANIZATION	Genentech	dep	100	SENT_30	[p2l168t755r566b829],
59	,	,	ORGANIZATION	,	_	0	SENT_30	[p2l168t755r566b829],
60	Inc.	NNP	ORGANIZATION	Inc.	dep	100	SENT_30	[p2l603t757r755b829],
61	,	,	O	,	_	0	SENT_30	[p2l603t757r755b829],
62	South	NNP	LOCATION	South	dep	100	SENT_30	[p2l795t755r999b818],
63	San	NNP	LOCATION	San	dep	100	SENT_30	[p2l1035t756r1164b818],
64	Francisco	NNP	LOCATION	Francisco	dep	100	SENT_30	[p2l1197t755r1561b829],
65	,	,	O	,	_	0	SENT_30	[p2l1197t755r1561b829],
66	CA	NNP	LOCATION	CA	dep	100	SENT_30	[p2l1600t756r1769b832],
67	)	NNP	O	)	dep	100	SENT_30	[p2l1600t756r1769b832],
68	,	,	O	,	_	0	SENT_30	[p2l1600t756r1769b832],
69	a	DT	O	a	dep	100	SENT_30	[p2l1808t775r1845b817],
70	humanized	JJ	O	humanized	dep	100	SENT_30	[p2l1876t755r2145b817, p2l7t855r154b917],
71	monoclonal	JJ	O	monoclonal	dep	100	SENT_30	[p2l200t855r619b917],
72	antibody	NN	O	antibody	dep	100	SENT_30	[p2l668t855r976b936],
73	Fab	NNP	O	Fab	dep	100	SENT_30	[p2l1023t855r1154b917],
74	fragment	NN	O	fragment	dep	100	SENT_30	[p2l1203t855r1524b936],
75	that	WDT	O	that	dep	100	SENT_30	[p2l1570t855r1703b917],
76	inhibits	VBZ	O	inhibit	dep	100	SENT_30	[p2l1749t855r2012b917],
77	all	DT	O	all	dep	100	SENT_30	[p2l2063t855r2148b917],
78	active	JJ	O	active	dep	100	SENT_30	[p2l8t956r217b1018],
79	forms	NNS	O	form	dep	100	SENT_30	[p2l240t956r443b1018],
80	of	IN	O	of	dep	100	SENT_30	[p2l469t956r545b1018],
81	VEGF-A	NN	O	vegf-a	dep	100	SENT_30	[p2l561t956r906b1029],
82	,	,	O	,	_	0	SENT_30	[p2l561t956r906b1029],
83	was	VBD	O	be	dep	100	SENT_30	[p2l931t975r1065b1018],
84	approved	VBN	O	approve	dep	100	SENT_30	[p2l1092t956r1420b1036],
85	in	IN	O	in	dep	100	SENT_30	[p2l1441t956r1509b1017],
86	2006	CD	DATE	2006	dep	100	SENT_30	[p2l1532t955r1706b1018],
87	by	IN	O	by	dep	100	SENT_30	[p2l1728t956r1815b1036],
88	the	DT	O	the	dep	100	SENT_30	[p2l1838t956r1944b1018],
89	Food	NNP	ORGANIZATION	Food	dep	100	SENT_30	[p2l1966t956r2149b1018],
90	and	CC	ORGANIZATION	and	dep	100	SENT_30	[p2l8t1056r134b1118],
91	Drug	NNP	ORGANIZATION	Drug	dep	100	SENT_30	[p2l197t1057r377b1136],
92	Administration	NNP	ORGANIZATION	Administration	dep	100	SENT_30	[p2l441t1056r980b1118],
93	for	IN	O	for	dep	100	SENT_30	[p2l1043t1056r1147b1118],
94	the	DT	O	the	dep	100	SENT_30	[p2l1208t1056r1315b1118],
95	treatment	NN	O	treatment	dep	100	SENT_30	[p2l1378t1065r1715b1118],
96	of	IN	O	of	dep	100	SENT_30	[p2l1778t1056r1855b1118],
97	AMDassociated	NNP	O	AMDassociated	dep	100	SENT_30	[p2l1912t1056r2145b1117, p2l8t1156r372b1219],
98	CNV	NNP	O	CNV	dep	100	SENT_30	[p2l403t1145r643b1219],
99	.9	CD	NUMBER	.9	dep	100	SENT_30	[p2l403t1145r643b1219],
100	Anti	NNP	O	Anti	_	0	SENT_30	[p2l675t1156r1094b1219],
101	.	.	O	.	_	0	SENT_30	[p2l675t1156r1094b1219],

1	—	NN	O	—	_	0	SENT_31	[p2l675t1156r1094b1219],
2	.	.	O	.	_	0	SENT_31	[p2l675t1156r1094b1219],

1	VEGF	NN	O	vegf	nn	2	SENT_32	[p2l675t1156r1094b1219],
2	therapy	NN	O	therapy	nsubj	6	SENT_32	[p2l1124t1156r1390b1237],
3	is	VBZ	O	be	cop	6	SENT_32	[p2l1421t1156r1476b1219],
4	the	DT	O	the	det	6	SENT_32	[p2l1508t1156r1615b1219],
5	ﬁrst	NN	O	ﬁrst	nn	6	SENT_32	[p2l1647t1156r1784b1219],
6	treatment	NN	O	treatment	_	0	SENT_32	[p2l1813t1165r2149b1219],
7	to	TO	O	to	aux	8	SENT_32	[p2l6t1266r73b1319],
8	improve	VB	O	improve	infmod	6	SENT_32	[p2l102t1257r397b1337],
9	visual	JJ	O	visual	amod	13	SENT_32	[p2l427t1257r637b1319],
10	acuity	NN	O	acuity	nn	13	SENT_32	[p2l668t1257r882b1337],
11	(	CD	NUMBER	(	num	13	SENT_32	[p2l915t1257r1095b1333],
12	VA	NN	ORGANIZATION	va	nn	13	SENT_32	[p2l915t1257r1095b1333],
13	)	NN	O	)	nsubj	14	SENT_32	[p2l915t1257r1095b1333],
14	signiﬁcantly	RB	O	signiﬁcantly	xcomp	8	SENT_32	[p2l1130t1257r1565b1337],
15	in	IN	O	in	_	0	SENT_32	[p2l1595t1257r1662b1318],
16	a	DT	O	a	det	18	SENT_32	[p2l1693t1276r1730b1319],
17	large	JJ	O	large	amod	18	SENT_32	[p2l1757t1257r1932b1337],
18	numISSN	NN	O	numissn	prep_in	14	SENT_32	[p2l1962t1276r2146b1319, p2l1160t1497r1294b1541],

1	0161-6420/12	CD	DURATION	0161-6420/12	_	0	SENT_33	[p2l1317t1494r1825b1545],
2	/	:	O	/	punct	1	SENT_33	[p2l1317t1494r1825b1545],
3	$	$	MONEY	$	dep	1	SENT_33	[p2l1317t1494r1825b1545],
4	.	.	MONEY	.	_	0	SENT_33	[p2l1317t1494r1825b1545],

1	—	NN	O	—	_	0	SENT_34	[p2l1317t1494r1825b1545],
2	.	.	O	.	_	0	SENT_34	[p2l1317t1494r1825b1545],

1	see	VB	O	see	_	0	SENT_35	[p2l1317t1494r1825b1545],
2	front	JJ	O	front	amod	4	SENT_35	[p2l1848t1497r1969b1541],
3	matter	NN	O	matter	nn	4	SENT_35	[p2l1990t1504r2150b1541],
4	http://dx.doi.org/10.1016/j.ophtha.20l2.05.040	NN	O	http://dx.doi.org/10.1016/j.ophtha.20l2.05.040	dobj	1	SENT_35	[p2l974t1576r2148b1633],

1	Smailhodzic	JJ	MISC	smailhodzic	_	0	SENT_36	[p2l468t1708r670b1747],
2	et	FW	O	et	nn	3	SENT_36	[p2l686t1719r716b1743],
3	al	FW	O	al	dep	1	SENT_36	[p2l732t1708r762b1743],
4	-	:	O	-	_	0	SENT_36	[p2l788t1723r796b1730],
5	Risk	NN	O	risk	nn	6	SENT_36	[p2l823t1708r904b1743],
6	Alleles	NNS	O	allele	dep	1	SENT_36	[p2l919t1708r1048b1743],
7	on	IN	O	on	_	0	SENT_36	[p2l1065t1722r1112b1743],
8	Treatment	NN	O	treatment	nn	9	SENT_36	[p2l1128t1710r1326b1743],
9	Response	NN	O	response	prep_on	6	SENT_36	[p2l1342t1710r1513b1752],
10	in	IN	O	in	_	0	SENT_36	[p2l1532t1713r1568b1743],
11	AMD	NNP	ORGANIZATION	AMD	prep_in	6	SENT_36	[p2l1584t1709r1692b1743],

1	ber	NN	O	ber	nsubjpass	29	SENT_37	[p2l12t1883r126b1945],
2	of	IN	O	of	_	0	SENT_37	[p2l154t1883r231b1945],
3	patients	NNS	O	patient	prep_of	1	SENT_37	[p2l254t1883r548b1964],
4	,	,	O	,	_	0	SENT_37	[p2l254t1883r548b1964],
5	representing	VBG	O	represent	partmod	29	SENT_37	[p2l580t1883r1018b1964],
6	an	DT	O	a	det	8	SENT_37	[p2l1049t1903r1130b1945],
7	unparalleled	JJ	O	unparalleled	amod	8	SENT_37	[p2l1158t1883r1597b1964],
8	advance	NN	O	advance	dobj	5	SENT_37	[p2l1628t1883r1915b1946],
9	in	IN	O	in	_	0	SENT_37	[p2l1944t1883r2011b1945],
10	the	DT	O	the	det	11	SENT_37	[p2l2041t1883r2147b1945],
11	treatment	NN	O	treatment	prep_in	8	SENT_37	[p2l13t1990r348b2044],
12	of	IN	O	of	_	0	SENT_37	[p2l373t1981r449b2044],
13	neovascular	JJ	O	neovascular	amod	14	SENT_37	[p2l468t1981r893b2044],
14	AMD	NNP	O	AMD	prep_of	11	SENT_37	[p2l916t1970r1175b2044],
15	.8	CD	NUMBER	.8	num	14	SENT_37	[p2l916t1970r1175b2044],
16	However	RB	O	however	advmod	5	SENT_37	[p2l1202t1983r1544b2055],
17	,	,	O	,	_	0	SENT_37	[p2l1202t1983r1544b2055],
18	a	DT	O	a	det	20	SENT_37	[p2l1575t2001r1611b2044],
19	broad	JJ	O	broad	amod	20	SENT_37	[p2l1634t1981r1836b2044],
20	range	NN	O	range	nsubjpass	29	SENT_37	[p2l1859t2001r2055b2062],
21	in	IN	O	in	_	0	SENT_37	[p2l2080t1981r2147b2043],
22	response	NN	O	response	nn	23	SENT_37	[p2l12t2100r321b2160],
23	rates	NNS	O	rate	prep_in	20	SENT_37	[p2l369t2089r533b2142],
24	to	TO	O	to	_	0	SENT_37	[p2l583t2089r649b2142],
25	anti-VEGF	JJ	O	anti-vegf	amod	26	SENT_37	[p2l699t2080r1091b2142],
26	therapy	NN	O	therapy	prep_to	23	SENT_37	[p2l1138t2080r1402b2160],
27	has	VBZ	O	have	aux	29	SENT_37	[p2l1450t2080r1565b2142],
28	been	VBN	O	be	auxpass	29	SENT_37	[p2l1613t2080r1780b2142],
29	observed	VBN	O	observe	_	0	SENT_37	[p2l1829t2080r2148b2142],
30	because	IN	O	because	mark	33	SENT_37	[p2l12t2178r292b2240],
31	some	DT	O	some	det	32	SENT_37	[p2l329t2198r511b2240],
32	patients	NNS	O	patient	nsubj	33	SENT_37	[p2l544t2178r817b2258],
33	showed	VBD	O	show	advcl	29	SENT_37	[p2l856t2178r1123b2240],
34	a	DT	O	a	det	36	SENT_37	[p2l1158t2198r1195b2240],
35	better	JJR	O	better	amod	36	SENT_37	[p2l1226t2178r1429b2240],
36	outcome	NN	O	outcome	dobj	33	SENT_37	[p2l1462t2187r1764b2240],
37	compared	VBN	O	compare	_	0	SENT_37	[p2l1799t2178r2148b2258],
38	with	IN	O	with	prepc_compared_with	33	SENT_37	[p2l13t2275r169b2338],
39	the	DT	O	the	det	40	SENT_37	[p2l200t2275r306b2337],
40	average	NN	O	average	pobj	33	SENT_37	[p2l341t2295r632b2356],
41	,	,	O	,	_	0	SENT_37	[p2l341t2295r632b2356],
42	whereas	IN	O	whereas	mark	44	SENT_37	[p2l668t2275r955b2338],
43	others	NNS	O	other	nsubj	44	SENT_37	[p2l990t2275r1201b2337],
44	showed	VBD	O	show	advcl	33	SENT_37	[p2l1238t2275r1506b2338],
45	VA	NNP	O	VA	nn	46	SENT_37	[p2l1537t2276r1663b2337],
46	deterioration	NN	O	deterioration	dobj	44	SENT_37	[p2l1696t2275r2148b2337],
47	instead	RB	O	instead	_	0	SENT_37	[p2l13t2374r263b2436],
48	of	IN	O	of	_	0	SENT_37	[p2l288t2374r364b2436],
49	improvement	NN	O	improvement	prep_instead_of	46	SENT_37	[p2l383t2374r872b2454],
50	.	.	O	.	_	0	SENT_37	[p2l383t2374r872b2454],

1	The	DT	O	the	det	2	SENT_38	[p2l901t2374r1037b2436],
2	reasons	NNS	O	reason	nsubjpass	11	SENT_38	[p2l1060t2393r1323b2436],
3	for	IN	O	for	_	0	SENT_38	[p2l1350t2374r1452b2436],
4	different	JJ	O	different	amod	5	SENT_38	[p2l1476t2374r1780b2436],
5	responses	NNS	O	response	prep_for	2	SENT_38	[p2l1802t2393r2145b2454],
6	to	TO	O	to	_	0	SENT_38	[p2l13t2481r79b2534],
7	anti-VEGF	JJ	O	anti-vegf	amod	8	SENT_38	[p2l104t2472r496b2534],
8	treatment	NN	O	treatment	prep_to	5	SENT_38	[p2l517t2481r852b2534],
9	are	VBP	O	be	auxpass	11	SENT_38	[p2l875t2492r979b2534],
10	poorly	RB	O	poorly	advmod	11	SENT_38	[p2l1001t2472r1231b2552],
11	understood	VBN	O	understand	_	0	SENT_38	[p2l1254t2472r1665b2534],
12	.	.	O	.	_	0	SENT_38	[p2l1254t2472r1665b2534],

1	10	CD	NUMBER	10	_	0	SENT_39	[p2l1679t2460r1736b2500],
2	Because	IN	O	because	_	0	SENT_39	[p2l1759t2474r2053b2534],
3	of	IN	O	of	prepc_because_of	1	SENT_39	[p2l2076t2472r2153b2534],
4	the	DT	O	the	det	10	SENT_39	[p2l13t2569r119b2631],
5	invasive	JJ	O	invasive	amod	10	SENT_39	[p2l145t2569r439b2632],
6	and	CC	O	and	_	0	SENT_39	[p2l467t2569r592b2631],
7	time	NN	O	time	npadvmod	9	SENT_39	[p2l617t2569r1192b2650],
8	—	CD	NUMBER	—	num	7	SENT_39	[p2l617t2569r1192b2650],
9	consuming	JJ	O	consuming	amod	10	SENT_39	[p2l617t2569r1192b2650],
10	nature	NN	O	nature	pobj	1	SENT_39	[p2l1219t2579r1439b2631],
11	of	IN	O	of	_	0	SENT_39	[p2l1466t2569r1542b2631],
12	anti-VEGF	JJ	O	anti-vegf	amod	13	SENT_39	[p2l1564t2569r1957b2632],
13	therapy	NN	O	therapy	prep_of	10	SENT_39	[p2l1982t2569r2145b2631, p2l15t2687r158b2748],
14	,	,	O	,	_	0	SENT_39	[p2l1982t2569r2145b2631, p2l15t2687r158b2748],
15	it	PRP	O	it	appos	13	SENT_39	[p2l213t2668r261b2730],
16	important	JJ	O	important	amod	15	SENT_39	[p2l311t2668r657b2748],
17	to	TO	O	to	aux	18	SENT_39	[p2l707t2677r772b2730],
18	understand	VB	O	understand	xcomp	16	SENT_39	[p2l824t2668r1214b2730],
19	which	WDT	O	which	nsubj	20	SENT_39	[p2l1265t2668r1480b2730],
20	factors	NNS	O	factor	xcomp	18	SENT_39	[p2l1532t2668r1769b2730],
21	inﬂuence	NN	O	inﬂuence	nn	23	SENT_39	[p2l1823t2668r2147b2730],
22	treatment	NN	O	treatment	nn	23	SENT_39	[p2l13t2775r348b2828],
23	response	NN	O	response	dep	20	SENT_39	[p2l381t2785r708b2846],
24	.	.	O	.	_	0	SENT_39	[p2l381t2785r708b2846],

1	Genetic	JJ	O	genetic	amod	2	SENT_40	[p2l749t2766r1021b2828],
2	variation	NN	O	variation	nsubjpass	5	SENT_40	[p2l1058t2766r1372b2828],
3	has	VBZ	O	have	aux	5	SENT_40	[p2l1406t2766r1521b2828],
4	been	VBN	O	be	auxpass	5	SENT_40	[p2l1557t2766r1724b2828],
5	recognized	VBN	O	recognize	_	0	SENT_40	[p2l1758t2766r2148b2846],
6	as	IN	O	as	_	0	SENT_40	[p2l15t2884r83b2926],
7	an	DT	O	a	det	9	SENT_40	[p2l110t2884r190b2926],
8	important	JJ	O	important	amod	9	SENT_40	[p2l213t2864r558b2944],
9	determinant	NN	O	determinant	prep_as	5	SENT_40	[p2l581t2864r1005b2926],
10	of	IN	O	of	_	0	SENT_40	[p2l1028t2864r1104b2926],
11	individual	JJ	O	individual	amod	12	SENT_40	[p2l1122t2864r1480b2926],
12	variability	NN	O	variability	prep_of	9	SENT_40	[p2l1505t2864r1867b2944],
13	of	IN	O	of	_	0	SENT_40	[p2l1892t2864r1969b2926],
14	drug	NN	O	drug	nn	15	SENT_40	[p2l1987t2864r2146b2944],
15	response	NN	O	response	prep_of	12	SENT_40	[p2l12t2981r341b3042],
16	,	,	O	,	_	0	SENT_40	[p2l12t2981r341b3042],
17	and	CC	O	and	_	0	SENT_40	[p2l391t2961r517b3023],
18	the	DT	O	the	det	19	SENT_40	[p2l561t2961r667b3023],
19	identiﬁcation	NN	O	identiﬁcation	nsubj	24	SENT_40	[p2l713t2961r1180b3023],
20	of	IN	O	of	_	0	SENT_40	[p2l1227t2961r1303b3023],
21	such	JJ	O	such	amod	22	SENT_40	[p2l1346t2961r1504b3023],
22	variants	NNS	O	variant	prep_of	19	SENT_40	[p2l1549t2961r1826b3024],
23	has	VBZ	O	have	aux	24	SENT_40	[p2l1873t2961r1988b3023],
24	enhanced	VBN	O	enhance	conj_and	5	SENT_40	[p2l2036t2981r2144b3023, p2l12t3060r263b3122],
25	patient	NN	O	patient	nn	26	SENT_40	[p2l295t3060r537b3140],
26	care	NN	O	care	dobj	24	SENT_40	[p2l571t3060r1214b3140],
27	—	CD	NUMBER	—	num	26	SENT_40	[p2l571t3060r1214b3140],
28	particularly	RB	O	particularly	advmod	24	SENT_40	[p2l571t3060r1214b3140],
29	in	IN	O	in	_	0	SENT_40	[p2l1249t3060r1316b3121],
30	oncology	NN	O	oncology	prep_in	24	SENT_40	[p2l1351t3060r1678b3140],
31	and	CC	O	and	_	0	SENT_40	[p2l1715t3060r1839b3122],
32	cardiology	NN	O	cardiology	prep_in	24	SENT_40	[p2l1873t3060r2144b3122, p2l14t3146r316b3238],
33	.	.	O	.	_	0	SENT_40	[p2l1873t3060r2144b3122, p2l14t3146r316b3238],

1	“’	NN	O	“’	nn	3	SENT_41	[p2l1873t3060r2144b3122, p2l14t3146r316b3238],
2	12	CD	NUMBER	12	num	3	SENT_41	[p2l1873t3060r2144b3122, p2l14t3146r316b3238],
3	Knowledge	NN	O	knowledge	nsubj	12	SENT_41	[p2l346t3158r753b3238],
4	of	IN	O	of	_	0	SENT_41	[p2l783t3158r860b3220],
5	genetic	JJ	O	genetic	amod	6	SENT_41	[p2l883t3158r1135b3238],
6	variants	NNS	O	variant	prep_of	3	SENT_41	[p2l1166t3158r1443b3220],
7	that	WDT	O	that	nsubj	8	SENT_41	[p2l1473t3158r1606b3220],
8	inﬂuence	VBP	O	inﬂuence	rcmod	6	SENT_41	[p2l1633t3158r1957b3220],
9	antiVEGF	NN	O	antivegf	nn	10	SENT_41	[p2l1988t3158r2144b3220, p2l13t3257r243b3319],
10	therapy	NN	O	therapy	dobj	8	SENT_41	[p2l303t3256r567b3337],
11	may	MD	O	may	aux	12	SENT_41	[p2l627t3276r778b3337],
12	facilitate	VB	O	facilitate	_	0	SENT_41	[p2l839t3256r1148b3318],
13	a	DT	O	a	det	16	SENT_41	[p2l1210t3276r1247b3318],
14	personalized	JJ	O	personalized	amod	16	SENT_41	[p2l1304t3256r1754b3337],
15	treatment	NN	O	treatment	nn	16	SENT_41	[p2l1813t3265r2148b3318],
16	approach	NN	O	approach	dobj	12	SENT_41	[p2l15t3354r337b3434],
17	for	IN	O	for	_	0	SENT_41	[p2l369t3354r472b3416],
18	neovascular	JJ	O	neovascular	amod	20	SENT_41	[p2l502t3354r927b3416],
19	AMD	NN	ORGANIZATION	amd	nn	20	SENT_41	[p2l957t3354r1161b3415],
20	patients	NNS	O	patient	prep_for	12	SENT_41	[p2l1193t3354r1486b3434],
21	.	.	O	.	_	0	SENT_41	[p2l1193t3354r1486b3434],

1	During	IN	O	during	_	0	SENT_42	[p2l120t3452r368b3532],
2	the	DT	DATE	the	det	4	SENT_42	[p2l422t3452r528b3514],
3	past	JJ	DATE	past	amod	4	SENT_42	[p2l580t3461r723b3532],
4	decade	NN	DATE	decade	prep_during	17	SENT_42	[p2l776t3452r1038b3525],
5	,	,	O	,	_	0	SENT_42	[p2l776t3452r1038b3525],
6	the	DT	O	the	det	7	SENT_42	[p2l1094t3452r1200b3514],
7	identiﬁcation	NN	O	identiﬁcation	nsubj	17	SENT_42	[p2l1253t3452r1721b3514],
8	of	IN	O	of	_	0	SENT_42	[p2l1775t3452r1851b3514],
9	several	JJ	O	several	amod	12	SENT_42	[p2l1901t3452r2147b3514],
10	genetic	JJ	O	genetic	amod	12	SENT_42	[p2l14t3550r266b3630],
11	risk	NN	O	risk	nn	12	SENT_42	[p2l299t3550r433b3612],
12	factors	NNS	O	factor	prep_of	7	SENT_42	[p2l463t3550r700b3612],
13	involved	VBN	O	involve	partmod	12	SENT_42	[p2l735t3550r1045b3612],
14	in	IN	O	in	_	0	SENT_42	[p2l1076t3550r1143b3611],
15	AMD	NNP	ORGANIZATION	AMD	prep_in	13	SENT_42	[p2l1175t3551r1379b3611],
16	has	VBZ	O	have	aux	17	SENT_42	[p2l1412t3550r1527b3612],
17	provided	VBN	O	provide	_	0	SENT_42	[p2l1560t3550r1876b3630],
18	important	JJ	O	important	amod	19	SENT_42	[p2l1907t3550r2144b3630, p2l13t3657r145b3710],
19	insights	NNS	O	insight	dobj	17	SENT_42	[p2l170t3648r442b3729],
20	into	IN	O	into	_	0	SENT_42	[p2l470t3648r605b3710],
21	the	DT	O	the	det	22	SENT_42	[p2l632t3648r738b3710],
22	pathogenesis	NN	O	pathogenesis	prep_into	17	SENT_42	[p2l763t3648r1220b3729],
23	of	IN	O	of	_	0	SENT_42	[p2l1249t3648r1325b3710],
24	the	DT	O	the	det	25	SENT_42	[p2l1345t3648r1451b3710],
25	disease	NN	O	disease	prep_of	22	SENT_42	[p2l1478t3648r1749b3710],
26	.	.	O	.	_	0	SENT_42	[p2l1478t3648r1749b3710],

1	The	DT	O	the	det	4	SENT_43	[p2l1780t3648r1916b3710],
2	strongest	JJS	O	strongest	amod	4	SENT_43	[p2l1945t3658r2145b3710, p2l14t3755r155b3826],
3	genetic	JJ	O	genetic	amod	4	SENT_43	[p2l199t3746r452b3826],
4	association	NN	O	association	nsubjpass	7	SENT_43	[p2l499t3746r891b3808],
5	has	VBZ	O	have	aux	7	SENT_43	[p2l935t3746r1050b3808],
6	been	VBN	O	be	auxpass	7	SENT_43	[p2l1095t3746r1262b3808],
7	found	VBN	O	find	_	0	SENT_43	[p2l1307t3746r1512b3808],
8	with	IN	O	with	_	0	SENT_43	[p2l1557t3746r1712b3808],
9	a	DT	O	a	det	11	SENT_43	[p2l1758t3765r1795b3808],
10	common	JJ	O	common	amod	11	SENT_43	[p2l1839t3765r2147b3808],
11	variant	NN	O	variant	prep_with	7	SENT_43	[p3l13t21r259b83],
12	in	IN	O	in	_	0	SENT_43	[p3l292t21r359b82],
13	the	DT	O	the	det	15	SENT_43	[p3l394t21r500b83],
14	complement	NN	O	complement	nn	15	SENT_43	[p3l536t21r965b100],
15	factor	NN	O	factor	prep_in	11	SENT_43	[p3l983t21r1211b100],
16	H	NN	O	h	nn	18	SENT_43	[p3l1240t23r1309b82],
17	(	CD	NUMBER	(	num	18	SENT_43	[p3l1341t22r1570b97],
18	CFH	NNP	O	CFH	tmod	7	SENT_43	[p3l1341t22r1570b97],
19	)	CD	NUMBER	)	num	20	SENT_43	[p3l1341t22r1570b97],
20	gene	NN	O	gene	nsubjpass	41	SENT_43	[p3l1609t40r1792b101],
21	,	,	O	,	_	0	SENT_43	[p3l1609t40r1792b101],
22	the	DT	O	the	det	24	SENT_43	[p3l1830t21r1936b83],
23	main	JJ	O	main	amod	24	SENT_43	[p3l1971t21r2147b83],
24	regulator	NN	O	regulator	appos	20	SENT_43	[p3l12t119r333b199],
25	of	IN	O	of	_	0	SENT_43	[p3l369t119r446b181],
26	the	DT	O	the	det	29	SENT_43	[p3l476t119r582b181],
27	alternative	JJ	O	alternative	amod	29	SENT_43	[p3l621t119r992b181],
28	complement	NN	O	complement	nn	29	SENT_43	[p3l1030t119r1468b199],
29	pathway	NN	O	pathway	prep_of	24	SENT_43	[p3l1502t107r1974b199],
30	.13	CD	NUMBER	.13	number	31	SENT_43	[p3l1502t107r1974b199],
31	’14	CD	NUMBER	’14	dep	29	SENT_43	[p3l1502t107r1974b199],
32	The	DT	O	the	det	37	SENT_43	[p3l2011t119r2147b181],
33	second	JJ	ORDINAL	second	amod	37	SENT_43	[p3l16t216r258b278],
34	major	JJ	O	major	amod	37	SENT_43	[p3l286t216r493b297],
35	genetic	JJ	O	genetic	amod	37	SENT_43	[p3l521t216r773b297],
36	risk	NN	O	risk	nn	37	SENT_43	[p3l802t216r936b278],
37	factor	NN	O	factor	dep	31	SENT_43	[p3l962t216r1169b278],
38	for	IN	O	for	_	0	SENT_43	[p3l1196t216r1299b278],
39	AMD	NNP	ORGANIZATION	AMD	prep_for	24	SENT_43	[p3l1325t217r1529b278],
40	was	VBD	O	be	auxpass	41	SENT_43	[p3l1559t236r1693b279],
41	identiﬁed	VBN	O	identiﬁed	rcmod	18	SENT_43	[p3l1723t216r2058b278],
42	at	IN	O	at	_	0	SENT_43	[p3l2087t225r2148b278],
43	the	DT	O	the	det	46	SENT_43	[p3l13t315r118b377],
44	chromosome	NN	O	chromosome	nn	46	SENT_43	[p3l172t315r628b377],
45	10q26	NN	O	10q26	nn	46	SENT_43	[p3l689t314r899b395],
46	locus	NN	O	locus	prep_at	41	SENT_43	[p3l952t303r1224b388],
47	,	,	O	,	_	0	SENT_43	[p3l952t303r1224b388],
48	”	CD	NUMBER	”	conj_and	18	SENT_43	[p3l952t303r1224b388],
49	encompassing	VBG	O	encompass	partmod	48	SENT_43	[p3l1280t315r1780b395],
50	the	DT	O	the	det	58	SENT_43	[p3l1832t315r1939b377],
51	agerelated	JJ	O	agerelated	amod	58	SENT_43	[p3l1991t336r2144b394, p3l15t413r267b475],
52	maculopathy	NN	O	maculopathy	nn	58	SENT_43	[p3l293t413r751b492],
53	susceptibility	NN	O	susceptibility	nn	58	SENT_43	[p3l782t413r1249b492],
54	2	CD	NUMBER	2	num	58	SENT_43	[p3l1280t413r1320b474],
55	(	CD	NUMBER	(	num	58	SENT_43	[p3l1356t413r2145b490],
56	ARMS2/LOC387715	NN	O	arms2/loc387715	nn	58	SENT_43	[p3l1356t413r2145b490],
57	)	NN	O	)	nn	58	SENT_43	[p3l1356t413r2145b490],
58	gene	NN	O	gene	dobj	49	SENT_43	[p3l14t531r178b592],
59	and	CC	O	and	_	0	SENT_43	[p3l210t511r335b573],
60	the	DT	O	the	det	67	SENT_43	[p3l364t511r470b573],
61	adjacent	JJ	O	adjacent	amod	67	SENT_43	[p3l502t511r796b592],
62	high	JJ	O	high	amod	67	SENT_43	[p3l825t511r1444b591],
63	—	NN	O	—	nn	67	SENT_43	[p3l825t511r1444b591],
64	temperature	NN	O	temperature	nn	67	SENT_43	[p3l825t511r1444b591],
65	requirement	NN	O	requirement	nn	67	SENT_43	[p3l1477t514r1910b591],
66	factor	NN	O	factor	nn	67	SENT_43	[p3l1922t511r2151b591],
67	A	NN	O	a	tmod	7	SENT_43	[p3l7t609r103b670],
68	]	CD	NUMBER	]	number	69	SENT_43	[p3l7t609r103b670],
69	(	CD	NUMBER	(	dep	67	SENT_43	[p3l150t609r702b685],
70	HTRA1/PRSS1	NN	O	htra1/prss1	nn	73	SENT_43	[p3l150t609r702b685],
71	1	CD	NUMBER	1	num	73	SENT_43	[p3l714t609r780b685],
72	)	NN	O	)	nn	73	SENT_43	[p3l714t609r780b685],
73	gene	NN	O	gene	dep	18	SENT_43	[p3l821t628r1003b689],
74	.	.	O	.	_	0	SENT_43	[p3l821t628r1003b689],

1	Several	JJ	O	several	amod	3	SENT_44	[p3l1048t609r1309b671],
2	recent	JJ	O	recent	amod	3	SENT_44	[p3l1347t618r1564b671],
3	studies	NNS	O	study	nsubj	4	SENT_44	[p3l1603t609r1843b671],
4	suggest	VBP	O	suggest	dep	27	SENT_44	[p3l1886t618r2149b689],
5	that	IN	O	that	complm	9	SENT_44	[p3l13t707r145b769],
6	genetic	JJ	O	genetic	amod	7	SENT_44	[p3l191t707r443b787],
7	background	NN	O	background	nsubj	9	SENT_44	[p3l489t707r909b787],
8	may	MD	O	may	aux	9	SENT_44	[p3l954t726r1104b787],
9	play	VB	O	play	ccomp	4	SENT_44	[p3l1150t707r1301b787],
10	a	DT	O	a	det	11	SENT_44	[p3l1349t726r1386b769],
11	role	NN	O	role	dobj	9	SENT_44	[p3l1430t707r1566b769],
12	in	IN	O	in	_	0	SENT_44	[p3l1612t707r1679b768],
13	the	DT	O	the	det	15	SENT_44	[p3l1725t707r1831b769],
14	varying	VBG	O	vary	amod	15	SENT_44	[p3l1877t707r2146b787],
15	response	NN	O	response	prep_in	11	SENT_44	[p3l12t824r321b885],
16	to	TO	O	to	_	0	SENT_44	[p3l368t814r434b867],
17	treatment	NN	O	treatment	prep_to	9	SENT_44	[p3l481t814r816b867],
18	with	IN	O	with	_	0	SENT_44	[p3l861t805r1017b867],
19	ranibizumab	NN	O	ranibizumab	prep_with	9	SENT_44	[p3l1062t793r1701b867],
20	.16	CD	NUMBER	.16	num	19	SENT_44	[p3l1062t793r1701b867],
21	‘	CD	NUMBER	‘	number	22	SENT_44	[p3l1062t793r1701b867],
22	19	CD	NUMBER	19	num	24	SENT_44	[p3l1062t793r1701b867],
23	Conﬂicting	NN	O	conﬂicting	nn	24	SENT_44	[p3l1750t805r2146b886],
24	results	NNS	O	result	nsubjpass	27	SENT_44	[p3l12t902r241b964],
25	have	VBP	O	have	aux	27	SENT_44	[p3l274t902r440b965],
26	been	VBN	O	be	auxpass	27	SENT_44	[p3l471t902r638b964],
27	reported	VBN	O	report	_	0	SENT_44	[p3l668t902r964b983],
28	for	IN	O	for	_	0	SENT_44	[p3l995t902r1098b964],
29	the	DT	O	the	det	30	SENT_44	[p3l1128t902r1234b964],
30	role	NN	O	role	prep_for	27	SENT_44	[p3l1265t902r1402b964],
31	of	IN	O	of	_	0	SENT_44	[p3l1435t902r1511b964],
32	the	DT	O	the	det	34	SENT_44	[p3l1537t902r1644b964],
33	CFH	NNP	O	CFH	nn	34	SENT_44	[p3l1680t904r1857b965],
34	gene	NN	O	gene	prep_of	30	SENT_44	[p3l1884t922r2048b983],
35	in	IN	O	in	_	0	SENT_44	[p3l2080t902r2148b964],
36	response	NN	O	response	prep_in	27	SENT_44	[p3l12t1020r321b1081],
37	to	TO	O	to	_	0	SENT_44	[p3l347t1010r413b1063],
38	ranibizumab	NN	O	ranibizumab	nn	39	SENT_44	[p3l438t1001r880b1063],
39	treatment	NN	O	treatment	prep_to	27	SENT_44	[p3l907t1010r1258b1063],
40	.	.	O	.	_	0	SENT_44	[p3l907t1010r1258b1063],

1	Homozygous	JJ	O	homozygous	amod	2	SENT_45	[p3l1289t1002r1759b1081],
2	carriers	NNS	O	carrier	nsubj	16	SENT_45	[p3l1786t1001r2048b1063],
3	of	IN	O	of	_	0	SENT_45	[p3l2076t1000r2153b1063],
4	the	DT	O	the	det	5	SENT_45	[p3l13t1099r119b1161],
5	402H	NN	O	402h	nn	15	SENT_45	[p3l141t1099r337b1161],
6	high	JJ	O	high	amod	15	SENT_45	[p3l358t1099r680b1179],
7	—	NN	O	—	nn	9	SENT_45	[p3l358t1099r680b1179],
8	risk	NN	O	risk	nn	9	SENT_45	[p3l358t1099r680b1179],
9	allele	NN	O	allele	dep	6	SENT_45	[p3l702t1099r891b1161],
10	in	IN	O	in	_	0	SENT_45	[p3l913t1099r980b1160],
11	CFH	NNP	O	CFH	nn	13	SENT_45	[p3l1003t1099r1173b1161],
12	(	CD	NUMBER	(	num	13	SENT_45	[p3l1198t1099r1339b1176],
13	CC	NN	O	cc	prep_in	9	SENT_45	[p3l1198t1099r1339b1176],
14	genotype	NN	O	genotype	nn	15	SENT_45	[p3l1365t1100r1714b1179],
15	)	NN	O	)	prep_of	2	SENT_45	[p3l1365t1100r1714b1179],
16	had	VBD	O	have	_	0	SENT_45	[p3l1738t1099r1866b1161],
17	a	DT	O	a	det	20	SENT_45	[p3l1889t1119r1926b1161],
18	lower	JJR	O	lower	amod	20	SENT_45	[p3l1947t1099r2149b1161],
19	VA	NN	O	va	nn	20	SENT_45	[p3l13t1198r139b1259],
20	outcome	NN	O	outcome	dobj	16	SENT_45	[p3l182t1206r485b1259],
21	in	IN	O	in	_	0	SENT_45	[p3l527t1197r595b1258],
22	one	CD	NUMBER	one	num	23	SENT_45	[p3l638t1217r762b1259],
23	study16	NN	O	study16	prep_in	20	SENT_45	[p3l808t1185r1062b1278],
24	but	CC	O	but	_	0	SENT_45	[p3l1103t1197r1217b1259],
25	a	DT	O	a	det	27	SENT_45	[p3l1260t1217r1297b1259],
26	better	JJR	O	better	amod	27	SENT_45	[p3l1336t1197r1539b1259],
27	outcome	NN	O	outcome	dobj	16	SENT_45	[p3l1581t1206r1884b1259],
28	in	IN	O	in	_	0	SENT_45	[p3l1926t1197r1993b1258],
29	another	DT	O	another	prep_in	27	SENT_45	[p3l2037t1217r2144b1259, p3l14t1282r280b1357],
30	.	.	O	.	_	0	SENT_45	[p3l2037t1217r2144b1259, p3l14t1282r280b1357],

1	”	NN	O	”	nsubj	5	SENT_46	[p3l2037t1217r2144b1259, p3l14t1282r280b1357],
2	Yet	RB	O	yet	advmod	5	SENT_46	[p3l332t1296r459b1357],
3	another	DT	O	another	det	4	SENT_46	[p3l508t1294r772b1357],
4	study	NN	O	study	nsubj	5	SENT_46	[p3l823t1294r1009b1375],
5	concluded	VBD	O	conclude	_	0	SENT_46	[p3l1060t1294r1423b1357],
6	that	IN	O	that	complm	8	SENT_46	[p3l1471t1294r1604b1357],
7	there	EX	O	there	expl	8	SENT_46	[p3l1651t1295r1826b1357],
8	was	VBD	O	be	ccomp	5	SENT_46	[p3l1876t1314r2010b1357],
9	no	DT	O	no	det	10	SENT_46	[p3l2061t1314r2146b1357],
10	association	NN	O	association	nsubj	8	SENT_46	[p3l15t1393r406b1455],
11	between	IN	O	between	_	0	SENT_46	[p3l452t1393r747b1455],
12	the	DT	O	the	det	15	SENT_46	[p3l794t1393r900b1455],
13	CFH	NNP	O	CFH	nn	15	SENT_46	[p3l952t1394r1129b1455],
14	Y402H	NN	O	y402h	nn	15	SENT_46	[p3l1170t1393r1430b1455],
15	genotype	NN	O	genotype	prep_between	10	SENT_46	[p3l1478t1402r1800b1473],
16	and	CC	O	and	_	0	SENT_46	[p3l1850t1393r1975b1455],
17	VA	NN	ORGANIZATION	va	prep_between	10	SENT_46	[p3l2021t1393r2147b1455],
18	after	IN	O	after	_	0	SENT_46	[p3l15t1492r175b1553],
19	ranibizumab	NN	O	ranibizumab	nn	20	SENT_46	[p3l228t1492r670b1553],
20	treatment	NN	O	treatment	prep_after	8	SENT_46	[p3l727t1480r1148b1553],
21	.	.	O	.	_	0	SENT_46	[p3l727t1480r1148b1553],

1	”	NN	O	”	npadvmod	8	SENT_47	[p3l727t1480r1148b1553],
2	For	IN	O	for	_	0	SENT_47	[p3l1205t1494r1328b1554],
3	ARMS2/HTRA	NN	O	arms2/htra	nn	4	SENT_47	[p3l1376t1492r1936b1554],
4	]	NN	O	]	prep_for	8	SENT_47	[p3l1376t1492r1936b1554],
5	,	,	O	,	_	0	SENT_47	[p3l1949t1543r1962b1565],
6	one	CD	NUMBER	one	num	7	SENT_47	[p3l2022t1512r2146b1554],
7	study	NN	O	study	nsubj	8	SENT_47	[p3l16t1588r203b1669],
8	reported	VBD	O	report	_	0	SENT_47	[p3l243t1588r539b1669],
9	that	IN	O	that	complm	22	SENT_47	[p3l579t1588r711b1650],
10	heterozygous	JJ	O	heterozygous	amod	11	SENT_47	[p3l750t1588r1221b1669],
11	carriers	NNS	O	carrier	nsubjpass	22	SENT_47	[p3l1264t1588r1526b1650],
12	of	IN	O	of	_	0	SENT_47	[p3l1570t1588r1647b1650],
13	the	DT	O	the	det	20	SENT_47	[p3l1681t1588r1787b1650],
14	high	JJ	O	high	amod	20	SENT_47	[p3l1827t1588r2149b1669],
15	—	NN	O	—	nn	20	SENT_47	[p3l1827t1588r2149b1669],
16	risk	NN	O	risk	nn	20	SENT_47	[p3l1827t1588r2149b1669],
17	HT	NN	O	ht	nn	20	SENT_47	[p3l11t1690r132b1748],
18	RA	NN	O	ra	nn	20	SENT_47	[p3l124t1688r271b1748],
19	]	CD	NUMBER	]	num	20	SENT_47	[p3l124t1688r271b1748],
20	allele	NN	O	allele	prep_of	11	SENT_47	[p3l313t1687r501b1749],
21	were	VBD	O	be	auxpass	22	SENT_47	[p3l535t1707r705b1749],
22	associated	VBN	O	associate	ccomp	8	SENT_47	[p3l741t1687r1103b1749],
23	with	IN	O	with	_	0	SENT_47	[p3l1137t1687r1292b1749],
24	better	JJR	O	better	amod	26	SENT_47	[p3l1324t1687r1527b1749],
25	VA	NN	O	va	nn	26	SENT_47	[p3l1559t1688r1686b1749],
26	outcomes	NNS	O	outcome	prep_with	22	SENT_47	[p3l1720t1676r2145b1760],
27	,	,	O	,	_	0	SENT_47	[p3l1720t1676r2145b1760],
28	”	IN	O	”	amod	26	SENT_47	[p3l1720t1676r2145b1760],

1	whereas	IN	O	whereas	mark	4	SENT_48	[p3l13t1785r300b1847],
2	another	DT	O	another	det	3	SENT_48	[p3l333t1785r598b1847],
3	study	NN	O	study	nsubj	4	SENT_48	[p3l628t1785r815b1865],
4	presented	VBD	O	present	_	0	SENT_48	[p3l844t1785r1185b1865],
5	lower	JJR	O	lower	amod	7	SENT_48	[p3l1214t1785r1415b1847],
6	VA	NNP	O	VA	nn	7	SENT_48	[p3l1443t1786r1569b1847],
7	outcomes	NNS	O	outcome	dobj	4	SENT_48	[p3l1600t1794r1935b1847],
8	associated	VBN	O	associate	partmod	7	SENT_48	[p3l1968t1805r2145b1847, p3l13t1883r224b1945],
9	with	IN	O	with	_	0	SENT_48	[p3l289t1883r445b1945],
10	the	DT	O	the	det	16	SENT_48	[p3l510t1883r616b1945],
11	homozygous	JJ	O	homozygous	amod	12	SENT_48	[p3l682t1883r1133b1964],
12	high	JJ	O	high	amod	16	SENT_48	[p3l1200t1883r1522b1964],
13	—	NN	O	—	nn	16	SENT_48	[p3l1200t1883r1522b1964],
14	risk	NN	O	risk	nn	16	SENT_48	[p3l1200t1883r1522b1964],
15	ARMS2/HTRAI	NN	O	arms2/htrai	nn	16	SENT_48	[p3l1580t1884r2140b1946],
16	genotype	NN	O	genotype	prep_with	8	SENT_48	[p3l14t1968r425b2061],
17	.	.	O	.	_	0	SENT_48	[p3l14t1968r425b2061],

1	”	NN	O	”	_	0	SENT_49	[p3l14t1968r425b2061],

1	To	TO	O	to	aux	2	SENT_50	[p3l120t2080r217b2141],
2	clarify	VB	O	clarify	_	0	SENT_50	[p3l247t2079r487b2159],
3	and	CC	O	and	_	0	SENT_50	[p3l517t2079r646b2141],
4	elaborate	VB	O	elaborate	conj_and	2	SENT_50	[p3l675t2079r1011b2141],
5	on	IN	O	on	_	0	SENT_50	[p3l1042t2098r1129b2141],
6	the	DT	O	the	det	7	SENT_50	[p3l1157t2079r1267b2141],
7	impact	NN	O	impact	prep_on	2	SENT_50	[p3l1296t2079r1546b2159],
8	of	IN	O	of	_	0	SENT_50	[p3l1574t2079r1652b2141],
9	the	DT	O	the	det	13	SENT_50	[p3l1675t2079r1785b2141],
10	high	JJ	O	high	amod	13	SENT_50	[p3l1813t2079r2149b2159],
11	—	NN	O	—	nn	13	SENT_50	[p3l1813t2079r2149b2159],
12	risk	NN	O	risk	nn	13	SENT_50	[p3l1813t2079r2149b2159],
13	alleles	NNS	O	allele	prep_of	7	SENT_50	[p3l15t2177r246b2239],
14	in	IN	O	in	_	0	SENT_50	[p3l281t2177r350b2238],
15	CFH	NNP	O	CFH	prep_in	13	SENT_50	[p3l386t2178r567b2239],
16	and	CC	O	and	_	0	SENT_50	[p3l595t2177r724b2239],
17	ARMS2	NN	O	arms2	prep_in	13	SENT_50	[p3l749t2177r1029b2239],
18	on	IN	O	on	_	0	SENT_50	[p3l1065t2196r1153b2239],
19	the	DT	O	the	det	20	SENT_50	[p3l1185t2177r1295b2239],
20	treatment	NN	O	treatment	prep_on	13	SENT_50	[p3l1327t2186r1677b2239],
21	with	IN	O	with	_	0	SENT_50	[p3l1708t2177r1870b2239],
22	ranibizumab	NN	O	ranibizumab	prep_with	20	SENT_50	[p3l1901t2177r2144b2239, p3l14t2275r275b2348],
23	,	,	O	,	_	0	SENT_50	[p3l1901t2177r2144b2239, p3l14t2275r275b2348],

1	a	DT	O	a	det	3	SENT_51	[p3l310t2295r347b2337],
2	multicenter	JJ	O	multicenter	amod	3	SENT_51	[p3l374t2275r797b2337],
3	study	NN	O	study	nsubjpass	5	SENT_51	[p3l827t2275r1021b2355],
4	was	VBD	O	be	auxpass	5	SENT_51	[p3l1051t2295r1188b2337],
5	conducted	VBN	O	conduct	_	0	SENT_51	[p3l1220t2275r1597b2337],
6	that	WDT	O	that	nsubj	7	SENT_51	[p3l1625t2275r1763b2337],
7	allowed	VBD	O	allow	ccomp	5	SENT_51	[p3l1793t2275r2082b2337],
8	a	DT	O	a	det	10	SENT_51	[p3l2112t2295r2149b2337],
9	thorough	JJ	O	thorough	amod	10	SENT_51	[p3l13t2373r345b2454],
10	analysis	NN	O	analysis	dobj	7	SENT_51	[p3l397t2373r690b2454],
11	in	IN	O	in	_	0	SENT_51	[p3l744t2373r813b2434],
12	the	DT	O	the	det	14	SENT_51	[p3l864t2373r973b2435],
13	largest	JJS	O	largest	amod	14	SENT_51	[p3l1025t2373r1272b2454],
14	series	NN	O	series	prep_in	7	SENT_51	[p3l1324t2373r1528b2435],
15	of	IN	O	of	_	0	SENT_51	[p3l1583t2373r1662b2435],
16	neovascular	JJ	O	neovascular	amod	18	SENT_51	[p3l1707t2373r2149b2435],
17	AMD	NN	ORGANIZATION	amd	nn	18	SENT_51	[p3l13t2471r220b2532],
18	patients	NNS	O	patient	prep_of	14	SENT_51	[p3l261t2470r547b2551],
19	studied	VBN	O	study	partmod	18	SENT_51	[p3l592t2470r855b2532],
20	to	TO	O	to	_	0	SENT_51	[p3l894t2480r962b2532],
21	date	NN	O	date	prep_to	19	SENT_51	[p3l1004t2470r1174b2532],
22	.	.	O	.	_	0	SENT_51	[p3l1004t2470r1174b2532],

1	Furthermore	RB	O	furthermore	advmod	9	SENT_52	[p3l1217t2470r1699b2544],
2	,	,	O	,	_	0	SENT_52	[p3l1217t2470r1699b2544],
3	the	DT	O	the	det	4	SENT_52	[p3l1743t2470r1852b2532],
4	role	NN	O	role	nsubj	9	SENT_52	[p3l1891t2470r2034b2532],
5	of	IN	O	of	_	0	SENT_52	[p3l2075t2470r2153b2532],
6	single	JJ	O	single	amod	8	SENT_52	[p3l16t2568r232b2649],
7	nucleotide	NN	O	nucleotide	nn	8	SENT_52	[p3l268t2568r652b2630],
8	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_52	[p3l687t2568r1259b2649],
9	(	VBP	O	(	_	0	SENT_52	[p3l1299t2569r1558b2645],
10	SNPs	NNS	O	snp	dobj	9	SENT_52	[p3l1299t2569r1558b2645],
11	)	CD	NUMBER	)	num	10	SENT_52	[p3l1299t2569r1558b2645],
12	in	IN	O	in	_	0	SENT_52	[p3l1596t2568r1665b2630],
13	VEGF	NN	O	vegf	prep_in	10	SENT_52	[p3l1706t2570r2039b2642],
14	.	.	O	.	_	0	SENT_52	[p3l1706t2570r2039b2642],

1	—	NN	O	—	_	0	SENT_53	[p3l1706t2570r2039b2642],
2	.	.	O	.	_	0	SENT_53	[p3l1706t2570r2039b2642],

1	A	DT	O	a	det	13	SENT_54	[p3l1706t2570r2039b2642],
2	,	,	O	,	_	0	SENT_54	[p3l1706t2570r2039b2642],
3	in	IN	O	in	dep	13	SENT_54	[p3l2078t2568r2148b2630],
4	its	PRP$	O	its	poss	6	SENT_54	[p3l13t2667r96b2729],
5	receptor	NN	O	receptor	nn	6	SENT_54	[p3l137t2676r442b2747],
6	VEGFR-2	NN	O	vegfr-2	pobj	3	SENT_54	[p3l485t2667r841b2729],
7	(	CD	NUMBER	(	num	8	SENT_54	[p3l887t2668r1147b2744],
8	KDR	NN	O	kdr	dep	6	SENT_54	[p3l887t2668r1147b2744],
9	)	NN	O	)	dep	8	SENT_54	[p3l887t2668r1147b2744],
10	,	,	O	,	_	0	SENT_54	[p3l887t2668r1147b2744],
11	and	CC	O	and	_	0	SENT_54	[p3l1192t2667r1321b2729],
12	in	IN	O	in	dep	6	SENT_54	[p3l1360t2667r1429b2728],
13	genes	NNS	O	gene	nsubj	14	SENT_54	[p3l1470t2686r1674b2747],
14	involved	VBN	O	involve	_	0	SENT_54	[p3l1717t2667r2039b2729],
15	in	IN	O	in	_	0	SENT_54	[p3l2078t2667r2147b2728],
16	angiogenesis	NN	O	angiogenesis	prep_in	14	SENT_54	[p3l15t2765r488b2845],
17	and	CC	O	and	_	0	SENT_54	[p3l521t2765r649b2827],
18	vascularization	NN	O	vascularization	prep_in	14	SENT_54	[p3l679t2765r1240b2827],
19	(	CD	NUMBER	(	num	20	SENT_54	[p3l1272t2766r1507b2841],
20	LPR5	NN	O	lpr5	nsubjpass	25	SENT_54	[p3l1272t2766r1507b2841],
21	and	CC	O	and	_	0	SENT_54	[p3l1538t2765r1666b2827],
22	FZD4	NN	O	fzd4	nn	23	SENT_54	[p3l1694t2765r1939b2841],
23	)	NN	O	)	nsubjpass	25	SENT_54	[p3l1694t2765r1939b2841],
24	were	VBD	O	be	auxpass	25	SENT_54	[p3l1972t2784r2147b2827],
25	analyzed	VBN	O	analyze	rcmod	16	SENT_54	[p3l15t2851r432b2943],
26	.	.	O	.	_	0	SENT_54	[p3l15t2851r432b2943],

1	“	NN	O	“	dep	6	SENT_55	[p3l15t2851r432b2943],
2	Because	IN	O	because	dep	6	SENT_55	[p3l465t2865r769b2925],
3	individual	JJ	O	individual	amod	4	SENT_55	[p3l802t2863r1177b2925],
4	patients	NNS	O	patient	nsubj	6	SENT_55	[p3l1208t2863r1494b2943],
5	can	MD	O	can	aux	6	SENT_55	[p3l1529t2883r1653b2925],
6	carry	VB	O	carry	advcl	18	SENT_55	[p3l1686t2883r1872b2944],
7	a	DT	O	a	det	9	SENT_55	[p3l1907t2883r1944b2925],
8	variable	JJ	O	variable	amod	9	SENT_55	[p3l1975t2863r2144b2925, p3l15t2961r164b3023],
9	number	NN	O	number	dobj	6	SENT_55	[p3l208t2961r488b3023],
10	of	IN	O	of	_	0	SENT_55	[p3l531t2961r610b3023],
11	high	JJ	O	high	amod	14	SENT_55	[p3l647t2961r982b3042],
12	—	NN	O	—	nn	14	SENT_55	[p3l647t2961r982b3042],
13	risk	NN	O	risk	nn	14	SENT_55	[p3l647t2961r982b3042],
14	variants	NNS	O	variant	prep_of	9	SENT_55	[p3l1025t2961r1337b3035],
15	,	,	O	,	_	0	SENT_55	[p3l1025t2961r1337b3035],
16	it	PRP	O	it	nsubjpass	18	SENT_55	[p3l1384t2961r1434b3023],
17	was	VBD	O	be	auxpass	18	SENT_55	[p3l1477t2981r1614b3023],
18	hypothesized	VBN	O	hypothesize	_	0	SENT_55	[p3l1659t2961r2147b3042],
19	that	IN	O	that	complm	27	SENT_55	[p3l13t3058r150b3120],
20	combinations	NNS	O	combination	nsubj	27	SENT_55	[p3l196t3058r690b3120],
21	of	IN	O	of	_	0	SENT_55	[p3l740t3058r818b3120],
22	high	JJ	O	high	amod	25	SENT_55	[p3l858t3058r1194b3139],
23	—	NN	O	—	nn	25	SENT_55	[p3l858t3058r1194b3139],
24	risk	NN	O	risk	nn	25	SENT_55	[p3l858t3058r1194b3139],
25	alleles	NNS	O	allele	prep_of	20	SENT_55	[p3l1240t3058r1472b3120],
26	may	MD	O	may	aux	27	SENT_55	[p3l1520t3078r1674b3139],
27	explain	VB	O	explain	ccomp	18	SENT_55	[p3l1721t3058r1991b3139],
28	the	DT	O	the	det	29	SENT_55	[p3l2037t3058r2147b3120],
29	heterogeneity	NN	O	heterogeneity	dobj	27	SENT_55	[p3l12t3157r516b3237],
30	in	IN	O	in	_	0	SENT_55	[p3l549t3157r617b3218],
31	the	DT	O	the	det	32	SENT_55	[p3l650t3157r759b3219],
32	age	NN	O	age	prep_in	29	SENT_55	[p3l794t3176r916b3237],
33	of	IN	O	of	_	0	SENT_55	[p3l950t3157r1028b3219],
34	neovascular	JJ	O	neovascular	amod	36	SENT_55	[p3l1055t3157r1497b3219],
35	disease	NN	O	disease	nn	36	SENT_55	[p3l1529t3157r1793b3219],
36	manifestation	NN	O	manifestation	prep_of	32	SENT_55	[p3l1825t3157r2144b3219, p3l13t3255r222b3317],
37	and	CC	O	and	_	0	SENT_55	[p3l250t3255r379b3317],
38	the	DT	O	the	det	40	SENT_55	[p3l404t3255r513b3317],
39	variable	JJ	O	variable	amod	40	SENT_55	[p3l540t3255r836b3317],
40	responses	NNS	O	response	conj_and	36	SENT_55	[p3l861t3274r1218b3335],
41	to	TO	O	to	_	0	SENT_55	[p3l1246t3264r1314b3317],
42	treatment	NN	O	treatment	prep_to	27	SENT_55	[p3l1341t3264r1690b3317],
43	with	IN	O	with	_	0	SENT_55	[p3l1715t3255r1876b3317],
44	ranibizumab	NN	O	ranibizumab	prep_with	27	SENT_55	[p3l1901t3255r2145b3317, p3l14t3353r274b3415],
45	.	.	O	.	_	0	SENT_55	[p3l1901t3255r2145b3317, p3l14t3353r274b3415],

1	Therefore	RB	O	therefore	advmod	12	SENT_56	[p3l328t3353r712b3426],
2	,	,	O	,	_	0	SENT_56	[p3l328t3353r712b3426],
3	in	IN	O	in	_	0	SENT_56	[p3l764t3353r834b3414],
4	contrast	NN	O	contrast	prep_in	12	SENT_56	[p3l883t3362r1176b3415],
5	to	TO	O	to	_	0	SENT_56	[p3l1224t3362r1291b3415],
6	previous	JJ	O	previous	amod	7	SENT_56	[p3l1341t3353r1656b3433],
7	studies	NNS	O	study	prep_to	4	SENT_56	[p3l1711t3353r1984b3426],
8	,	,	O	,	_	0	SENT_56	[p3l1711t3353r1984b3426],
9	the	DT	O	the	det	10	SENT_56	[p3l2037t3353r2147b3415],
10	data	NNS	O	datum	nsubjpass	12	SENT_56	[p3l14t3451r165b3513],
11	were	VBD	O	be	auxpass	12	SENT_56	[p3l197t3471r372b3513],
12	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_56	[p3l407t3451r728b3513],
13	according	VBG	O	accord	_	0	SENT_56	[p3l761t3451r1121b3532],
14	to	TO	O	to	prepc_according_to	12	SENT_56	[p3l1154t3460r1222b3513],
15	the	DT	O	the	det	16	SENT_56	[p3l1255t3451r1365b3513],
16	number	NN	O	number	pobj	12	SENT_56	[p3l1397t3451r1678b3513],
17	of	IN	O	of	_	0	SENT_56	[p3l1709t3451r1787b3513],
18	high	JJ	O	high	amod	21	SENT_56	[p3l1813t3451r2149b3532],
19	—	NN	O	—	nn	21	SENT_56	[p3l1813t3451r2149b3532],
20	risk	NN	O	risk	nn	21	SENT_56	[p3l1813t3451r2149b3532],
21	alleles	NNS	O	allele	prep_of	16	SENT_56	[p3l15t3549r246b3611],
22	to	TO	O	to	aux	23	SENT_56	[p3l287t3559r354b3611],
23	enable	VB	O	enable	xcomp	12	SENT_56	[p3l394t3549r632b3611],
24	study	NN	O	study	dobj	23	SENT_56	[p3l673t3549r867b3630],
25	of	IN	O	of	_	0	SENT_56	[p3l907t3549r986b3611],
26	the	DT	O	the	det	28	SENT_56	[p3l1017t3549r1127b3611],
27	combined	JJ	O	combined	amod	28	SENT_56	[p3l1166t3549r1527b3611],
28	effects	NNS	O	effect	prep_of	24	SENT_56	[p3l1565t3549r1808b3611],
29	of	IN	O	of	_	0	SENT_56	[p3l1849t3549r1928b3611],
30	these	DT	O	these	det	31	SENT_56	[p3l1960t3549r2147b3611],
31	genotypes	NNS	O	genotype	prep_of	28	SENT_56	[p3l14t3656r383b3727],
32	in	IN	O	in	_	0	SENT_56	[p3l424t3646r493b3708],
33	the	DT	O	the	det	34	SENT_56	[p3l532t3646r642b3708],
34	development	NN	O	development	prep_in	23	SENT_56	[p3l681t3646r1157b3727],
35	and	CC	O	and	_	0	SENT_56	[p3l1196t3646r1325b3708],
36	treatment	NN	O	treatment	prep_in	23	SENT_56	[p3l1363t3655r1712b3708],
37	of	IN	O	of	_	0	SENT_56	[p3l1751t3646r1829b3708],
38	neovascular	JJ	O	neovascular	amod	39	SENT_56	[p3l1862t3666r2145b3709, p3l13t3745r197b3807],
39	AMD	NNP	O	AMD	prep_of	34	SENT_56	[p3l231t3745r459b3807],
40	.	.	O	.	_	0	SENT_56	[p3l231t3745r459b3807],

1	Patients	NNS	O	patient	_	0	SENT_57	[p4l7t52r390b130],
2	and	CC	O	and	_	0	SENT_57	[p4l432t47r606b130],
3	Methods	NNS	O	method	conj_and	1	SENT_57	[p4l644t47r1057b130],

1	Study	NNP	O	Study	nn	2	SENT_58	[p4l11t237r246b330],
2	Population	NNP	O	Population	_	0	SENT_58	[p4l280t237r725b330],

1	Four	CD	NUMBER	four	num	4	SENT_59	[p4l7t400r158b454],
2	hundred	CD	NUMBER	hundred	num	4	SENT_59	[p4l179t398r441b454],
3	twenty	CD	NUMBER	twenty	num	4	SENT_59	[p4l463t406r679b471],
4	eyes	NNS	O	eye	nsubjpass	24	SENT_59	[p4l703t416r841b471],
5	of	IN	O	of	_	0	SENT_59	[p4l866t398r935b454],
6	397	CD	NUMBER	397	num	9	SENT_59	[p4l954t399r1068b455],
7	unrelated	JJ	O	unrelated	amod	9	SENT_59	[p4l1093t398r1391b454],
8	white	JJ	O	white	amod	9	SENT_59	[p4l1413t398r1588b454],
9	patients	NNS	O	patient	prep_of	4	SENT_59	[p4l1610t398r1857b471],
10	50	CD	DURATION	50	num	11	SENT_59	[p4l1883t398r1959b455],
11	years	NNS	NUMBER	year	tmod	9	SENT_59	[p4l1982t416r2148b471],
12	of	IN	O	of	_	0	SENT_59	[p4l8t486r78b542],
13	age	NN	O	age	prep_of	9	SENT_59	[p4l110t504r217b559],
14	or	CC	O	or	_	0	SENT_59	[p4l255t504r320b543],
15	older	JJR	O	older	nsubjpass	24	SENT_59	[p4l356t486r520b543],
16	with	IN	O	with	_	0	SENT_59	[p4l555t486r695b543],
17	active	JJ	O	active	amod	19	SENT_59	[p4l733t486r921b543],
18	subfoveal	JJ	O	subfoveal	amod	19	SENT_59	[p4l960t486r1267b543],
19	CNV	NN	ORGANIZATION	cnv	prep_with	15	SENT_59	[p4l1305t487r1470b543],
20	secondary	JJ	O	secondary	amod	15	SENT_59	[p4l1510t486r1831b559],
21	to	TO	O	to	_	0	SENT_59	[p4l1867t495r1927b542],
22	AMD	NNP	ORGANIZATION	AMD	prep_to	15	SENT_59	[p4l1964t487r2148b542],
23	were	VBD	O	be	auxpass	24	SENT_59	[p4l8t592r161b631],
24	evaluated	VBN	O	evaluate	_	0	SENT_59	[p4l239t575r560b631],
25	.	.	O	.	_	0	SENT_59	[p4l239t575r560b631],

1	All	DT	O	all	det	3	SENT_60	[p4l642t575r742b630],
2	study	NN	O	study	nn	3	SENT_60	[p4l823t575r991b648],
3	participants	NNS	O	participant	nsubjpass	5	SENT_60	[p4l1068t575r1440b648],
4	were	VBD	O	be	auxpass	5	SENT_60	[p4l1520t592r1673b631],
5	enrolled	VBN	O	enrol	_	0	SENT_60	[p4l1751t575r2013b631],
6	in	IN	O	in	_	0	SENT_60	[p4l2089t575r2150b630],
7	EUGENDA	NNP	O	EUGENDA	prep_in	5	SENT_60	[p4l7t662r394b719],
8	(	CD	NUMBER	(	num	7	SENT_60	[p4l424t663r754b735],
9	European	JJ	ORGANIZATION	european	amod	12	SENT_60	[p4l424t663r754b735],
10	Genetic	JJ	ORGANIZATION	genetic	amod	12	SENT_60	[p4l782t662r1028b719],
11	Database	NN	ORGANIZATION	database	nn	12	SENT_60	[p4l1056t662r1392b731],
12	)	NN	O	)	tmod	5	SENT_60	[p4l1056t662r1392b731],
13	,	,	O	,	_	0	SENT_60	[p4l1056t662r1392b731],
14	a	DT	O	a	det	16	SENT_60	[p4l1425t680r1458b718],
15	multicenter	NN	O	multicenter	nn	16	SENT_60	[p4l1484t662r1849b718],
16	database	NN	O	database	appos	12	SENT_60	[p4l1876t662r2149b718],
17	for	IN	O	for	_	0	SENT_60	[p4l8t750r100b806],
18	the	DT	O	the	det	22	SENT_60	[p4l123t750r218b807],
19	clinical	JJ	O	clinical	amod	22	SENT_60	[p4l244t750r477b806],
20	and	CC	O	and	_	0	SENT_60	[p4l503t750r616b807],
21	molecular	JJ	O	molecular	amod	22	SENT_60	[p4l639t750r960b807],
22	analysis	NN	O	analysis	prep_for	16	SENT_60	[p4l984t750r1237b823],
23	of	IN	O	of	_	0	SENT_60	[p4l1264t750r1333b806],
24	AMD	NNP	ORGANIZATION	AMD	prep_of	22	SENT_60	[p4l1351t751r1554b817],
25	,	,	O	,	_	0	SENT_60	[p4l1351t751r1554b817],
26	and	CC	O	and	_	0	SENT_60	[p4l1583t750r1695b806],
27	venous	JJ	O	venous	amod	28	SENT_60	[p4l1719t768r1942b807],
28	blood	NN	O	blood	nsubjpass	32	SENT_60	[p4l1967t750r2150b807],
29	for	IN	O	for	_	0	SENT_60	[p4l8t839r100b895],
30	genotyping	VBG	O	genotype	prep_for	28	SENT_60	[p4l125t839r482b912],
31	was	VBD	O	be	auxpass	32	SENT_60	[p4l508t856r628b895],
32	drawn	VBN	O	draw	conj_and	5	SENT_60	[p4l655t839r854b895],
33	before	IN	O	before	_	0	SENT_60	[p4l876t839r1080b895],
34	onset	NN	O	onset	prep_before	32	SENT_60	[p4l1106t847r1274b895],
35	of	IN	O	of	_	0	SENT_60	[p4l1298t839r1367b895],
36	treatment	NN	O	treatment	prep_of	34	SENT_60	[p4l1386t847r1704b895],
37	.	.	O	.	_	0	SENT_60	[p4l1386t847r1704b895],

1	One	CD	NUMBER	one	num	4	SENT_61	[p4l1734t839r1864b895],
2	hundred	CD	NUMBER	hundred	num	4	SENT_61	[p4l1887t839r2150b895],
3	seventy-two	CD	NUMBER	seventy-two	num	4	SENT_61	[p4l10t934r397b999],
4	eyes	NNS	O	eye	nsubj	57	SENT_61	[p4l424t944r561b999],
5	(	VBP	O	(	rcmod	4	SENT_61	[p4l591t926r784b996],
6	41	CD	PERCENT	41	num	7	SENT_61	[p4l591t926r784b996],
7	%	NN	PERCENT	%	dobj	5	SENT_61	[p4l591t926r784b996],
8	)	CD	NUMBER	)	nsubjpass	12	SENT_61	[p4l591t926r784b996],
9	were	VBD	O	be	auxpass	10	SENT_61	[p4l812t944r965b982],
10	examined	VBN	O	examine	rcmod	7	SENT_61	[p4l991t926r1301b982],
11	and	CC	O	and	_	0	SENT_61	[p4l1326t926r1439b982],
12	treated	VBN	O	treat	conj_and	10	SENT_61	[p4l1463t926r1681b982],
13	at	IN	O	at	_	0	SENT_61	[p4l1706t934r1762b982],
14	the	DT	O	the	det	15	SENT_61	[p4l1785t926r1881b982],
15	Department	NNP	ORGANIZATION	Department	prep_at	12	SENT_61	[p4l1906t928r2147b999, p4l8t1023r167b1071],
16	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l200t1014r269b1071],
17	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	prep_of	15	SENT_61	[p4l297t1014r815b1087],
18	,	,	O	,	_	0	SENT_61	[p4l297t1014r815b1087],
19	Radboud	NNP	ORGANIZATION	Radboud	nn	23	SENT_61	[p4l850t1014r1139b1071],
20	University	NNP	ORGANIZATION	University	nn	23	SENT_61	[p4l1171t1014r1508b1087],
21	Nijmegen	NNP	ORGANIZATION	Nijmegen	nn	23	SENT_61	[p4l1541t1014r1856b1087],
22	Medical	NNP	ORGANIZATION	Medical	nn	23	SENT_61	[p4l1888t1014r2149b1071],
23	Centre	NNP	ORGANIZATION	Centre	dep	10	SENT_61	[p4l8t1103r237b1169],
24	,	,	O	,	_	0	SENT_61	[p4l8t1103r237b1169],
25	Nijmegen	NNP	ORGANIZATION	Nijmegen	appos	23	SENT_61	[p4l268t1103r601b1176],
26	,	,	O	,	_	0	SENT_61	[p4l268t1103r601b1176],
27	The	DT	LOCATION	the	det	28	SENT_61	[p4l633t1103r755b1159],
28	Netherlands	NNP	LOCATION	Netherlands	appos	23	SENT_61	[p4l784t1103r1190b1169],
29	;	:	O	;	_	0	SENT_61	[p4l784t1103r1190b1169],
30	193	CD	NUMBER	193	num	31	SENT_61	[p4l1230t1103r1337b1160],
31	eyes	NNS	O	eye	dep	23	SENT_61	[p4l1371t1120r1509b1175],
32	(	RB	O	(	dep	34	SENT_61	[p4l1542t1103r1736b1172],
33	46	CD	PERCENT	46	num	34	SENT_61	[p4l1542t1103r1736b1172],
34	%	NN	PERCENT	%	dep	37	SENT_61	[p4l1542t1103r1736b1172],
35	)	CD	NUMBER	)	nsubjpass	39	SENT_61	[p4l1542t1103r1736b1172],
36	were	VBD	O	be	auxpass	37	SENT_61	[p4l1768t1120r1922b1159],
37	examined	VBN	O	examine	dep	23	SENT_61	[p4l1951t1120r2147b1159, p4l7t1191r144b1247],
38	and	CC	O	and	_	0	SENT_61	[p4l173t1191r286b1247],
39	treated	VBN	O	treat	dep	23	SENT_61	[p4l313t1191r530b1247],
40	at	IN	O	at	_	0	SENT_61	[p4l559t1199r614b1247],
41	the	DT	O	the	det	42	SENT_61	[p4l641t1191r736b1247],
42	Department	NNP	ORGANIZATION	Department	prep_at	37	SENT_61	[p4l764t1192r1143b1264],
43	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l1170t1191r1240b1247],
44	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	prep_of	42	SENT_61	[p4l1263t1191r1781b1264],
45	,	,	O	,	_	0	SENT_61	[p4l1263t1191r1781b1264],
46	University	NNP	ORGANIZATION	University	conj_and	42	SENT_61	[p4l1812t1191r2149b1264],
47	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l8t1278r78b1334],
48	Cologne	NNP	ORGANIZATION	Cologne	prep_of	46	SENT_61	[p4l93t1278r380b1351],
49	,	,	O	,	_	0	SENT_61	[p4l93t1278r380b1351],
50	Cologne	NNP	LOCATION	Cologne	conj_and	42	SENT_61	[p4l404t1278r690b1351],
51	,	,	O	,	_	0	SENT_61	[p4l404t1278r690b1351],
52	Germany	NNP	LOCATION	Germany	appos	50	SENT_61	[p4l714t1279r1029b1351],
53	;	:	O	;	_	0	SENT_61	[p4l714t1279r1029b1351],
54	and	CC	O	and	_	0	SENT_61	[p4l1054t1278r1167b1335],
55	55	CD	NUMBER	55	num	56	SENT_61	[p4l1188t1278r1261b1335],
56	eyes	NNS	O	eye	conj_and	42	SENT_61	[p4l1286t1296r1424b1351],
57	(	VBP	O	(	_	0	SENT_61	[p4l1448t1279r1642b1348],
58	13	CD	PERCENT	13	num	59	SENT_61	[p4l1448t1279r1642b1348],
59	%	NN	PERCENT	%	dobj	57	SENT_61	[p4l1448t1279r1642b1348],
60	)	CD	NUMBER	)	nsubjpass	62	SENT_61	[p4l1448t1279r1642b1348],
61	were	VBD	O	be	auxpass	62	SENT_61	[p4l1665t1296r1818b1335],
62	examined	VBN	O	examine	rcmod	59	SENT_61	[p4l1840t1278r2150b1335],
63	and	CC	O	and	_	0	SENT_61	[p4l9t1367r122b1423],
64	treated	VBN	O	treat	rcmod	59	SENT_61	[p4l148t1367r366b1423],
65	at	IN	O	at	_	0	SENT_61	[p4l394t1375r449b1423],
66	the	DT	O	the	det	67	SENT_61	[p4l475t1367r571b1423],
67	Department	NNP	ORGANIZATION	Department	prep_at	62	SENT_61	[p4l598t1368r977b1440],
68	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l1004t1367r1073b1423],
69	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	nn	74	SENT_61	[p4l1096t1367r1614b1440],
70	,	,	O	,	_	0	SENT_61	[p4l1096t1367r1614b1440],
71	McGill	NNP	ORGANIZATION	McGill	appos	74	SENT_61	[p4l1644t1367r1874b1423],
72	University	NNP	ORGANIZATION	University	nn	74	SENT_61	[p4l1901t1367r2147b1423, p4l10t1455r121b1528],
73	Health	NNP	ORGANIZATION	Health	nn	74	SENT_61	[p4l157t1455r370b1511],
74	Center	NNP	ORGANIZATION	Center	prep_of	67	SENT_61	[p4l406t1455r634b1521],
75	,	,	O	,	_	0	SENT_61	[p4l406t1455r634b1521],
76	Montreal	NNP	LOCATION	Montreal	nn	78	SENT_61	[p4l672t1455r982b1522],
77	,	,	O	,	_	0	SENT_61	[p4l672t1455r982b1522],
78	Canada	NNP	LOCATION	Canada	appos	74	SENT_61	[p4l1022t1455r1275b1511],
79	.	.	O	.	_	0	SENT_61	[p4l1022t1455r1275b1511],

1	All	DT	O	all	det	2	SENT_62	[p4l1315t1455r1416b1510],
2	participants	NNS	O	participant	nsubjpass	4	SENT_62	[p4l1450t1455r1822b1528],
3	were	VBD	O	be	auxpass	4	SENT_62	[p4l1860t1473r2014b1511],
4	enrolled	VBN	O	enrol	_	0	SENT_62	[p4l2050t1473r2148b1511, p4l7t1542r193b1599],
5	between	IN	O	between	_	0	SENT_62	[p4l212t1542r478b1599],
6	June	NNP	DATE	June	prep_between	4	SENT_62	[p4l498t1544r643b1599],
7	2008	CD	DATE	2008	num	6	SENT_62	[p4l664t1543r819b1599],
8	and	CC	O	and	_	0	SENT_62	[p4l843t1542r956b1599],
9	June	NNP	DATE	June	prep_between	4	SENT_62	[p4l975t1544r1120b1599],
10	2010	CD	DATE	2010	num	9	SENT_62	[p4l1142t1543r1315b1599],
11	.	.	O	.	_	0	SENT_62	[p4l1142t1543r1315b1599],

1	The	DT	O	the	det	2	SENT_63	[p4l1339t1542r1462b1598],
2	study	NN	O	study	nsubjpass	4	SENT_63	[p4l1485t1542r1653b1615],
3	was	VBD	O	be	auxpass	4	SENT_63	[p4l1674t1560r1795b1599],
4	performed	VBN	O	perform	_	0	SENT_63	[p4l1815t1542r2150b1615],
5	in	IN	O	in	_	0	SENT_63	[p4l7t1631r68b1686],
6	accordance	NN	O	accordance	_	0	SENT_63	[p4l94t1631r451b1687],
7	with	IN	O	with	_	0	SENT_63	[p4l477t1631r618b1687],
8	the	DT	O	the	det	9	SENT_63	[p4l642t1631r737b1687],
9	tenets	NNS	O	tenet	prep_in_accordance_with	4	SENT_63	[p4l763t1639r946b1687],
10	of	IN	O	of	_	0	SENT_63	[p4l974t1631r1043b1687],
11	the	DT	O	the	det	12	SENT_63	[p4l1062t1631r1157b1687],
12	Declaration	NN	O	declaration	prep_of	9	SENT_63	[p4l1182t1631r1556b1687],
13	of	IN	O	of	_	0	SENT_63	[p4l1581t1631r1650b1687],
14	Helsinki	NNP	LOCATION	Helsinki	prep_of	12	SENT_63	[p4l1669t1631r1939b1687],
15	(	CD	NUMBER	(	num	14	SENT_63	[p4l1967t1631r2146b1700],
16	1983	CD	DATE	1983	num	18	SENT_63	[p4l1967t1631r2146b1700],
17	revision	NN	O	revision	nn	18	SENT_63	[p4l7t1719r289b1788],
18	)	NN	O	)	tmod	4	SENT_63	[p4l7t1719r289b1788],
19	and	CC	O	and	_	0	SENT_63	[p4l333t1719r446b1775],
20	the	DT	O	the	det	26	SENT_63	[p4l485t1719r581b1775],
21	Medical	NNP	MISC	Medical	nn	26	SENT_63	[p4l621t1719r882b1775],
22	Research	NNP	MISC	Research	nn	26	SENT_63	[p4l922t1719r1215b1775],
23	Involving	NNP	MISC	Involving	nn	26	SENT_63	[p4l1254t1719r1564b1792],
24	Human	NNP	MISC	Human	nn	26	SENT_63	[p4l1605t1720r1840b1775],
25	Subjects	NNP	MISC	Subjects	nn	26	SENT_63	[p4l1882t1719r2148b1792],
26	Act	NNP	MISC	Act	conj_and	18	SENT_63	[p4l7t1807r137b1863],
27	.	.	O	.	_	0	SENT_63	[p4l7t1807r137b1863],

1	The	DT	O	the	det	2	SENT_64	[p4l170t1806r292b1862],
2	approval	NN	O	approval	nsubjpass	16	SENT_64	[p4l322t1806r599b1879],
3	of	IN	O	of	_	0	SENT_64	[p4l629t1806r698b1862],
4	the	DT	O	the	det	7	SENT_64	[p4l720t1806r816b1862],
5	local	JJ	O	local	amod	7	SENT_64	[p4l844t1806r998b1863],
6	ethics	NNS	O	ethic	nn	7	SENT_64	[p4l1027t1806r1210b1863],
7	committee	NN	O	committee	prep_of	2	SENT_64	[p4l1241t1806r1576b1863],
8	was	VBD	O	be	auxpass	9	SENT_64	[p4l1605t1824r1726b1863],
9	obtained	VBN	O	obtain	ccomp	21	SENT_64	[p4l1757t1806r2031b1863],
10	for	IN	O	for	_	0	SENT_64	[p4l2059t1806r2151b1862],
11	all	DT	O	all	det	13	SENT_64	[p4l9t1895r85b1951],
12	3	CD	NUMBER	3	num	13	SENT_64	[p4l113t1895r145b1951],
13	centers	NNS	O	center	prep_for	9	SENT_64	[p4l175t1903r417b1961],
14	,	,	O	,	_	0	SENT_64	[p4l175t1903r417b1961],
15	and	CC	O	and	_	0	SENT_64	[p4l447t1895r560b1951],
16	written	VBN	O	write	ccomp	21	SENT_64	[p4l586t1895r828b1961],
17	,	,	O	,	_	0	SENT_64	[p4l586t1895r828b1961],
18	informed	VBN	O	inform	amod	19	SENT_64	[p4l856t1895r1150b1951],
19	consent	NN	O	consent	nsubjpass	21	SENT_64	[p4l1175t1903r1419b1951],
20	was	VBD	O	be	auxpass	21	SENT_64	[p4l1444t1912r1564b1951],
21	acquired	VBN	O	acquire	_	0	SENT_64	[p4l1593t1895r1867b1967],
22	from	IN	O	from	_	0	SENT_64	[p4l1892t1895r2047b1951],
23	all	DT	O	all	det	24	SENT_64	[p4l2073t1895r2149b1951],
24	participants	NNS	O	participant	prep_from	21	SENT_64	[p4l7t1983r396b2056],
25	.	.	O	.	_	0	SENT_64	[p4l7t1983r396b2056],

1	The	DT	O	the	det	2	SENT_65	[p4l115t2070r237b2126],
2	diagnosis	NN	O	diagnosis	nsubjpass	8	SENT_65	[p4l268t2070r567b2143],
3	and	CC	O	and	_	0	SENT_65	[p4l601t2070r713b2126],
4	grading	NN	O	grading	conj_and	2	SENT_65	[p4l743t2070r985b2143],
5	of	IN	O	of	_	0	SENT_65	[p4l1017t2070r1086b2126],
6	AMD	NNP	ORGANIZATION	AMD	prep_of	2	SENT_65	[p4l1111t2071r1294b2126],
7	was	VBD	O	be	auxpass	8	SENT_65	[p4l1326t2088r1447b2127],
8	based	VBN	O	base	_	0	SENT_65	[p4l1478t2070r1660b2126],
9	on	IN	O	on	_	0	SENT_65	[p4l1691t2088r1768b2126],
10	an	DT	O	a	det	12	SENT_65	[p4l1799t2088r1871b2127],
11	international	JJ	O	international	amod	12	SENT_65	[p4l1901t2070r2147b2127, p4l7t2158r188b2215],
12	classiﬁcation	NN	O	classiﬁcation	prep_on	8	SENT_65	[p4l213t2158r630b2215],
13	and	CC	O	and	_	0	SENT_65	[p4l654t2159r767b2215],
14	grading	NN	O	grading	nn	15	SENT_65	[p4l791t2158r1033b2231],
15	scheme	NN	O	scheme	prep_on	8	SENT_65	[p4l1060t2159r1296b2215],
16	for	IN	O	for	_	0	SENT_65	[p4l1320t2158r1412b2215],
17	age-related	JJ	O	age-related	amod	18	SENT_65	[p4l1436t2158r1790b2231],
18	macu1opathy	NN	O	macu1opathy	prep_for	12	SENT_65	[p4l1812t2159r2147b2231, p4l7t2247r107b2320],
19	and	CC	O	and	_	0	SENT_65	[p4l151t2247r263b2303],
20	AMD	NNP	ORGANIZATION	AMD	conj_and	18	SENT_65	[p4l304t2248r506b2314],
21	,	,	O	,	_	0	SENT_65	[p4l304t2248r506b2314],
22	as	IN	O	as	mark	23	SENT_65	[p4l552t2265r613b2303],
23	described	VBN	O	describe	advcl	8	SENT_65	[p4l657t2247r962b2303],
24	previously	RB	DATE	previously	advmod	23	SENT_65	[p4l1002t2247r1339b2320],
25	in	IN	O	in	_	0	SENT_65	[p4l1381t2247r1441b2302],
26	another	DT	O	another	det	27	SENT_65	[p4l1484t2247r1723b2303],
27	study	NN	O	study	prep_in	23	SENT_65	[p4l1765t2240r1985b2320],
28	?	.	O	?	_	0	SENT_65	[p4l1765t2240r1985b2320],

1	The	DT	O	the	det	2	SENT_66	[p4l2026t2247r2149b2303],
2	diagnosis	NN	O	diagnosis	nsubjpass	11	SENT_66	[p4l8t2334r307b2407],
3	of	IN	O	of	_	0	SENT_66	[p4l335t2334r404b2391],
4	active	JJ	O	active	amod	6	SENT_66	[p4l426t2334r614b2391],
5	subfoveal	JJ	O	subfoveal	amod	6	SENT_66	[p4l641t2334r949b2391],
6	CNV	NN	ORGANIZATION	cnv	prep_of	2	SENT_66	[p4l975t2335r1141b2391],
7	secondary	JJ	O	secondary	amod	6	SENT_66	[p4l1170t2335r1490b2407],
8	to	TO	O	to	_	0	SENT_66	[p4l1516t2343r1575b2391],
9	AMD	NNP	ORGANIZATION	AMD	prep_to	7	SENT_66	[p4l1601t2335r1785b2390],
10	was	VBD	O	be	auxpass	11	SENT_66	[p4l1812t2352r1932b2391],
11	established	VBN	O	establish	ccomp	38	SENT_66	[p4l1960t2334r2147b2391, p4l8t2423r198b2479],
12	by	IN	O	by	_	0	SENT_66	[p4l240t2423r319b2495],
13	retinal	JJ	O	retinal	amod	14	SENT_66	[p4l363t2423r567b2479],
14	specialists	NNS	O	specialist	agent	11	SENT_66	[p4l614t2423r938b2496],
15	based	VBN	O	base	_	0	SENT_66	[p4l982t2423r1165b2479],
16	on	IN	O	on	prepc_based_on	11	SENT_66	[p4l1209t2440r1287b2479],
17	ophthalmic	JJ	O	ophthalmic	amod	18	SENT_66	[p4l1332t2423r1689b2495],
18	examination	NN	O	examination	pobj	11	SENT_66	[p4l1735t2423r2147b2489],
19	,	,	O	,	_	0	SENT_66	[p4l1735t2423r2147b2489],
20	ﬂuorescein	NN	O	ﬂuorescein	nn	21	SENT_66	[p4l9t2510r358b2566],
21	angiography	NN	O	angiography	conj_and	18	SENT_66	[p4l400t2510r815b2583],
22	,	,	O	,	_	0	SENT_66	[p4l400t2510r815b2583],
23	and	CC	O	and	_	0	SENT_66	[p4l860t2510r973b2566],
24	spectral-domain	JJ	O	spectral-domain	amod	27	SENT_66	[p4l1016t2510r1529b2583],
25	optical	JJ	O	optical	amod	27	SENT_66	[p4l1570t2510r1785b2583],
26	coherence	NN	O	coherence	nn	27	SENT_66	[p4l1827t2510r2149b2566],
27	tomography	NN	O	tomography	conj_and	18	SENT_66	[p4l7t2591r575b2671],
28	.16	CD	NUMBER	.16	number	29	SENT_66	[p4l7t2591r575b2671],
29	‘	CD	NUMBER	‘	amod	27	SENT_66	[p4l7t2591r575b2671],
30	18	CD	NUMBER	18	dep	29	SENT_66	[p4l7t2591r575b2671],
31	Before	IN	O	before	dep	30	SENT_66	[p4l604t2599r820b2655],
32	retinal	JJ	O	retinal	amod	33	SENT_66	[p4l846t2599r1050b2655],
33	imaging	NN	O	imaging	pobj	31	SENT_66	[p4l1077t2599r1355b2671],
34	,	,	O	,	_	0	SENT_66	[p4l1077t2599r1355b2671],
35	pupillary	JJ	O	pupillary	amod	36	SENT_66	[p4l1383t2599r1672b2671],
36	dilatation	NN	O	dilatation	nsubjpass	38	SENT_66	[p4l1700t2599r2001b2655],
37	was	VBD	O	be	auxpass	38	SENT_66	[p4l2027t2617r2148b2655],
38	achieved	VBN	O	achieve	_	0	SENT_66	[p4l9t2687r291b2743],
39	with	IN	O	with	_	0	SENT_66	[p4l320t2687r460b2743],
40	topical	JJ	O	topical	amod	43	SENT_66	[p4l488t2687r704b2759],
41	1.0	CD	PERCENT	1.0	number	42	SENT_66	[p4l740t2687r895b2743],
42	%	NN	PERCENT	%	amod	43	SENT_66	[p4l740t2687r895b2743],
43	tropicamide	NN	O	tropicamide	prep_with	38	SENT_66	[p4l926t2687r1308b2760],
44	and	CC	O	and	_	0	SENT_66	[p4l1338t2687r1451b2743],
45	2.5	CD	PERCENT	2.5	number	46	SENT_66	[p4l1479t2687r1640b2743],
46	%	NN	PERCENT	%	amod	47	SENT_66	[p4l1479t2687r1640b2743],
47	phenylephrine	NN	O	phenylephrine	conj_and	43	SENT_66	[p4l1670t2687r2146b2760],
48	.	.	O	.	_	0	SENT_66	[p4l1670t2687r2146b2760],

1	Digital	NNP	O	Digital	nn	4	SENT_67	[p4l7t2774r228b2847],
2	color	NN	O	color	nn	4	SENT_67	[p4l261t2774r425b2830],
3	fundus	NN	O	fundus	nn	4	SENT_67	[p4l456t2774r670b2830],
4	photography	NN	O	photography	nsubjpass	6	SENT_67	[p4l703t2774r1107b2847],
5	was	VBD	O	be	auxpass	6	SENT_67	[p4l1140t2792r1261b2830],
6	carried	VBN	O	carry	_	0	SENT_67	[p4l1295t2774r1516b2830],
7	out	RP	O	out	prt	6	SENT_67	[p4l1548t2783r1649b2830],
8	with	IN	O	with	_	0	SENT_67	[p4l1680t2774r1821b2830],
9	Imagenet	NN	O	imagenet	nn	12	SENT_67	[p4l1853t2776r2151b2847],
10	(	CD	NUMBER	(	num	12	SENT_67	[p4l10t2863r81b2932],
11	T	NN	O	t	nn	12	SENT_67	[p4l10t2863r81b2932],
12	opcon	NN	O	opcon	prep_with	6	SENT_67	[p4l84t2880r278b2935],
13	Corporation	NNP	O	Corporation	nn	19	SENT_67	[p4l306t2862r708b2935],
14	,	,	O	,	_	0	SENT_67	[p4l306t2862r708b2935],
15	Tokyo	NNP	LOCATION	Tokyo	appos	19	SENT_67	[p4l738t2863r962b2935],
16	,	,	O	,	_	0	SENT_67	[p4l738t2863r962b2935],
17	Japan	NNP	LOCATION	Japan	appos	19	SENT_67	[p4l992t2864r1173b2935],
18	[	CD	NUMBER	[	num	19	SENT_67	[p4l1206t2862r1613b2935],
19	Nijmegen	NNP	MISC	Nijmegen	dep	12	SENT_67	[p4l1206t2862r1613b2935],
20	]	CD	NUMBER	]	number	21	SENT_67	[p4l1206t2862r1613b2935],
21	)	CD	NUMBER	)	dep	19	SENT_67	[p4l1206t2862r1613b2935],
22	,	,	O	,	_	0	SENT_67	[p4l1206t2862r1613b2935],
23	Zeiss	NNP	PERSON	Zeiss	nn	28	SENT_67	[p4l1642t2862r1808b2919],
24	FF450	NNP	O	FF450	nn	28	SENT_67	[p4l1836t2862r2044b2919],
25	IR	NNP	O	IR	nn	28	SENT_67	[p4l2071t2864r2151b2918],
26	(	NNP	O	(	nn	28	SENT_67	[p4l10t2951r170b3020],
27	Carl	NNP	PERSON	Carl	nn	28	SENT_67	[p4l10t2951r170b3020],
28	Zeiss	NNP	PERSON	Zeiss	appos	12	SENT_67	[p4l191t2951r376b3017],
29	,	,	O	,	_	0	SENT_67	[p4l191t2951r376b3017],
30	Jena	NNP	PERSON	Jena	conj_and	28	SENT_67	[p4l400t2952r558b3017],
31	,	,	O	,	_	0	SENT_67	[p4l400t2952r558b3017],
32	Germany	NNP	LOCATION	Germany	nn	33	SENT_67	[p4l584t2951r923b3023],
33	)	NNP	O	)	conj_and	28	SENT_67	[p4l584t2951r923b3023],
34	,	,	O	,	_	0	SENT_67	[p4l584t2951r923b3023],
35	and	CC	O	and	_	0	SENT_67	[p4l949t2951r1062b3007],
36	Canon	NNP	ORGANIZATION	Canon	nn	40	SENT_67	[p4l1083t2951r1290b3007],
37	CF-60	NNP	O	CF-60	nn	40	SENT_67	[p4l1312t2951r1513b3007],
38	DSi	NNP	O	DSi	nn	40	SENT_67	[p4l1535t2951r1657b3007],
39	(	NNP	O	(	nn	40	SENT_67	[p4l1682t2951r1931b3020],
40	Canon	NNP	ORGANIZATION	Canon	conj_and	28	SENT_67	[p4l1682t2951r1931b3020],
41	,	,	O	,	_	0	SENT_67	[p4l1682t2951r1931b3020],
42	HaagStreit	NNP	O	HaagStreit	nn	43	SENT_67	[p4l1955t2952r2147b3024, p4l10t3038r181b3095],
43	Deutschland	NNP	ORGANIZATION	Deutschland	appos	12	SENT_67	[p4l222t3038r622b3094],
44	GmbH	NN	ORGANIZATION	gmbh	dep	43	SENT_67	[p4l665t3038r898b3105],
45	,	,	O	,	_	0	SENT_67	[p4l665t3038r898b3105],
46	Wedel	NNP	ORGANIZATION	Wedel	nn	50	SENT_67	[p4l943t3038r1168b3105],
47	,	,	O	,	_	0	SENT_67	[p4l943t3038r1168b3105],
48	Germany	NNP	LOCATION	Germany	appos	50	SENT_67	[p4l1215t3038r1510b3111],
49	[	CD	NUMBER	[	num	50	SENT_67	[p4l1559t3038r1901b3111],
50	Cologne	NNP	LOCATION	Cologne	appos	12	SENT_67	[p4l1559t3038r1901b3111],
51	]	CD	NUMBER	]	number	52	SENT_67	[p4l1559t3038r1901b3111],
52	)	CD	NUMBER	)	num	55	SENT_67	[p4l1559t3038r1901b3111],
53	digital	JJ	O	digital	amod	55	SENT_67	[p4l1947t3038r2150b3111],
54	fundus	NN	O	fundus	nn	55	SENT_67	[p4l8t3126r222b3183],
55	cameras	NNS	O	camera	dep	50	SENT_67	[p4l250t3144r526b3183],
56	.	.	O	.	_	0	SENT_67	[p4l250t3144r526b3183],

1	Each	DT	O	each	det	2	SENT_68	[p4l555t3126r714b3183],
2	participant	NN	O	participant	nsubj	3	SENT_68	[p4l738t3126r1082b3199],
3	underwent	VBD	O	undergo	_	0	SENT_68	[p4l1105t3126r1444b3183],
4	ﬂuorescein	NN	O	ﬂuorescein	nn	5	SENT_68	[p4l1469t3126r1819b3183],
5	angiography	NN	O	angiography	dobj	3	SENT_68	[p4l1845t3126r2147b3199, p4l7t3215r125b3288],
6	with	IN	O	with	_	0	SENT_68	[p4l157t3215r298b3271],
7	a	DT	O	a	det	14	SENT_68	[p4l330t3232r363b3271],
8	combined	JJ	O	combined	amod	14	SENT_68	[p4l394t3215r708b3271],
9	instrument	NN	O	instrument	nn	14	SENT_68	[p4l739t3215r1082b3271],
10	Spectralis	NNP	O	Spectralis	nn	14	SENT_68	[p4l1113t3215r1424b3288],
11	HRA+OCT	NNP	O	HRA+OCT	nn	14	SENT_68	[p4l1458t3215r1853b3271],
12	(	NNP	O	(	nn	14	SENT_68	[p4l1886t3215r2147b3284, p4l6t3302r147b3375],
13	Heidelberg	NNP	ORGANIZATION	Heidelberg	nn	14	SENT_68	[p4l1886t3215r2147b3284, p4l6t3302r147b3375],
14	Engineering	NNP	ORGANIZATION	Engineering	prep_with	3	SENT_68	[p4l170t3302r578b3375],
15	,	,	O	,	_	0	SENT_68	[p4l170t3302r578b3375],
16	Heidelberg	NNP	LOCATION	Heidelberg	conj_and	14	SENT_68	[p4l603t3302r975b3375],
17	,	,	O	,	_	0	SENT_68	[p4l603t3302r975b3375],
18	Germany	NNP	LOCATION	Germany	nn	20	SENT_68	[p4l1000t3302r1296b3375],
19	[	NNP	O	[	nn	20	SENT_68	[p4l1323t3302r1677b3375],
20	Nijmegen	NNP	ORGANIZATION	Nijmegen	prep_with	3	SENT_68	[p4l1323t3302r1677b3375],
21	,	,	O	,	_	0	SENT_68	[p4l1323t3302r1677b3375],
22	Montreal	NNP	LOCATION	Montreal	conj_and	14	SENT_68	[p4l1701t3302r2011b3369],
23	,	,	O	,	_	0	SENT_68	[p4l1701t3302r2011b3369],
24	and	CC	O	and	_	0	SENT_68	[p4l2037t3302r2150b3358],
25	Cologne	NNP	LOCATION	Cologne	conj_and	14	SENT_68	[p4l8t3390r329b3463],
26	]	CD	NUMBER	]	number	27	SENT_68	[p4l8t3390r329b3463],
27	)	CD	NUMBER	)	dep	25	SENT_68	[p4l8t3390r329b3463],
28	or	CC	O	or	_	0	SENT_68	[p4l373t3408r438b3446],
29	with	IN	O	with	_	0	SENT_68	[p4l478t3390r618b3447],
30	Imagenet	NNP	O	Imagenet	nn	35	SENT_68	[p4l659t3392r957b3463],
31	(	NNP	O	(	nn	35	SENT_68	[p4l999t3391r1266b3463],
32	Topcon	NNP	ORGANIZATION	Topcon	nn	35	SENT_68	[p4l999t3391r1266b3463],
33	Corporation	NNP	ORGANIZATION	Corporation	nn	35	SENT_68	[p4l1308t3390r1693b3463],
34	[	NNP	O	[	nn	35	SENT_68	[p4l1740t3390r2145b3463],
35	Nijmegen	NNP	MISC	Nijmegen	conj_or	14	SENT_68	[p4l1740t3390r2145b3463],
36	]	CD	NUMBER	]	num	37	SENT_68	[p4l1740t3390r2145b3463],
37	)	CD	NUMBER	)	dep	3	SENT_68	[p4l1740t3390r2145b3463],
38	.	.	O	.	_	0	SENT_68	[p4l1740t3390r2145b3463],

1	The	DT	O	the	det	3	SENT_69	[p4l7t3479r130b3535],
2	lesion	NN	O	lesion	nn	3	SENT_69	[p4l166t3479r356b3535],
3	type	NN	O	type	dep	8	SENT_69	[p4l391t3487r527b3552],
4	of	IN	O	of	_	0	SENT_69	[p4l563t3479r632b3535],
5	the	DT	O	the	det	6	SENT_69	[p4l662t3479r758b3535],
6	CNV	NN	ORGANIZATION	cnv	prep_of	3	SENT_69	[p4l795t3479r961b3535],
7	was	VBD	O	be	auxpass	8	SENT_69	[p4l997t3496r1118b3535],
8	determined	VBN	O	determine	_	0	SENT_69	[p4l1156t3479r1515b3535],
9	by	IN	O	by	_	0	SENT_69	[p4l1548t3479r1627b3551],
10	ﬂuorescein	NN	O	ﬂuorescein	nn	11	SENT_69	[p4l1664t3479r2014b3535],
11	angiography	NN	O	angiography	agent	8	SENT_69	[p4l2051t3496r2147b3535, p4l8t3566r331b3639],
12	and	CC	O	and	_	0	SENT_69	[p4l373t3566r486b3622],
13	was	VBD	O	be	auxpass	14	SENT_69	[p4l527t3584r647b3623],
14	classiﬁed	VBN	O	classiﬁed	conj_and	8	SENT_69	[p4l690t3566r987b3622],
15	into	IN	O	into	_	0	SENT_69	[p4l1027t3566r1149b3622],
16	4	CD	NUMBER	4	num	17	SENT_69	[p4l1190t3566r1227b3622],
17	categories	NNS	O	category	prep_into	14	SENT_69	[p4l1269t3566r1609b3639],
18	:	:	O	:	_	0	SENT_69	[p4l1269t3566r1609b3639],
19	occult	NN	O	occult	dep	17	SENT_69	[p4l1656t3566r1851b3622],
20	with	IN	O	with	_	0	SENT_69	[p4l1890t3566r2031b3622],
21	no	DT	O	no	det	23	SENT_69	[p4l2071t3584r2148b3622],
22	classic	JJ	O	classic	amod	23	SENT_69	[p4l8t3654r218b3711],
23	lesion	NN	O	lesion	prep_with	19	SENT_69	[p4l249t3654r456b3721],
24	,	,	O	,	_	0	SENT_69	[p4l249t3654r456b3721],
25	minimally	RB	O	minimally	advmod	14	SENT_69	[p4l489t3654r817b3727],
26	classic	JJ	O	classic	amod	27	SENT_69	[p4l848t3654r1058b3711],
27	lesion	NN	O	lesion	dobj	8	SENT_69	[p4l1089t3654r1296b3721],
28	,	,	O	,	_	0	SENT_69	[p4l1089t3654r1296b3721],
29	predominantly	RB	O	predominantly	advmod	31	SENT_69	[p4l1328t3654r1795b3727],
30	classic	JJ	O	classic	amod	31	SENT_69	[p4l1826t3654r2036b3711],
31	lesion	NN	O	lesion	conj_and	27	SENT_69	[p4l2067t3654r2148b3710, p4l10t3743r156b3809],
32	,	,	O	,	_	0	SENT_69	[p4l2067t3654r2148b3710, p4l10t3743r156b3809],
33	and	CC	O	and	_	0	SENT_69	[p4l190t3743r303b3799],
34	retinal	JJ	O	retinal	amod	36	SENT_69	[p4l330t3743r534b3799],
35	angiomatous	JJ	O	angiomatous	amod	36	SENT_69	[p4l565t3743r970b3816],
36	proliferation	NN	O	proliferation	conj_and	27	SENT_69	[p4l1000t3736r1530b3816],
37	.9	CD	NUMBER	.9	num	40	SENT_69	[p4l1000t3736r1530b3816],
38	’	NN	O	’	nn	40	SENT_69	[p4l1000t3736r1530b3816],
39	2	CD	NUMBER	2	num	40	SENT_69	[p4l1000t3736r1530b3816],
40	°	NN	O	°	nsubjpass	8	SENT_69	[p4l1000t3736r1530b3816],

1	Study	NNP	O	Study	nn	2	SENT_70	[p5l11t133r246b226],
2	Design	NNP	O	Design	_	0	SENT_70	[p5l280t137r562b226],

1	According	VBG	O	accord	_	0	SENT_71	[p5l7t294r344b367],
2	to	TO	O	to	prepc_according_to	13	SENT_71	[p5l385t302r445b350],
3	the	DT	O	the	det	5	SENT_71	[p5l487t294r583b350],
4	standard	JJ	O	standard	amod	5	SENT_71	[p5l627t294r895b350],
5	protocol	NN	O	protocol	pobj	13	SENT_71	[p5l935t294r1201b367],
6	for	IN	O	for	_	0	SENT_71	[p5l1243t294r1335b350],
7	anti-VEGF	JJ	O	anti-vegf	amod	8	SENT_71	[p5l1377t294r1731b351],
8	therapy	NN	O	therapy	prep_for	5	SENT_71	[p5l1771t294r2027b367],
9	,	,	O	,	_	0	SENT_71	[p5l1771t294r2027b367],
10	all	DT	O	all	det	11	SENT_71	[p5l2073t294r2149b350],
11	patients	NNS	O	patient	nsubjpass	13	SENT_71	[p5l6t382r254b455],
12	were	VBD	O	be	auxpass	13	SENT_71	[p5l295t400r449b439],
13	treated	VBN	O	treat	_	0	SENT_71	[p5l488t383r705b439],
14	with	IN	O	with	_	0	SENT_71	[p5l745t382r885b439],
15	3	CD	NUMBER	3	prep_with	13	SENT_71	[p5l927t383r958b439],
16	initial	JJ	O	initial	amod	15	SENT_71	[p5l1002t382r1187b439],
17	monthly	JJ	SET	monthly	amod	19	SENT_71	[p5l1227t383r1492b455],
18	intravitreal	JJ	O	intravitreal	amod	19	SENT_71	[p5l1532t382r1882b439],
19	O.	NNP	O	O.	dobj	13	SENT_71	[p5l1922t382r2149b455],
20	5	CD	NUMBER	5	num	24	SENT_71	[p5l1922t382r2149b455],
21	—	CD	NUMBER	—	num	24	SENT_71	[p5l1922t382r2149b455],
22	mg	NN	O	mg	nn	24	SENT_71	[p5l1922t382r2149b455],
23	ranibizumab	NN	O	ranibizumab	nn	24	SENT_71	[p5l7t471r406b527],
24	injections	NNS	O	injection	dep	19	SENT_71	[p5l428t471r756b544],
25	,	,	O	,	_	0	SENT_71	[p5l428t471r756b544],
26	followed	VBN	O	follow	partmod	24	SENT_71	[p5l780t471r1064b527],
27	by	IN	O	by	dep	26	SENT_71	[p5l1083t471r1162b543],
28	on	IN	O	on	_	0	SENT_71	[p5l1185t488r1262b527],
29	demand	NN	O	demand	nn	31	SENT_71	[p5l1284t471r1536b527],
30	reinj	NN	O	reinj	nn	31	SENT_71	[p5l1556t471r1696b544],
31	ections	NNS	O	ection	prep_on	26	SENT_71	[p5l1705t471r1928b527],
32	whenever	WRB	O	whenever	advmod	38	SENT_71	[p5l1951t471r2147b527, p5l8t576r145b614],
33	signs	NNS	O	sign	nsubjpass	38	SENT_71	[p5l169t558r328b631],
34	of	IN	O	of	_	0	SENT_71	[p5l353t558r423b614],
35	CNV	NN	ORGANIZATION	cnv	nn	36	SENT_71	[p5l441t558r607b615],
36	activity	NN	O	activity	prep_of	33	SENT_71	[p5l632t558r869b631],
37	were	VBD	O	be	auxpass	38	SENT_71	[p5l893t576r1046b615],
38	detected	VBN	O	detect	dep	31	SENT_71	[p5l1070t558r1336b614],
39	on	IN	O	on	_	0	SENT_71	[p5l1359t576r1436b614],
40	funduscopy	NN	O	funduscopy	nn	45	SENT_71	[p5l1459t558r1849b631],
41	,	,	O	,	_	0	SENT_71	[p5l1459t558r1849b631],
42	spectraldomain	NN	O	spectraldomain	nn	45	SENT_71	[p5l1878t558r2148b631, p5l8t646r247b703],
43	optical	JJ	O	optical	amod	45	SENT_71	[p5l280t646r496b719],
44	coherence	NN	O	coherence	nn	45	SENT_71	[p5l529t646r852b703],
45	tomography	NN	O	tomography	prep_on	38	SENT_71	[p5l885t647r1289b719],
46	,	,	O	,	_	0	SENT_71	[p5l885t647r1289b719],
47	or	CC	O	or	_	0	SENT_71	[p5l1326t664r1391b703],
48	angiography	NN	O	angiography	dep	19	SENT_71	[p5l1424t640r1899b719],
49	.	.	O	.	_	0	SENT_71	[p5l1424t640r1899b719],

1	”	NN	O	”	ccomp	13	SENT_72	[p5l1424t640r1899b719],
2	Therefore	RB	O	therefore	advmod	1	SENT_72	[p5l1937t647r2147b703, p5l8t735r152b801],
3	,	,	O	,	_	0	SENT_72	[p5l1937t647r2147b703, p5l8t735r152b801],
4	the	DT	O	the	det	6	SENT_72	[p5l193t735r289b791],
5	follow-up	JJ	O	follow-up	amod	6	SENT_72	[p5l329t735r642b808],
6	protocol	NN	O	protocol	nsubj	13	SENT_72	[p5l681t735r947b807],
7	and	CC	O	and	_	0	SENT_72	[p5l988t735r1101b791],
8	the	DT	O	the	det	10	SENT_72	[p5l1139t735r1235b791],
9	total	JJ	O	total	amod	10	SENT_72	[p5l1274t735r1415b791],
10	number	NN	O	number	nsubj	13	SENT_72	[p5l1453t735r1699b791],
11	of	IN	O	of	_	0	SENT_72	[p5l1737t735r1806b791],
12	injections	NNS	O	injection	prep_of	10	SENT_72	[p5l1839t735r2148b808],
13	varied	VBD	O	vary	_	0	SENT_72	[p5l8t822r207b878],
14	among	IN	O	among	_	0	SENT_72	[p5l246t840r460b895],
15	patients	NNS	O	patient	prep_among	13	SENT_72	[p5l497t822r762b895],
16	.	.	O	.	_	0	SENT_72	[p5l497t822r762b895],

1	Because	IN	O	because	mark	5	SENT_73	[p5l804t824r1069b878],
2	VA	NNP	O	VA	nn	3	SENT_73	[p5l1107t823r1222b878],
3	change	NN	O	change	nsubj	5	SENT_73	[p5l1260t822r1484b895],
4	is	VBZ	O	be	cop	5	SENT_73	[p5l1522t822r1572b878],
5	maximal	JJ	O	maximal	advcl	36	SENT_73	[p5l1611t822r1890b878],
6	after	IN	O	after	_	0	SENT_73	[p5l1930t822r2075b878],
7	3	CD	NUMBER	3	num	9	SENT_73	[p5l2113t823r2145b879],
8	monthly	JJ	SET	monthly	amod	9	SENT_73	[p5l7t911r273b983],
9	injections	NNS	O	injection	prep_after	5	SENT_73	[p5l304t904r697b983],
10	,	,	O	,	_	0	SENT_73	[p5l304t904r697b983],
11	”	NN	O	”	appos	9	SENT_73	[p5l304t904r697b983],
12	and	CC	O	and	_	0	SENT_73	[p5l730t911r843b967],
13	to	TO	O	to	aux	14	SENT_73	[p5l873t919r932b967],
14	achieve	VB	O	achieve	appos	9	SENT_73	[p5l966t911r1208b967],
15	a	DT	O	a	det	19	SENT_73	[p5l1241t929r1274b967],
16	comparable	JJ	O	comparable	amod	19	SENT_73	[p5l1305t911r1676b983],
17	and	CC	O	and	_	0	SENT_73	[p5l1709t911r1822b967],
18	standardized	JJ	O	standardized	conj_and	16	SENT_73	[p5l1855t911r2147b967, p5l7t999r140b1055],
19	evaluation	NN	O	evaluation	dobj	14	SENT_73	[p5l160t999r493b1055],
20	of	IN	O	of	_	0	SENT_73	[p5l514t999r583b1055],
21	the	DT	O	the	det	22	SENT_73	[p5l598t999r694b1055],
22	response	NN	O	response	prep_of	19	SENT_73	[p5l713t1016r993b1072],
23	to	TO	O	to	_	0	SENT_73	[p5l1014t1007r1074b1055],
24	ranibizumab	NN	O	ranibizumab	nn	25	SENT_73	[p5l1094t999r1493b1055],
25	treatment	NN	O	treatment	prep_to	14	SENT_73	[p5l1515t1007r1834b1065],
26	,	,	O	,	_	0	SENT_73	[p5l1515t1007r1834b1065],
27	only	RB	O	only	advmod	28	SENT_73	[p5l1858t999r1997b1071],
28	data	NNS	O	datum	nsubjpass	36	SENT_73	[p5l2019t999r2151b1055],
29	obtained	VBN	O	obtain	partmod	28	SENT_73	[p5l8t1086r283b1142],
30	after	IN	O	after	_	0	SENT_73	[p5l328t1086r473b1142],
31	3	CD	NUMBER	3	num	34	SENT_73	[p5l517t1086r549b1143],
32	consecutive	JJ	O	consecutive	amod	34	SENT_73	[p5l598t1086r974b1142],
33	ranibizumab	NN	O	ranibizumab	nn	34	SENT_73	[p5l1018t1086r1418b1142],
34	injections	NNS	O	injection	prep_after	29	SENT_73	[p5l1463t1086r1771b1159],
35	was	VBD	O	be	auxpass	36	SENT_73	[p5l1817t1104r1938b1143],
36	used	VBN	O	use	_	0	SENT_73	[p5l1983t1086r2145b1142],
37	.	.	O	.	_	0	SENT_73	[p5l1983t1086r2145b1142],

1	Each	DT	O	each	det	2	SENT_74	[p5l7t1175r166b1231],
2	participant	NN	O	participant	nsubj	3	SENT_74	[p5l190t1174r533b1247],
3	underwent	VBD	O	undergo	conj_and	3	SENT_74	[p5l557t1175r895b1231],
4	best-corrected	JJ	O	best-corrected	amod	6	SENT_74	[p5l918t1174r1373b1231],
5	VA	NN	O	va	nn	6	SENT_74	[p5l1396t1175r1511b1231],
6	assessments	NNS	O	assessment	dobj	3	SENT_74	[p5l1537t1183r1920b1231],
7	before	IN	O	before	_	0	SENT_74	[p5l1945t1174r2149b1231],
8	and	CC	O	and	_	0	SENT_74	[p5l9t1263r122b1319],
9	after	IN	O	after	_	0	SENT_74	[p5l145t1263r290b1319],
10	treatment	NN	O	treatment	prep_before	3	SENT_74	[p5l310t1271r613b1319],
11	with	IN	O	with	_	0	SENT_74	[p5l634t1263r775b1319],
12	3	CD	NUMBER	3	num	14	SENT_74	[p5l798t1263r830b1319],
13	ranibizumab	NN	O	ranibizumab	nn	14	SENT_74	[p5l855t1263r1255b1319],
14	injections	NNS	O	injection	prep_with	3	SENT_74	[p5l1277t1263r1604b1335],
15	.	.	O	.	_	0	SENT_74	[p5l1277t1263r1604b1335],

1	For	IN	O	for	_	0	SENT_75	[p5l1630t1264r1741b1319],
2	347	CD	NUMBER	347	num	3	SENT_75	[p5l1764t1263r1877b1319],
3	patients	NNS	O	patient	prep_for	14	SENT_75	[p5l1901t1263r2148b1336],
4	(	IN	O	(	_	0	SENT_75	[p5l10t1350r284b1420],
5	81.6	CD	PERCENT	81.6	num	6	SENT_75	[p5l10t1350r284b1420],
6	%	NN	PERCENT	%	prep_(	14	SENT_75	[p5l10t1350r284b1420],
7	)	CD	NUMBER	)	dep	6	SENT_75	[p5l10t1350r284b1420],
8	,	,	O	,	_	0	SENT_75	[p5l10t1350r284b1420],
9	the	DT	O	the	det	12	SENT_75	[p5l314t1350r410b1406],
10	Snellen	NNP	O	Snellen	nn	12	SENT_75	[p5l441t1350r677b1407],
11	VA	NNP	O	VA	nn	12	SENT_75	[p5l705t1351r819b1406],
12	measurements	NNS	O	measurement	nsubjpass	14	SENT_75	[p5l847t1358r1303b1406],
13	were	VBD	O	be	auxpass	14	SENT_75	[p5l1333t1368r1486b1406],
14	collected	VBN	O	collect	_	0	SENT_75	[p5l1515t1350r1803b1406],
15	retrospectively	RB	O	retrospectively	advmod	14	SENT_75	[p5l1829t1359r2147b1423, p5l7t1438r188b1511],
16	at	IN	O	at	_	0	SENT_75	[p5l216t1447r271b1495],
17	a	DT	O	a	det	19	SENT_75	[p5l297t1456r330b1495],
18	time	NN	O	time	nn	19	SENT_75	[p5l354t1438r495b1495],
19	point	NN	O	point	prep_at	14	SENT_75	[p5l519t1438r685b1511],
20	after	IN	O	after	_	0	SENT_75	[p5l711t1438r856b1495],
21	treatment	NN	O	treatment	prep_after	14	SENT_75	[p5l880t1447r1198b1505],
22	,	,	O	,	_	0	SENT_75	[p5l880t1447r1198b1505],
23	whereas	IN	O	whereas	mark	31	SENT_75	[p5l1227t1439r1486b1495],
24	78	CD	NUMBER	78	num	25	SENT_75	[p5l1514t1439r1588b1495],
25	patients	NNS	O	patient	nsubjpass	31	SENT_75	[p5l1616t1438r1863b1511],
26	(	IN	O	(	_	0	SENT_75	[p5l1893t1439r2147b1508],
27	18.4	CD	PERCENT	18.4	num	28	SENT_75	[p5l1893t1439r2147b1508],
28	%	NN	PERCENT	%	prep_(	25	SENT_75	[p5l1893t1439r2147b1508],
29	)	CD	NUMBER	)	dep	28	SENT_75	[p5l1893t1439r2147b1508],
30	were	VBD	O	be	auxpass	31	SENT_75	[p5l8t1544r161b1583],
31	followed	VBN	O	follow	advcl	14	SENT_75	[p5l211t1527r495b1583],
32	up	RP	O	up	prt	31	SENT_75	[p5l543t1544r620b1600],
33	prospectively	RB	O	prospectively	advmod	31	SENT_75	[p5l669t1527r1100b1600],
34	during	IN	O	during	_	0	SENT_75	[p5l1151t1527r1357b1600],
35	treatment	NN	O	treatment	prep_during	31	SENT_75	[p5l1407t1535r1709b1583],
36	using	VBG	O	use	partmod	35	SENT_75	[p5l1756t1527r1928b1600],
37	Early	JJ	O	early	amod	41	SENT_75	[p5l1977t1527r2149b1599],
38	Treatment	NN	O	treatment	nn	41	SENT_75	[p5l7t1616r337b1670],
39	Diabetic	NNP	O	Diabetic	nn	41	SENT_75	[p5l383t1614r652b1670],
40	Retinopathy	NNP	O	Retinopathy	nn	41	SENT_75	[p5l700t1614r1091b1687],
41	Study	NNP	O	Study	dobj	36	SENT_75	[p5l1141t1614r1323b1687],
42	(	CD	NUMBER	(	num	45	SENT_75	[p5l1374t1615r1675b1684],
43	ETDRS	NNP	O	ETDRS	nn	45	SENT_75	[p5l1374t1615r1675b1684],
44	)	CD	NUMBER	)	num	45	SENT_75	[p5l1374t1615r1675b1684],
45	VA.	NNP	O	VA.	dep	41	SENT_75	[p5l1724t1615r1854b1670],
46	.	.	O	.	_	0	SENT_75	[p5l1724t1615r1854b1670],

1	Venous	JJ	O	venous	amod	3	SENT_76	[p5l1905t1616r2147b1670],
2	blood	NN	O	blood	nn	3	SENT_76	[p5l6t1702r189b1758],
3	samples	NNS	O	sample	nsubjpass	8	SENT_76	[p5l222t1702r474b1775],
4	for	IN	O	for	_	0	SENT_76	[p5l508t1702r600b1759],
5	the	DT	O	the	det	6	SENT_76	[p5l630t1702r725b1758],
6	genotyping	NN	O	genotyping	prep_for	3	SENT_76	[p5l758t1702r1116b1775],
7	were	VBD	O	be	auxpass	8	SENT_76	[p5l1148t1720r1301b1759],
8	collected	VBN	O	collect	_	0	SENT_76	[p5l1333t1702r1621b1759],
9	before	RB	O	before	advmod	8	SENT_76	[p5l1651t1702r1855b1759],
10	onset	NN	O	onset	dobj	8	SENT_76	[p5l1887t1711r2055b1758],
11	of	IN	O	of	_	0	SENT_76	[p5l2085t1702r2154b1758],
12	the	DT	O	the	det	13	SENT_76	[p5l7t1791r104b1847],
13	treatment	NN	O	treatment	prep_of	10	SENT_76	[p5l133t1799r436b1847],
14	and	CC	O	and	_	0	SENT_76	[p5l466t1791r579b1847],
15	before	IN	O	before	mark	19	SENT_76	[p5l607t1791r811b1847],
16	VA	NNP	O	VA	nn	17	SENT_76	[p5l841t1791r955b1847],
17	measurements	NNS	O	measurement	nsubjpass	19	SENT_76	[p5l984t1799r1440b1847],
18	were	VBD	O	be	auxpass	19	SENT_76	[p5l1472t1808r1626b1847],
19	collected	VBN	O	collect	conj_and	10	SENT_76	[p5l1656t1791r1944b1847],
20	retrospectively	RB	O	retrospectively	advmod	19	SENT_76	[p5l1972t1799r2147b1847, p5l10t1878r347b1951],
21	.	.	O	.	_	0	SENT_76	[p5l1972t1799r2147b1847, p5l10t1878r347b1951],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_77	[p5l392t1878r643b1934],
2	were	VBD	O	be	auxpass	3	SENT_77	[p5l685t1896r839b1934],
3	excluded	VBN	O	exclude	_	0	SENT_77	[p5l881t1878r1169b1934],
4	from	IN	O	from	_	0	SENT_77	[p5l1209t1878r1364b1934],
5	this	DT	O	this	det	6	SENT_77	[p5l1403t1878r1515b1934],
6	study	NN	O	study	prep_from	3	SENT_77	[p5l1561t1878r1730b1951],
7	if	IN	O	if	mark	10	SENT_77	[p5l1771t1878r1823b1934],
8	they	PRP	O	they	nsubj	10	SENT_77	[p5l1858t1878r1994b1951],
9	had	VBD	O	have	aux	10	SENT_77	[p5l2035t1878r2150b1934],
10	received	VBN	O	receive	advcl	3	SENT_77	[p5l7t1966r278b2023],
11	other	JJ	O	other	amod	13	SENT_77	[p5l305t1966r469b2023],
12	prior	JJ	O	prior	amod	13	SENT_77	[p5l493t1966r650b2039],
13	treatments	NNS	O	treatment	dobj	10	SENT_77	[p5l675t1975r1006b2023],
14	for	IN	O	for	_	0	SENT_77	[p5l1035t1966r1128b2022],
15	active	JJ	O	active	amod	18	SENT_77	[p5l1155t1966r1343b2023],
16	subfoveal	JJ	O	subfoveal	amod	18	SENT_77	[p5l1373t1966r1680b2023],
17	CNV	NN	O	cnv	nn	18	SENT_77	[p5l1708t1967r1874b2023],
18	secondZ305	NN	O	secondz305	prep_for	13	SENT_77	[p5l1904t1966r2147b2022, p5l1957t2189r2145b2264],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_78	[p5l995t2311r1590b2401],
2	Volume	NN	O	volume	dep	1	SENT_78	[p5l1685t2311r1956b2383],
3	119	CD	NUMBER	119	dep	2	SENT_78	[p5l2000t2315r2152b2395],
4	,	,	O	,	_	0	SENT_78	[p5l2000t2315r2152b2395],

1	ary	NN	O	ary	_	0	SENT_79	[p5l14t2540r107b2592],
2	to	TO	O	to	_	0	SENT_79	[p5l139t2532r195b2577],
3	AMD	NNP	ORGANIZATION	AMD	prep_to	1	SENT_79	[p5l227t2524r419b2577],
4	.	.	O	.	_	0	SENT_79	[p5l227t2524r419b2577],

1	If	IN	O	if	mark	6	SENT_80	[p5l454t2524r508b2576],
2	the	DT	O	the	det	4	SENT_80	[p5l533t2524r624b2577],
3	second	JJ	ORDINAL	second	amod	4	SENT_80	[p5l658t2524r866b2577],
4	eye	NN	O	eye	nsubj	6	SENT_80	[p5l897t2540r1001b2593],
5	became	VBD	O	become	cop	6	SENT_80	[p5l1031t2524r1263b2577],
6	eligible	JJ	O	eligible	advcl	21	SENT_80	[p5l1295t2524r1521b2593],
7	for	IN	O	for	_	0	SENT_80	[p5l1552t2524r1641b2577],
8	ranibizumab	NN	O	ranibizumab	nn	9	SENT_80	[p5l1669t2524r2049b2577],
9	treatment	NN	O	treatment	prep_for	6	SENT_80	[p5l12t2614r301b2659],
10	during	IN	O	during	_	0	SENT_80	[p5l339t2606r535b2675],
11	the	DT	O	the	det	12	SENT_80	[p5l574t2606r665b2659],
12	course	NN	O	course	prep_during	6	SENT_80	[p5l704t2623r901b2659],
13	of	IN	O	of	_	0	SENT_80	[p5l941t2606r1007b2659],
14	the	DT	O	the	det	15	SENT_80	[p5l1040t2606r1131b2659],
15	study	NN	O	study	prep_of	12	SENT_80	[p5l1173t2606r1350b2675],
16	,	,	O	,	_	0	SENT_80	[p5l1173t2606r1350b2675],
17	then	RB	O	then	advmod	19	SENT_80	[p5l1391t2606r1521b2659],
18	both	DT	O	both	det	19	SENT_80	[p5l1558t2606r1693b2659],
19	eyes	NNS	O	eye	nsubjpass	21	SENT_80	[p5l1733t2623r1864b2675],
20	were	VBD	O	be	auxpass	21	SENT_80	[p5l1904t2623r2050b2660],
21	included	VBN	O	include	_	0	SENT_80	[p5l12t2689r274b2743],
22	in	IN	O	in	_	0	SENT_80	[p5l304t2689r361b2742],
23	the	DT	O	the	det	24	SENT_80	[p5l390t2690r481b2743],
24	study	NN	O	study	prep_in	21	SENT_80	[p5l514t2689r690b2758],
25	.	.	O	.	_	0	SENT_80	[p5l514t2689r690b2758],

1	Age	NN	O	age	_	0	SENT_81	[p5l724t2690r849b2758],
2	at	IN	O	at	dep	1	SENT_81	[p5l880t2698r933b2743],
3	the	DT	O	the	det	6	SENT_81	[p5l961t2690r1052b2743],
4	ﬁrst	NN	O	ﬁrst	nn	6	SENT_81	[p5l1083t2689r1200b2743],
5	ranibizumab	NN	O	ranibizumab	nn	6	SENT_81	[p5l1228t2689r1608b2743],
6	injection	NN	O	injection	nsubjpass	8	SENT_81	[p5l1639t2689r1904b2758],
7	was	VBD	O	be	auxpass	8	SENT_81	[p5l1934t2706r2049b2743],
8	collected	VBN	O	collect	pobj	2	SENT_81	[p5l13t2773r303b2835],
9	,	,	O	,	_	0	SENT_81	[p5l13t2773r303b2835],
10	as	RB	O	as	_	0	SENT_81	[p5l338t2789r396b2826],
11	well	RB	O	well	_	0	SENT_81	[p5l429t2773r558b2826],
12	as	IN	O	as	_	0	SENT_81	[p5l591t2789r649b2826],
13	the	DT	O	the	det	14	SENT_81	[p5l682t2773r773b2826],
14	duration	NN	O	duration	pobj	2	SENT_81	[p5l805t2773r1058b2826],
15	of	IN	O	of	_	0	SENT_81	[p5l1089t2773r1155b2826],
16	visual	JJ	O	visual	amod	17	SENT_81	[p5l1181t2773r1361b2826],
17	symptoms	NNS	O	symptom	prep_of	14	SENT_81	[p5l1395t2781r1703b2842],
18	before	IN	O	before	_	0	SENT_81	[p5l1734t2773r1928b2826],
19	the	DT	O	the	det	20	SENT_81	[p5l1959t2773r2050b2826],
20	treatment	NN	O	treatment	prep_before	17	SENT_81	[p5l12t2863r315b2918],
21	,	,	O	,	_	0	SENT_81	[p5l12t2863r315b2918],
22	but	CC	O	but	_	0	SENT_81	[p5l355t2855r453b2908],
23	this	DT	O	this	nsubj	26	SENT_81	[p5l488t2855r595b2908],
24	was	VBD	O	be	cop	26	SENT_81	[p5l634t2872r749b2909],
25	not	RB	O	not	neg	26	SENT_81	[p5l788t2863r885b2908],
26	available	JJ	O	available	conj_but	1	SENT_81	[p5l922t2855r1194b2909],
27	for	IN	O	for	_	0	SENT_81	[p5l1232t2855r1321b2908],
28	all	DT	O	all	det	29	SENT_81	[p5l1358t2855r1430b2908],
29	patients	NNS	O	patient	prep_for	26	SENT_81	[p5l1467t2855r1702b2924],
30	(	IN	O	(	_	0	SENT_81	[p5l1743t2856r1802b2921],
31	n	NN	O	n	prep_(	26	SENT_81	[p5l1743t2856r1802b2921],
32	=	JJ	O	=	advmod	36	SENT_81	[p5l1847t2874r1893b2892],
33	218	CD	PERCENT	218	num	34	SENT_81	[p5l1939t2856r2048b2909],
34	[	CD	PERCENT	[	dep	32	SENT_81	[p5l18t2938r242b3004],
35	52	CD	PERCENT	52	num	36	SENT_81	[p5l18t2938r242b3004],
36	%	NN	PERCENT	%	rcmod	31	SENT_81	[p5l18t2938r242b3004],
37	]	CD	NUMBER	]	num	38	SENT_81	[p5l18t2938r242b3004],
38	)	NN	O	)	dep	36	SENT_81	[p5l18t2938r242b3004],
39	.	.	O	.	_	0	SENT_81	[p5l18t2938r242b3004],

1	Genotyping	NN	O	genotyping	nsubjpass	47	SENT_82	[p5l282t2938r640b3007],
2	of	IN	O	of	_	0	SENT_82	[p5l676t2938r742b2991],
3	SNPs	NNS	O	snp	prep_of	1	SENT_82	[p5l774t2939r938b2992],
4	in	IN	O	in	_	0	SENT_82	[p5l975t2938r1033b2991],
5	the	DT	O	the	det	8	SENT_82	[p5l1068t2938r1159b2991],
6	CFH	NNP	O	CFH	nn	8	SENT_82	[p5l1198t2939r1350b2992],
7	(	CD	NUMBER	(	num	8	SENT_82	[p5l1383t2939r1647b3004],
8	Y402H	NN	O	y402h	prep_in	3	SENT_82	[p5l1383t2939r1647b3004],
9	;	:	O	;	_	0	SENT_82	[p5l1383t2939r1647b3004],
10	rslO6ll70	NN	O	rslo6ll70	nn	11	SENT_82	[p5l1684t2938r2048b3004],
11	)	NN	O	)	dep	1	SENT_82	[p5l1684t2938r2048b3004],
12	,	,	O	,	_	0	SENT_82	[p5l1684t2938r2048b3004],
13	ARMS2	NN	O	arms2	nn	15	SENT_82	[p5l7t3022r242b3075],
14	(	CD	NUMBER	(	num	15	SENT_82	[p5l280t3022r493b3087],
15	A69S	NN	O	a69	appos	11	SENT_82	[p5l280t3022r493b3087],
16	;	:	O	;	_	0	SENT_82	[p5l280t3022r493b3087],
17	rs10490924	NN	O	rs10490924	nn	18	SENT_82	[p5l529t3022r930b3087],
18	)	NN	O	)	dep	1	SENT_82	[p5l529t3022r930b3087],
19	,	,	O	,	_	0	SENT_82	[p5l529t3022r930b3087],
20	VEGFA	NNP	O	VEGFA	nn	22	SENT_82	[p5l971t3023r1205b3076],
21	(	CD	NUMBER	(	num	22	SENT_82	[p5l1242t3022r1546b3087],
22	rs699947	NN	O	rs699947	conj_and	18	SENT_82	[p5l1242t3022r1546b3087],
23	and	CC	O	and	_	0	SENT_82	[p5l1583t3022r1691b3075],
24	rs833069	NN	O	rs833069	nn	25	SENT_82	[p5l1722t3022r2048b3087],
25	)	NN	O	)	conj_and	18	SENT_82	[p5l1722t3022r2048b3087],
26	,	,	O	,	_	0	SENT_82	[p5l1722t3022r2048b3087],
27	KDR	NN	O	kdr	nn	29	SENT_82	[p5l12t3106r163b3157],
28	(	CD	NUMBER	(	num	29	SENT_82	[p5l197t3104r539b3170],
29	rs207l559	NN	O	rs207l559	conj_and	1	SENT_82	[p5l197t3104r539b3170],
30	and	CC	O	and	_	0	SENT_82	[p5l573t3104r680b3157],
31	rs7671745	NN	O	rs7671745	nn	32	SENT_82	[p5l709t3104r1073b3170],
32	)	NN	O	)	conj_and	1	SENT_82	[p5l709t3104r1073b3170],
33	,	,	O	,	_	0	SENT_82	[p5l709t3104r1073b3170],
34	LPR5	NN	O	lpr5	conj_and	1	SENT_82	[p5l1104t3105r1279b3157],
35	(	CD	NUMBER	(	num	34	SENT_82	[p5l1312t3104r1697b3170],
36	rs3736228	CD	NUMBER	rs3736228	num	37	SENT_82	[p5l1312t3104r1697b3170],
37	)	NN	O	)	dep	34	SENT_82	[p5l1312t3104r1697b3170],
38	,	,	O	,	_	0	SENT_82	[p5l1312t3104r1697b3170],
39	and	CC	O	and	_	0	SENT_82	[p5l1733t3104r1840b3157],
40	FZD4	NN	O	fzd4	nn	42	SENT_82	[p5l1869t3104r2050b3157],
41	(	CD	NUMBER	(	num	42	SENT_82	[p5l15t3187r317b3253],
42	rslO8985	NN	O	rslo8985	conj_and	1	SENT_82	[p5l15t3187r317b3253],
43	63	CD	NUMBER	63	num	45	SENT_82	[p5l324t3187r420b3253],
44	)	NN	O	)	nn	45	SENT_82	[p5l324t3187r420b3253],
45	genes	NNS	O	gene	dep	42	SENT_82	[p5l442t3204r612b3256],
46	was	VBD	O	be	auxpass	47	SENT_82	[p5l633t3204r748b3241],
47	performed	VBN	O	perform	ccomp	69	SENT_82	[p5l768t3187r1086b3256],
48	with	IN	O	with	_	0	SENT_82	[p5l1105t3187r1239b3241],
49	TaqMan	NN	O	taqman	nn	50	SENT_82	[p5l1258t3189r1515b3256],
50	probes	NNS	O	probe	prep_with	47	SENT_82	[p5l1533t3187r1734b3256],
51	and	CC	O	and	_	0	SENT_82	[p5l1757t3187r1864b3240],
52	primers	NNS	O	primer	conj_and	50	SENT_82	[p5l1882t3187r2048b3256, p5l13t3287r98b3324],
53	using	VBG	O	use	xcomp	47	SENT_82	[p5l133t3271r296b3340],
54	assays	NNS	O	assay	dobj	53	SENT_82	[p5l332t3287r522b3340],
55	developed	VBN	O	develop	partmod	54	SENT_82	[p5l559t3271r871b3340],
56	by	IN	O	by	_	0	SENT_82	[p5l903t3271r978b3339],
57	Applied	NNP	O	Applied	nn	58	SENT_82	[p5l1012t3271r1257b3340],
58	Biosystems	NNPS	O	Biosystems	agent	55	SENT_82	[p5l1290t3271r1639b3340],
59	and	CC	O	and	_	0	SENT_82	[p5l1676t3271r1784b3324],
60	an	DT	O	a	det	63	SENT_82	[p5l1818t3287r1887b3324],
61	ABI	NN	MISC	abus	nn	63	SENT_82	[p5l1921t3271r2050b3323],
62	790OHT	NN	O	790oht	nn	63	SENT_82	[p5l13t3354r265b3407],
63	system	NN	O	system	conj_and	54	SENT_82	[p5l288t3361r498b3422],
64	(	CD	NUMBER	(	num	66	SENT_82	[p5l519t3353r787b3422],
65	Applied	NNP	O	Applied	nn	66	SENT_82	[p5l519t3353r787b3422],
66	Biosystems	NNP	O	Biosystems	dep	63	SENT_82	[p5l807t3353r1174b3422],
67	,	,	O	,	_	0	SENT_82	[p5l807t3353r1174b3422],
68	Nieuwerkerk	NNP	O	Nieuwerkerk	nsubj	69	SENT_82	[p5l1197t3353r1596b3406],
69	a/d	VBD	O	a/d	_	0	SENT_82	[p5l1616t3353r1707b3407],
70	IJssel	NNP	O	IJssel	dobj	69	SENT_82	[p5l1726t3353r1910b3416],
71	,	,	O	,	_	0	SENT_82	[p5l1726t3353r1910b3416],
72	The	DT	LOCATION	the	det	74	SENT_82	[p5l1934t3353r2050b3406],
73	Netherlands	NNP	LOCATION	Netherlands	nn	74	SENT_82	[p5l12t3436r421b3502],
74	)	NN	O	)	appos	70	SENT_82	[p5l12t3436r421b3502],
75	.	.	O	.	_	0	SENT_82	[p5l12t3436r421b3502],

1	Statistical	JJ	O	statistical	amod	2	SENT_83	[p5l16t3621r394b3693],
2	Analysis	NN	O	analysis	_	0	SENT_83	[p5l428t3621r761b3710],

1	Snellen	NNP	ORGANIZATION	Snellen	nn	2	SENT_84	[p6l15t37r240b90],
2	VA	NNP	ORGANIZATION	VA	nsubjpass	4	SENT_84	[p6l266t37r374b90],
3	was	VBD	O	be	auxpass	4	SENT_84	[p6l401t54r515b90],
4	converted	VBN	O	convert	_	0	SENT_84	[p6l544t37r843b90],
5	to	TO	O	to	_	0	SENT_84	[p6l868t45r925b90],
6	the	DT	O	the	det	7	SENT_84	[p6l952t37r1043b90],
7	logarithm	NN	O	logarithm	prep_to	4	SENT_84	[p6l1069t37r1366b106],
8	of	IN	O	of	_	0	SENT_84	[p6l1392t37r1457b90],
9	minimum	JJ	O	minimum	amod	10	SENT_84	[p6l1478t37r1775b90],
10	angle	NN	O	angle	prep_of	7	SENT_84	[p6l1801t37r1963b106],
11	of	IN	O	of	_	0	SENT_84	[p6l1990t37r2056b90],
12	resolution	NN	O	resolution	nn	14	SENT_84	[p6l12t119r316b172],
13	(	CD	NUMBER	(	num	14	SENT_84	[p6l353t119r669b188],
14	logMAR	NN	O	logmar	prep_of	10	SENT_84	[p6l353t119r669b188],
15	)	CD	NUMBER	)	num	14	SENT_84	[p6l353t119r669b188],
16	VA	NNP	O	VA	dobj	4	SENT_84	[p6l706t120r814b173],
17	for	IN	O	for	_	0	SENT_84	[p6l849t119r937b172],
18	the	DT	O	the	det	19	SENT_84	[p6l970t119r1061b172],
19	purpose	NN	O	purpose	prep_for	16	SENT_84	[p6l1095t136r1335b188],
20	of	IN	O	of	_	0	SENT_84	[p6l1371t119r1437b172],
21	statistical	JJ	O	statistical	amod	22	SENT_84	[p6l1469t119r1752b172],
22	analysis	NN	O	analysis	prep_of	19	SENT_84	[p6l1789t119r2047b188],
23	.	.	O	.	_	0	SENT_84	[p6l1789t119r2047b188],

1	Change	NNP	O	Change	nsubjpass	5	SENT_85	[p6l13t203r244b272],
2	in	IN	O	in	_	0	SENT_85	[p6l278t203r336b255],
3	VA	NNP	O	VA	prep_in	1	SENT_85	[p6l370t203r478b256],
4	was	VBD	O	be	auxpass	5	SENT_85	[p6l513t219r627b256],
5	calculated	VBN	O	calculate	_	0	SENT_85	[p6l664t203r972b256],
6	as	IN	O	as	_	0	SENT_85	[p6l1007t219r1065b256],
7	the	DT	O	the	det	8	SENT_85	[p6l1101t203r1192b256],
8	difference	NN	O	difference	prep_as	5	SENT_85	[p6l1227t203r1534b256],
9	between	IN	O	between	_	0	SENT_85	[p6l1567t203r1822b256],
10	VA	NNP	O	VA	prep_between	8	SENT_85	[p6l1855t203r1964b256],
11	at	IN	O	at	_	0	SENT_85	[p6l1999t211r2052b256],
12	baseline	NN	O	baseline	prep_at	5	SENT_85	[p6l11t286r260b339],
13	and	CC	O	and	_	0	SENT_85	[p6l291t286r398b339],
14	VA	NN	ORGANIZATION	va	conj_and	12	SENT_85	[p6l426t286r535b339],
15	at	IN	O	at	_	0	SENT_85	[p6l565t294r617b339],
16	follow-up	NN	O	follow-up	prep_at	5	SENT_85	[p6l644t286r959b355],
17	.	.	O	.	_	0	SENT_85	[p6l644t286r959b355],

1	LeVene	NNP	PERSON	LeVene	poss	3	SENT_86	[p6l991t286r1268b339],
2	’s	POS	O	’s	_	0	SENT_86	[p6l991t286r1268b339],
3	test	NN	O	test	nsubjpass	9	SENT_86	[p6l1298t294r1403b339],
4	for	IN	O	for	_	0	SENT_86	[p6l1431t286r1519b339],
5	equality	NN	O	equality	prep_for	3	SENT_86	[p6l1547t286r1790b355],
6	of	IN	O	of	_	0	SENT_86	[p6l1819t286r1885b339],
7	Variances	NNS	O	variance	prep_of	5	SENT_86	[p6l1909t286r2049b339, p6l14t385r179b421],
8	was	VBD	O	be	auxpass	9	SENT_86	[p6l205t385r320b422],
9	used	VBN	O	use	_	0	SENT_86	[p6l346t368r485b421],
10	to	TO	O	to	aux	11	SENT_86	[p6l509t376r566b421],
11	test	VB	O	test	xcomp	9	SENT_86	[p6l591t376r697b421],
12	Variability	NN	O	variability	dobj	11	SENT_86	[p6l720t368r1032b437],
13	of	IN	O	of	_	0	SENT_86	[p6l1058t368r1124b421],
14	VA	NN	O	va	nn	15	SENT_86	[p6l1143t369r1252b422],
15	changes	NNS	O	change	prep_of	12	SENT_86	[p6l1277t368r1519b437],
16	between	IN	O	between	_	0	SENT_86	[p6l1544t368r1798b422],
17	Snellen	NNP	O	Snellen	nn	20	SENT_86	[p6l1825t368r2050b422],
18	and	CC	O	and	_	0	SENT_86	[p6l14t452r121b505],
19	ETDRS	NNP	O	ETDRS	nn	20	SENT_86	[p6l156t452r393b505],
20	techniques	NNS	O	technique	prep_between	15	SENT_86	[p6l433t452r773b521],
21	.	.	O	.	_	0	SENT_86	[p6l433t452r773b521],

1	The	DT	O	the	det	2	SENT_87	[p6l813t452r929b505],
2	association	NN	O	association	nsubjpass	13	SENT_87	[p6l967t452r1304b505],
3	between	IN	O	between	_	0	SENT_87	[p6l1338t452r1592b505],
4	genotype	NN	O	genotype	nn	7	SENT_87	[p6l1629t460r1906b521],
5	and	CC	O	and	_	0	SENT_87	[p6l1944t452r2051b505],
6	Visual	JJ	O	visual	nn	7	SENT_87	[p6l13t535r193b588],
7	response	NN	O	response	prep_between	2	SENT_87	[p6l221t552r488b604],
8	after	IN	O	after	_	0	SENT_87	[p6l519t535r657b588],
9	3	CD	NUMBER	3	num	11	SENT_87	[p6l686t535r717b588],
10	ranibizumab	NN	O	ranibizumab	nn	11	SENT_87	[p6l749t535r1129b588],
11	injections	NNS	O	injection	prep_after	7	SENT_87	[p6l1159t535r1453b604],
12	was	VBD	O	be	auxpass	13	SENT_87	[p6l1485t552r1599b588],
13	assessed	VBN	O	assess	_	0	SENT_87	[p6l1632t535r1888b588],
14	with	IN	O	with	_	0	SENT_87	[p6l1917t535r2051b588],
15	linear	JJ	O	linear	amod	17	SENT_87	[p6l13t617r186b670],
16	mixed	JJ	O	mixed	amod	17	SENT_87	[p6l207t617r396b670],
17	models	NNS	O	model	prep_with	13	SENT_87	[p6l418t617r635b670],
18	using	VBG	O	use	xcomp	13	SENT_87	[p6l658t617r821b686],
19	the	DT	O	the	det	21	SENT_87	[p6l844t617r935b670],
20	delta	NN	O	delta	nn	21	SENT_87	[p6l958t617r1105b670],
21	VA	NN	O	va	dobj	18	SENT_87	[p6l1126t618r1234b670],
22	as	IN	O	as	_	0	SENT_87	[p6l1257t634r1316b670],
23	the	DT	O	the	det	25	SENT_87	[p6l1339t617r1430b670],
24	dependent	JJ	O	dependent	amod	25	SENT_87	[p6l1454t617r1766b686],
25	Variable	NNP	O	Variable	prep_as	18	SENT_87	[p6l1787t617r2046b671],
26	.	.	O	.	_	0	SENT_87	[p6l1787t617r2046b671],

1	Association	NNP	O	Association	nsubjpass	26	SENT_88	[p6l12t700r372b754],
2	between	IN	O	between	_	0	SENT_88	[p6l397t701r651b754],
3	single	JJ	O	single	amod	4	SENT_88	[p6l679t700r857b769],
4	genotypes	NNS	O	genotype	prep_between	1	SENT_88	[p6l884t709r1190b769],
5	and	CC	O	and	_	0	SENT_88	[p6l1219t701r1327b754],
6	the	DT	O	the	det	7	SENT_88	[p6l1352t700r1443b754],
7	age	NN	O	age	prep_between	1	SENT_88	[p6l1471t717r1573b769],
8	of	IN	O	of	_	0	SENT_88	[p6l1601t700r1667b754],
9	neovascular	JJ	O	neovascular	amod	11	SENT_88	[p6l1688t701r2052b754],
10	disease	NN	O	disease	nn	11	SENT_88	[p6l13t784r231b837],
11	onset	NN	O	onset	prep_of	7	SENT_88	[p6l256t792r430b847],
12	,	,	O	,	_	0	SENT_88	[p6l256t792r430b847],
13	deﬁned	VBN	O	deﬁned	partmod	1	SENT_88	[p6l458t784r681b837],
14	as	IN	O	as	_	0	SENT_88	[p6l705t801r764b837],
15	the	DT	O	the	det	16	SENT_88	[p6l789t784r880b837],
16	age	NN	O	age	prep_as	13	SENT_88	[p6l906t801r1008b853],
17	when	WRB	O	when	advmod	23	SENT_88	[p6l1032t784r1195b837],
18	the	DT	O	the	det	21	SENT_88	[p6l1219t784r1310b837],
19	ﬁrst	NN	O	ﬁrst	nn	21	SENT_88	[p6l1335t784r1452b837],
20	ranibizumab	NN	O	ranibizumab	nn	21	SENT_88	[p6l1474t784r1854b837],
21	injection	NN	O	injection	nsubjpass	23	SENT_88	[p6l1878t784r2048b853, p6l12t866r130b919],
22	was	VBD	O	be	auxpass	23	SENT_88	[p6l168t883r283b920],
23	administered	VBN	O	administer	dep	16	SENT_88	[p6l324t866r732b929],
24	,	,	O	,	_	0	SENT_88	[p6l324t866r732b929],
25	was	VBD	O	be	auxpass	26	SENT_88	[p6l773t883r888b920],
26	assessed	VBN	O	assess	_	0	SENT_88	[p6l929t866r1185b919],
27	with	IN	O	with	_	0	SENT_88	[p6l1223t866r1357b920],
28	linear	JJ	O	linear	amod	30	SENT_88	[p6l1395t866r1568b919],
29	mixed	JJ	O	mixed	amod	30	SENT_88	[p6l1605t866r1795b919],
30	models	NNS	O	model	prep_with	26	SENT_88	[p6l1832t866r2049b919],
31	using	VBG	O	use	partmod	30	SENT_88	[p6l12t949r175b1018],
32	the	DT	O	the	det	33	SENT_88	[p6l211t950r302b1003],
33	age	NN	O	age	dobj	31	SENT_88	[p6l339t966r441b1018],
34	of	IN	O	of	_	0	SENT_88	[p6l477t949r544b1003],
35	onset	NN	O	onset	prep_of	33	SENT_88	[p6l574t957r734b1003],
36	as	IN	O	as	_	0	SENT_88	[p6l769t966r827b1003],
37	the	DT	O	the	det	39	SENT_88	[p6l864t950r955b1003],
38	dependent	JJ	O	dependent	amod	39	SENT_88	[p6l991t949r1304b1018],
39	Variable	NNP	O	Variable	prep_as	31	SENT_88	[p6l1338t949r1597b1003],
40	.	.	O	.	_	0	SENT_88	[p6l1338t949r1597b1003],

1	Relationships	NNPS	O	Relationships	nsubjpass	3	SENT_89	[p6l1636t949r2049b1018],
2	were	VBD	O	be	auxpass	3	SENT_89	[p6l13t1050r159b1086],
3	adjusted	VBN	O	adjust	_	0	SENT_89	[p6l188t1033r440b1102],
4	for	IN	O	for	_	0	SENT_89	[p6l467t1033r556b1086],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_89	[p6l584t1033r900b1102],
6	confounders	NNS	O	confounder	prep_for	3	SENT_89	[p6l927t1033r1317b1086],
7	.	.	O	.	_	0	SENT_89	[p6l927t1033r1317b1086],

1	To	TO	O	to	aux	2	SENT_90	[p6l115t1117r196b1168],
2	explore	VB	O	explore	dep	59	SENT_90	[p6l226t1115r452b1184],
3	whether	IN	O	whether	complm	7	SENT_90	[p6l480t1115r726b1169],
4	a	DT	O	a	det	6	SENT_90	[p6l754t1132r785b1168],
5	genetic	JJ	O	genetic	amod	6	SENT_90	[p6l813t1115r1029b1184],
6	interaction	NN	O	interaction	nsubj	7	SENT_90	[p6l1058t1115r1383b1168],
7	exists	VBZ	O	exist	ccomp	2	SENT_90	[p6l1412t1115r1581b1168],
8	between	IN	O	between	dep	15	SENT_90	[p6l1610t1115r1864b1169],
9	highrisk	JJ	O	highrisk	amod	10	SENT_90	[p6l1891t1115r2049b1184, p6l12t1198r127b1252],
10	alleles	NNS	O	allele	pobj	8	SENT_90	[p6l167t1198r357b1252],
11	in	IN	O	in	_	0	SENT_90	[p6l399t1198r456b1251],
12	CFH	NNP	O	CFH	prep_in	10	SENT_90	[p6l500t1200r652b1252],
13	(	CD	NUMBER	(	num	12	SENT_90	[p6l689t1199r764b1264],
14	C	NN	O	c	nn	15	SENT_90	[p6l689t1199r764b1264],
15	allele	NN	O	allele	dep	29	SENT_90	[p6l803t1199r983b1261],
16	;	:	O	;	_	0	SENT_90	[p6l803t1199r983b1261],
17	Y402H	NN	O	y402h	nn	18	SENT_90	[p6l1026t1199r1272b1264],
18	)	NN	O	)	dep	15	SENT_90	[p6l1026t1199r1272b1264],
19	and	CC	O	and	_	0	SENT_90	[p6l1316t1199r1424b1252],
20	ARMS2	NN	O	arms2	nn	23	SENT_90	[p6l1463t1199r1715b1252],
21	(	CD	NUMBER	(	num	23	SENT_90	[p6l1758t1199r1826b1264],
22	T	NN	O	t	nn	23	SENT_90	[p6l1758t1199r1826b1264],
23	allele	NN	O	allele	conj_and	18	SENT_90	[p6l1867t1198r2047b1261],
24	;	:	O	;	_	0	SENT_90	[p6l1867t1198r2047b1261],
25	A69S	NN	O	a69	nn	26	SENT_90	[p6l12t1282r226b1347],
26	)	NN	O	)	dep	15	SENT_90	[p6l12t1282r226b1347],
27	,	,	O	,	_	0	SENT_90	[p6l12t1282r226b1347],
28	we	PRP	O	we	nsubj	29	SENT_90	[p6l268t1299r354b1335],
29	stratiﬁed	VBD	O	stratiﬁed	ccomp	7	SENT_90	[p6l395t1282r659b1335],
30	the	DT	O	the	det	31	SENT_90	[p6l697t1282r788b1335],
31	data	NNS	O	datum	nsubj	32	SENT_90	[p6l827t1282r953b1335],
32	(	VBP	O	(	ccomp	29	SENT_90	[p6l993t1282r1107b1347],
33	the	DT	O	the	det	34	SENT_90	[p6l993t1282r1107b1347],
34	age	NN	O	age	dobj	32	SENT_90	[p6l1147t1299r1249b1351],
35	of	IN	O	of	_	0	SENT_90	[p6l1289t1282r1354b1335],
36	onset	NN	O	onset	prep_of	34	SENT_90	[p6l1389t1290r1548b1335],
37	and	CC	O	and	_	0	SENT_90	[p6l1587t1282r1694b1335],
38	delta	NN	O	delta	nn	39	SENT_90	[p6l1733t1282r1880b1335],
39	VA	NN	MISC	va	conj_and	34	SENT_90	[p6l1916t1282r2048b1347],
40	)	CD	NUMBER	)	dep	39	SENT_90	[p6l1916t1282r2048b1347],
41	according	VBG	O	accord	_	0	SENT_90	[p6l14t1364r311b1433],
42	to	TO	O	to	prepc_according_to	32	SENT_90	[p6l338t1372r395b1417],
43	the	DT	O	the	det	44	SENT_90	[p6l421t1364r512b1417],
44	number	NN	O	number	pobj	32	SENT_90	[p6l539t1364r772b1417],
45	of	IN	O	of	_	0	SENT_90	[p6l797t1364r863b1417],
46	high-risk	JJ	O	high-risk	amod	47	SENT_90	[p6l883t1364r1160b1433],
47	alleles	NNS	O	allele	prep_of	44	SENT_90	[p6l1186t1364r1376b1417],
48	by	IN	O	by	_	0	SENT_90	[p6l1402t1364r1477b1433],
49	creating	VBG	O	create	prepc_by	2	SENT_90	[p6l1504t1364r1747b1433],
50	4	CD	NUMBER	4	number	51	SENT_90	[p6l1773t1364r1809b1417],
51	‘	CD	NUMBER	‘	num	54	SENT_90	[p6l1844t1364r2043b1417],
52	allele	NN	O	allele	nn	54	SENT_90	[p6l1844t1364r2043b1417],
53	’	NN	O	’	nn	54	SENT_90	[p6l1844t1364r2043b1417],
54	groups	NNS	O	group	dobj	49	SENT_90	[p6l13t1464r235b1516],
55	:	:	O	:	_	0	SENT_90	[p6l13t1464r235b1516],
56	(	CD	NUMBER	(	num	59	SENT_90	[p6l268t1448r351b1513],
57	o	NN	O	o	nn	59	SENT_90	[p6l268t1448r351b1513],
58	)	CD	NUMBER	)	num	59	SENT_90	[p6l268t1448r351b1513],
59	patients	NNS	O	patient	_	0	SENT_90	[p6l378t1447r613b1516],
60	without	IN	O	without	_	0	SENT_90	[p6l641t1447r874b1501],
61	high-risk	JJ	O	high-risk	amod	62	SENT_90	[p6l898t1447r1175b1516],
62	alleles	NNS	O	allele	prep_without	59	SENT_90	[p6l1200t1448r1390b1501],
63	in	IN	O	in	prep	59	SENT_90	[p6l1418t1447r1476b1500],
64	either	CC	O	either	dep	63	SENT_90	[p6l1502t1447r1676b1501],
65	gene	NN	O	gene	conj	63	SENT_90	[p6l1701t1464r1858b1516],
66	,	,	O	,	_	0	SENT_90	[p6l1701t1464r1858b1516],
67	(	CD	NUMBER	(	number	68	SENT_90	[p6l1890t1448r2049b1513],
68	1-2	CD	NUMBER	1-2	num	70	SENT_90	[p6l1890t1448r2049b1513],
69	)	NN	O	)	nn	70	SENT_90	[p6l1890t1448r2049b1513],
70	patients	NNS	O	patient	appos	59	SENT_90	[p6l12t1531r247b1600],
71	carrying	VBG	O	carry	partmod	70	SENT_90	[p6l281t1531r532b1600],
72	1	CD	NUMBER	1	num	76	SENT_90	[p6l572t1531r594b1583],
73	or	CC	O	or	_	0	SENT_90	[p6l633t1548r696b1584],
74	2	CD	NUMBER	2	conj_or	72	SENT_90	[p6l727t1531r761b1583],
75	high-risk	JJ	O	high-risk	amod	76	SENT_90	[p6l793t1531r1070b1600],
76	alleles	NNS	O	allele	dobj	71	SENT_90	[p6l1101t1531r1309b1594],
77	,	,	O	,	_	0	SENT_90	[p6l1101t1531r1309b1594],
78	(	NN	O	(	appos	76	SENT_90	[p6l1346t1531r1428b1596],
79	3	CD	NUMBER	3	num	81	SENT_90	[p6l1346t1531r1428b1596],
80	)	NN	O	)	nn	81	SENT_90	[p6l1346t1531r1428b1596],
81	patients	NNS	O	patient	dep	78	SENT_90	[p6l1461t1531r1696b1600],
82	carrying	VBG	O	carry	xcomp	71	SENT_90	[p6l1731t1531r1982b1600],
83	3	CD	NUMBER	3	num	85	SENT_90	[p6l2016t1531r2047b1584],
84	high-risk	JJ	O	high-risk	amod	85	SENT_90	[p6l12t1613r289b1682],
85	alleles	NNS	O	allele	dobj	82	SENT_90	[p6l318t1613r526b1676],
86	,	,	O	,	_	0	SENT_90	[p6l318t1613r526b1676],
87	and	CC	O	and	_	0	SENT_90	[p6l561t1613r668b1666],
88	(	NN	O	(	appos	59	SENT_90	[p6l700t1613r782b1679],
89	4	CD	NUMBER	4	num	91	SENT_90	[p6l700t1613r782b1679],
90	)	NN	O	)	nn	91	SENT_90	[p6l700t1613r782b1679],
91	patients	NNS	O	patient	dep	70	SENT_90	[p6l814t1613r1049b1682],
92	carrying	VBG	O	carry	partmod	91	SENT_90	[p6l1081t1613r1332b1682],
93	all	DT	O	all	quantmod	94	SENT_90	[p6l1365t1613r1437b1666],
94	4	CD	NUMBER	4	num	96	SENT_90	[p6l1467t1613r1503b1666],
95	high-risk	JJ	O	high-risk	amod	96	SENT_90	[p6l1533t1613r1810b1682],
96	alleles	NNS	O	allele	dobj	92	SENT_90	[p6l1840t1613r2047b1666],
97	.	.	O	.	_	0	SENT_90	[p6l1840t1613r2047b1666],

1	Adding	VBG	O	add	csubj	9	SENT_91	[p6l12t1696r239b1765],
2	other	JJ	O	other	amod	4	SENT_91	[p6l265t1697r421b1750],
3	risk	NN	O	risk	nn	4	SENT_91	[p6l443t1696r558b1750],
4	alleles	NNS	O	allele	dobj	1	SENT_91	[p6l582t1697r772b1750],
5	to	TO	O	to	_	0	SENT_91	[p6l798t1705r855b1750],
6	the	DT	O	the	det	8	SENT_91	[p6l880t1697r971b1750],
7	additive	JJ	O	additive	amod	8	SENT_91	[p6l997t1696r1240b1750],
8	model	NN	O	model	prep_to	1	SENT_91	[p6l1265t1696r1454b1750],
9	showed	VBD	O	show	_	0	SENT_91	[p6l1481t1697r1710b1750],
10	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_91	[p6l1737t1696r2052b1765],
11	results	NNS	O	result	dobj	9	SENT_91	[p6l12t1780r208b1833],
12	only	RB	O	only	advmod	9	SENT_91	[p6l237t1780r370b1849],
13	for	IN	O	for	_	0	SENT_91	[p6l397t1780r486b1833],
14	the	DT	O	the	det	17	SENT_91	[p6l511t1780r602b1833],
15	VEGF-A	NN	O	vegf-a	nn	17	SENT_91	[p6l628t1780r907b1833],
16	rs699947	NN	O	rs699947	nn	17	SENT_91	[p6l932t1780r1214b1834],
17	polymorphism	NN	O	polymorphism	prep_for	9	SENT_91	[p6l1242t1780r1702b1849],
18	.	.	O	.	_	0	SENT_91	[p6l1242t1780r1702b1849],

1	Therefore	RB	O	therefore	advmod	5	SENT_92	[p6l1732t1780r2048b1843],
2	,	,	O	,	_	0	SENT_92	[p6l1732t1780r2048b1843],
3	the	DT	O	the	det	4	SENT_92	[p6l12t1862r103b1915],
4	data	NNS	O	datum	nsubj	5	SENT_92	[p6l133t1862r259b1915],
5	(	VBP	O	(	_	0	SENT_92	[p6l288t1863r415b1931],
6	age	NN	O	age	nsubjpass	14	SENT_92	[p6l288t1863r415b1931],
7	of	IN	O	of	_	0	SENT_92	[p6l445t1862r511b1915],
8	onset	NN	O	onset	nn	12	SENT_92	[p6l535t1870r695b1915],
9	and	CC	O	and	_	0	SENT_92	[p6l724t1862r831b1915],
10	delta	NN	O	delta	nn	12	SENT_92	[p6l860t1862r1007b1915],
11	VA	NN	O	va	nn	12	SENT_92	[p6l1034t1863r1166b1928],
12	)	NN	O	)	prep_of	6	SENT_92	[p6l1034t1863r1166b1928],
13	were	VBD	O	be	auxpass	14	SENT_92	[p6l1197t1879r1342b1916],
14	stratiﬁed	VBN	O	stratiﬁed	ccomp	5	SENT_92	[p6l1374t1862r1638b1915],
15	according	VBG	O	accord	_	0	SENT_92	[p6l1667t1862r1964b1931],
16	to	TO	O	to	prepc_according_to	14	SENT_92	[p6l1994t1870r2050b1915],
17	the	DT	O	the	det	18	SENT_92	[p6l12t1945r103b1999],
18	number	NN	O	number	pobj	14	SENT_92	[p6l132t1946r365b1999],
19	of	IN	O	of	_	0	SENT_92	[p6l393t1945r459b1999],
20	high-risk	JJ	O	high-risk	amod	21	SENT_92	[p6l482t1945r758b2014],
21	alleles	NNS	O	allele	prep_of	18	SENT_92	[p6l787t1945r977b1999],
22	in	IN	O	in	_	0	SENT_92	[p6l1007t1945r1065b1998],
23	CFH	NNP	O	CFH	prep_in	21	SENT_92	[p6l1097t1947r1260b2008],
24	,	,	O	,	_	0	SENT_92	[p6l1097t1947r1260b2008],
25	ARMS2	NN	O	arms2	conj_and	23	SENT_92	[p6l1286t1946r1539b2008],
26	,	,	O	,	_	0	SENT_92	[p6l1286t1946r1539b2008],
27	and	CC	O	and	_	0	SENT_92	[p6l1572t1946r1680b1999],
28	VEGFA	NN	O	vegfa	conj_and	23	SENT_92	[p6l1712t1947r1945b1999],
29	by	IN	O	by	_	0	SENT_92	[p6l1975t1945r2050b2014],
30	creating	VBG	O	create	agent	14	SENT_92	[p6l13t2029r256b2098],
31	5	CD	NUMBER	5	num	33	SENT_92	[p6l289t2028r320b2082],
32	allele	NN	O	allele	nn	33	SENT_92	[p6l356t2029r517b2082],
33	groups	NNS	O	group	dobj	30	SENT_92	[p6l549t2045r771b2098],
34	:	:	O	:	_	0	SENT_92	[p6l549t2045r771b2098],
35	(	CD	NUMBER	(	num	38	SENT_92	[p6l809t2029r891b2094],
36	o	NN	O	o	nn	38	SENT_92	[p6l809t2029r891b2094],
37	)	CD	NUMBER	)	num	38	SENT_92	[p6l809t2029r891b2094],
38	patients	NNS	O	patient	nsubj	50	SENT_92	[p6l923t2029r1158b2098],
39	without	IN	O	without	_	0	SENT_92	[p6l1191t2029r1424b2082],
40	or	CC	O	or	_	0	SENT_92	[p6l1454t2045r1516b2082],
41	with	IN	O	with	_	0	SENT_92	[p6l1546t2029r1680b2082],
42	1	CD	NUMBER	1	num	44	SENT_92	[p6l1717t2029r1739b2081],
43	high-risk	JJ	O	high-risk	amod	44	SENT_92	[p6l1776t2029r2052b2098],
44	allele	NN	O	allele	prep_with	38	SENT_92	[p6l14t2111r192b2174],
45	,	,	O	,	_	0	SENT_92	[p6l14t2111r192b2174],
46	(	NN	O	(	appos	44	SENT_92	[p6l232t2112r315b2177],
47	1	CD	NUMBER	1	number	48	SENT_92	[p6l232t2112r315b2177],
48	)	CD	NUMBER	)	num	49	SENT_92	[p6l232t2112r315b2177],
49	patients	NNS	O	patient	prep_without	38	SENT_92	[p6l351t2111r586b2180],
50	carrying	VBG	O	carry	parataxis	14	SENT_92	[p6l624t2111r875b2180],
51	2	CD	NUMBER	2	num	55	SENT_92	[p6l912t2111r946b2164],
52	and	CC	O	and	_	0	SENT_92	[p6l983t2111r1091b2164],
53	3	CD	NUMBER	3	num	55	SENT_92	[p6l1127t2112r1157b2165],
54	high-risk	JJ	O	high-risk	amod	55	SENT_92	[p6l1195t2111r1472b2180],
55	alleles	NNS	O	allele	dobj	50	SENT_92	[p6l1507t2111r1715b2174],
56	,	,	O	,	_	0	SENT_92	[p6l1507t2111r1715b2174],
57	(	NN	O	(	appos	55	SENT_92	[p6l1755t2111r1837b2176],
58	2	CD	NUMBER	2	number	59	SENT_92	[p6l1755t2111r1837b2176],
59	)	CD	NUMBER	)	num	61	SENT_92	[p6l1755t2111r1837b2176],
60	AMD	NN	ORGANIZATION	amd	nn	61	SENT_92	[p6l1874t2112r2049b2164],
61	patients	NNS	O	patient	dep	57	SENT_92	[p6l11t2194r247b2263],
62	carrying	VBG	O	carry	xcomp	50	SENT_92	[p6l275t2194r527b2263],
63	4	CD	NUMBER	4	num	65	SENT_92	[p6l554t2195r590b2247],
64	high-risk	JJ	O	high-risk	amod	65	SENT_92	[p6l616t2194r893b2263],
65	alleles	NNS	O	allele	nsubj	72	SENT_92	[p6l919t2195r1127b2257],
66	,	,	O	,	_	0	SENT_92	[p6l919t2195r1127b2257],
67	(	NN	O	(	appos	65	SENT_92	[p6l1159t2195r1241b2260],
68	3	CD	NUMBER	3	num	71	SENT_92	[p6l1159t2195r1241b2260],
69	)	NN	O	)	nn	71	SENT_92	[p6l1159t2195r1241b2260],
70	AMD	NN	ORGANIZATION	amd	nn	71	SENT_92	[p6l1270t2195r1445b2247],
71	patients	NNS	O	patient	dep	67	SENT_92	[p6l1472t2194r1707b2263],
72	carrying	VBG	O	carry	dep	62	SENT_92	[p6l1736t2194r1987b2263],
73	5	CD	NUMBER	5	num	75	SENT_92	[p6l2016t2194r2047b2248],
74	high-risk	JJ	O	high-risk	amod	75	SENT_92	[p6l12t2278r289b2347],
75	alleles	NNS	O	allele	dobj	72	SENT_92	[p6l315t2278r523b2341],
76	,	,	O	,	_	0	SENT_92	[p6l315t2278r523b2341],
77	and	CC	O	and	_	0	SENT_92	[p6l554t2278r662b2331],
78	(	NN	O	(	nsubj	82	SENT_92	[p6l690t2278r772b2343],
79	4	CD	NUMBER	4	num	81	SENT_92	[p6l690t2278r772b2343],
80	)	NN	O	)	nn	81	SENT_92	[p6l690t2278r772b2343],
81	patients	NNS	O	patient	dep	78	SENT_92	[p6l800t2278r1035b2347],
82	carrying	VBG	O	carry	conj_and	5	SENT_92	[p6l1064t2278r1316b2347],
83	all	DT	O	all	quantmod	84	SENT_92	[p6l1345t2278r1421b2331],
84	6	CD	NUMBER	6	num	86	SENT_92	[p6l1450t2278r1484b2331],
85	high-risk	JJ	O	high-risk	amod	86	SENT_92	[p6l1512t2278r1801b2347],
86	alleles	NNS	O	allele	dobj	82	SENT_92	[p6l1829t2278r2047b2331],
87	.	.	O	.	_	0	SENT_92	[p6l1829t2278r2047b2331],

1	Relationships	NNPS	O	Relationships	nsubjpass	3	SENT_93	[p6l12t2360r444b2429],
2	were	VBD	O	be	auxpass	3	SENT_93	[p6l489t2377r639b2413],
3	assessed	VBN	O	assess	_	0	SENT_93	[p6l685t2360r952b2413],
4	using	VBG	O	use	xcomp	3	SENT_93	[p6l994t2360r1163b2429],
5	linear	JJ	O	linear	amod	7	SENT_93	[p6l1207t2360r1388b2413],
6	mixed	JJ	O	mixed	amod	7	SENT_93	[p6l1431t2360r1627b2413],
7	models	NNS	O	model	dobj	4	SENT_93	[p6l1669t2360r1894b2413],
8	and	CC	O	and	_	0	SENT_93	[p6l1941t2360r2051b2413],
9	were	VBD	O	be	auxpass	10	SENT_93	[p6l13t2460r163b2497],
10	adjusted	VBN	O	adjust	conj_and	3	SENT_93	[p6l202t2443r464b2512],
11	for	IN	O	for	_	0	SENT_93	[p6l501t2443r592b2497],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_93	[p6l630t2443r959b2512],
13	confounders	NNS	O	confounder	prep_for	10	SENT_93	[p6l995t2443r1402b2497],
14	.	.	O	.	_	0	SENT_93	[p6l995t2443r1402b2497],

1	Reported	VBN	O	report	_	0	SENT_94	[p6l1443t2444r1732b2512],
2	P	NN	O	p	nn	3	SENT_94	[p6l1767t2446r1814b2496],
3	Values	NNS	O	value	dobj	1	SENT_94	[p6l1850t2443r2049b2497],
4	are	VBP	O	be	auxpass	1	SENT_94	[p6l14t2543r106b2580],
5	2	CD	NUMBER	2	number	6	SENT_94	[p6l131t2527r363b2580],
6	—	CD	NUMBER	—	nsubjpass	1	SENT_94	[p6l131t2527r363b2580],
7	sided	VBD	O	side	rcmod	6	SENT_94	[p6l131t2527r363b2580],
8	and	CC	O	and	_	0	SENT_94	[p6l387t2527r498b2580],
9	were	VBD	O	be	auxpass	10	SENT_94	[p6l521t2543r671b2580],
10	considered	VBN	O	consider	rcmod	6	SENT_94	[p6l696t2527r1039b2580],
11	statistically	RB	O	statistically	advmod	12	SENT_94	[p6l1064t2527r1425b2596],
12	signiﬁcant	JJ	O	signiﬁcant	acomp	10	SENT_94	[p6l1452t2527r1781b2596],
13	if	IN	O	if	dep	12	SENT_94	[p6l1803t2527r1854b2579],
14	lower	JJR	O	lower	dep	12	SENT_94	[p6l1873t2527r2052b2580],
15	than	IN	O	than	_	0	SENT_94	[p6l12t2609r147b2662],
16	0.05	CD	NUMBER	0.05	prep_than	10	SENT_94	[p6l196t2609r349b2663],
17	.	.	O	.	_	0	SENT_94	[p6l196t2609r349b2663],

1	Statistical	JJ	O	statistical	amod	2	SENT_95	[p6l404t2609r716b2663],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_95	[p6l767t2609r1031b2678],
3	were	VBD	O	be	auxpass	4	SENT_95	[p6l1082t2626r1232b2662],
4	performed	VBN	O	perform	_	0	SENT_95	[p6l1281t2609r1611b2678],
5	using	VBG	O	use	xcomp	4	SENT_95	[p6l1659t2609r1829b2678],
6	SPSS	NNP	ORGANIZATION	SPSS	nn	8	SENT_95	[p6l1880t2609r2047b2663],
7	software	NN	O	software	nn	8	SENT_95	[p6l15t2692r284b2746],
8	Version	NNP	O	Version	dobj	5	SENT_95	[p6l315t2692r547b2746],
9	18.0	CD	NUMBER	18.0	number	10	SENT_95	[p6l585t2693r714b2746],
10	(	CD	NUMBER	(	num	18	SENT_95	[p6l747t2693r962b2758],
11	SPSS	NNP	ORGANIZATION	SPSS	nn	18	SENT_95	[p6l747t2693r962b2758],
12	,	,	O	,	_	0	SENT_95	[p6l747t2693r962b2758],
13	Inc.	NNP	ORGANIZATION	Inc.	appos	18	SENT_95	[p6l996t2694r1133b2755],
14	,	,	O	,	_	0	SENT_95	[p6l996t2694r1133b2755],
15	Chicago	NNP	LOCATION	Chicago	dep	18	SENT_95	[p6l1167t2692r1446b2761],
16	,	,	O	,	_	0	SENT_95	[p6l1167t2692r1446b2761],
17	IL	NN	LOCATION	il	nn	18	SENT_95	[p6l1480t2693r1595b2758],
18	)	NN	O	)	dep	8	SENT_95	[p6l1480t2693r1595b2758],
19	.	.	O	.	_	0	SENT_95	[p6l1480t2693r1595b2758],

1	Results	NNS	O	result	_	0	SENT_96	[p6l13t2914r337b2992],

1	This	DT	O	this	det	2	SENT_97	[p7l13t26r145b79],
2	study	NN	O	study	nsubj	3	SENT_97	[p7l176t26r336b95],
3	evaluated	VBD	O	evaluate	_	0	SENT_97	[p7l364t26r655b79],
4	various	JJ	O	various	amod	5	SENT_97	[p7l681t26r903b79],
5	factors	NNS	O	factor	dobj	3	SENT_97	[p7l931t26r1135b79],
6	that	WDT	O	that	nsubj	8	SENT_97	[p7l1163t26r1277b79],
7	may	MD	O	may	aux	8	SENT_97	[p7l1303t43r1432b95],
8	inﬂuence	VB	O	inﬂuence	rcmod	5	SENT_97	[p7l1459t26r1737b79],
9	treatment	NN	O	treatment	nn	10	SENT_97	[p7l1764t34r2052b79],
10	response	NN	O	response	dobj	8	SENT_97	[p7l12t126r278b178],
11	to	TO	O	to	_	0	SENT_97	[p7l303t117r360b163],
12	intravitreal	JJ	O	intravitreal	amod	14	SENT_97	[p7l386t109r719b163],
13	ranibizumab	NN	O	ranibizumab	nn	14	SENT_97	[p7l744t109r1124b163],
14	injections	NNS	O	injection	prep_to	8	SENT_97	[p7l1151t109r1444b178],
15	in	IN	O	in	_	0	SENT_97	[p7l1472t109r1529b162],
16	420	CD	NUMBER	420	num	17	SENT_97	[p7l1554t110r1667b163],
17	eyes	NNS	O	eye	prep_in	14	SENT_97	[p7l1693t126r1824b178],
18	of	IN	O	of	_	0	SENT_97	[p7l1852t109r1918b163],
19	397	CD	NUMBER	397	num	26	SENT_97	[p7l1941t110r2048b163],
20	unrelated	JJ	O	unrelated	amod	26	SENT_97	[p7l12t193r311b255],
21	,	,	O	,	_	0	SENT_97	[p7l12t193r311b255],
22	white	JJ	O	white	amod	26	SENT_97	[p7l340t193r524b256],
23	,	,	O	,	_	0	SENT_97	[p7l340t193r524b256],
24	neovascular	JJ	O	neovascular	amod	26	SENT_97	[p7l552t193r917b246],
25	AMD	NN	ORGANIZATION	amd	nn	26	SENT_97	[p7l941t193r1116b245],
26	patients	NNS	O	patient	prep_of	17	SENT_97	[p7l1142t193r1394b261],
27	.	.	O	.	_	0	SENT_97	[p7l1142t193r1394b261],

1	After	IN	O	after	_	0	SENT_98	[p7l1424t193r1584b246],
2	3	CD	NUMBER	3	num	4	SENT_98	[p7l1610t193r1641b246],
3	ranibizumab	NN	O	ranibizumab	nn	4	SENT_98	[p7l1669t193r2049b246],
4	injections	NNS	O	injection	prep_after	11	SENT_98	[p7l12t275r324b344],
5	,	,	O	,	_	0	SENT_98	[p7l12t275r324b344],
6	the	DT	O	the	det	8	SENT_98	[p7l367t275r458b328],
7	study	NN	O	study	nn	8	SENT_98	[p7l500t275r661b344],
8	population	NN	O	population	nsubj	11	SENT_98	[p7l700t275r1026b344],
9	on	IN	O	on	_	0	SENT_98	[p7l1067t292r1140b328],
10	average	NN	O	average	prep_on	8	SENT_98	[p7l1181t292r1415b344],
11	showed	VBD	O	show	conj_and	11	SENT_98	[p7l1457t275r1687b328],
12	visual	JJ	O	visual	amod	13	SENT_98	[p7l1726t275r1906b329],
13	improvement	NN	O	improvement	dobj	11	SENT_98	[p7l1946t275r2048b328, p7l12t366r354b427],
14	,	,	O	,	_	0	SENT_98	[p7l1946t275r2048b328, p7l12t366r354b427],
15	with	IN	O	with	_	0	SENT_98	[p7l385t358r519b412],
16	a	DT	O	a	det	18	SENT_98	[p7l548t375r579b411],
17	median	JJ	O	median	amod	18	SENT_98	[p7l606t358r829b411],
18	VA	NN	O	va	prep_with	11	SENT_98	[p7l856t359r965b411],
19	before	IN	O	before	_	0	SENT_98	[p7l991t358r1185b411],
20	and	CC	O	and	_	0	SENT_98	[p7l1215t358r1323b411],
21	after	IN	O	after	_	0	SENT_98	[p7l1351t358r1489b411],
22	treatment	NN	O	treatment	prep_before	11	SENT_98	[p7l1515t366r1803b411],
23	of	IN	O	of	_	0	SENT_98	[p7l1831t358r1897b411],
24	0.54	CD	NUMBER	0.54	prep_of	22	SENT_98	[p7l1920t358r2050b412],
25	and	CC	O	and	_	0	SENT_98	[p7l14t442r121b495],
26	0.44	CD	NUMBER	0.44	num	27	SENT_98	[p7l149t442r279b495],
27	logMAR	NN	O	logmar	prep_of	22	SENT_98	[p7l308t442r594b511],
28	,	,	O	,	_	0	SENT_98	[p7l308t442r594b511],
29	respectively	RB	O	respectively	advmod	11	SENT_98	[p7l623t442r1007b511],
30	.	.	O	.	_	0	SENT_98	[p7l623t442r1007b511],

1	An	DT	O	a	det	3	SENT_99	[p7l1038t442r1130b494],
2	increased	VBN	O	increase	amod	3	SENT_99	[p7l1157t442r1444b495],
3	age	NN	O	age	nsubjpass	10	SENT_99	[p7l1473t458r1575b511],
4	at	IN	O	at	_	0	SENT_99	[p7l1604t450r1657b495],
5	the	DT	O	the	det	6	SENT_99	[p7l1683t442r1774b495],
6	onset	NN	O	onset	prep_at	3	SENT_99	[p7l1803t450r1962b495],
7	of	IN	O	of	_	0	SENT_99	[p7l1990t442r2055b495],
8	treatment	NN	O	treatment	prep_of	6	SENT_99	[p7l12t532r301b577],
9	was	VBD	O	be	auxpass	10	SENT_99	[p7l339t541r454b577],
10	associated	VBN	O	associate	dep	20	SENT_99	[p7l497t524r808b577],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_99	[p7l849t524r1223b593],
12	with	IN	O	with	_	0	SENT_99	[p7l1263t524r1397b577],
13	loss	NN	O	loss	prep_with	10	SENT_99	[p7l1436t524r1551b577],
14	in	IN	O	in	_	0	SENT_99	[p7l1593t524r1650b577],
15	VA	NNP	ORGANIZATION	VA	prep_in	13	SENT_99	[p7l1689t525r1798b577],
16	after	IN	O	after	_	0	SENT_99	[p7l1839t524r1977b577],
17	3	CD	NUMBER	3	num	19	SENT_99	[p7l2017t525r2047b578],
18	ranibizumab	NN	O	ranibizumab	nn	19	SENT_99	[p7l12t607r392b660],
19	injections	NNS	O	injection	prep_after	10	SENT_99	[p7l418t607r712b676],
20	(	VBP	O	(	_	0	SENT_99	[p7l742t608r896b673],
21	0.02	CD	NUMBER	0.02	num	22	SENT_99	[p7l742t608r896b673],
22	logMAR	NN	O	logmar	nsubj	55	SENT_99	[p7l922t607r1193b676],
23	or	CC	O	or	_	0	SENT_99	[p7l1219t624r1280b660],
24	1	CD	NUMBER	1	num	27	SENT_99	[p7l1312t608r1334b660],
25	ETDRS	NN	O	etdr	nn	27	SENT_99	[p7l1366t608r1603b661],
26	letter	NN	O	letter	nn	27	SENT_99	[p7l1632t607r1788b660],
27	loss	NN	O	loss	nsubj	55	SENT_99	[p7l1812t607r1928b660],
28	per	IN	O	per	_	0	SENT_99	[p7l1954t624r2052b676],
29	4	CD	DURATION	4	num	30	SENT_99	[p7l12t691r48b743],
30	years	NNS	NUMBER	year	prep_per	27	SENT_99	[p7l75t707r253b759],
31	;	:	O	;	_	0	SENT_99	[p7l75t707r253b759],
32	P	NN	O	p	dep	27	SENT_99	[p7l282t693r328b743],
33	=	JJ	O	=	amod	35	SENT_99	[p7l363t709r408b727],
34	0.003	CD	NUMBER	0.003	tmod	33	SENT_99	[p7l443t691r655b756],
35	)	NN	O	)	dep	32	SENT_99	[p7l443t691r655b756],
36	,	,	O	,	_	0	SENT_99	[p7l443t691r655b756],
37	whereas	IN	O	whereas	mark	43	SENT_99	[p7l685t691r931b744],
38	a	DT	O	a	det	41	SENT_99	[p7l961t707r993b744],
39	poor	JJ	O	poor	amod	41	SENT_99	[p7l1018t707r1158b760],
40	baseline	NN	O	baseline	nn	41	SENT_99	[p7l1183t691r1432b744],
41	VA	NN	ORGANIZATION	va	nsubjpass	43	SENT_99	[p7l1459t691r1568b744],
42	was	VBD	O	be	auxpass	43	SENT_99	[p7l1595t707r1709b744],
43	associated	VBN	O	associate	dep	27	SENT_99	[p7l1740t691r2051b744],
44	signiﬁcantly	RB	O	signiﬁcantly	advmod	43	SENT_99	[p7l15t773r388b842],
45	with	IN	O	with	_	0	SENT_99	[p7l425t773r559b826],
46	a	DT	O	a	det	49	SENT_99	[p7l597t790r628b826],
47	greater	JJR	O	greater	amod	49	SENT_99	[p7l664t781r875b842],
48	VA	NN	O	va	nn	49	SENT_99	[p7l909t774r1018b826],
49	improvement	NN	O	improvement	prep_with	43	SENT_99	[p7l1054t773r1461b842],
50	after	IN	O	after	_	0	SENT_99	[p7l1498t773r1636b826],
51	ranibizumab	NN	O	ranibizumab	nn	52	SENT_99	[p7l1670t773r2050b826],
52	treatment	NN	O	treatment	prep_after	49	SENT_99	[p7l12t864r301b909],
53	(	CD	NUMBER	(	num	54	SENT_99	[p7l332t857r677b922],
54	P	NN	O	p	npadvmod	55	SENT_99	[p7l332t857r677b922],
55	<	JJR	O	<	xcomp	20	SENT_99	[p7l332t857r677b922],
56	o.	CD	NUMBER	o.	num	58	SENT_99	[p7l332t857r677b922],
57	ool	NN	O	ool	nn	58	SENT_99	[p7l332t857r677b922],
58	)	NN	O	)	nsubj	20	SENT_99	[p7l332t857r677b922],
59	.	.	O	.	_	0	SENT_99	[p7l332t857r677b922],

1	Individuals	NNS	O	individual	_	0	SENT_100	[p7l711t856r1052b910],
2	carrying	VBG	O	carry	partmod	1	SENT_100	[p7l1085t856r1336b925],
3	the	DT	O	the	det	8	SENT_100	[p7l1368t856r1459b909],
4	CFH	NNP	O	CFH	nn	8	SENT_100	[p7l1494t857r1646b910],
5	low-risk	JJ	O	low-risk	amod	8	SENT_100	[p7l1672t856r1926b909],
6	genotype	NN	O	genotype	nn	8	SENT_100	[p7l1956t873r2049b925, p7l12t948r218b1009],
7	(	CD	NUMBER	(	num	8	SENT_100	[p7l250t940r382b1005],
8	TT	NN	ORGANIZATION	tt	dobj	2	SENT_100	[p7l250t940r382b1005],
9	;	:	O	;	_	0	SENT_100	[p7l250t940r382b1005],
10	n	NN	O	n	dep	8	SENT_100	[p7l414t956r450b992],
11	=	JJ	O	=	advmod	15	SENT_100	[p7l486t958r532b976],
12	78	CD	PERCENT	78	num	13	SENT_100	[p7l569t940r640b993],
13	[	CD	PERCENT	[	dep	11	SENT_100	[p7l676t940r940b1005],
14	18.6	CD	PERCENT	18.6	num	15	SENT_100	[p7l676t940r940b1005],
15	%	NN	PERCENT	%	rcmod	10	SENT_100	[p7l676t940r940b1005],
16	]	CD	NUMBER	]	number	17	SENT_100	[p7l676t940r940b1005],
17	)	CD	NUMBER	)	num	15	SENT_100	[p7l676t940r940b1005],
18	performed	VBN	O	perform	partmod	15	SENT_100	[p7l970t940r1288b1009],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_100	[p7l1319t940r1692b1009],
20	better	JJR	O	better	acomp	18	SENT_100	[p7l1719t940r1894b993],
21	than	IN	O	than	_	0	SENT_100	[p7l1921t940r2051b993],
22	those	DT	O	those	nsubj	23	SENT_100	[p7l12t1023r171b1076],
23	carrying	VBG	O	carry	prepc_than	18	SENT_100	[p7l199t1023r450b1092],
24	the	DT	O	the	det	28	SENT_100	[p7l477t1023r568b1076],
25	high-risk	JJ	O	high-risk	amod	28	SENT_100	[p7l594t1023r871b1092],
26	genotype	NN	O	genotype	nn	28	SENT_100	[p7l896t1031r1174b1092],
27	(	CD	NUMBER	(	num	28	SENT_100	[p7l1203t1023r1344b1088],
28	CC	NN	O	cc	dobj	23	SENT_100	[p7l1203t1023r1344b1088],
29	;	:	O	;	_	0	SENT_100	[p7l1203t1023r1344b1088],
30	n	NN	O	n	dep	1	SENT_100	[p7l1373t1040r1410b1075],
31	=	JJ	O	=	amod	30	SENT_100	[p7l1444t1041r1490b1059],
32	144	CD	PERCENT	144	number	33	SENT_100	[p7l1531t1023r1636b1075],
33	[	CD	PERCENT	[	prep	31	SENT_100	[p7l1668t1023r1928b1087],
34	34.4	CD	PERCENT	34.4	num	35	SENT_100	[p7l1668t1023r1928b1087],
35	%	NN	PERCENT	%	dep	33	SENT_100	[p7l1668t1023r1928b1087],
36	]	CD	NUMBER	]	tmod	31	SENT_100	[p7l1668t1023r1928b1087],
37	;	:	O	;	_	0	SENT_100	[p7l1668t1023r1928b1087],
38	5.3	CD	NUMBER	5.3	num	40	SENT_100	[p7l1958t1023r2047b1076],
39	ETDRS	NN	O	etdr	nn	40	SENT_100	[p7l12t1106r249b1159],
40	letters	NNS	O	letter	dep	1	SENT_100	[p7l289t1105r472b1158],
41	better	RBR	O	better	advmod	40	SENT_100	[p7l508t1105r700b1168],
42	;	:	O	;	_	0	SENT_100	[p7l508t1105r700b1168],
43	P	NN	O	p	dep	1	SENT_100	[p7l737t1107r784b1158],
44	=	JJ	O	=	amod	43	SENT_100	[p7l827t1124r873b1142],
45	0.009	CD	NUMBER	0.009	tmod	44	SENT_100	[p7l918t1106r1105b1168],
46	;	:	O	;	_	0	SENT_100	[p7l918t1106r1105b1168],
47	Table	NNP	O	Table	dep	1	SENT_100	[p7l1144t1105r1316b1158],
48	1	CD	NUMBER	1	number	49	SENT_100	[p7l1360t1106r1429b1171],
49	)	CD	NUMBER	)	dep	47	SENT_100	[p7l1360t1106r1429b1171],
50	.	.	O	.	_	0	SENT_100	[p7l1360t1106r1429b1171],

1	Furthermore	RB	O	furthermore	_	0	SENT_101	[p7l1468t1105r1866b1168],
2	,	,	O	,	_	0	SENT_101	[p7l1468t1105r1866b1168],
3	male	NN	O	male	appos	1	SENT_101	[p7l1904t1105r2050b1158],

1	Number	NN	O	number	_	0	SENT_102	[p7l6t1436r316b1510],
2	11	CD	NUMBER	11	num	1	SENT_102	[p7l358t1440r469b1523],
3	,	,	O	,	_	0	SENT_102	[p7l358t1440r469b1523],
4	November	NNP	DATE	November	appos	1	SENT_102	[p7l511t1436r897b1510],
5	2012	CD	DATE	2012	num	4	SENT_102	[p7l933t1440r1120b1510],

1	patients	NNS	O	patient	nsubjpass	12	SENT_103	[p7l18t1658r264b1731],
2	(	CD	NUMBER	(	num	3	SENT_103	[p7l289t1658r351b1727],
3	n	NN	O	n	dep	1	SENT_103	[p7l289t1658r351b1727],
4	=	JJ	O	=	amod	3	SENT_103	[p7l379t1677r427b1696],
5	240	CD	PERCENT	240	number	6	SENT_103	[p7l457t1658r573b1714],
6	[	CD	PERCENT	[	prep	4	SENT_103	[p7l600t1658r876b1727],
7	57.1	CD	PERCENT	57.1	num	8	SENT_103	[p7l600t1658r876b1727],
8	%	NN	PERCENT	%	dep	6	SENT_103	[p7l600t1658r876b1727],
9	]	CD	NUMBER	]	num	10	SENT_103	[p7l600t1658r876b1727],
10	)	NN	O	)	dep	1	SENT_103	[p7l600t1658r876b1727],
11	were	VBD	O	be	auxpass	12	SENT_103	[p7l899t1675r1052b1714],
12	affected	VBN	O	affect	_	0	SENT_103	[p7l1074t1658r1328b1714],
13	with	IN	O	with	_	0	SENT_103	[p7l1349t1658r1489b1714],
14	neovascular	JJ	O	neovascular	amod	15	SENT_103	[p7l1509t1658r1890b1714],
15	leakage	NN	O	leakage	prep_with	12	SENT_103	[p7l1909t1658r2150b1731],
16	resulting	VBG	O	result	partmod	15	SENT_103	[p7l18t1746r296b1819],
17	from	IN	O	from	_	0	SENT_103	[p7l329t1746r483b1802],
18	AMD	NNP	O	AMD	prep_from	16	SENT_103	[p7l513t1746r696b1801],
19	2.1	CD	DATE	2.1	num	20	SENT_103	[p7l730t1746r820b1802],
20	years	NNS	DATE	year	npadvmod	21	SENT_103	[p7l858t1764r1023b1819],
21	earlier	RBR	DATE	earlier	advmod	16	SENT_103	[p7l1057t1746r1260b1802],
22	than	IN	O	than	_	0	SENT_103	[p7l1290t1746r1426b1802],
23	female	JJ	O	female	amod	24	SENT_103	[p7l1457t1746r1672b1802],
24	patients	NNS	O	patient	prep_than	16	SENT_103	[p7l1703t1746r1948b1819],
25	(	IN	O	(	_	0	SENT_103	[p7l1984t1747r2056b1815],
26	P	NN	O	p	prep_(	24	SENT_103	[p7l1984t1747r2056b1815],
27	=	JJ	O	=	advmod	16	SENT_103	[p7l2094t1765r2142b1784],
28	0.004	CD	NUMBER	0.004	num	29	SENT_103	[p7l20t1834r240b1903],
29	)	NN	O	)	dep	27	SENT_103	[p7l20t1834r240b1903],
30	.	.	O	.	_	0	SENT_103	[p7l20t1834r240b1903],

1	Patients	NNS	O	patient	nsubj	30	SENT_104	[p7l268t1833r518b1890],
2	carrying	VBG	O	carry	partmod	1	SENT_104	[p7l546t1833r808b1906],
3	the	DT	O	the	det	8	SENT_104	[p7l835t1833r930b1889],
4	heterozygous	JJ	O	heterozygous	amod	8	SENT_104	[p7l954t1833r1378b1906],
5	ARMS2	NN	O	arms2	nn	8	SENT_104	[p7l1399t1834r1644b1890],
6	(	CD	NUMBER	(	num	8	SENT_104	[p7l1674t1834r1827b1903],
7	GT	NN	O	gt	nn	8	SENT_104	[p7l1674t1834r1827b1903],
8	)	NN	O	)	dobj	2	SENT_104	[p7l1674t1834r1827b1903],
9	and	CC	O	and	_	0	SENT_104	[p7l1856t1833r1968b1890],
10	KDR	NN	O	kdr	dobj	2	SENT_104	[p7l1992t1835r2150b1889],
11	(	CD	NUMBER	(	num	14	SENT_104	[p7l22t1922r183b1991],
12	GA	NN	O	ga	nn	14	SENT_104	[p7l22t1922r183b1991],
13	)	NN	O	)	nn	14	SENT_104	[p7l22t1922r183b1991],
14	genotype	NN	O	genotype	nsubj	17	SENT_104	[p7l215t1930r505b1995],
15	were	VBD	O	be	cop	17	SENT_104	[p7l533t1939r686b1978],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_104	[p7l717t1922r1107b1995],
17	older	JJR	O	older	dep	2	SENT_104	[p7l1136t1922r1299b1978],
18	at	IN	O	at	_	0	SENT_104	[p7l1327t1930r1382b1978],
19	the	DT	O	the	det	21	SENT_104	[p7l1409t1922r1504b1978],
20	ﬁrst	NN	O	ﬁrst	nn	21	SENT_104	[p7l1533t1922r1656b1978],
21	injection	NN	O	injection	prep_at	17	SENT_104	[p7l1683t1922r1961b1995],
22	compared	VBN	O	compare	_	0	SENT_104	[p7l1989t1939r2149b1978, p7l18t2010r196b2083],
23	with	IN	O	with	prepc_compared_with	17	SENT_104	[p7l223t2010r363b2066],
24	patients	NNS	O	patient	pobj	17	SENT_104	[p7l389t2010r635b2083],
25	carrying	VBG	O	carry	partmod	24	SENT_104	[p7l665t2010r928b2083],
26	the	DT	O	the	det	29	SENT_104	[p7l957t2010r1052b2066],
27	homozygous	JJ	O	homozygous	amod	29	SENT_104	[p7l1079t2010r1485b2083],
28	high-risk	JJ	O	high-risk	amod	29	SENT_104	[p7l1514t2010r1803b2083],
29	genotypes	NNS	O	genotype	dobj	25	SENT_104	[p7l1830t2018r2149b2083],
30	(	VBP	O	(	_	0	SENT_104	[p7l22t2098r94b2167],
31	P	NN	O	p	dobj	30	SENT_104	[p7l22t2098r94b2167],
32	=	JJ	O	=	amod	31	SENT_104	[p7l124t2117r172b2136],
33	0.026	CD	NUMBER	0.026	tmod	32	SENT_104	[p7l204t2097r381b2154],
34	and	CC	O	and	_	0	SENT_104	[p7l407t2097r519b2153],
35	P	NN	O	p	dobj	30	SENT_104	[p7l541t2099r590b2153],
36	=	JJ	O	=	amod	35	SENT_104	[p7l620t2117r668b2136],
37	0.043	CD	NUMBER	0.043	tmod	36	SENT_104	[p7l701t2098r897b2164],
38	;	:	O	;	_	0	SENT_104	[p7l701t2098r897b2164],
39	Table	NNP	O	Table	dep	35	SENT_104	[p7l923t2097r1103b2153],
40	1	CD	NUMBER	1	number	41	SENT_104	[p7l1135t2098r1207b2167],
41	)	CD	NUMBER	)	dep	39	SENT_104	[p7l1135t2098r1207b2167],
42	.	.	O	.	_	0	SENT_104	[p7l1135t2098r1207b2167],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_105	[p7l1237t2097r1580b2170],
2	associations	NNS	O	association	nsubjpass	10	SENT_105	[p7l1605t2097r1986b2154],
3	with	IN	O	with	_	0	SENT_105	[p7l2011t2097r2151b2154],
4	FZD4	NN	O	fzd4	nn	7	SENT_105	[p7l19t2186r208b2241],
5	and	CC	O	and	_	0	SENT_105	[p7l256t2186r369b2242],
6	LRP5	NN	O	lrp5	conj_and	4	SENT_105	[p7l412t2187r595b2242],
7	genotypes	NNS	O	genotype	prep_with	2	SENT_105	[p7l642t2194r961b2259],
8	were	VBD	O	be	auxpass	10	SENT_105	[p7l1010t2203r1162b2242],
9	not	RB	O	not	neg	10	SENT_105	[p7l1209t2194r1311b2242],
10	observed	VBN	O	observe	_	0	SENT_105	[p7l1357t2186r1658b2242],
11	.	.	O	.	_	0	SENT_105	[p7l1357t2186r1658b2242],

1	In	IN	O	in	_	0	SENT_106	[p7l1709t2187r1773b2241],
2	this	DT	O	this	det	4	SENT_106	[p7l1819t2186r1931b2242],
3	study	NN	O	study	nn	4	SENT_106	[p7l1982t2186r2150b2259],
4	population	NN	O	population	prep_in	11	SENT_106	[p7l19t2274r376b2347],
5	,	,	O	,	_	0	SENT_106	[p7l19t2274r376b2347],
6	the	DT	O	the	det	8	SENT_106	[p7l401t2274r496b2330],
7	CNV	NNP	O	CNV	nn	8	SENT_106	[p7l519t2274r684b2330],
8	type	NN	O	type	nsubj	11	SENT_106	[p7l706t2282r841b2347],
9	did	VBD	O	do	aux	11	SENT_106	[p7l864t2274r964b2330],
10	not	RB	O	not	neg	11	SENT_106	[p7l985t2283r1086b2330],
11	show	VB	O	show	_	0	SENT_106	[p7l1110t2274r1272b2330],
12	an	DT	O	a	det	13	SENT_106	[p7l1296t2292r1368b2330],
13	association	NN	O	association	dobj	11	SENT_106	[p7l1391t2274r1743b2330],
14	with	IN	O	with	_	0	SENT_106	[p7l1765t2274r1905b2330],
15	change	NN	O	change	prep_with	11	SENT_106	[p7l1927t2274r2150b2347],
16	in	IN	O	in	_	0	SENT_106	[p7l20t2361r80b2417],
17	VA	NNP	LOCATION	VA	prep_in	15	SENT_106	[p7l104t2362r218b2418],
18	after	IN	O	after	mark	23	SENT_106	[p7l244t2361r388b2417],
19	3	CD	NUMBER	3	num	22	SENT_106	[p7l414t2362r446b2418],
20	consecutive	JJ	O	consecutive	amod	22	SENT_106	[p7l475t2361r850b2418],
21	ranibizumab	NN	O	ranibizumab	nn	22	SENT_106	[p7l874t2361r1271b2418],
22	injections	NNS	O	injection	nsubj	23	SENT_106	[p7l1298t2361r1605b2434],
23	(	VBP	O	(	advcl	11	SENT_106	[p7l1634t2362r1706b2431],
24	P	NN	O	p	dobj	23	SENT_106	[p7l1634t2362r1706b2431],
25	=	JJ	O	=	advmod	23	SENT_106	[p7l1738t2381r1786b2400],
26	0.14	CD	NUMBER	0.14	num	27	SENT_106	[p7l1820t2362r2000b2431],
27	)	NN	O	)	dep	25	SENT_106	[p7l1820t2362r2000b2431],
28	.	.	O	.	_	0	SENT_106	[p7l1820t2362r2000b2431],

1	The	DT	O	the	det	2	SENT_107	[p7l2028t2361r2150b2417],
2	duration	NN	O	duration	nsubj	11	SENT_107	[p7l20t2450r284b2506],
3	of	IN	O	of	_	0	SENT_107	[p7l306t2450r375b2506],
4	visual	JJ	O	visual	amod	5	SENT_107	[p7l391t2450r579b2506],
5	symptoms	NNS	O	symptom	prep_of	2	SENT_107	[p7l603t2458r925b2523],
6	before	IN	O	before	_	0	SENT_107	[p7l947t2450r1150b2506],
7	treatment	NN	O	treatment	prep_before	5	SENT_107	[p7l1172t2458r1473b2506],
8	was	VBD	O	be	cop	11	SENT_107	[p7l1493t2467r1613b2506],
9	not	RB	O	not	neg	11	SENT_107	[p7l1636t2458r1737b2506],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_107	[p7l1760t2450r2150b2523],
11	different	JJ	O	different	_	0	SENT_107	[p7l20t2538r294b2594],
12	between	IN	O	between	_	0	SENT_107	[p7l317t2538r583b2594],
13	the	DT	O	the	det	15	SENT_107	[p7l609t2538r704b2594],
14	genotype	NN	O	genotype	nn	15	SENT_107	[p7l731t2547r1021b2611],
15	groups	NNS	O	group	prep_between	11	SENT_107	[p7l1048t2556r1279b2611],
16	.	.	O	.	_	0	SENT_107	[p7l1048t2556r1279b2611],

1	A	DT	O	a	det	2	SENT_108	[p7l1309t2538r1365b2593],
2	difference	NN	O	difference	nsubjpass	12	SENT_108	[p7l1391t2538r1712b2594],
3	in	IN	O	in	_	0	SENT_108	[p7l1738t2538r1799b2593],
4	variability	NN	O	variability	prep_in	2	SENT_108	[p7l1824t2538r2150b2611],
5	between	IN	O	between	_	0	SENT_108	[p7l18t2625r284b2682],
6	the	DT	O	the	det	9	SENT_108	[p7l305t2625r400b2681],
7	different	JJ	O	different	amod	9	SENT_108	[p7l422t2625r696b2681],
8	VA	NN	O	va	nn	9	SENT_108	[p7l715t2626r829b2682],
9	techniques	NNS	O	technique	prep_between	4	SENT_108	[p7l850t2625r1188b2698],
10	was	VBD	O	be	auxpass	12	SENT_108	[p7l1211t2643r1331b2682],
11	not	RB	O	not	neg	12	SENT_108	[p7l1354t2634r1456b2681],
12	observed	VBN	O	observe	dep	24	SENT_108	[p7l1477t2625r1763b2682],
13	because	IN	O	because	_	0	SENT_108	[p7l1782t2625r2034b2681],
14	the	DT	O	the	det	16	SENT_108	[p7l2055t2625r2150b2681],
15	standard	JJ	O	standard	amod	16	SENT_108	[p7l22t2713r289b2770],
16	deviation	NN	O	deviation	prep_because	12	SENT_108	[p7l332t2713r628b2770],
17	of	IN	O	of	_	0	SENT_108	[p7l672t2713r741b2770],
18	the	DT	O	the	det	19	SENT_108	[p7l779t2714r874b2770],
19	change	NN	O	change	prep_of	16	SENT_108	[p7l919t2714r1142b2786],
20	in	IN	O	in	_	0	SENT_108	[p7l1186t2713r1246b2769],
21	VA	NNP	O	VA	prep_in	19	SENT_108	[p7l1290t2714r1403b2770],
22	was	VBD	O	be	cop	24	SENT_108	[p7l1447t2731r1567b2770],
23	very	RB	O	very	advmod	24	SENT_108	[p7l1613t2731r1752b2786],
24	similar	JJ	O	similar	_	0	SENT_108	[p7l1799t2713r2018b2770],
25	for	IN	O	for	_	0	SENT_108	[p7l2060t2713r2152b2770],
26	Snellen	NNP	O	Snellen	prep_for	24	SENT_108	[p7l21t2802r258b2858],
27	and	CC	O	and	_	0	SENT_108	[p7l287t2802r400b2858],
28	ETDRS	NNP	O	ETDRS	prep_for	24	SENT_108	[p7l428t2802r676b2858],
29	(	CD	NUMBER	(	num	30	SENT_108	[p7l711t2802r871b2871],
30	0.29	CD	NUMBER	0.29	nsubj	24	SENT_108	[p7l711t2802r871b2871],
31	and	CC	O	and	_	0	SENT_108	[p7l903t2802r1015b2858],
32	0.25	CD	NUMBER	0.25	num	33	SENT_108	[p7l1044t2802r1177b2858],
33	logMAR	NN	O	logmar	nsubj	24	SENT_108	[p7l1210t2802r1511b2875],
34	;	:	O	;	_	0	SENT_108	[p7l1210t2802r1511b2875],
35	P	NN	O	p	dep	30	SENT_108	[p7l1542t2804r1591b2857],
36	=	JJ	O	=	quantmod	37	SENT_108	[p7l1627t2821r1675b2840],
37	0.26	CD	NUMBER	0.26	num	38	SENT_108	[p7l1712t2802r1892b2871],
38	)	NN	O	)	dep	35	SENT_108	[p7l1712t2802r1892b2871],
39	.	.	O	.	_	0	SENT_108	[p7l1712t2802r1892b2871],

1	Combined	VBN	O	combine	_	0	SENT_109	[p7l20t3009r436b3083],
2	Effect	NN	O	effect	dep	1	SENT_109	[p7l469t3010r712b3083],
3	of	IN	O	of	_	0	SENT_109	[p7l748t3010r827b3083],
4	CFH	NNP	O	CFH	prep_of	2	SENT_109	[p7l862t3012r1060b3083],
5	and	CC	O	and	_	0	SENT_109	[p7l1095t3009r1239b3083],
6	ARMS2	NNP	O	ARMS2	nn	8	SENT_109	[p7l1270t3011r1603b3083],
7	High-Risk	NNP	O	High-Risk	nn	8	SENT_109	[p7l19t3115r446b3208],
8	Alleles	NNPS	O	Alleles	prep_of	2	SENT_109	[p7l481t3115r758b3189],

1	The	DT	O	the	det	3	SENT_110	[p8l19t40r141b96],
2	AMD	NNP	ORGANIZATION	AMD	nn	3	SENT_110	[p8l165t41r348b96],
3	patients	NNS	O	patient	_	0	SENT_110	[p8l372t40r618b113],
4	who	WP	O	who	nsubj	7	SENT_110	[p8l644t40r778b97],
5	did	VBD	O	do	aux	7	SENT_110	[p8l803t40r903b96],
6	not	RB	O	not	neg	7	SENT_110	[p8l926t49r1027b96],
7	carry	VB	O	carry	rcmod	3	SENT_110	[p8l1051t58r1211b113],
8	high-risk	JJ	O	high-risk	amod	9	SENT_110	[p8l1235t40r1524b113],
9	alleles	NNS	O	allele	nsubj	14	SENT_110	[p8l1547t40r1747b97],
10	in	IN	O	in	_	0	SENT_110	[p8l1772t40r1832b96],
11	CFH	NNP	O	CFH	prep_in	9	SENT_110	[p8l1860t41r2019b97],
12	and	CC	O	and	_	0	SENT_110	[p8l2039t40r2151b96],
13	ARMS2	NNP	O	ARMS2	prep_in	9	SENT_110	[p8l14t129r259b185],
14	demonstrated	VBD	O	demonstrate	ccomp	7	SENT_110	[p8l285t129r714b185],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_110	[p8l739t129r1129b202],
16	more	RBR	O	more	amod	17	SENT_110	[p8l1153t146r1315b185],
17	improvement	NN	O	improvement	dobj	14	SENT_110	[p8l1339t129r1764b202],
18	in	IN	O	in	_	0	SENT_110	[p8l1786t129r1847b184],
19	VA	NNP	O	VA	prep_in	14	SENT_110	[p8l1870t129r1983b185],
20	after	IN	O	after	_	0	SENT_110	[p8l2008t129r2152b185],
21	ranibizumab	NN	O	ranibizumab	nn	22	SENT_110	[p8l18t217r416b273],
22	treatment	NN	O	treatment	prep_after	14	SENT_110	[p8l451t225r753b273],
23	compared	VBN	O	compare	_	0	SENT_110	[p8l787t217r1100b290],
24	with	IN	O	with	prepc_compared_with	14	SENT_110	[p8l1134t217r1274b273],
25	carriers	NNS	O	carrier	pobj	14	SENT_110	[p8l1309t217r1544b273],
26	of	IN	O	of	_	0	SENT_110	[p8l1581t217r1650b273],
27	all	DT	O	all	det	30	SENT_110	[p8l1681t217r1757b273],
28	4	CD	NUMBER	4	num	30	SENT_110	[p8l1791t217r1829b272],
29	high-risk	JJ	O	high-risk	amod	30	SENT_110	[p8l1863t217r2152b290],
30	alleles	NNS	O	allele	prep_of	25	SENT_110	[p8l21t304r219b361],
31	in	IN	O	in	_	0	SENT_110	[p8l267t304r327b360],
32	these	DT	O	these	det	34	SENT_110	[p8l373t304r534b361],
33	2	CD	NUMBER	2	num	34	SENT_110	[p8l582t305r617b360],
34	genes	NNS	O	gene	prep_in	30	SENT_110	[p8l665t322r842b377],
35	(	CD	NUMBER	(	num	36	SENT_110	[p8l891t305r963b374],
36	P	NN	O	p	dep	3	SENT_110	[p8l891t305r963b374],
37	=	JJ	O	=	amod	36	SENT_110	[p8l1016t324r1064b343],
38	0.009	CD	NUMBER	0.009	tmod	37	SENT_110	[p8l1118t305r1315b371],
39	;	:	O	;	_	0	SENT_110	[p8l1118t305r1315b371],
40	Table	NNP	O	Table	dep	3	SENT_110	[p8l1364t304r1543b360],
41	2	CD	NUMBER	2	number	42	SENT_110	[p8l1591t305r1669b374],
42	)	CD	NUMBER	)	dep	40	SENT_110	[p8l1591t305r1669b374],
43	.	.	O	.	_	0	SENT_110	[p8l1591t305r1669b374],

1	A	DT	O	a	det	4	SENT_111	[p8l1719t305r1775b360],
2	mean	JJ	O	mean	amod	4	SENT_111	[p8l1820t322r1991b361],
3	VA	NN	O	va	nn	4	SENT_111	[p8l2037t305r2150b360],
4	improvement	NN	O	improvement	nsubjpass	10	SENT_111	[p8l19t393r445b466],
5	of	IN	O	of	_	0	SENT_111	[p8l471t393r540b449],
6	10	CD	NUMBER	10	num	8	SENT_111	[p8l568t393r638b449],
7	ETDRS	NN	O	etdr	nn	8	SENT_111	[p8l665t393r913b449],
8	letters	NNS	O	letter	prep_of	4	SENT_111	[p8l943t393r1134b449],
9	was	VBD	O	be	auxpass	10	SENT_111	[p8l1163t410r1283b449],
10	observed	VBN	O	observe	_	0	SENT_111	[p8l1312t393r1598b449],
11	in	IN	O	in	_	0	SENT_111	[p8l1624t393r1685b448],
12	patients	NNS	O	patient	prep_in	10	SENT_111	[p8l1709t393r1955b465],
13	without	IN	O	without	_	0	SENT_111	[p8l1984t393r2148b449, p8l20t489r120b537],
14	any	DT	O	any	det	16	SENT_111	[p8l158t499r269b554],
15	high	JJ	O	high	amod	16	SENT_111	[p8l306t481r447b554],
16	risk	NN	O	risk	prep_without	10	SENT_111	[p8l483t481r603b537],
17	alleles	NNS	O	allele	nsubj	18	SENT_111	[p8l640t481r839b537],
18	(	VBP	O	(	rcmod	16	SENT_111	[p8l880t482r943b550],
19	n	NN	O	n	nsubj	39	SENT_111	[p8l880t482r943b550],
20	=	JJ	O	=	dep	39	SENT_111	[p8l988t500r1035b519],
21	20	CD	PERCENT	20	number	22	SENT_111	[p8l1082t481r1158b537],
22	[	CD	PERCENT	[	prep	20	SENT_111	[p8l1201t481r1457b550],
23	4.8	CD	PERCENT	4.8	num	24	SENT_111	[p8l1201t481r1457b550],
24	%	NN	PERCENT	%	dep	22	SENT_111	[p8l1201t481r1457b550],
25	]	CD	NUMBER	]	num	26	SENT_111	[p8l1201t481r1457b550],
26	)	NN	O	)	nsubj	39	SENT_111	[p8l1201t481r1457b550],
27	,	,	O	,	_	0	SENT_111	[p8l1201t481r1457b550],
28	5	CD	NUMBER	5	num	30	SENT_111	[p8l1498t481r1531b537],
29	ETDRS	NN	ORGANIZATION	etdr	nn	30	SENT_111	[p8l1571t481r1819b537],
30	letters	NNS	O	letter	appos	26	SENT_111	[p8l1860t481r2052b537],
31	in	IN	O	in	_	0	SENT_111	[p8l2090t481r2151b536],
32	patients	NNS	O	patient	prep_in	30	SENT_111	[p8l18t568r264b641],
33	with	IN	O	with	_	0	SENT_111	[p8l287t568r427b625],
34	l	NN	O	l	prep_with	32	SENT_111	[p8l455t569r478b624],
35	or	CC	O	or	_	0	SENT_111	[p8l507t586r572b624],
36	2	CD	NUMBER	2	num	38	SENT_111	[p8l593t569r629b624],
37	risk	NN	O	risk	nn	38	SENT_111	[p8l650t568r770b624],
38	alleles	NNS	O	allele	prep_with	32	SENT_111	[p8l791t568r990b625],
39	(	VBP	O	(	xcomp	18	SENT_111	[p8l1015t569r1077b638],
40	n	NN	O	n	dobj	39	SENT_111	[p8l1015t569r1077b638],
41	=	JJ	O	=	amod	40	SENT_111	[p8l1105t588r1154b607],
42	267	CD	PERCENT	267	tmod	41	SENT_111	[p8l1184t568r1298b625],
43	[	CD	PERCENT	[	number	44	SENT_111	[p8l1327t568r1623b638],
44	63.5	CD	PERCENT	63.5	num	45	SENT_111	[p8l1327t568r1623b638],
45	%	NN	PERCENT	%	dep	66	SENT_111	[p8l1327t568r1623b638],
46	]	CD	NUMBER	]	num	47	SENT_111	[p8l1327t568r1623b638],
47	)	NN	O	)	dep	45	SENT_111	[p8l1327t568r1623b638],
48	,	,	O	,	_	0	SENT_111	[p8l1327t568r1623b638],
49	and	CC	O	and	_	0	SENT_111	[p8l1648t568r1761b625],
50	2.5	CD	NUMBER	2.5	num	52	SENT_111	[p8l1782t568r1875b625],
51	ETDRS	NNS	O	etdr	nn	52	SENT_111	[p8l1899t569r2147b625],
52	letters	NNS	O	letter	dep	66	SENT_111	[p8l19t657r211b712],
53	in	IN	O	in	_	0	SENT_111	[p8l243t656r304b711],
54	carriers	NNS	O	carrier	prep_in	52	SENT_111	[p8l334t656r569b712],
55	of	IN	O	of	_	0	SENT_111	[p8l603t656r672b712],
56	3	CD	NUMBER	3	num	58	SENT_111	[p8l699t657r730b712],
57	risk	NN	O	risk	nn	58	SENT_111	[p8l764t656r885b712],
58	alleles	NNS	O	allele	prep_of	54	SENT_111	[p8l915t656r1114b712],
59	in	IN	O	in	_	0	SENT_111	[p8l1146t656r1207b711],
60	CFH	NNP	O	CFH	prep_in	45	SENT_111	[p8l1241t658r1400b713],
61	and	CC	O	and	_	0	SENT_111	[p8l1428t657r1540b712],
62	ARMS2	NNP	O	ARMS2	conj_and	60	SENT_111	[p8l1564t657r1809b713],
63	(	CD	NUMBER	(	num	64	SENT_111	[p8l1845t657r1907b725],
64	n	NN	O	n	dep	66	SENT_111	[p8l1845t657r1907b725],
65	=	JJ	O	=	amod	66	SENT_111	[p8l1946t676r1994b694],
66	104	CD	PERCENT	104	dep	71	SENT_111	[p8l2040t657r2150b712],
67	[	CD	PERCENT	[	num	69	SENT_111	[p8l25t744r320b813],
68	24.8	CD	PERCENT	24.8	num	69	SENT_111	[p8l25t744r320b813],
69	%	NN	PERCENT	%	dep	66	SENT_111	[p8l25t744r320b813],
70	]	CD	NUMBER	]	num	71	SENT_111	[p8l25t744r320b813],
71	)	NN	O	)	dep	39	SENT_111	[p8l25t744r320b813],
72	,	,	O	,	_	0	SENT_111	[p8l25t744r320b813],
73	whereas	IN	O	whereas	mark	78	SENT_111	[p8l346t744r604b800],
74	no	DT	O	no	det	76	SENT_111	[p8l628t762r705b800],
75	mean	NN	O	mean	nn	76	SENT_111	[p8l728t762r900b800],
76	improvement	NN	O	improvement	nsubjpass	78	SENT_111	[p8l921t744r1347b817],
77	was	VBD	O	be	auxpass	78	SENT_111	[p8l1369t762r1489b800],
78	observed	VBN	O	observe	advcl	18	SENT_111	[p8l1514t744r1800b800],
79	in	IN	O	in	_	0	SENT_111	[p8l1821t744r1882b799],
80	patients	NNS	O	patient	prep_in	78	SENT_111	[p8l1903t744r2149b817],
81	carrying	VBG	O	carry	xcomp	78	SENT_111	[p8l20t831r282b904],
82	all	DT	O	all	det	85	SENT_111	[p8l332t831r407b888],
83	4	CD	NUMBER	4	num	85	SENT_111	[p8l454t832r491b887],
84	high-risk	JJ	O	high-risk	amod	85	SENT_111	[p8l538t831r827b904],
85	alleles	NNS	O	allele	nsubj	86	SENT_111	[p8l874t831r1073b888],
86	(	VBP	O	(	ccomp	81	SENT_111	[p8l1124t832r1186b901],
87	n	NN	O	n	dobj	86	SENT_111	[p8l1124t832r1186b901],
88	=	JJ	O	=	amod	87	SENT_111	[p8l1241t851r1288b870],
89	29	CD	PERCENT	29	number	90	SENT_111	[p8l1344t832r1419b888],
90	[	CD	PERCENT	[	prep	88	SENT_111	[p8l1474t831r1705b899],
91	6.9	CD	PERCENT	6.9	num	92	SENT_111	[p8l1474t831r1705b899],
92	%	NN	PERCENT	%	dep	90	SENT_111	[p8l1474t831r1705b899],
93	]	CD	NUMBER	]	tmod	88	SENT_111	[p8l1474t831r1705b899],
94	;	:	O	;	_	0	SENT_111	[p8l1474t831r1705b899],
95	Fig	NN	O	fig	nn	97	SENT_111	[p8l1754t831r1858b904],
96	1A	NN	O	1a	nn	97	SENT_111	[p8l1914t832r2044b901],
97	)	NN	O	)	dep	16	SENT_111	[p8l1914t832r2044b901],
98	.	.	O	.	_	0	SENT_111	[p8l1914t832r2044b901],

1	A	DT	O	a	det	3	SENT_112	[p8l2094t832r2151b887],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_112	[p8l22t919r351b992],
3	association	NN	O	association	nsubjpass	23	SENT_112	[p8l381t919r732b976],
4	between	IN	O	between	_	0	SENT_112	[p8l760t920r1026b976],
5	the	DT	O	the	det	6	SENT_112	[p8l1054t920r1150b976],
6	number	NN	O	number	prep_between	3	SENT_112	[p8l1179t919r1423b976],
7	of	IN	O	of	_	0	SENT_112	[p8l1451t919r1520b976],
8	high-risk	JJ	O	high-risk	amod	9	SENT_112	[p8l1543t919r1832b992],
9	alleles	NNS	O	allele	prep_of	6	SENT_112	[p8l1861t919r2060b976],
10	in	IN	O	in	_	0	SENT_112	[p8l2091t919r2151b975],
11	CFH	NNP	O	CFH	prep_in	9	SENT_112	[p8l23t1009r182b1065],
12	and	CC	O	and	_	0	SENT_112	[p8l212t1008r324b1064],
13	ARMS2	NN	O	arms2	prep_in	9	SENT_112	[p8l350t1008r596b1065],
14	and	CC	O	and	_	0	SENT_112	[p8l633t1008r745b1064],
15	the	DT	O	the	det	16	SENT_112	[p8l777t1008r872b1064],
16	age	NN	O	age	conj_and	9	SENT_112	[p8l907t1026r1014b1081],
17	at	IN	O	at	_	0	SENT_112	[p8l1049t1016r1104b1064],
18	the	DT	O	the	det	21	SENT_112	[p8l1136t1008r1231b1064],
19	ﬁrst	NN	O	ﬁrst	nn	21	SENT_112	[p8l1265t1008r1388b1064],
20	ranibizumab	NN	O	ranibizumab	nn	21	SENT_112	[p8l1418t1008r1816b1064],
21	treatment	NN	O	treatment	prep_at	16	SENT_112	[p8l1850t1016r2151b1064],
22	was	VBD	O	be	auxpass	23	SENT_112	[p8l19t1113r139b1152],
23	observed	VBN	O	observe	_	0	SENT_112	[p8l166t1095r452b1152],
24	(	RB	O	(	advmod	25	SENT_112	[p8l478t1096r549b1165],
25	P	NN	O	p	dobj	23	SENT_112	[p8l478t1096r549b1165],
26	=	JJ	O	=	amod	25	SENT_112	[p8l581t1115r628b1134],
27	0.002	CD	NUMBER	0.002	tmod	26	SENT_112	[p8l661t1096r857b1162],
28	;	:	O	;	_	0	SENT_112	[p8l661t1096r857b1162],
29	Fig	NN	O	fig	nn	31	SENT_112	[p8l884t1095r988b1168],
30	1B	NN	O	1b	nn	31	SENT_112	[p8l1020t1096r1146b1165],
31	)	NN	O	)	dep	25	SENT_112	[p8l1020t1096r1146b1165],
32	.	.	O	.	_	0	SENT_112	[p8l1020t1096r1146b1165],

1	Carriers	NNS	O	carrier	nsubj	15	SENT_113	[p8l1175t1095r1428b1152],
2	of	IN	O	of	_	0	SENT_113	[p8l1454t1095r1523b1151],
3	4	CD	NUMBER	4	num	5	SENT_113	[p8l1541t1096r1579b1151],
4	risk	NN	O	risk	nn	5	SENT_113	[p8l1603t1095r1723b1151],
5	alleles	NNS	O	allele	prep_of	1	SENT_113	[p8l1747t1095r1945b1152],
6	in	IN	O	in	_	0	SENT_113	[p8l1971t1095r2031b1151],
7	the	DT	O	the	det	8	SENT_113	[p8l2055t1095r2150b1151],
8	CFH	NNP	O	CFH	prep_in	5	SENT_113	[p8l23t1185r182b1240],
9	and	CC	O	and	_	0	SENT_113	[p8l202t1183r314b1240],
10	ARMS2	NN	O	arms2	nn	11	SENT_113	[p8l332t1184r577b1240],
11	genes	NNS	O	gene	prep_in	5	SENT_113	[p8l604t1201r782b1256],
12	were	VBD	O	be	cop	15	SENT_113	[p8l808t1201r960b1240],
13	4.4	CD	DURATION	4.4	num	14	SENT_113	[p8l984t1184r1081b1240],
14	years	NNS	NUMBER	year	dep	15	SENT_113	[p8l1106t1201r1270b1256],
15	younger	JJR	O	younger	_	0	SENT_113	[p8l1296t1201r1558b1256],
16	at	IN	O	at	_	0	SENT_113	[p8l1582t1192r1637b1240],
17	treatment	NN	O	treatment	nn	18	SENT_113	[p8l1659t1192r1960b1240],
18	onset	NN	O	onset	prep_at	15	SENT_113	[p8l1984t1192r2151b1240],
19	than	IN	O	than	mark	26	SENT_113	[p8l19t1272r154b1328],
20	the	DT	O	the	det	21	SENT_113	[p8l184t1272r279b1328],
21	carriers	NNS	O	carrier	nsubj	26	SENT_113	[p8l309t1272r544b1328],
22	of	IN	O	of	_	0	SENT_113	[p8l576t1272r645b1328],
23	3	CD	NUMBER	3	num	25	SENT_113	[p8l671t1272r703b1328],
24	high-risk	JJ	O	high-risk	amod	25	SENT_113	[p8l736t1272r1025b1345],
25	alleles	NNS	O	allele	prep_of	21	SENT_113	[p8l1054t1272r1253b1328],
26	(	VBP	O	(	ccomp	15	SENT_113	[p8l1286t1273r1358b1341],
27	P	NN	O	p	dobj	26	SENT_113	[p8l1286t1273r1358b1341],
28	=	JJ	O	=	amod	38	SENT_113	[p8l1395t1291r1443b1310],
29	0.006	CD	NUMBER	0.006	num	30	SENT_113	[p8l1481t1272r1682b1341],
30	)	NN	O	)	nn	38	SENT_113	[p8l1481t1272r1682b1341],
31	and	CC	O	and	_	0	SENT_113	[p8l1716t1272r1828b1328],
32	5.2	CD	DURATION	5.2	num	33	SENT_113	[p8l1858t1272r1954b1328],
33	years	NNS	NUMBER	year	tmod	34	SENT_113	[p8l1983t1290r2148b1345],
34	younger	JJR	O	younger	conj_and	30	SENT_113	[p8l19t1377r280b1432],
35	than	IN	O	than	_	0	SENT_113	[p8l305t1359r441b1415],
36	the	DT	O	the	det	37	SENT_113	[p8l467t1359r562b1415],
37	AMD	NNP	ORGANIZATION	AMD	prep_than	34	SENT_113	[p8l588t1360r772b1415],
38	carriers	NNS	O	carrier	dep	27	SENT_113	[p8l800t1359r1035b1415],
39	of	IN	O	of	_	0	SENT_113	[p8l1065t1359r1133b1415],
40	1	CD	NUMBER	1	num	44	SENT_113	[p8l1162t1360r1185b1415],
41	or	CC	O	or	_	0	SENT_113	[p8l1220t1377r1285b1415],
42	2	CD	NUMBER	2	conj_or	40	SENT_113	[p8l1310t1360r1347b1415],
43	risk	NN	O	risk	nn	44	SENT_113	[p8l1373t1359r1493b1415],
44	alleles	NNS	O	allele	prep_of	27	SENT_113	[p8l1519t1359r1737b1426],
45	,	,	O	,	_	0	SENT_113	[p8l1519t1359r1737b1426],
46	respectively	RB	O	respectively	advmod	27	SENT_113	[p8l1765t1359r2150b1432],
47	(	CD	NUMBER	(	num	48	SENT_113	[p8l21t1448r398b1516],
48	P	NN	O	p	dep	49	SENT_113	[p8l21t1448r398b1516],
49	<	JJR	O	<	dep	27	SENT_113	[p8l21t1448r398b1516],
50	o.	CD	NUMBER	o.	num	51	SENT_113	[p8l21t1448r398b1516],
51	oool	NN	O	oool	dep	49	SENT_113	[p8l21t1448r398b1516],
52	;	:	O	;	_	0	SENT_113	[p8l21t1448r398b1516],
53	Table	NNP	O	Table	dep	27	SENT_113	[p8l430t1448r609b1503],
54	2	CD	NUMBER	2	number	55	SENT_113	[p8l640t1448r719b1516],
55	)	CD	NUMBER	)	dep	53	SENT_113	[p8l640t1448r719b1516],
56	.	.	O	.	_	0	SENT_113	[p8l640t1448r719b1516],

1	Combined	JJ	O	combined	amod	2	SENT_114	[p8l20t1653r436b1728],
2	effect	NN	O	effect	_	0	SENT_114	[p8l472t1654r696b1728],
3	of	IN	O	of	_	0	SENT_114	[p8l732t1654r811b1728],
4	CFH	NNP	O	CFH	prep_of	2	SENT_114	[p8l846t1656r1066b1740],
5	,	,	O	,	_	0	SENT_114	[p8l846t1656r1066b1740],
6	ARMS2	NN	O	arms2	conj_and	4	SENT_114	[p8l1101t1655r1463b1740],
7	,	,	O	,	_	0	SENT_114	[p8l1101t1655r1463b1740],
8	and	CC	O	and	_	0	SENT_114	[p8l1502t1653r1646b1728],
9	VEGFA	NNP	O	VEGFA	nn	10	SENT_114	[p8l1678t1655r2011b1745],
10	High	NNP	O	High	conj_and	4	SENT_114	[p8l19t1759r446b1852],
11	.	.	O	.	_	0	SENT_114	[p8l19t1759r446b1852],

1	—	NN	O	—	_	0	SENT_115	[p8l19t1759r446b1852],
2	.	.	O	.	_	0	SENT_115	[p8l19t1759r446b1852],

1	Risk	NN	O	risk	nn	2	SENT_116	[p8l19t1759r446b1852],
2	Alleles	NNS	O	allele	_	0	SENT_116	[p8l481t1759r759b1834],

1	Adding	VBG	O	add	csubj	10	SENT_117	[p8l19t1920r256b1993],
2	the	DT	O	the	det	5	SENT_117	[p8l301t1920r397b1976],
3	VEGFA	NNP	O	VEGFA	nn	5	SENT_117	[p8l446t1921r690b1977],
4	rs699947	CD	NUMBER	rs699947	num	5	SENT_117	[p8l736t1920r1030b1977],
5	SNP	NN	ORGANIZATION	snp	dobj	1	SENT_117	[p8l1079t1920r1222b1976],
6	to	TO	O	to	_	0	SENT_117	[p8l1266t1928r1325b1976],
7	the	DT	O	the	det	9	SENT_117	[p8l1370t1920r1465b1976],
8	stratiﬁcation	NN	O	stratiﬁcation	nn	9	SENT_117	[p8l1513t1920r1908b1976],
9	model	NN	O	model	prep_to	5	SENT_117	[p8l1952t1920r2150b1976],
10	demonstrated	VBD	O	demonstrate	_	0	SENT_117	[p8l20t2007r449b2064],
11	a	DT	O	a	det	13	SENT_117	[p8l473t2025r505b2063],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_117	[p8l530t2007r859b2080],
13	decrease	NN	O	decrease	dobj	10	SENT_117	[p8l882t2007r1154b2064],
14	in	IN	O	in	_	0	SENT_117	[p8l1177t2007r1237b2063],
15	VA	NNP	O	VA	prep_in	10	SENT_117	[p8l1260t2008r1374b2064],
16	after	IN	O	after	_	0	SENT_117	[p8l1398t2007r1542b2064],
17	ranibizumab	NN	O	ranibizumab	nn	18	SENT_117	[p8l1563t2007r1960b2064],
18	treatment	NN	O	treatment	prep_after	10	SENT_117	[p8l1984t2016r2149b2063, p8l19t2104r178b2152],
19	in	IN	O	in	_	0	SENT_117	[p8l201t2095r261b2151],
20	the	DT	O	the	det	21	SENT_117	[p8l285t2096r380b2152],
21	group	NN	O	group	prep_in	10	SENT_117	[p8l406t2113r588b2168],
22	carrying	VBG	O	carry	partmod	21	SENT_117	[p8l614t2095r876b2168],
23	all	DT	O	all	det	26	SENT_117	[p8l903t2095r979b2152],
24	6	CD	NUMBER	6	num	26	SENT_117	[p8l1005t2095r1040b2152],
25	high-risk	JJ	O	high-risk	amod	26	SENT_117	[p8l1065t2095r1354b2168],
26	alleles	NNS	O	allele	dobj	22	SENT_117	[p8l1377t2095r1576b2152],
27	in	IN	O	in	_	0	SENT_117	[p8l1602t2095r1662b2151],
28	CFH	NNP	O	CFH	prep_in	26	SENT_117	[p8l1690t2097r1861b2162],
29	,	,	O	,	_	0	SENT_117	[p8l1690t2097r1861b2162],
30	ARMS2	NN	O	arms2	conj_and	28	SENT_117	[p8l1883t2096r2148b2162],
31	,	,	O	,	_	0	SENT_117	[p8l1883t2096r2148b2162],
32	and	CC	O	and	_	0	SENT_117	[p8l21t2184r133b2240],
33	VEGFA	NNP	O	VEGFA	conj_and	28	SENT_117	[p8l161t2185r405b2241],
34	compared	VBN	O	compare	_	0	SENT_117	[p8l432t2184r745b2257],
35	with	IN	O	with	prepc_compared_with	22	SENT_117	[p8l768t2184r908b2240],
36	the	DT	O	the	det	39	SENT_117	[p8l932t2184r1027b2240],
37	remaining	VBG	O	remain	amod	39	SENT_117	[p8l1050t2184r1372b2257],
38	AMD	NNP	ORGANIZATION	AMD	nn	39	SENT_117	[p8l1397t2184r1580b2239],
39	patients	NNS	O	patient	pobj	22	SENT_117	[p8l1604t2184r1867b2257],
40	.	.	O	.	_	0	SENT_117	[p8l1604t2184r1867b2257],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_118	[p8l1896t2184r2149b2240],
2	of	IN	O	of	_	0	SENT_118	[p8l20t2271r89b2327],
3	all	DT	O	all	det	6	SENT_118	[p8l109t2271r185b2327],
4	6	CD	NUMBER	6	num	6	SENT_118	[p8l211t2271r246b2328],
5	risk	NN	O	risk	nn	6	SENT_118	[p8l271t2271r391b2327],
6	alleles	NNS	O	allele	prep_of	1	SENT_118	[p8l415t2271r614b2327],
7	demonstrated	VBD	O	demonstrate	_	0	SENT_118	[p8l641t2271r1070b2327],
8	a	DT	O	a	det	10	SENT_118	[p8l1095t2289r1127b2327],
9	mean	JJ	O	mean	amod	10	SENT_118	[p8l1150t2289r1321b2327],
10	loss	NN	O	loss	dobj	7	SENT_118	[p8l1346t2271r1466b2327],
11	of	IN	O	of	_	0	SENT_118	[p8l1493t2271r1561b2327],
12	10	CD	NUMBER	10	num	14	SENT_118	[p8l1588t2271r1658b2328],
13	ETDRS	NN	ORGANIZATION	etdr	nn	14	SENT_118	[p8l1682t2271r1929b2328],
14	letters	NNS	O	letter	prep_of	10	SENT_118	[p8l1958t2271r2149b2327],
15	after	IN	O	after	_	0	SENT_118	[p8l21t2359r165b2416],
16	treatment	NN	O	treatment	nn	18	SENT_118	[p8l207t2368r508b2416],
17	(	CD	NUMBER	(	num	18	SENT_118	[p8l552t2360r614b2429],
18	n	NN	O	n	prep_after	7	SENT_118	[p8l552t2360r614b2429],
19	=	JJ	O	=	amod	21	SENT_118	[p8l665t2379r713b2398],
20	8	CD	NUMBER	8	tmod	19	SENT_118	[p8l767t2360r799b2416],
21	[	NN	O	[	dep	7	SENT_118	[p8l851t2360r1046b2429],
22	2	CD	PERCENT	2	number	23	SENT_118	[p8l851t2360r1046b2429],
23	%	NN	PERCENT	%	amod	21	SENT_118	[p8l851t2360r1046b2429],
24	]	CD	NUMBER	]	num	25	SENT_118	[p8l851t2360r1046b2429],
25	)	NN	O	)	tmod	7	SENT_118	[p8l851t2360r1046b2429],
26	,	,	O	,	_	0	SENT_118	[p8l851t2360r1046b2429],
27	whereas	IN	O	whereas	mark	32	SENT_118	[p8l1093t2360r1350b2416],
28	all	DT	O	all	det	31	SENT_118	[p8l1397t2360r1473b2416],
29	other	JJ	O	other	amod	31	SENT_118	[p8l1517t2359r1680b2416],
30	allele	NN	O	allele	nn	31	SENT_118	[p8l1723t2359r1892b2416],
31	groups	NNS	O	group	nsubj	32	SENT_118	[p8l1936t2377r2149b2432],
32	demonstrated	VBD	O	demonstrate	dep	25	SENT_118	[p8l20t2448r449b2504],
33	an	DT	O	a	det	34	SENT_118	[p8l477t2466r549b2504],
34	improvement	NN	O	improvement	dobj	32	SENT_118	[p8l577t2448r1002b2521],
35	in	IN	O	in	_	0	SENT_118	[p8l1029t2448r1089b2503],
36	VA	NNP	O	VA	prep_in	32	SENT_118	[p8l1116t2448r1230b2504],
37	after	IN	O	after	_	0	SENT_118	[p8l1259t2448r1403b2504],
38	treatment	NN	O	treatment	nn	42	SENT_118	[p8l1430t2456r1731b2504],
39	(	CD	NUMBER	(	num	42	SENT_118	[p8l1760t2448r1888b2521],
40	Fig	NN	O	fig	nn	42	SENT_118	[p8l1760t2448r1888b2521],
41	2A	NN	O	2a	nn	42	SENT_118	[p8l1917t2448r2054b2517],
42	)	NN	O	)	prep_after	32	SENT_118	[p8l1917t2448r2054b2517],
43	.	.	O	.	_	0	SENT_118	[p8l1917t2448r2054b2517],

1	In	IN	O	in	_	0	SENT_119	[p8l2086t2449r2151b2503],
2	addition	NN	O	addition	prep_in	14	SENT_119	[p8l21t2535r296b2602],
3	,	,	O	,	_	0	SENT_119	[p8l21t2535r296b2602],
4	a	DT	O	a	det	6	SENT_119	[p8l322t2553r355b2591],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_119	[p8l378t2535r707b2608],
6	decrease	NN	O	decrease	nsubjpass	14	SENT_119	[p8l728t2535r1000b2591],
7	of	IN	O	of	_	0	SENT_119	[p8l1022t2535r1091b2591],
8	the	DT	O	the	det	9	SENT_119	[p8l1107t2535r1202b2591],
9	age	NN	O	age	prep_of	6	SENT_119	[p8l1225t2553r1332b2608],
10	of	IN	O	of	_	0	SENT_119	[p8l1355t2535r1424b2591],
11	neovascular	JJ	O	neovascular	amod	12	SENT_119	[p8l1439t2535r1821b2592],
12	onset	NN	O	onset	prep_of	9	SENT_119	[p8l1841t2543r2008b2591],
13	was	VBD	O	be	auxpass	14	SENT_119	[p8l2029t2553r2149b2591],
14	observed	VBN	O	observe	_	0	SENT_119	[p8l20t2624r322b2680],
15	.	.	O	.	_	0	SENT_119	[p8l20t2624r322b2680],

1	The	DT	O	the	det	3	SENT_120	[p8l355t2624r477b2680],
2	mean	NN	O	mean	nn	3	SENT_120	[p8l505t2641r677b2680],
3	age	NN	O	age	_	0	SENT_120	[p8l707t2641r814b2696],
4	at	IN	O	at	_	0	SENT_120	[p8l844t2632r899b2680],
5	which	WDT	O	which	rel	11	SENT_120	[p8l927t2623r1121b2680],
6	the	DT	O	the	det	9	SENT_120	[p8l1149t2624r1244b2680],
7	ﬁrst	NN	O	ﬁrst	nn	9	SENT_120	[p8l1274t2623r1396b2680],
8	ranibizumab	NN	O	ranibizumab	nn	9	SENT_120	[p8l1423t2623r1820b2680],
9	treatment	NN	O	treatment	nsubjpass	11	SENT_120	[p8l1850t2632r2152b2680],
10	was	VBD	O	be	auxpass	11	SENT_120	[p8l20t2730r140b2768],
11	carried	VBN	O	carry	rcmod	3	SENT_120	[p8l180t2712r400b2768],
12	out	RP	O	out	prt	11	SENT_120	[p8l437t2720r537b2768],
13	among	IN	O	among	_	0	SENT_120	[p8l575t2730r788b2785],
14	the	DT	O	the	det	15	SENT_120	[p8l826t2712r922b2768],
15	carriers	NNS	O	carrier	prep_among	11	SENT_120	[p8l960t2712r1195b2768],
16	of	IN	O	of	_	0	SENT_120	[p8l1236t2712r1304b2768],
17	all	DT	O	all	det	20	SENT_120	[p8l1338t2712r1414b2768],
18	6	CD	NUMBER	6	num	20	SENT_120	[p8l1453t2712r1488b2768],
19	high-risk	JJ	O	high-risk	amod	20	SENT_120	[p8l1526t2712r1815b2785],
20	alleles	NNS	O	allele	prep_of	15	SENT_120	[p8l1852t2712r2051b2768],
21	in	IN	O	in	_	0	SENT_120	[p8l2090t2712r2151b2767],
22	CFH	NNP	O	CFH	prep_in	20	SENT_120	[p8l23t2800r194b2866],
23	,	,	O	,	_	0	SENT_120	[p8l23t2800r194b2866],
24	ARMS2	NN	O	arms2	appos	22	SENT_120	[p8l213t2800r478b2866],
25	,	,	O	,	_	0	SENT_120	[p8l213t2800r478b2866],
26	and	CC	O	and	_	0	SENT_120	[p8l504t2799r616b2855],
27	VEGFA	NNP	O	VEGFA	nsubj	30	SENT_120	[p8l643t2800r886b2856],
28	was	VBD	O	be	cop	30	SENT_120	[p8l910t2817r1030b2856],
29	65.9	CD	DURATION	65.9	num	30	SENT_120	[p8l1055t2799r1190b2856],
30	years	NNS	NUMBER	year	rcmod	3	SENT_120	[p8l1213t2817r1378b2872],
31	versus	CC	O	versus	prep	30	SENT_120	[p8l1402t2817r1602b2855],
32	75.3	CD	DURATION	75.3	num	33	SENT_120	[p8l1626t2799r1759b2856],
33	years	NNS	NUMBER	year	dep	31	SENT_120	[p8l1785t2817r1950b2872],
34	in	IN	O	in	_	0	SENT_120	[p8l1973t2799r2033b2855],
35	the	DT	O	the	det	37	SENT_120	[p8l2055t2799r2150b2855],
36	AMD	NNP	ORGANIZATION	AMD	nn	37	SENT_120	[p8l19t2888r202b2943],
37	carriers	NNS	O	carrier	prep_in	33	SENT_120	[p8l225t2887r460b2944],
38	of	IN	O	of	_	0	SENT_120	[p8l484t2887r552b2944],
39	o	NN	O	o	nn	45	SENT_120	[p8l568t2888r605b2944],
40	or	CC	O	or	_	0	SENT_120	[p8l627t2905r692b2944],
41	1	CD	NUMBER	1	nn	45	SENT_120	[p8l719t2888r742b2943],
42	high-risk	JJ	O	high-risk	amod	45	SENT_120	[p8l769t2887r1058b2960],
43	allele	NN	O	allele	nn	45	SENT_120	[p8l1079t2887r1248b2944],
44	(	NN	O	(	nn	45	SENT_120	[p8l1272t2888r1334b2957],
45	n	NN	O	n	prep_of	37	SENT_120	[p8l1272t2888r1334b2957],
46	=	JJ	O	=	amod	48	SENT_120	[p8l1362t2907r1410b2926],
47	35	CD	NUMBER	35	tmod	46	SENT_120	[p8l1441t2887r1513b2944],
48	[	NN	O	[	dep	3	SENT_120	[p8l1543t2888r1774b2956],
49	8.8	CD	PERCENT	8.8	number	50	SENT_120	[p8l1543t2888r1774b2956],
50	%	NN	PERCENT	%	amod	48	SENT_120	[p8l1543t2888r1774b2956],
51	]	CD	NUMBER	]	dep	48	SENT_120	[p8l1543t2888r1774b2956],
52	;	:	O	;	_	0	SENT_120	[p8l1543t2888r1774b2956],
53	P	NN	O	p	dep	3	SENT_120	[p8l1797t2890r1846b2943],
54	=	JJ	O	=	amod	53	SENT_120	[p8l1874t2907r1922b2926],
55	0.001	CD	NUMBER	0.001	tmod	54	SENT_120	[p8l1951t2888r2148b2954],
56	;	:	O	;	_	0	SENT_120	[p8l1951t2888r2148b2954],
57	Table	NNP	ORGANIZATION	Table	dep	3	SENT_120	[p8l19t2976r199b3031],
58	2	CD	NUMBER	2	num	57	SENT_120	[p8l229t2976r265b3030],
59	and	CC	O	and	_	0	SENT_120	[p8l296t2976r409b3031],
60	Fig	NN	O	fig	nn	62	SENT_120	[p8l437t2976r540b3047],
61	2B	NN	O	2b	nn	62	SENT_120	[p8l571t2976r704b3044],
62	)	NN	O	)	conj_and	57	SENT_120	[p8l571t2976r704b3044],
63	.	.	O	.	_	0	SENT_120	[p8l571t2976r704b3044],

1	Discussion	NN	O	discussion	_	0	SENT_121	[p8l19t3207r526b3284],

1	Pharmacogenetics	NNS	MISC	pharmacogenetic	nsubj	4	SENT_122	[p9l19t40r662b120],
2	is	VBZ	O	be	cop	4	SENT_122	[p9l705t40r760b102],
3	the	DT	O	the	det	4	SENT_122	[p9l804t40r910b102],
4	ﬁeld	NN	O	ﬁeld	_	0	SENT_122	[p9l954t40r1109b102],
5	of	IN	O	of	_	0	SENT_122	[p9l1151t40r1228b102],
6	study	NN	O	study	prep_of	4	SENT_122	[p9l1267t40r1453b120],
7	that	WDT	O	that	nsubj	8	SENT_122	[p9l1496t40r1628b102],
8	examines	VBZ	O	examine	rcmod	4	SENT_122	[p9l1670t40r2000b102],
9	the	DT	O	the	det	10	SENT_122	[p9l2044t40r2150b102],
10	impact	NN	O	impact	dobj	8	SENT_122	[p9l19t137r260b217],
11	of	IN	O	of	_	0	SENT_122	[p9l301t137r377b199],
12	genetic	JJ	O	genetic	amod	13	SENT_122	[p9l414t137r666b217],
13	Variation	NN	O	variation	prep_of	10	SENT_122	[p9l709t137r1022b199],
14	on	IN	O	on	_	0	SENT_122	[p9l1064t156r1150b199],
15	the	DT	O	the	det	16	SENT_122	[p9l1191t137r1296b199],
16	response	NN	O	response	prep_on	8	SENT_122	[p9l1337t156r1646b217],
17	to	TO	O	to	_	0	SENT_122	[p9l1688t146r1753b199],
18	drugs	NNS	O	drug	prep_to	16	SENT_122	[p9l1797t137r2008b217],
19	.	.	O	.	_	0	SENT_122	[p9l1797t137r2008b217],

1	As	IN	O	as	mark	6	SENT_123	[p9l2054t137r2148b199],
2	more	JJR	O	more	amod	4	SENT_123	[p9l19t253r199b295],
3	eye	NN	O	eye	nn	4	SENT_123	[p9l244t253r364b314],
4	diseases	NNS	O	disease	nsubjpass	6	SENT_123	[p9l409t233r695b295],
5	are	VBP	O	be	auxpass	6	SENT_123	[p9l743t253r847b295],
6	linked	VBN	O	link	advcl	17	SENT_123	[p9l891t233r1111b295],
7	to	TO	O	to	_	0	SENT_123	[p9l1154t243r1220b295],
8	their	PRP$	O	they	poss	11	SENT_123	[p9l1265t233r1427b295],
9	underlying	JJ	O	underlying	amod	11	SENT_123	[p9l1469t233r1851b314],
10	genetic	JJ	O	genetic	amod	11	SENT_123	[p9l1897t233r2149b314],
11	defects	NNS	O	defect	prep_to	6	SENT_123	[p9l20t331r288b405],
12	,	,	O	,	_	0	SENT_123	[p9l20t331r288b405],
13	pharmacogenetics	NNS	O	pharmacogenetic	nsubj	17	SENT_123	[p9l331t331r969b411],
14	and	CC	O	and	_	0	SENT_123	[p9l1015t331r1140b393],
15	genomics	NNS	O	genomic	conj_and	13	SENT_123	[p9l1182t331r1517b411],
16	will	MD	O	will	aux	17	SENT_123	[p9l1561t331r1697b393],
17	play	VB	O	play	_	0	SENT_123	[p9l1737t331r1888b411],
18	an	DT	O	a	det	21	SENT_123	[p9l1932t351r2012b393],
19	increasingly	RB	O	increasingly	advmod	20	SENT_123	[p9l2054t331r2147b392, p9l20t428r381b508],
20	important	JJ	O	important	amod	21	SENT_123	[p9l416t428r761b508],
21	role	NN	O	role	dobj	17	SENT_123	[p9l793t428r929b490],
22	in	IN	O	in	_	0	SENT_123	[p9l963t428r1030b489],
23	clinical	JJ	O	clinical	amod	25	SENT_123	[p9l1065t428r1322b490],
24	trial	NN	O	trial	nn	25	SENT_123	[p9l1357t428r1497b490],
25	design	NN	O	design	prep_in	21	SENT_123	[p9l1533t428r1762b508],
26	and	CC	O	and	_	0	SENT_123	[p9l1797t428r1922b490],
27	eventually	RB	O	eventually	conj_and	17	SENT_123	[p9l1956t447r2148b490, p9l19t524r219b605],
28	in	IN	O	in	_	0	SENT_123	[p9l251t524r318b586],
29	everyday	JJ	O	everyday	amod	31	SENT_123	[p9l350t524r672b605],
30	ophthalmology	NN	O	ophthalmology	nn	31	SENT_123	[p9l706t524r1240b605],
31	practice	NN	O	practice	prep_in	27	SENT_123	[p9l1271t524r1569b605],
32	.	.	O	.	_	0	SENT_123	[p9l1271t524r1569b605],

1	Genetic	JJ	O	genetic	amod	2	SENT_124	[p9l1607t524r1878b587],
2	factors	NNS	O	factor	nsubjpass	4	SENT_124	[p9l1911t524r2148b586],
3	are	VBP	O	be	auxpass	4	SENT_124	[p9l21t642r125b684],
4	known	VBN	O	know	_	0	SENT_124	[p9l148t622r389b684],
5	to	TO	O	to	aux	6	SENT_124	[p9l412t631r478b684],
6	play	VB	O	play	xcomp	4	SENT_124	[p9l502t622r653b702],
7	a	DT	O	a	det	9	SENT_124	[p9l679t642r716b684],
8	major	JJ	O	major	amod	9	SENT_124	[p9l738t622r945b702],
9	role	NN	O	role	dobj	6	SENT_124	[p9l966t622r1102b684],
10	in	IN	O	in	_	0	SENT_124	[p9l1126t622r1193b683],
11	the	DT	O	the	det	12	SENT_124	[p9l1217t622r1322b684],
12	pathogenesis	NN	O	pathogenesis	prep_in	6	SENT_124	[p9l1345t622r1801b702],
13	of	IN	O	of	_	0	SENT_124	[p9l1828t622r1905b684],
14	AMD	NNP	ORGANIZATION	AMD	prep_of	12	SENT_124	[p9l1923t623r2147b696],
15	,	,	O	,	_	0	SENT_124	[p9l1923t623r2147b696],
16	and	CC	O	and	_	0	SENT_124	[p9l21t719r146b781],
17	it	PRP	O	it	nsubjpass	20	SENT_124	[p9l191t719r240b781],
18	has	VBZ	O	have	aux	20	SENT_124	[p9l283t719r398b781],
19	been	VBN	O	be	auxpass	20	SENT_124	[p9l444t719r611b781],
20	suggested	VBN	O	suggest	conj_and	4	SENT_124	[p9l660t719r1006b799],
21	that	IN	O	that	complm	25	SENT_124	[p9l1051t719r1183b781],
22	genetic	JJ	O	genetic	amod	23	SENT_124	[p9l1228t719r1480b799],
23	factors	NNS	O	factor	nsubj	25	SENT_124	[p9l1528t719r1765b781],
24	also	RB	O	also	advmod	25	SENT_124	[p9l1815t719r1952b781],
25	may	MD	O	may	ccomp	20	SENT_124	[p9l1999t738r2149b799],

1	Smailhodzic	JJ	MISC	smailhodzic	_	0	SENT_125	[p9l467t874r669b913],
2	et	FW	O	et	nn	3	SENT_125	[p9l686t884r716b909],
3	al	FW	O	al	dep	1	SENT_125	[p9l731t874r762b909],
4	-	:	O	-	_	0	SENT_125	[p9l788t889r795b896],
5	Risk	NN	O	risk	nn	6	SENT_125	[p9l822t874r903b909],
6	Alleles	NNS	O	allele	dep	1	SENT_125	[p9l919t874r1047b909],
7	on	IN	O	on	_	0	SENT_125	[p9l1065t888r1112b909],
8	Treatment	NN	O	treatment	nn	9	SENT_125	[p9l1128t876r1326b909],
9	Response	NN	O	response	prep_on	6	SENT_125	[p9l1342t876r1513b918],
10	in	IN	O	in	_	0	SENT_125	[p9l1532t879r1568b909],
11	AMD	NNP	ORGANIZATION	AMD	prep_in	6	SENT_125	[p9l1584t875r1692b909],

1	Table	NNP	O	Table	_	0	SENT_126	[p9l336t976r422b1005],
2	1	CD	NUMBER	1	dep	1	SENT_126	[p9l439t978r461b1004],
3	.	.	O	.	_	0	SENT_126	[p9l439t978r461b1004],

1	Effect	NN	O	effect	_	0	SENT_127	[p9l483t976r570b1005],
2	of	IN	O	of	_	0	SENT_127	[p9l583t976r614b1005],
3	Genotype	NN	O	genotype	prep_of	1	SENT_127	[p9l625t977r773b1012],
4	on	IN	O	on	_	0	SENT_127	[p9l787t987r826b1005],
5	the	DT	O	the	det	8	SENT_127	[p9l840t976r887b1005],
6	Visual	JJ	O	visual	amod	8	SENT_127	[p9l901t976r996b1005],
7	Acuity	NN	O	acuity	nn	8	SENT_127	[p9l1010t977r1113b1012],
8	Response	NN	O	response	prep_on	1	SENT_127	[p9l1127t977r1267b1012],
9	after	IN	O	after	_	0	SENT_127	[p9l1282t976r1349b1005],
10	3	CD	NUMBER	3	num	12	SENT_127	[p9l1362t977r1377b1005],
11	Ranibizumab	NN	O	ranibizumab	nn	12	SENT_127	[p9l1393t976r1590b1005],
12	Injections	NNS	O	injection	prep_after	8	SENT_127	[p9l1605t977r1754b1012],
13	and	CC	O	and	_	0	SENT_127	[p9l1769t976r1824b1005],
14	on	IN	O	on	_	0	SENT_127	[p9l536t1029r574b1046],
15	the	DT	O	the	det	16	SENT_127	[p9l588t1017r636b1046],
16	Age	NNP	O	Age	prep_on	8	SENT_127	[p9l650t1018r711b1053],
17	When	WRB	O	when	advmod	23	SENT_127	[p9l725t1017r820b1046],
18	the	DT	O	the	det	21	SENT_127	[p9l834t1017r882b1046],
19	First	NNP	ORDINAL	First	nn	21	SENT_127	[p9l896t1019r962b1046],
20	Ranibizurnab	NNP	O	Ranibizurnab	nn	21	SENT_127	[p9l975t1017r1171b1046],
21	Injection	NN	O	injection	nsubjpass	23	SENT_127	[p9l1186t1019r1324b1053],
22	Was	VBD	O	be	auxpass	23	SENT_127	[p9l1337t1019r1403b1046],
23	Administered	VBN	O	administer	dep	1	SENT_127	[p9l1417t1017r1624b1046],

1	CFH	NNP	O	CFH	_	0	SENT_128	[p9l9t1407r224b1485],
2	rsl06ll70	CD	NUMBER	rsl06ll70	dep	1	SENT_128	[p9l262t1407r699b1488],
3	(	CD	NUMBER	(	num	4	SENT_128	[p9l737t1404r1138b1499],
4	Y402H	NN	O	y402h	rcmod	2	SENT_128	[p9l737t1404r1138b1499],
5	)	NN	O	)	dep	4	SENT_128	[p9l737t1404r1138b1499],
6	,	,	O	,	_	0	SENT_128	[p9l737t1404r1138b1499],

1	n	NN	O	n	_	0	SENT_129	[p9l220t1539r277b1586],
2	=	JJ	O	=	amod	1	SENT_129	[p9l326t1539r390b1564],
3	420	CD	NUMBER	420	tmod	2	SENT_129	[p9l439t1511r593b1594],

1	TT	NN	ORGANIZATION	tt	nn	2	SENT_130	[p9l114t1636r253b1711],
2	n	NN	O	n	_	0	SENT_130	[p9l520t1664r577b1711],
3	=	JJ	O	=	advmod	7	SENT_130	[p9l617t1664r680b1688],
4	78	CD	NUMBER	78	num	5	SENT_130	[p9l727t1636r821b1715],
5	(	CD	NUMBER	(	dep	3	SENT_130	[p9l860t1631r1112b1726],
6	18.6	CD	NUMBER	18.6	num	7	SENT_130	[p9l860t1631r1112b1726],
7	)	NN	O	)	rcmod	2	SENT_130	[p9l860t1631r1112b1726],
8	0.105	CD	NUMBER	0.105	num	9	SENT_130	[p9l1577t1633r1805b1712],
9	(	CD	NUMBER	(	dep	7	SENT_130	[p9l1847t1631r2152b1726],
10	0.039	CD	NUMBER	0.039	num	13	SENT_130	[p9l1847t1631r2152b1726],
11	)	NN	O	)	nn	13	SENT_130	[p9l1847t1631r2152b1726],
12	TC	NN	ORGANIZATION	tc	nn	13	SENT_130	[p9l114t1758r258b1836],
13	n	NN	O	n	dep	9	SENT_130	[p9l467t1788r524b1836],
14	=	JJ	O	=	dep	13	SENT_130	[p9l563t1788r627b1812],
15	198	CD	NUMBER	198	iobj	14	SENT_130	[p9l677t1760r821b1836],
16	(	CD	NUMBER	(	number	17	SENT_130	[p9l860t1755r1112b1850],
17	47.1	CD	NUMBER	47.1	num	18	SENT_130	[p9l860t1755r1112b1850],
18	)	NN	O	)	dobj	14	SENT_130	[p9l860t1755r1112b1850],
19	0.031	CD	NUMBER	0.031	number	20	SENT_130	[p9l1577t1760r1801b1836],
20	(	CD	NUMBER	(	dep	25	SENT_130	[p9l1847t1755r2152b1850],
21	0.031	CD	NUMBER	0.031	number	22	SENT_130	[p9l1847t1755r2152b1850],
22	)	CD	NUMBER	)	num	24	SENT_130	[p9l1847t1755r2152b1850],
23	CC	NN	ORGANIZATION	cc	nn	24	SENT_130	[p9l115t1883r264b1961],
24	n	NN	O	n	npadvmod	25	SENT_130	[p9l467t1913r524b1961],
25	=	JJ	O	=	amod	18	SENT_130	[p9l563t1913r627b1937],
26	144	CD	NUMBER	144	number	27	SENT_130	[p9l677t1885r822b1967],
27	(	CD	NUMBER	(	dep	2	SENT_130	[p9l860t1880r1112b1975],
28	34.4	CD	NUMBER	34.4	num	30	SENT_130	[p9l860t1880r1112b1975],
29	)	NN	O	)	nn	30	SENT_130	[p9l860t1880r1112b1975],
30	o	NN	O	o	dep	27	SENT_130	[p9l1799t1885r1846b1961],

1	ARMS2	NN	O	arms2	_	0	SENT_131	[p9l6t2010r343b2087],
2	rsl0490924	NN	O	rsl0490924	dep	1	SENT_131	[p9l385t2010r875b2094],
3	(	CD	NUMBER	(	num	4	SENT_131	[p9l914t2007r1256b2101],
4	A698	NN	O	a698	rcmod	2	SENT_131	[p9l914t2007r1256b2101],
5	)	NN	O	)	dep	4	SENT_131	[p9l914t2007r1256b2101],
6	,	,	O	,	_	0	SENT_131	[p9l914t2007r1256b2101],

1	n	NN	O	n	_	0	SENT_132	[p9l221t2144r277b2192],
2	=	JJ	O	=	amod	1	SENT_132	[p9l316t2144r380b2170],
3	420	CD	NUMBER	420	tmod	2	SENT_132	[p9l421t2116r576b2200],

1	GG	NNS	O	gg	nn	2	SENT_133	[p9l115t2240r275b2317],
2	n	NN	O	n	dep	10	SENT_133	[p9l467t2269r524b2316],
3	=	JJ	O	=	amod	4	SENT_133	[p9l563t2269r627b2294],
4	141	CD	NUMBER	141	dep	2	SENT_133	[p9l677t2241r814b2324],
5	(	CD	NUMBER	(	number	6	SENT_133	[p9l860t2237r1112b2332],
6	33.6	CD	NUMBER	33.6	dep	4	SENT_133	[p9l860t2237r1112b2332],
7	)	NN	O	)	dep	10	SENT_133	[p9l860t2237r1112b2332],
8	0.033	CD	NUMBER	0.033	num	7	SENT_133	[p9l1577t2240r1804b2317],
9	(	CD	NUMBER	(	num	10	SENT_133	[p9l1847t2237r2152b2332],
10	0.037	CD	NUMBER	0.037	_	0	SENT_133	[p9l1847t2237r2152b2332],
11	)	NN	O	)	nn	13	SENT_133	[p9l1847t2237r2152b2332],
12	GT	NN	O	gt	nn	13	SENT_133	[p9l115t2365r265b2442],
13	n	NN	O	n	dep	10	SENT_133	[p9l467t2394r524b2441],
14	=	JJ	O	=	dep	13	SENT_133	[p9l563t2394r627b2419],
15	175	CD	NUMBER	175	iobj	14	SENT_133	[p9l677t2363r818b2446],
16	(	CD	NUMBER	(	number	17	SENT_133	[p9l860t2362r1112b2457],
17	41.7	CD	NUMBER	41.7	num	18	SENT_133	[p9l860t2362r1112b2457],
18	)	NN	O	)	dobj	14	SENT_133	[p9l860t2362r1112b2457],
19	0.061	CD	NUMBER	0.061	number	20	SENT_133	[p9l1577t2365r1801b2442],
20	(	CD	NUMBER	(	dep	25	SENT_133	[p9l1847t2362r2152b2457],
21	0.035	CD	NUMBER	0.035	number	22	SENT_133	[p9l1847t2362r2152b2457],
22	)	CD	NUMBER	)	num	24	SENT_133	[p9l1847t2362r2152b2457],
23	TT	NN	ORGANIZATION	tt	nn	24	SENT_133	[p9l114t2491r253b2566],
24	n	NN	O	n	npadvmod	25	SENT_133	[p9l467t2520r524b2566],
25	=	JJ	O	=	amod	18	SENT_133	[p9l563t2520r627b2544],
26	104	CD	NUMBER	104	number	27	SENT_133	[p9l677t2491r822b2574],
27	(	CD	NUMBER	(	dep	13	SENT_133	[p9l860t2487r1112b2582],
28	24.8	CD	NUMBER	24.8	num	30	SENT_133	[p9l860t2487r1112b2582],
29	)	NN	O	)	nn	30	SENT_133	[p9l860t2487r1112b2582],
30	o	NN	O	o	dep	27	SENT_133	[p9l1799t2491r1846b2568],

1	VEGFA	NNP	O	VEGFA	nsubj	2	SENT_134	[p9l7t2615r360b2693],
2	rs699947	NN	O	rs699947	_	0	SENT_134	[p9l397t2615r805b2707],
3	,	,	O	,	_	0	SENT_134	[p9l397t2615r805b2707],

1	n	NN	O	n	_	0	SENT_135	[p9l221t2747r277b2794],
2	=	JJ	O	=	amod	1	SENT_135	[p9l316t2748r380b2772],
3	400	CD	NUMBER	400	tmod	2	SENT_135	[p9l421t2719r576b2802],

1	AA	NN	ORGANIZATION	aa	nn	2	SENT_136	[p9l114t2842r277b2919],
2	n	NN	O	n	dep	10	SENT_136	[p9l467t2872r524b2919],
3	=	JJ	O	=	amod	4	SENT_136	[p9l563t2872r627b2896],
4	ll7	CD	NUMBER	ll7	dep	2	SENT_136	[p9l677t2844r818b2923],
5	(	CD	NUMBER	(	number	6	SENT_136	[p9l860t2839r1112b2934],
6	29.3	CD	NUMBER	29.3	dep	4	SENT_136	[p9l860t2839r1112b2934],
7	)	NN	O	)	dep	10	SENT_136	[p9l860t2839r1112b2934],
8	0.048	CD	NUMBER	0.048	num	7	SENT_136	[p9l1577t2844r1808b2926],
9	(	CD	NUMBER	(	num	10	SENT_136	[p9l1847t2839r2152b2934],
10	0.040	CD	NUMBER	0.040	dep	26	SENT_136	[p9l1847t2839r2152b2934],
11	)	CD	NUMBER	)	num	13	SENT_136	[p9l1847t2839r2152b2934],
12	CA	NNP	O	CA	nn	13	SENT_136	[p9l115t2966r270b3044],
13	n	NN	O	n	dep	10	SENT_136	[p9l467t2996r524b3044],
14	=	JJ	O	=	dep	13	SENT_136	[p9l563t2996r627b3020],
15	194	CD	NUMBER	194	iobj	14	SENT_136	[p9l677t2968r822b3050],
16	(	CD	NUMBER	(	number	17	SENT_136	[p9l860t2963r1112b3058],
17	48.5	CD	NUMBER	48.5	num	18	SENT_136	[p9l860t2963r1112b3058],
18	)	NN	O	)	dobj	14	SENT_136	[p9l860t2963r1112b3058],
19	0.035	CD	NUMBER	0.035	number	20	SENT_136	[p9l1577t2965r1804b3044],
20	(	CD	NUMBER	(	dep	25	SENT_136	[p9l1847t2963r2152b3058],
21	0.033	CD	NUMBER	0.033	number	22	SENT_136	[p9l1847t2963r2152b3058],
22	)	CD	NUMBER	)	num	24	SENT_136	[p9l1847t2963r2152b3058],
23	CC	NN	ORGANIZATION	cc	nn	24	SENT_136	[p9l115t3093r264b3170],
24	n	NN	O	n	npadvmod	25	SENT_136	[p9l520t3122r577b3170],
25	=	JJ	O	=	amod	18	SENT_136	[p9l617t3122r680b3147],
26	89	CD	NUMBER	89	_	0	SENT_136	[p9l724t3093r821b3170],
27	(	CD	NUMBER	(	number	28	SENT_136	[p9l860t3090r1112b3184],
28	22.3	CD	NUMBER	22.3	dep	26	SENT_136	[p9l860t3090r1112b3184],
29	)	NN	O	)	nn	30	SENT_136	[p9l860t3090r1112b3184],
30	o	NN	O	o	dep	28	SENT_136	[p9l1799t3093r1846b3170],

1	VEGFA	NNP	O	VEGFA	_	0	SENT_137	[p9l7t3219r359b3297],
2	rs833069	NN	O	rs833069	dep	1	SENT_137	[p9l397t3219r805b3310],
3	,	,	O	,	_	0	SENT_137	[p9l397t3219r805b3310],
4	n	NN	O	n	appos	2	SENT_137	[p9l848t3248r905b3296],
5	=	JJ	O	=	amod	4	SENT_137	[p9l945t3248r1007b3273],
6	393	CD	NUMBER	393	tmod	5	SENT_137	[p9l1048t3219r1198b3296],

1	TT	NN	ORGANIZATION	tt	nn	2	SENT_138	[p9l114t3344r253b3420],
2	n	NN	O	n	_	0	SENT_138	[p9l467t3373r524b3420],
3	=	JJ	O	=	dep	2	SENT_138	[p9l563t3373r627b3398],
4	168	CD	NUMBER	168	iobj	3	SENT_138	[p9l677t3344r821b3421],
5	(	CD	NUMBER	(	number	6	SENT_138	[p9l860t3341r1112b3436],
6	42.7	CD	NUMBER	42.7	num	7	SENT_138	[p9l860t3341r1112b3436],
7	)	NN	O	)	dobj	3	SENT_138	[p9l860t3341r1112b3436],
8	-0.020	CD	NUMBER	-0.020	num	9	SENT_138	[p9l1497t3344r1809b3421],
9	(	CD	NUMBER	(	dep	18	SENT_138	[p9l1847t3341r2152b3436],
10	0.044	CD	NUMBER	0.044	num	13	SENT_138	[p9l1847t3341r2152b3436],
11	)	NN	O	)	nn	13	SENT_138	[p9l1847t3341r2152b3436],
12	TC	NN	ORGANIZATION	tc	nn	13	SENT_138	[p9l114t3469r258b3547],
13	n	NN	O	n	dep	9	SENT_138	[p9l467t3499r524b3545],
14	=	JJ	O	=	amod	15	SENT_138	[p9l563t3499r627b3523],
15	l73	NN	O	l73	dep	18	SENT_138	[p9l677t3470r816b3550],
16	(	CD	NUMBER	(	num	18	SENT_138	[p9l860t3466r1112b3561],
17	44.0	CD	NUMBER	44.0	num	18	SENT_138	[p9l860t3466r1112b3561],
18	)	NN	O	)	dep	7	SENT_138	[p9l860t3466r1112b3561],
19	—	CD	NUMBER	—	number	20	SENT_138	[p9l1497t3470r1809b3553],
20	0.0	CD	NUMBER	0.0	dep	18	SENT_138	[p9l1497t3470r1809b3553],
21	l4	NN	O	l4	dep	20	SENT_138	[p9l1497t3470r1809b3553],
22	(	CD	NUMBER	(	num	21	SENT_138	[p9l1847t3466r2152b3561],
23	0.044	CD	NUMBER	0.044	number	24	SENT_138	[p9l1847t3466r2152b3561],
24	)	CD	NUMBER	)	num	26	SENT_138	[p9l1847t3466r2152b3561],
25	CC	NN	ORGANIZATION	cc	nn	26	SENT_138	[p9l116t3594r264b3672],
26	n	NN	O	n	npadvmod	27	SENT_138	[p9l520t3624r577b3670],
27	=	JJ	O	=	amod	2	SENT_138	[p9l617t3624r681b3648],
28	52	CD	NUMBER	52	number	29	SENT_138	[p9l722t3592r820b3671],
29	(	CD	NUMBER	(	dep	2	SENT_138	[p9l860t3591r1112b3686],
30	13.2	CD	NUMBER	13.2	num	32	SENT_138	[p9l860t3591r1112b3686],
31	)	NN	O	)	nn	32	SENT_138	[p9l860t3591r1112b3686],
32	o	NN	O	o	dep	29	SENT_138	[p9l1799t3595r1846b3672],

1	KDR	NN	O	kdr	nn	2	SENT_139	[p9l7t3722r216b3797],
2	rs207l559	NN	O	rs207l559	dep	5	SENT_139	[p9l256t3719r716b3813],
3	,	,	O	,	_	0	SENT_139	[p9l256t3719r716b3813],
4	n	NN	O	n	appos	2	SENT_139	[p9l759t3751r816b3797],
5	=	JJ	O	=	_	0	SENT_139	[p9l856t3751r920b3775],
6	393	CD	NUMBER	393	tmod	5	SENT_139	[p9l960t3722r1109b3799],

1	AA	NN	ORGANIZATION	aa	nn	2	SENT_140	[p10l114t27r277b105],
2	n	NN	O	n	dep	7	SENT_140	[p10l520t57r577b105],
3	=	JJ	O	=	amod	4	SENT_140	[p10l617t57r681b81],
4	91	CD	NUMBER	91	dep	2	SENT_140	[p10l722t29r815b105],
5	(	CD	NUMBER	(	dep	7	SENT_140	[p10l860t24r1112b119],
6	23.2	CD	NUMBER	23.2	num	7	SENT_140	[p10l860t24r1112b119],
7	)	NN	O	)	dep	15	SENT_140	[p10l860t24r1112b119],
8	0.007	CD	NUMBER	0.007	number	9	SENT_140	[p10l1577t29r1806b108],
9	(	CD	NUMBER	(	dep	7	SENT_140	[p10l1847t24r2152b119],
10	0.040	CD	NUMBER	0.040	num	13	SENT_140	[p10l1847t24r2152b119],
11	)	NN	O	)	nn	13	SENT_140	[p10l1847t24r2152b119],
12	GA	NN	ORGANIZATION	ga	nn	13	SENT_140	[p10l116t152r277b230],
13	n	NN	O	n	dep	9	SENT_140	[p10l467t182r525b230],
14	=	JJ	O	=	amod	15	SENT_140	[p10l563t182r627b206],
15	197	CD	NUMBER	197	dep	23	SENT_140	[p10l677t154r818b233],
16	(	CD	NUMBER	(	number	17	SENT_140	[p10l860t149r1112b244],
17	50.1	CD	NUMBER	50.1	num	18	SENT_140	[p10l860t149r1112b244],
18	)	NN	O	)	dep	15	SENT_140	[p10l860t149r1112b244],
19	-0.064	CD	NUMBER	-0.064	num	20	SENT_140	[p10l1497t152r1809b236],
20	(	CD	NUMBER	(	dep	18	SENT_140	[p10l1847t149r2152b244],
21	0.034	CD	NUMBER	0.034	num	23	SENT_140	[p10l1847t149r2152b244],
22	)	NN	O	)	nn	23	SENT_140	[p10l1847t149r2152b244],
23	GG	NNS	O	gg	_	0	SENT_140	[p10l116t279r275b356],
24	n	NN	O	n	dep	23	SENT_140	[p10l467t308r525b356],
25	=	JJ	O	=	dep	24	SENT_140	[p10l563t308r627b333],
26	105	CD	NUMBER	105	iobj	25	SENT_140	[p10l677t276r818b356],
27	(	CD	NUMBER	(	number	28	SENT_140	[p10l860t276r1112b370],
28	26.7	CD	NUMBER	26.7	num	30	SENT_140	[p10l860t276r1112b370],
29	)	NN	O	)	nn	30	SENT_140	[p10l860t276r1112b370],
30	o	NN	O	o	dobj	25	SENT_140	[p10l1799t279r1846b356],

1	KDR	NN	O	kdr	nn	2	SENT_141	[p10l8t405r217b481],
2	rs7671745	NN	O	rs7671745	dep	5	SENT_141	[p10l256t403r716b495],
3	,	,	O	,	_	0	SENT_141	[p10l256t403r716b495],
4	n	NN	O	n	appos	2	SENT_141	[p10l759t433r816b481],
5	=	JJ	O	=	_	0	SENT_141	[p10l856t433r920b459],
6	388	CD	NUMBER	388	tmod	5	SENT_141	[p10l961t406r1114b481],

1	GG	NNS	O	gg	nn	2	SENT_142	[p10l116t529r275b606],
2	n	NN	O	n	dep	10	SENT_142	[p10l467t558r524b605],
3	=	JJ	O	=	amod	4	SENT_142	[p10l564t558r627b583],
4	129	CD	NUMBER	129	dep	2	SENT_142	[p10l677t530r821b606],
5	(	CD	NUMBER	(	number	6	SENT_142	[p10l860t526r1112b621],
6	33.2	CD	NUMBER	33.2	dep	4	SENT_142	[p10l860t526r1112b621],
7	)	NN	O	)	dep	10	SENT_142	[p10l860t526r1112b621],
8	-0.029	CD	NUMBER	-0.029	num	7	SENT_142	[p10l1497t529r1808b606],
9	(	CD	NUMBER	(	num	10	SENT_142	[p10l1847t526r2152b621],
10	0.049	CD	NUMBER	0.049	dep	20	SENT_142	[p10l1847t526r2152b621],
11	)	CD	NUMBER	)	num	13	SENT_142	[p10l1847t526r2152b621],
12	AG	NNP	ORGANIZATION	AG	nn	13	SENT_142	[p10l114t654r275b732],
13	n	NN	O	n	dep	10	SENT_142	[p10l467t684r525b730],
14	=	JJ	O	=	advmod	18	SENT_142	[p10l564t684r627b708],
15	214	CD	NUMBER	214	dep	14	SENT_142	[p10l671t655r823b738],
16	(	CD	NUMBER	(	number	17	SENT_142	[p10l860t651r1112b746],
17	55.2	CD	NUMBER	55.2	num	18	SENT_142	[p10l860t651r1112b746],
18	)	NN	O	)	rcmod	13	SENT_142	[p10l860t651r1112b746],
19	-0.051	CD	NUMBER	-0.051	num	20	SENT_142	[p10l1497t652r1802b732],
20	(	CD	NUMBER	(	_	0	SENT_142	[p10l1847t651r2152b746],
21	0.045	CD	NUMBER	0.045	number	22	SENT_142	[p10l1847t651r2152b746],
22	)	CD	NUMBER	)	num	24	SENT_142	[p10l1847t651r2152b746],
23	AA	NN	ORGANIZATION	aa	nn	24	SENT_142	[p10l114t755r277b832],
24	n	NN	O	n	npadvmod	25	SENT_142	[p10l520t785r578b832],
25	=	JJ	O	=	amod	27	SENT_142	[p10l617t785r681b809],
26	45	CD	NUMBER	45	number	27	SENT_142	[p10l721t754r818b839],
27	(	CD	NUMBER	(	dep	20	SENT_142	[p10l860t752r1112b847],
28	11.6	CD	NUMBER	11.6	num	30	SENT_142	[p10l860t752r1112b847],
29	)	NN	O	)	nn	30	SENT_142	[p10l860t752r1112b847],
30	o	NN	O	o	dep	27	SENT_142	[p10l1799t757r1846b833],

1	FZD4	NN	O	fzd4	nn	2	SENT_143	[p10l9t881r250b965],
2	rs10898563	NN	O	rs10898563	dep	5	SENT_143	[p10l292t879r805b973],
3	,	,	O	,	_	0	SENT_143	[p10l292t879r805b973],
4	n	NN	O	n	appos	2	SENT_143	[p10l848t911r905b957],
5	=	JJ	O	=	_	0	SENT_143	[p10l945t911r1009b935],
6	397	CD	NUMBER	397	tmod	5	SENT_143	[p10l1048t882r1200b962],

1	AA	NN	ORGANIZATION	aa	nn	2	SENT_144	[p10l114t1004r277b1082],
2	n	NN	O	n	dep	10	SENT_144	[p10l467t1034r525b1082],
3	=	JJ	O	=	amod	4	SENT_144	[p10l564t1034r627b1058],
4	135	CD	NUMBER	135	dep	2	SENT_144	[p10l678t1003r818b1082],
5	(	CD	NUMBER	(	number	6	SENT_144	[p10l860t1001r1112b1096],
6	34.0	CD	NUMBER	34.0	dep	4	SENT_144	[p10l860t1001r1112b1096],
7	)	NN	O	)	dep	10	SENT_144	[p10l860t1001r1112b1096],
8	-0.018	CD	NUMBER	-0.018	num	7	SENT_144	[p10l1497t1006r1808b1082],
9	(	CD	NUMBER	(	num	10	SENT_144	[p10l1847t1001r2152b1096],
10	0.042	CD	NUMBER	0.042	dep	20	SENT_144	[p10l1847t1001r2152b1096],
11	)	CD	NUMBER	)	num	13	SENT_144	[p10l1847t1001r2152b1096],
12	AG	NNP	ORGANIZATION	AG	nn	13	SENT_144	[p10l114t1130r275b1208],
13	n	NN	O	n	dep	10	SENT_144	[p10l467t1160r525b1208],
14	=	JJ	O	=	advmod	18	SENT_144	[p10l564t1160r627b1185],
15	193	CD	NUMBER	193	dep	14	SENT_144	[p10l678t1131r818b1208],
16	(	CD	NUMBER	(	number	17	SENT_144	[p10l860t1128r1112b1222],
17	48.6	CD	NUMBER	48.6	num	18	SENT_144	[p10l860t1128r1112b1222],
18	)	NN	O	)	rcmod	13	SENT_144	[p10l860t1128r1112b1222],
19	-0.040	CD	NUMBER	-0.040	num	20	SENT_144	[p10l1497t1131r1809b1214],
20	(	CD	NUMBER	(	dep	24	SENT_144	[p10l1847t1128r2152b1222],
21	0.040	CD	NUMBER	0.040	num	23	SENT_144	[p10l1847t1128r2152b1222],
22	)	NN	O	)	nn	23	SENT_144	[p10l1847t1128r2152b1222],
23	GG	NNS	O	gg	dep	20	SENT_144	[p10l116t1257r275b1334],
24	n	NN	O	n	_	0	SENT_144	[p10l520t1286r578b1334],
25	=	JJ	O	=	amod	24	SENT_144	[p10l617t1286r681b1311],
26	69	CD	NUMBER	69	number	27	SENT_144	[p10l724t1257r821b1334],
27	(	CD	NUMBER	(	dep	24	SENT_144	[p10l860t1254r1112b1348],
28	17.4	CD	NUMBER	17.4	num	30	SENT_144	[p10l860t1254r1112b1348],
29	)	NN	O	)	nn	30	SENT_144	[p10l860t1254r1112b1348],
30	o	NN	O	o	dep	27	SENT_144	[p10l1799t1257r1846b1334],

1	LRP5	NN	O	lrp5	nn	2	SENT_145	[p10l7t1380r237b1461],
2	rs3736228	NN	O	rs3736228	dep	5	SENT_145	[p10l280t1383r740b1474],
3	,	,	O	,	_	0	SENT_145	[p10l280t1383r740b1474],
4	n	NN	O	n	appos	2	SENT_145	[p10l783t1412r840b1460],
5	=	JJ	O	=	_	0	SENT_145	[p10l880t1412r944b1437],
6	388	CD	NUMBER	388	tmod	5	SENT_145	[p10l984t1383r1138b1460],

1	TT	NN	ORGANIZATION	tt	nn	2	SENT_146	[p10l114t1509r253b1584],
2	n	NN	O	n	dep	10	SENT_146	[p10l467t1538r525b1584],
3	=	JJ	O	=	amod	4	SENT_146	[p10l564t1538r627b1562],
4	230	CD	NUMBER	230	dep	2	SENT_146	[p10l671t1509r823b1586],
5	(	CD	NUMBER	(	number	6	SENT_146	[p10l861t1505r1112b1600],
6	59.3	CD	NUMBER	59.3	dep	4	SENT_146	[p10l861t1505r1112b1600],
7	)	NN	O	)	dep	10	SENT_146	[p10l861t1505r1112b1600],
8	-0.011	CD	NUMBER	-0.011	num	7	SENT_146	[p10l1499t1510r1802b1586],
9	(	CD	NUMBER	(	num	10	SENT_146	[p10l1847t1505r2152b1600],
10	0.041	CD	NUMBER	0.041	dep	26	SENT_146	[p10l1847t1505r2152b1600],
11	)	NN	O	)	nn	13	SENT_146	[p10l1847t1505r2152b1600],
12	CT	NN	O	ct	nn	13	SENT_146	[p10l116t1633r259b1711],
13	n	NN	O	n	dep	10	SENT_146	[p10l467t1663r525b1709],
14	=	JJ	O	=	dep	13	SENT_146	[p10l564t1663r628b1687],
15	100	CD	NUMBER	100	iobj	14	SENT_146	[p10l678t1634r823b1711],
16	(	CD	NUMBER	(	number	17	SENT_146	[p10l861t1630r1112b1725],
17	25.8	CD	NUMBER	25.8	num	18	SENT_146	[p10l861t1630r1112b1725],
18	)	NN	O	)	dobj	14	SENT_146	[p10l861t1630r1112b1725],
19	-0.002	CD	NUMBER	-0.002	number	20	SENT_146	[p10l1499t1634r1808b1711],
20	(	CD	NUMBER	(	dep	25	SENT_146	[p10l1847t1630r2153b1725],
21	0.046	CD	NUMBER	0.046	number	22	SENT_146	[p10l1847t1630r2153b1725],
22	)	CD	NUMBER	)	num	24	SENT_146	[p10l1847t1630r2153b1725],
23	CC	NN	ORGANIZATION	cc	nn	24	SENT_146	[p10l116t1758r264b1836],
24	n	NN	O	n	npadvmod	25	SENT_146	[p10l520t1788r578b1835],
25	=	JJ	O	=	amod	18	SENT_146	[p10l617t1788r681b1812],
26	58	CD	NUMBER	58	dep	38	SENT_146	[p10l722t1757r821b1836],
27	(	CD	NUMBER	(	number	28	SENT_146	[p10l861t1755r1112b1850],
28	14.9	CD	NUMBER	14.9	num	33	SENT_146	[p10l861t1755r1112b1850],
29	)	NN	O	)	nn	33	SENT_146	[p10l861t1755r1112b1850],
30	o	NN	O	o	nn	33	SENT_146	[p10l1800t1760r1847b1836],
31	0.009	CD	NUMBER	0.009	number	32	SENT_146	[p10l99t1883r319b1956],
32	+1.70	CD	NUMBER	+1.70	num	33	SENT_146	[p10l847t1879r1317b1970],
33	(	NN	O	(	dep	26	SENT_146	[p10l847t1879r1317b1970],
34	1.1	CD	NUMBER	1.1	number	35	SENT_146	[p10l847t1879r1317b1970],
35	)	CD	NUMBER	)	num	33	SENT_146	[p10l847t1879r1317b1970],
36	0.11	CD	NUMBER	0.11	num	37	SENT_146	[p10l1840t1883r2003b1956],
37	0.31	CD	NUMBER	0.31	dep	33	SENT_146	[p10l99t2001r263b2075],
38	+1.13	CD	NUMBER	+1.13	dep	39	SENT_146	[p10l847t2001r1087b2075],
39	(	NN	O	(	dep	42	SENT_146	[p10l1129t1997r1317b2088],
40	0.8	CD	NUMBER	0.8	num	39	SENT_146	[p10l1129t1997r1317b2088],
41	)	CD	NUMBER	)	num	42	SENT_146	[p10l1129t1997r1317b2088],
42	0.18	CD	NUMBER	0.18	_	0	SENT_146	[p10l1840t2001r2009b2075],

1	Reference	NNP	O	Reference	_	0	SENT_147	[p10l6t2119r411b2195],
2	o	NN	O	o	dep	1	SENT_147	[p10l1058t2122r1102b2195],
3	Reference	NNP	O	Reference	dep	1	SENT_147	[p10l1748t2119r2152b2195],

1	Reference	NNP	O	Reference	_	0	SENT_148	[p10l6t2663r411b2739],
2	o	NN	O	o	dep	1	SENT_148	[p10l1058t2666r1102b2739],
3	Reference	NNP	O	Reference	dep	1	SENT_148	[p10l1748t2663r2152b2739],

1	Reference	NNP	O	Reference	_	0	SENT_149	[p10l6t3207r411b3283],
2	o	NN	O	o	dep	1	SENT_149	[p10l1058t3210r1102b3283],
3	Reference	NNP	O	Reference	dep	1	SENT_149	[p10l1747t3207r2152b3283],

1	Reference	NNP	O	Reference	_	0	SENT_150	[p10l7t3687r411b3763],
2	o	NN	O	o	dep	1	SENT_150	[p10l1058t3690r1102b3763],
3	Reference	NNP	O	Reference	dep	1	SENT_150	[p10l1748t3687r2152b3763],

1	Reference	NNP	O	Reference	_	0	SENT_151	[p11l7t374r411b450],
2	o	NN	O	o	dep	1	SENT_151	[p11l1058t377r1103b450],
3	Reference	NNP	O	Reference	dep	1	SENT_151	[p11l1748t374r2152b450],

1	Reference	NNP	O	Reference	_	0	SENT_152	[p11l7t854r411b930],
2	o	NN	O	o	dep	1	SENT_152	[p11l1058t857r1103b930],
3	Reference	NNP	O	Reference	dep	1	SENT_152	[p11l1748t854r2153b930],

1	Reference	NNP	O	Reference	_	0	SENT_153	[p11l7t1332r411b1408],
2	o	NN	O	o	dep	1	SENT_153	[p11l1058t1335r1103b1408],
3	Reference	NNP	O	Reference	dep	1	SENT_153	[p11l1748t1332r2153b1408],

1	Reference	NNP	O	Reference	_	0	SENT_154	[p11l7t1812r412b1888],
2	o	NN	O	o	dep	1	SENT_154	[p11l1058t1815r1103b1888],
3	Reference	NNP	O	Reference	dep	1	SENT_154	[p11l1748t1812r2153b1888],

1	*	NN	O	*	nn	2	SENT_155	[p11l331t1963r424b1988],
2	Mean	NN	O	mean	nsubj	32	SENT_155	[p11l331t1963r424b1988],
3	visual	JJ	O	visual	amod	5	SENT_155	[p11l438t1962r515b1988],
4	acuity	NN	O	acuity	nn	5	SENT_155	[p11l530t1966r610b1994],
5	improvement	NN	O	improvement	nsubj	18	SENT_155	[p11l625t1966r805b1994],
6	in	IN	O	in	_	0	SENT_155	[p11l820t1966r846b1987],
7	logarithm	NN	O	logarithm	prep_in	5	SENT_155	[p11l861t1962r991b1994],
8	of	IN	O	of	_	0	SENT_155	[p11l1005t1962r1033b1988],
9	the	DT	O	the	det	11	SENT_155	[p11l1045t1962r1088b1988],
10	minimum	JJ	O	minimum	amod	11	SENT_155	[p11l1103t1966r1233b1988],
11	angle	NN	O	angle	prep_of	7	SENT_155	[p11l1248t1962r1318b1994],
12	of	IN	O	of	_	0	SENT_155	[p11l1333t1962r1361b1988],
13	resolution	NN	O	resolution	nn	15	SENT_155	[p11l1372t1962r1507b1988],
14	(	CD	NUMBER	(	num	15	SENT_155	[p11l1523t1962r1663b1994],
15	logMAR	NN	O	logmar	prep_of	11	SENT_155	[p11l1523t1962r1663b1994],
16	)	CD	NUMBER	)	num	17	SENT_155	[p11l1523t1962r1663b1994],
17	units	NNS	O	unit	dep	15	SENT_155	[p11l1679t1966r1744b1988],
18	(	VBP	O	(	rcmod	2	SENT_155	[p11l1761t1962r1828b1992],
19	0.02	CD	NUMBER	0.02	num	20	SENT_155	[p11l1761t1962r1828b1992],
20	logMAR	NN	O	logmar	dobj	18	SENT_155	[p11l331t1999r448b2031],
21	=	JJ	O	=	amod	20	SENT_155	[p11l463t2009r483b2017],
22	1	CD	NUMBER	1	tmod	21	SENT_155	[p11l501t2000r511b2024],
23	Early	JJ	O	early	amod	27	SENT_155	[p11l527t1999r594b2031],
24	Treatment	NN	O	treatment	nn	27	SENT_155	[p11l605t2000r750b2025],
25	Diabetic	NNP	O	Diabetic	nn	27	SENT_155	[p11l762t1999r875b2025],
26	Retinopathy	NNP	O	Retinopathy	nn	27	SENT_155	[p11l887t1999r1055b2031],
27	letter	NN	O	letter	tmod	18	SENT_155	[p11l1068t1999r1139b2025],
28	TA	NNP	O	TA	nn	31	SENT_155	[p11l331t2032r367b2061],
29	positive	JJ	O	positive	amod	31	SENT_155	[p11l377t2039r481b2068],
30	age	NN	O	age	nn	31	SENT_155	[p11l492t2046r534b2068],
31	difference	NN	O	difference	dep	27	SENT_155	[p11l544t2036r676b2061],
32	indicates	VBZ	O	indicate	_	0	SENT_155	[p11l687t2036r805b2062],
33	older	JJR	O	older	amod	34	SENT_155	[p11l815t2036r883b2062],
34	age	NN	O	age	nsubj	40	SENT_155	[p11l893t2046r935b2068],
35	and	CC	O	and	_	0	SENT_155	[p11l946t2036r995b2061],
36	a	DT	O	a	det	39	SENT_155	[p11l1005t2046r1018b2061],
37	negative	JJ	O	negative	amod	39	SENT_155	[p11l1028t2039r1141b2068],
38	age	NN	O	age	nn	39	SENT_155	[p11l1152t2046r1194b2068],
39	difference	NN	O	difference	conj_and	34	SENT_155	[p11l1204t2036r1336b2061],
40	indicates	VBZ	O	indicate	ccomp	32	SENT_155	[p11l1347t2036r1465b2062],
41	younger	JJR	O	younger	amod	42	SENT_155	[p11l1475t2046r1582b2068],
42	age	NN	O	age	dobj	40	SENT_155	[p11l1592t2045r1634b2068],
43	when	WRB	O	when	advmod	49	SENT_155	[p11l1644t2036r1718b2061],
44	the	DT	O	the	det	47	SENT_155	[p11l1728t2036r1770b2061],
45	first	JJ	ORDINAL	first	amod	47	SENT_155	[p11l1780t2036r1830b2061],
46	ranibizumab	NN	O	ranibizumab	nn	47	SENT_155	[p11l330t2073r493b2099],
47	injection	NN	O	injection	nsubjpass	49	SENT_155	[p11l507t2077r627b2105],
48	was	VBD	O	be	auxpass	49	SENT_155	[p11l639t2083r686b2099],
49	given	VBN	O	give	advcl	40	SENT_155	[p11l698t2077r778b2105],
50	.	.	O	.	_	0	SENT_155	[p11l698t2077r778b2105],

1	inﬂuence	NN	O	inﬂuence	nn	2	SENT_156	[p11l13t2288r336b2350],
2	response	NN	O	response	_	0	SENT_156	[p11l372t2308r682b2369],
3	to	TO	O	to	_	0	SENT_156	[p11l718t2298r784b2350],
4	anti	JJ	O	anti	prep_to	2	SENT_156	[p11l824t2288r1215b2351],
5	.	.	O	.	_	0	SENT_156	[p11l824t2288r1215b2351],

1	—	NN	O	—	_	0	SENT_157	[p11l824t2288r1215b2351],
2	.	.	O	.	_	0	SENT_157	[p11l824t2288r1215b2351],

1	VEGF	NN	O	vegf	nn	2	SENT_158	[p11l824t2288r1215b2351],
2	treatment	NN	O	treatment	nsubj	14	SENT_158	[p11l1251t2297r1586b2350],
3	in	IN	O	in	_	0	SENT_158	[p11l1621t2288r1688b2350],
4	neovascular	JJ	O	neovascular	amod	5	SENT_158	[p11l1725t2288r2149b2351],
5	AMD	NNP	O	AMD	prep_in	14	SENT_158	[p11l13t2374r414b2448],
6	.16	CD	NUMBER	.16	num	5	SENT_158	[p11l13t2374r414b2448],
7	‘	CD	NUMBER	‘	number	8	SENT_158	[p11l13t2374r414b2448],
8	19	CD	NUMBER	19	num	11	SENT_158	[p11l13t2374r414b2448],
9	This	DT	O	this	det	11	SENT_158	[p11l437t2386r591b2448],
10	large	JJ	O	large	amod	11	SENT_158	[p11l616t2386r791b2466],
11	series	NN	O	series	nsubj	14	SENT_158	[p11l817t2386r1012b2448],
12	of	IN	O	of	_	0	SENT_158	[p11l1038t2386r1114b2448],
13	patients	NNS	O	patient	prep_of	11	SENT_158	[p11l1129t2386r1403b2466],
14	evaluated	VBD	O	evaluate	_	0	SENT_158	[p11l1428t2386r1767b2448],
15	the	DT	O	the	det	16	SENT_158	[p11l1788t2386r1894b2448],
16	role	NN	O	role	dobj	14	SENT_158	[p11l1916t2386r2053b2448],
17	of	IN	O	of	_	0	SENT_158	[p11l2076t2386r2153b2448],
18	the	DT	O	the	det	20	SENT_158	[p11l13t2483r118b2545],
19	high-risk	JJ	O	high-risk	amod	20	SENT_158	[p11l159t2483r480b2563],
20	alleles	NNS	O	allele	prep_of	16	SENT_158	[p11l521t2483r741b2545],
21	in	IN	O	in	_	0	SENT_158	[p11l784t2483r851b2544],
22	the	DT	O	the	det	31	SENT_158	[p11l890t2483r996b2545],
23	CFH	NNP	O	CFH	nn	31	SENT_158	[p11l1042t2484r1232b2556],
24	,	,	O	,	_	0	SENT_158	[p11l1042t2484r1232b2556],
25	ARMS2	NN	O	arms2	dep	31	SENT_158	[p11l1269t2483r1564b2556],
26	,	,	O	,	_	0	SENT_158	[p11l1269t2483r1564b2556],
27	VEGFA	NN	LOCATION	vegfa	dep	31	SENT_158	[p11l1612t2484r1905b2556],
28	,	,	O	,	_	0	SENT_158	[p11l1612t2484r1905b2556],
29	KDR	NN	O	kdr	dep	31	SENT_158	[p11l1948t2485r2144b2556],
30	,	,	O	,	_	0	SENT_158	[p11l1948t2485r2144b2556],
31	FZD4	NN	O	fzd4	prep_in	20	SENT_158	[p11l12t2580r242b2653],
32	,	,	O	,	_	0	SENT_158	[p11l12t2580r242b2653],
33	and	CC	O	and	_	0	SENT_158	[p11l270t2579r395b2641],
34	LPR5	NN	O	lpr5	nn	35	SENT_158	[p11l415t2581r618b2641],
35	genes	NNS	O	gene	prep_in	20	SENT_158	[p11l642t2599r839b2660],
36	on	IN	O	on	_	0	SENT_158	[p11l866t2599r951b2641],
37	VA	NNP	ORGANIZATION	VA	nn	38	SENT_158	[p11l974t2580r1100b2642],
38	outcome	NN	O	outcome	prep_on	14	SENT_158	[p11l1124t2589r1427b2641],
39	after	IN	O	after	_	0	SENT_158	[p11l1452t2579r1613b2641],
40	treatment	NN	O	treatment	prep_after	14	SENT_158	[p11l1634t2588r1969b2641],
41	with	IN	O	with	_	0	SENT_158	[p11l1991t2579r2147b2642],
42	ranibizumab	NN	O	ranibizumab	nn	43	SENT_158	[p11l11t2677r454b2739],
43	injections	NNS	O	injection	prep_with	40	SENT_158	[p11l493t2677r855b2757],
44	.	.	O	.	_	0	SENT_158	[p11l493t2677r855b2757],

1	Consistent	JJ	O	consistent	ccomp	10	SENT_159	[p11l899t2677r1273b2739],
2	with	IN	O	with	_	0	SENT_159	[p11l1310t2677r1466b2739],
3	a	DT	O	a	det	6	SENT_159	[p11l1506t2697r1542b2739],
4	previously	RB	DATE	previously	advmod	5	SENT_159	[p11l1578t2677r1952b2757],
5	conducted	VBN	O	conduct	amod	6	SENT_159	[p11l1992t2697r2144b2739, p11l13t2774r248b2836],
6	study	NN	O	study	prep_with	1	SENT_159	[p11l291t2774r497b2854],
7	,	,	O	,	_	0	SENT_159	[p11l291t2774r497b2854],
8	this	DT	O	this	det	9	SENT_159	[p11l540t2774r664b2836],
9	study	NN	O	study	nsubj	10	SENT_159	[p11l710t2774r896b2854],
10	demonstrated	VBD	O	demonstrate	_	0	SENT_159	[p11l937t2774r1415b2836],
11	that	IN	O	that	complm	18	SENT_159	[p11l1453t2774r1586b2836],
12	carriers	NNS	O	carrier	nsubj	18	SENT_159	[p11l1625t2774r1887b2836],
13	of	IN	O	of	_	0	SENT_159	[p11l1930t2774r2007b2836],
14	the	DT	O	the	det	17	SENT_159	[p11l2041t2774r2147b2836],
15	high-risk	JJ	O	high-risk	amod	17	SENT_159	[p11l12t2870r334b2951],
16	CFH	NNP	O	CFH	nn	17	SENT_159	[p11l384t2872r561b2933],
17	genotype	NN	O	genotype	prep_of	12	SENT_159	[p11l604t2880r926b2951],
18	show	VBP	O	show	ccomp	10	SENT_159	[p11l978t2870r1159b2933],
19	less	JJR	O	less	amod	20	SENT_159	[p11l1208t2870r1337b2932],
20	improvement	NN	O	improvement	dobj	18	SENT_159	[p11l1386t2870r1860b2951],
21	in	IN	O	in	_	0	SENT_159	[p11l1906t2870r1973b2932],
22	VA	NNP	O	VA	prep_in	20	SENT_159	[p11l2020t2871r2147b2932],
23	after	IN	O	after	_	0	SENT_159	[p11l15t2969r175b3031],
24	treatment	NN	O	treatment	prep_after	18	SENT_159	[p11l205t2957r628b3031],
25	.	.	O	.	_	0	SENT_159	[p11l205t2957r628b3031],

1	”	NN	O	”	_	0	SENT_160	[p11l205t2957r628b3031],

1	To	TO	O	to	aux	2	SENT_161	[p11l120t3067r215b3128],
2	test	VB	O	test	purpcl	20	SENT_161	[p11l241t3075r364b3128],
3	the	DT	O	the	det	4	SENT_161	[p11l387t3066r493b3128],
4	possibility	NN	O	possibility	dobj	2	SENT_161	[p11l517t3066r886b3146],
5	of	IN	O	of	_	0	SENT_161	[p11l913t3066r990b3128],
6	an	DT	O	a	det	9	SENT_161	[p11l1011t3085r1090b3128],
7	additive	JJ	O	additive	amod	9	SENT_161	[p11l1117t3066r1399b3128],
8	genetic	JJ	O	genetic	amod	9	SENT_161	[p11l1426t3066r1678b3146],
9	effect	NN	O	effect	prep_of	4	SENT_161	[p11l1705t3066r1906b3128],
10	on	IN	O	on	_	0	SENT_161	[p11l1931t3085r2016b3128],
11	the	DT	O	the	det	12	SENT_161	[p11l2041t3066r2147b3128],
12	response	NN	O	response	prep_on	9	SENT_161	[p11l12t3182r321b3243],
13	to	TO	O	to	_	0	SENT_161	[p11l354t3171r420b3224],
14	ranibizumab	NN	O	ranibizumab	nn	15	SENT_161	[p11l453t3162r895b3224],
15	treatment	NN	O	treatment	prep_to	2	SENT_161	[p11l929t3172r1282b3236],
16	,	,	O	,	_	0	SENT_161	[p11l929t3172r1282b3236],
17	the	DT	O	the	det	18	SENT_161	[p11l1317t3162r1423b3224],
18	data	NNS	O	datum	nsubjpass	20	SENT_161	[p11l1457t3162r1603b3224],
19	were	VBD	O	be	auxpass	20	SENT_161	[p11l1635t3182r1805b3225],
20	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_161	[p11l1841t3162r2148b3224],
21	according	VBG	O	accord	_	0	SENT_161	[p11l15t3260r361b3340],
22	to	TO	O	to	prepc_according_to	20	SENT_161	[p11l401t3269r467b3322],
23	the	DT	O	the	det	24	SENT_161	[p11l507t3260r613b3322],
24	number	NN	O	number	pobj	20	SENT_161	[p11l653t3260r925b3322],
25	of	IN	O	of	_	0	SENT_161	[p11l963t3260r1040b3322],
26	the	DT	O	the	det	28	SENT_161	[p11l1073t3260r1179b3322],
27	high-risk	JJ	O	high-risk	amod	28	SENT_161	[p11l1219t3260r1540b3340],
28	alleles	NNS	O	allele	prep_of	24	SENT_161	[p11l1580t3260r1801b3322],
29	in	IN	O	in	_	0	SENT_161	[p11l1843t3260r1910b3321],
30	CFH	NNP	O	CFH	prep_in	28	SENT_161	[p11l1953t3261r2144b3333],
31	,	,	O	,	_	0	SENT_161	[p11l1953t3261r2144b3333],
32	ARMS2	NN	O	arms2	conj_or	30	SENT_161	[p11l7t3358r301b3431],
33	,	,	O	,	_	0	SENT_161	[p11l7t3358r301b3431],
34	VEGFA	NN	LOCATION	vegfa	conj_or	30	SENT_161	[p11l338t3359r631b3431],
35	,	,	O	,	_	0	SENT_161	[p11l338t3359r631b3431],
36	or	CC	O	or	_	0	SENT_161	[p11l664t3377r736b3420],
37	a	DT	O	a	det	38	SENT_161	[p11l765t3377r802b3420],
38	combination	NN	O	combination	conj_or	30	SENT_161	[p11l829t3358r1272b3420],
39	thereof	RB	O	thereof	advmod	38	SENT_161	[p11l1299t3358r1567b3420],
40	.	.	O	.	_	0	SENT_161	[p11l1299t3358r1567b3420],

1	After	IN	O	after	_	0	SENT_162	[p11l1600t3358r1787b3420],
2	stratiﬁca	NN	O	stratiﬁca	nn	4	SENT_162	[p11l1816t3358r2145b3420],
3	—	CD	NUMBER	—	num	4	SENT_162	[p11l1816t3358r2145b3420],
4	tion	NN	O	tion	prep_after	22	SENT_162	[p11l13t3455r149b3518],
5	for	IN	O	for	_	0	SENT_162	[p11l179t3455r282b3518],
6	the	DT	O	the	det	7	SENT_162	[p11l309t3455r415b3518],
7	number	NN	O	number	prep_for	4	SENT_162	[p11l446t3455r717b3518],
8	of	IN	O	of	_	0	SENT_162	[p11l746t3455r822b3518],
9	risk	NN	O	risk	nn	10	SENT_162	[p11l845t3455r979b3518],
10	alleles	NNS	O	allele	prep_of	7	SENT_162	[p11l1009t3455r1230b3518],
11	in	IN	O	in	_	0	SENT_162	[p11l1261t3455r1329b3517],
12	CFH	NNP	O	CFH	prep_in	10	SENT_162	[p11l1362t3457r1539b3518],
13	and	CC	O	and	_	0	SENT_162	[p11l1565t3455r1690b3518],
14	ARMS2	NNP	O	ARMS2	conj_and	12	SENT_162	[p11l1713t3456r2008b3529],
15	,	,	O	,	_	0	SENT_162	[p11l1713t3456r2008b3529],
16	the	DT	O	the	det	17	SENT_162	[p11l2041t3455r2147b3518],
17	carriers	NNS	O	carrier	nsubj	22	SENT_162	[p11l13t3553r275b3615],
18	of	IN	O	of	_	0	SENT_162	[p11l323t3553r399b3615],
19	4	CD	NUMBER	4	num	21	SENT_162	[p11l437t3553r479b3614],
20	risk	NN	O	risk	nn	21	SENT_162	[p11l523t3553r657b3615],
21	alleles	NNS	O	allele	prep_of	17	SENT_162	[p11l701t3553r922b3615],
22	demonstrated	VBD	O	demonstrate	_	0	SENT_162	[p11l969t3553r1446b3615],
23	no	DT	O	no	det	26	SENT_162	[p11l1490t3573r1575b3615],
24	mean	NN	O	mean	nn	26	SENT_162	[p11l1621t3573r1811b3615],
25	VA	NN	O	va	nn	26	SENT_162	[p11l1855t3554r1982b3615],
26	improvement	NN	O	improvement	dobj	22	SENT_162	[p11l2026t3553r2145b3614, p12l12t33r393b104],

1	after	IN	O	after	_	0	SENT_163	[p12l416t24r576b86],
2	3	CD	NUMBER	3	num	3	SENT_163	[p12l600t24r635b86],
3	injections	NNS	O	injection	pobj	1	SENT_163	[p12l663t24r1005b104],
4	and	CC	O	and	_	0	SENT_163	[p12l1031t24r1156b86],
5	required	VBN	O	require	amod	7	SENT_163	[p12l1178t24r1474b104],
6	ranibizumab	NN	O	ranibizumab	nn	7	SENT_163	[p12l1495t24r1937b86],
7	treatment	NN	O	treatment	pobj	1	SENT_163	[p12l1961t33r2144b86, p12l7t130r184b182],
8	at	IN	O	at	_	0	SENT_163	[p12l215t130r276b182],
9	5	CD	DURATION	5	num	10	SENT_163	[p12l306t120r343b183],
10	years	NNS	NUMBER	year	dep	11	SENT_163	[p12l376t140r560b201],
11	younger	JJR	O	younger	prep_at	7	SENT_163	[p12l592t140r884b201],
12	in	IN	O	in	_	0	SENT_163	[p12l912t120r979b182],
13	age	NN	O	age	prep_in	11	SENT_163	[p12l1011t140r1148b201],
14	.	.	O	.	_	0	SENT_163	[p12l1011t140r1148b201],

1	In	IN	O	in	_	0	SENT_164	[p12l1183t122r1255b182],
2	AMD	NN	ORGANIZATION	amd	nn	3	SENT_164	[p12l1284t121r1489b182],
3	patients	NNS	O	patient	prep_in	15	SENT_164	[p12l1519t120r1794b201],
4	who	WP	O	who	nsubj	6	SENT_164	[p12l1826t120r1975b183],
5	also	RB	O	also	advmod	6	SENT_164	[p12l2008t120r2147b182],
6	carried	VBD	O	carry	rcmod	3	SENT_164	[p12l7t219r253b281],
7	2	CD	NUMBER	2	num	10	SENT_164	[p12l293t219r333b280],
8	VEGFA	NN	O	vegfa	nn	10	SENT_164	[p12l379t220r651b282],
9	risk	NN	O	risk	nn	10	SENT_164	[p12l693t219r827b281],
10	alleles	NNS	O	allele	dobj	6	SENT_164	[p12l867t219r1110b293],
11	,	,	O	,	_	0	SENT_164	[p12l867t219r1110b293],
12	ranibizumab	NN	O	ranibizumab	nn	13	SENT_164	[p12l1152t219r1596b281],
13	treatment	NN	O	treatment	nsubjpass	15	SENT_164	[p12l1637t228r1973b281],
14	was	VBD	O	be	auxpass	15	SENT_164	[p12l2012t239r2146b281],
15	needed	VBN	O	need	_	0	SENT_164	[p12l7t316r258b378],
16	almost	RB	O	almost	advmod	18	SENT_164	[p12l291t316r526b378],
17	10	CD	DATE	10	num	18	SENT_164	[p12l565t316r643b378],
18	years	NNS	DATE	year	npadvmod	19	SENT_164	[p12l676t335r860b396],
19	earlier	RBR	DATE	earlier	advmod	15	SENT_164	[p12l894t316r1137b378],
20	.	.	O	.	_	0	SENT_164	[p12l894t316r1137b378],

1	The	DT	O	the	det	3	SENT_165	[p12l1174t316r1310b378],
2	VEGFA	NNP	O	VEGFA	nn	3	SENT_165	[p12l1348t317r1620b379],
3	SNP	NN	ORGANIZATION	snp	nsubj	5	SENT_165	[p12l1657t316r1816b378],
4	also	RB	O	also	advmod	5	SENT_165	[p12l1850t316r1988b378],
5	had	VBD	O	have	_	0	SENT_165	[p12l2021t316r2149b378],
6	an	DT	O	a	det	9	SENT_165	[p12l8t432r89b474],
7	additional	JJ	O	additional	amod	9	SENT_165	[p12l131t412r484b474],
8	negative	JJ	O	negative	amod	9	SENT_165	[p12l526t412r825b493],
9	effect	NN	O	effect	dobj	5	SENT_165	[p12l868t412r1069b474],
10	on	IN	O	on	_	0	SENT_165	[p12l1110t432r1196b474],
11	the	DT	O	the	det	14	SENT_165	[p12l1237t412r1343b474],
12	VA	NN	ORGANIZATION	va	nn	14	SENT_165	[p12l1384t413r1511b474],
13	response	NN	O	response	nn	14	SENT_165	[p12l1551t432r1862b493],
14	rate	NN	O	rate	prep_on	9	SENT_165	[p12l1902t422r2034b474],
15	of	IN	O	of	_	0	SENT_165	[p12l2077t412r2154b474],
16	ranibizumab	NN	O	ranibizumab	prep_of	14	SENT_165	[p12l6t510r468b572],
17	.	.	O	.	_	0	SENT_165	[p12l6t510r468b572],

1	A	DT	O	a	det	3	SENT_166	[p12l521t511r584b571],
2	previous	JJ	O	previous	amod	3	SENT_166	[p12l631t510r935b590],
3	study	NN	O	study	nsubj	4	SENT_166	[p12l989t510r1176b590],
4	demonstrated	VBD	O	demonstrate	_	0	SENT_166	[p12l1226t510r1705b572],
5	a	DT	O	a	det	7	SENT_166	[p12l1754t530r1791b572],
6	potential	JJ	O	potential	amod	7	SENT_166	[p12l1837t510r2148b590],
7	association	NN	O	association	dobj	4	SENT_166	[p12l8t607r401b669],
8	between	IN	O	between	_	0	SENT_166	[p12l446t607r743b669],
9	the	DT	O	the	det	13	SENT_166	[p12l788t607r895b669],
10	VEGFA	NNP	O	VEGFA	nn	13	SENT_166	[p12l947t608r1219b669],
11	rs699947	NN	O	rs699947	nn	13	SENT_166	[p12l1268t607r1596b670],
12	risk	NN	O	risk	nn	13	SENT_166	[p12l1644t607r1779b669],
13	genotype	NN	O	genotype	prep_between	7	SENT_166	[p12l1824t616r2147b687],
14	and	CC	O	and	_	0	SENT_166	[p12l8t703r134b765],
15	neovascular	JJ	O	neovascular	amod	16	SENT_166	[p12l166t703r592b766],
16	lesions	NNS	O	lesion	dobj	4	SENT_166	[p12l623t703r867b765],
17	that	WDT	O	that	nsubj	19	SENT_166	[p12l902t703r1035b765],
18	remained	VBD	O	remain	cop	19	SENT_166	[p12l1066t703r1397b765],
19	exudative	JJ	O	exudative	rcmod	16	SENT_166	[p12l1430t703r1774b766],
20	after	IN	O	after	_	0	SENT_166	[p12l1809t703r1970b765],
21	several	JJ	O	several	amod	23	SENT_166	[p12l2005t723r2145b766, p12l7t801r138b863],
22	photodynamic	JJ	O	photodynamic	amod	23	SENT_166	[p12l178t801r686b881],
23	therapies	NNS	O	therapy	prep_after	19	SENT_166	[p12l729t789r1135b881],
24	.	.	O	.	_	0	SENT_166	[p12l729t789r1135b881],

1	”	NN	O	”	nsubj	2	SENT_167	[p12l729t789r1135b881],
2	Taking	VBG	O	take	partmod	9	SENT_167	[p12l1180t801r1429b881],
3	those	DT	O	those	det	4	SENT_167	[p12l1471t801r1657b863],
4	observations	NNS	O	observation	dobj	2	SENT_167	[p12l1700t801r2146b863],
5	together	RB	O	together	advmod	2	SENT_167	[p12l6t898r316b978],
6	,	,	O	,	_	0	SENT_167	[p12l6t898r316b978],
7	the	DT	O	the	det	8	SENT_167	[p12l357t898r464b960],
8	authors	NNS	O	author	nsubj	9	SENT_167	[p12l504t898r761b960],
9	conclude	VBP	O	conclude	_	0	SENT_167	[p12l802t898r1121b960],
10	that	IN	O	that	complm	27	SENT_167	[p12l1159t898r1292b960],
11	a	DT	O	a	det	13	SENT_167	[p12l1331t917r1367b960],
12	cumulative	JJ	O	cumulative	amod	13	SENT_167	[p12l1405t898r1798b960],
13	effect	NN	O	effect	nsubj	27	SENT_167	[p12l1838t898r2039b960],
14	of	IN	O	of	_	0	SENT_167	[p12l2077t898r2154b960],
15	high	JJ	O	high	amod	18	SENT_167	[p12l6t994r329b1075],
16	—	NN	O	—	nn	18	SENT_167	[p12l6t994r329b1075],
17	risk	NN	O	risk	nn	18	SENT_167	[p12l6t994r329b1075],
18	alleles	NNS	O	allele	prep_of	13	SENT_167	[p12l358t994r580b1056],
19	in	IN	O	in	_	0	SENT_167	[p12l611t994r679b1056],
20	CFH	NNP	O	CFH	prep_in	18	SENT_167	[p12l712t996r903b1068],
21	,	,	O	,	_	0	SENT_167	[p12l712t996r903b1068],
22	ARMS2	NN	O	arms2	prep_in	18	SENT_167	[p12l930t995r1226b1068],
23	,	,	O	,	_	0	SENT_167	[p12l930t995r1226b1068],
24	and	CC	O	and	_	0	SENT_167	[p12l1260t994r1386b1056],
25	VEGFA	NNP	O	VEGFA	conj_and	20	SENT_167	[p12l1420t996r1692b1057],
26	may	MD	O	may	aux	27	SENT_167	[p12l1724t1014r1875b1075],
27	lead	VB	O	lead	ccomp	9	SENT_167	[p12l1905t994r2052b1056],
28	to	TO	O	to	_	0	SENT_167	[p12l2081t1004r2147b1056],
29	a	DT	O	a	det	31	SENT_167	[p12l9t1112r46b1154],
30	younger	JJR	O	younger	amod	31	SENT_167	[p12l71t1112r363b1172],
31	age	NN	O	age	prep_to	27	SENT_167	[p12l391t1112r510b1172],
32	of	IN	O	of	_	0	SENT_167	[p12l539t1092r615b1154],
33	onset	NN	O	onset	prep_of	31	SENT_167	[p12l638t1101r824b1154],
34	in	IN	O	in	_	0	SENT_167	[p12l850t1092r917b1153],
35	combination	NN	O	combination	prep_in	33	SENT_167	[p12l945t1092r1389b1154],
36	with	IN	O	with	_	0	SENT_167	[p12l1416t1092r1573b1154],
37	worse	JJR	O	worse	amod	39	SENT_167	[p12l1600t1112r1810b1154],
38	response	NN	O	response	nn	39	SENT_167	[p12l1837t1112r2148b1172],
39	rates	NNS	O	rate	prep_with	27	SENT_167	[p12l6t1198r171b1251],
40	to	TO	O	to	_	0	SENT_167	[p12l206t1198r273b1251],
41	ranibizumab	JJ	O	ranibizumab	amod	42	SENT_167	[p12l307t1189r750b1251],
42	treatment	NN	O	treatment	prep_to	39	SENT_167	[p12l785t1198r1138b1251],
43	.	.	O	.	_	0	SENT_167	[p12l785t1198r1138b1251],

1	The	DT	O	the	det	2	SENT_168	[p12l1177t1189r1313b1251],
2	carriers	NNS	O	carrier	nsubj	16	SENT_168	[p12l1348t1189r1611b1251],
3	of	IN	O	of	_	0	SENT_168	[p12l1647t1189r1724b1251],
4	4	CD	NUMBER	4	num	8	SENT_168	[p12l1752t1189r1794b1250],
5	high	JJ	O	high	amod	8	SENT_168	[p12l1828t1189r2150b1269],
6	—	NN	O	—	nn	8	SENT_168	[p12l1828t1189r2150b1269],
7	risk	NN	O	risk	nn	8	SENT_168	[p12l1828t1189r2150b1269],
8	alleles	NNS	O	allele	prep_of	2	SENT_168	[p12l9t1286r230b1349],
9	in	IN	O	in	_	0	SENT_168	[p12l255t1286r322b1348],
10	CFH	NNP	O	CFH	prep_in	8	SENT_168	[p12l350t1288r541b1360],
11	,	,	O	,	_	0	SENT_168	[p12l350t1288r541b1360],
12	ARMS2	NN	O	arms2	conj_or	10	SENT_168	[p12l561t1287r856b1360],
13	,	,	O	,	_	0	SENT_168	[p12l561t1287r856b1360],
14	or	CC	O	or	_	0	SENT_168	[p12l884t1306r956b1349],
15	VEGFA	NNP	O	VEGFA	prep_in	8	SENT_168	[p12l982t1288r1255b1349],
16	demonstrate	VBP	O	demonstrate	_	0	SENT_168	[p12l1281t1286r1714b1349],
17	a	DT	O	a	det	20	SENT_168	[p12l1739t1306r1776b1349],
18	better	JJR	O	better	amod	20	SENT_168	[p12l1797t1286r2000b1349],
19	VA	NN	O	va	nn	20	SENT_168	[p12l2021t1287r2148b1349],
20	improvement	NN	O	improvement	dobj	16	SENT_168	[p12l7t1384r482b1464],
21	than	IN	O	than	_	0	SENT_168	[p12l504t1384r656b1446],
22	the	DT	O	the	det	24	SENT_168	[p12l679t1384r785b1446],
23	AMD	NNP	ORGANIZATION	AMD	nn	24	SENT_168	[p12l809t1385r1013b1445],
24	carriers	NNS	O	carrier	prep_than	16	SENT_168	[p12l1039t1384r1302b1446],
25	of	IN	O	of	_	0	SENT_168	[p12l1328t1384r1405b1446],
26	4	CD	NUMBER	4	num	30	SENT_168	[p12l1422t1384r1464b1445],
27	high	JJ	O	high	amod	30	SENT_168	[p12l1487t1384r1810b1464],
28	—	NN	O	—	nn	30	SENT_168	[p12l1487t1384r1810b1464],
29	risk	NN	O	risk	nn	30	SENT_168	[p12l1487t1384r1810b1464],
30	alleles	NNS	O	allele	prep_of	24	SENT_168	[p12l1833t1384r2055b1446],
31	in	IN	O	in	_	0	SENT_168	[p12l2081t1384r2148b1445],
32	CFH	NNP	O	CFH	prep_in	30	SENT_168	[p12l11t1482r188b1543],
33	and	CC	O	and	_	0	SENT_168	[p12l220t1481r346b1543],
34	ARMS2	NNP	O	ARMS2	conj_and	32	SENT_168	[p12l375t1481r670b1554],
35	,	,	O	,	_	0	SENT_168	[p12l375t1481r670b1554],
36	indicating	VBG	O	indicate	partmod	16	SENT_168	[p12l709t1481r1063b1561],
37	that	IN	O	that	_	0	SENT_168	[p12l1099t1481r1233b1543],
38	CFH	NNP	O	CFH	prep_that	36	SENT_168	[p12l1271t1482r1449b1543],
39	and	CC	O	and	_	0	SENT_168	[p12l1481t1481r1606b1543],
40	ARMS2	NN	O	arms2	nn	41	SENT_168	[p12l1635t1481r1909b1543],
41	genes	NNS	O	gene	prep_that	36	SENT_168	[p12l1948t1500r2146b1561],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_169	[p12l524t1862r816b1906],
2	Volume	NN	O	volume	dep	1	SENT_169	[p12l862t1862r995b1897],
3	119	CD	NUMBER	119	num	2	SENT_169	[p12l1017t1864r1092b1903],
4	,	,	O	,	_	0	SENT_169	[p12l1017t1864r1092b1903],
5	Number	NNP	O	Number	appos	2	SENT_169	[p12l1111t1862r1257b1897],
6	11	CD	NUMBER	11	num	5	SENT_169	[p12l1277t1864r1328b1903],
7	,	,	O	,	_	0	SENT_169	[p12l1277t1864r1328b1903],
8	November	NNP	DATE	November	tmod	2	SENT_169	[p12l1348t1862r1529b1897],
9	2012	CD	DATE	2012	num	8	SENT_169	[p12l1546t1864r1634b1897],

1	Table	NNP	O	Table	_	0	SENT_170	[p12l337t1964r423b1993],
2	2	CD	NUMBER	2	dep	1	SENT_170	[p12l439t1965r463b1992],
3	.	.	O	.	_	0	SENT_170	[p12l439t1965r463b1992],

1	Effect	NN	O	effect	_	0	SENT_171	[p12l485t1964r571b1993],
2	of	IN	O	of	_	0	SENT_171	[p12l585t1964r615b1993],
3	High	NNP	O	High	prep_of	1	SENT_171	[p12l626t1964r782b2000],
4	.	.	O	.	_	0	SENT_171	[p12l626t1964r782b2000],

1	—	NN	O	—	_	0	SENT_172	[p12l626t1964r782b2000],
2	.	.	O	.	_	0	SENT_172	[p12l626t1964r782b2000],

1	Risk	NN	O	risk	nn	2	SENT_173	[p12l626t1964r782b2000],
2	Alleles	NNS	O	allele	_	0	SENT_173	[p12l794t1964r899b1993],
3	in	IN	O	in	_	0	SENT_173	[p12l915t1968r944b1992],
4	CFH	NNP	O	CFH	prep_in	2	SENT_173	[p12l957t1965r1041b1998],
5	,	,	O	,	_	0	SENT_173	[p12l957t1965r1041b1998],
6	ARMS2	NN	O	arms2	prep_in	2	SENT_173	[p12l1055t1965r1184b1998],
7	,	,	O	,	_	0	SENT_173	[p12l1055t1965r1184b1998],
8	and	CC	O	and	_	0	SENT_173	[p12l1199t1964r1254b1993],
9	VEGFA	NNP	O	VEGFA	prep_in	2	SENT_173	[p12l1267t1965r1392b1993],
10	on	IN	O	on	_	0	SENT_173	[p12l1405t1975r1444b1993],
11	Visual	NNP	O	Visual	nn	12	SENT_173	[p12l1457t1964r1552b1993],
12	Acuity	NNP	O	Acuity	prep_on	9	SENT_173	[p12l1565t1965r1668b2000],
13	Response	NN	O	response	dep	2	SENT_173	[p12l1682t1965r1822b2000],
14	after	IN	O	after	_	0	SENT_173	[p12l340t2005r407b2034],
15	3	CD	NUMBER	3	num	17	SENT_173	[p12l420t2007r436b2034],
16	Ranibizumab	NN	O	ranibizumab	nn	17	SENT_173	[p12l451t2005r648b2034],
17	Injections	NNS	O	injection	prep_after	13	SENT_173	[p12l663t2007r812b2041],
18	and	CC	O	and	_	0	SENT_173	[p12l827t2005r882b2034],
19	on	IN	O	on	_	0	SENT_173	[p12l896t2017r934b2034],
20	the	DT	O	the	det	21	SENT_173	[p12l948t2005r996b2034],
21	Age	NN	MISC	age	prep_on	13	SENT_173	[p12l1010t2006r1071b2041],
22	in	IN	MISC	in	_	0	SENT_173	[p12l1086t2009r1115b2034],
23	Years	NNS	DURATION	year	prep_in	21	SENT_173	[p12l1128t2007r1208b2034],
24	When	WRB	MISC	when	dep	23	SENT_173	[p12l1222t2005r1317b2034],
25	the	DT	MISC	the	det	28	SENT_173	[p12l1331t2005r1379b2034],
26	First	NNP	ORDINAL	First	nn	28	SENT_173	[p12l1393t2007r1459b2034],
27	Ranibizurnab	NNP	MISC	Ranibizurnab	nn	28	SENT_173	[p12l1472t2005r1668b2034],
28	Injection	NN	MISC	injection	dep	13	SENT_173	[p12l1684t2007r1821b2041],

1	Was	VBD	O	be	auxpass	2	SENT_174	[p12l936t2047r1002b2075],
2	Administered	VBN	O	administer	_	0	SENT_174	[p12l1016t2046r1223b2075],

1	Mean	NN	O	mean	nn	3	SENT_175	[p12l810t2140r888b2165],
2	Visual	JJ	O	visual	amod	3	SENT_175	[p12l900t2139r989b2165],
3	Acuity	NN	O	acuity	_	0	SENT_175	[p12l1001t2140r1097b2171],
4	Change	NNP	O	Change	nn	8	SENT_175	[p12l828t2176r932b2208],
5	(	NNP	O	(	nn	8	SENT_175	[p12l946t2176r1080b2206],
6	Standard	NNP	O	Standard	nn	8	SENT_175	[p12l946t2176r1080b2206],
7	Error	NNP	O	Error	nn	8	SENT_175	[p12l827t2214r923b2244],
8	)	NN	O	)	dep	3	SENT_175	[p12l827t2214r923b2244],
9	,	,	O	,	_	0	SENT_175	[p12l827t2214r923b2244],
10	Logarithm	NN	O	logarithm	appos	8	SENT_175	[p12l936t2214r1080b2246],
11	of	IN	O	of	_	0	SENT_175	[p12l839t2253r866b2279],
12	the	DT	O	the	det	15	SENT_175	[p12l878t2253r921b2279],
13	Minimum	NNP	O	Minimum	nn	15	SENT_175	[p12l933t2254r1069b2279],
14	Mean	NN	O	mean	nn	15	SENT_175	[p12l1349t2254r1426b2279],
15	Difference	NN	O	difference	prep_of	10	SENT_175	[p12l1438t2253r1585b2279],
16	in	IN	O	in	_	0	SENT_175	[p12l1598t2256r1625b2279],
17	Angle	NNP	O	Angle	prep_in	15	SENT_175	[p12l893t2292r975b2324],
18	of	IN	O	of	_	0	SENT_175	[p12l988t2292r1015b2318],
19	Age	NNP	O	Age	nn	29	SENT_175	[p12l1331t2293r1385b2324],
20	(	NNP	O	(	nn	29	SENT_175	[p12l1400t2292r1534b2322],
21	Standard	NNP	O	Standard	nn	29	SENT_175	[p12l1400t2292r1534b2322],
22	Error	NNP	O	Error	nn	29	SENT_175	[p12l1545t2292r1642b2322],
23	)	NNP	O	)	nn	29	SENT_175	[p12l1545t2292r1642b2322],
24	,	,	O	,	_	0	SENT_175	[p12l1545t2292r1642b2322],
25	Resolution	NNP	O	Resolution	appos	29	SENT_175	[p12l870t2330r1036b2356],
26	*	CD	NUMBER	*	num	29	SENT_175	[p12l870t2330r1036b2356],
27	P	NN	O	p	nn	29	SENT_175	[p12l1156t2331r1177b2355],
28	Value	NN	O	value	nn	29	SENT_175	[p12l1190t2330r1271b2356],
29	Years	NNS	DURATION	year	prep_of	17	SENT_175	[p12l1442t2326r1531b2356],
30	?	.	O	?	_	0	SENT_175	[p12l1442t2326r1531b2356],

1	P	NN	O	p	nn	2	SENT_176	[p12l1702t2331r1723b2355],
2	Value	NN	O	value	_	0	SENT_176	[p12l1736t2330r1818b2356],

1	No.	NN	O	no.	_	0	SENT_177	[p12l330t2405r379b2430],
2	of	IN	O	of	_	0	SENT_177	[p12l393t2404r420b2430],
3	high	JJ	O	high	amod	6	SENT_177	[p12l429t2404r549b2436],
4	—	NN	O	—	nn	6	SENT_177	[p12l429t2404r549b2436],
5	risk	NN	O	risk	nn	6	SENT_177	[p12l429t2404r549b2436],
6	alleles	NNS	O	allele	prep_of	1	SENT_177	[p12l561t2404r643b2430],
7	in	IN	O	in	_	0	SENT_177	[p12l656t2408r682b2429],
8	CFH	NNP	O	CFH	prep_in	1	SENT_177	[p12l694t2405r761b2430],

1	and	CC	O	and	dep	4	SENT_178	[p12l398t2443r446b2469],
2	ARMS2	NN	O	arms2	nn	4	SENT_178	[p12l458t2444r569b2469],
3	o	NN	O	o	nn	4	SENT_178	[p12l364t2483r379b2508],
4	n	NN	O	n	_	0	SENT_178	[p12l524t2492r542b2508],
5	=	JJ	O	=	amod	4	SENT_178	[p12l554t2492r575b2500],
6	20	CD	PERCENT	20	number	7	SENT_178	[p12l588t2483r619b2508],
7	(	CD	PERCENT	(	prep	5	SENT_178	[p12l631t2482r721b2512],
8	4.8	CD	PERCENT	4.8	num	9	SENT_178	[p12l631t2482r721b2512],
9	%	NN	PERCENT	%	dep	7	SENT_178	[p12l631t2482r721b2512],
10	)	CD	NUMBER	)	num	12	SENT_178	[p12l631t2482r721b2512],
11	0.20	CD	NUMBER	0.20	num	12	SENT_178	[p12l879t2483r936b2508],
12	(	NN	O	(	npadvmod	83	SENT_178	[p12l948t2482r1027b2512],
13	0.08	CD	NUMBER	0.08	number	14	SENT_178	[p12l948t2482r1027b2512],
14	)	CD	NUMBER	)	num	18	SENT_178	[p12l948t2482r1027b2512],
15	0.014	CD	NUMBER	0.014	dep	18	SENT_178	[p12l1183t2483r1256b2510],
16	--	:	O	--	_	0	SENT_178	[p12l1418t2483r1482b2508],
17	2.8	CD	NUMBER	2.8	num	18	SENT_178	[p12l1418t2483r1482b2508],
18	(	NN	O	(	dep	35	SENT_178	[p12l1495t2482r1557b2512],
19	2.1	CD	NUMBER	2.1	number	20	SENT_178	[p12l1495t2482r1557b2512],
20	)	CD	NUMBER	)	dep	18	SENT_178	[p12l1495t2482r1557b2512],
21	0.19	CD	NUMBER	0.19	num	22	SENT_178	[p12l1729t2483r1785b2508],
22	1	CD	NUMBER	1	dep	20	SENT_178	[p12l366t2522r376b2547],
23	and	CC	O	and	_	0	SENT_178	[p12l392t2521r440b2547],
24	2	CD	NUMBER	2	num	25	SENT_178	[p12l454t2522r467b2546],
25	n	NN	O	n	dep	35	SENT_178	[p12l524t2531r542b2547],
26	=	JJ	O	=	amod	25	SENT_178	[p12l555t2531r575b2539],
27	267	CD	PERCENT	267	number	28	SENT_178	[p12l588t2522r635b2548],
28	(	CD	PERCENT	(	prep	26	SENT_178	[p12l648t2521r755b2551],
29	63.5	CD	PERCENT	63.5	num	30	SENT_178	[p12l648t2521r755b2551],
30	%	NN	PERCENT	%	dep	28	SENT_178	[p12l648t2521r755b2551],
31	)	CD	NUMBER	)	tmod	26	SENT_178	[p12l648t2521r755b2551],
32	0.10	CD	NUMBER	0.10	num	33	SENT_178	[p12l879t2522r936b2547],
33	(	NN	O	(	dep	35	SENT_178	[p12l948t2521r1027b2551],
34	0.06	CD	NUMBER	0.06	num	35	SENT_178	[p12l948t2521r1027b2551],
35	)	CD	NUMBER	)	dep	44	SENT_178	[p12l948t2521r1027b2551],
36	0.07	CD	NUMBER	0.07	num	38	SENT_178	[p12l1183t2522r1238b2548],
37	--	:	O	--	_	0	SENT_178	[p12l1418t2521r1482b2547],
38	5.2	CD	NUMBER	5.2	dep	35	SENT_178	[p12l1418t2521r1482b2547],
39	(	CD	NUMBER	(	number	40	SENT_178	[p12l1495t2521r1557b2551],
40	1.5	CD	NUMBER	1.5	num	41	SENT_178	[p12l1495t2521r1557b2551],
41	)	NN	O	)	npadvmod	42	SENT_178	[p12l1495t2521r1557b2551],
42	<	JJR	O	<	amod	38	SENT_178	[p12l1703t2522r1816b2547],
43	o.	CD	NUMBER	o.	num	44	SENT_178	[p12l1703t2522r1816b2547],
44	oool	NN	O	oool	dep	54	SENT_178	[p12l1703t2522r1816b2547],
45	3	CD	NUMBER	3	num	46	SENT_178	[p12l364t2561r377b2585],
46	n	NN	O	n	dep	44	SENT_178	[p12l524t2570r542b2585],
47	=	JJ	O	=	amod	46	SENT_178	[p12l554t2570r575b2578],
48	104	CD	PERCENT	104	number	49	SENT_178	[p12l590t2561r636b2588],
49	(	CD	PERCENT	(	prep	47	SENT_178	[p12l648t2560r754b2590],
50	24.8	CD	PERCENT	24.8	num	51	SENT_178	[p12l648t2560r754b2590],
51	%	NN	PERCENT	%	dep	49	SENT_178	[p12l648t2560r754b2590],
52	)	CD	NUMBER	)	num	53	SENT_178	[p12l648t2560r754b2590],
53	0.05	CD	NUMBER	0.05	dep	46	SENT_178	[p12l879t2560r934b2585],
54	(	NN	O	(	dep	57	SENT_178	[p12l948t2560r1027b2590],
55	0.06	CD	NUMBER	0.06	num	54	SENT_178	[p12l948t2560r1027b2590],
56	)	CD	NUMBER	)	num	57	SENT_178	[p12l948t2560r1027b2590],
57	0.45	CD	NUMBER	0.45	dep	12	SENT_178	[p12l1183t2560r1238b2587],
58	--	:	O	--	_	0	SENT_178	[p12l1418t2561r1483b2587],
59	4.4	CD	NUMBER	4.4	number	60	SENT_178	[p12l1418t2561r1483b2587],
60	(	CD	NUMBER	(	dep	57	SENT_178	[p12l1495t2560r1557b2590],
61	1.6	CD	NUMBER	1.6	num	62	SENT_178	[p12l1495t2560r1557b2590],
62	)	NN	O	)	dep	76	SENT_178	[p12l1495t2560r1557b2590],
63	0.006	CD	NUMBER	0.006	number	64	SENT_178	[p12l1729t2561r1802b2585],
64	4	CD	NUMBER	4	num	65	SENT_178	[p12l363t2599r379b2626],
65	n	NN	O	n	dep	62	SENT_178	[p12l524t2608r542b2623],
66	=	JJ	O	=	amod	65	SENT_178	[p12l554t2608r575b2616],
67	29	CD	PERCENT	29	number	68	SENT_178	[p12l588t2599r619b2623],
68	(	CD	PERCENT	(	prep	66	SENT_178	[p12l631t2598r721b2628],
69	6.9	CD	PERCENT	6.9	num	70	SENT_178	[p12l631t2598r721b2628],
70	%	NN	PERCENT	%	dep	68	SENT_178	[p12l631t2598r721b2628],
71	)	CD	NUMBER	)	dep	76	SENT_178	[p12l631t2598r721b2628],
72	o.	NN	O	o.	nn	76	SENT_178	[p12l925t2599r982b2623],
73	oo	NN	O	oo	nn	76	SENT_178	[p12l925t2599r982b2623],
74	Reference	NNP	O	Reference	nn	76	SENT_178	[p12l1147t2598r1280b2623],
75	o.o	NNP	O	o.o	nn	76	SENT_178	[p12l1467t2599r1507b2623],
76	Reference	NNP	O	Reference	dep	57	SENT_178	[p12l1693t2598r1827b2623],
77	No.	NN	O	no.	dep	76	SENT_178	[p12l329t2637r379b2661],
78	of	IN	O	of	_	0	SENT_178	[p12l392t2636r420b2661],
79	high	JJ	O	high	amod	82	SENT_178	[p12l429t2636r549b2668],
80	—	NN	O	—	nn	82	SENT_178	[p12l429t2636r549b2668],
81	risk	NN	O	risk	nn	82	SENT_178	[p12l429t2636r549b2668],
82	alleles	NNS	O	allele	prep_of	57	SENT_178	[p12l561t2636r643b2661],
83	in	IN	O	in	dep	5	SENT_178	[p12l656t2640r682b2661],
84	CFH	NNP	O	CFH	pobj	83	SENT_178	[p12l694t2637r768b2666],
85	,	,	O	,	_	0	SENT_178	[p12l694t2637r768b2666],

1	ARMS2	NN	O	arms2	dep	40	SENT_179	[p12l396t2675r510b2704],
2	,	,	O	,	_	0	SENT_179	[p12l396t2675r510b2704],
3	and	CC	O	and	_	0	SENT_179	[p12l524t2674r573b2699],
4	VEGFA	NNP	ORGANIZATION	VEGFA	nn	5	SENT_179	[p12l584t2675r695b2700],
5	o	NN	O	o	dep	40	SENT_179	[p12l364t2713r379b2738],
6	and	CC	O	and	_	0	SENT_179	[p12l392t2712r440b2738],
7	1	CD	NUMBER	1	num	8	SENT_179	[p12l455t2714r465b2737],
8	n	NN	O	n	dep	40	SENT_179	[p12l524t2722r542b2737],
9	=	JJ	O	=	dep	8	SENT_179	[p12l554t2722r575b2730],
10	35	CD	NUMBER	35	num	11	SENT_179	[p12l587t2713r617b2738],
11	(	NN	O	(	iobj	9	SENT_179	[p12l631t2712r721b2742],
12	8.8	CD	PERCENT	8.8	num	13	SENT_179	[p12l631t2712r721b2742],
13	%	NN	PERCENT	%	dobj	9	SENT_179	[p12l631t2712r721b2742],
14	)	CD	NUMBER	)	number	15	SENT_179	[p12l631t2712r721b2742],
15	0.40	CD	NUMBER	0.40	num	13	SENT_179	[p12l879t2713r936b2740],
16	(	CD	NUMBER	(	number	17	SENT_179	[p12l947t2712r1027b2742],
17	0.11	CD	NUMBER	0.11	num	18	SENT_179	[p12l947t2712r1027b2742],
18	)	NN	O	)	npadvmod	19	SENT_179	[p12l947t2712r1027b2742],
19	<	JJR	O	<	amod	13	SENT_179	[p12l1157t2713r1270b2738],
20	o.	CD	NUMBER	o.	num	21	SENT_179	[p12l1157t2713r1270b2738],
21	oool	NN	O	oool	dep	8	SENT_179	[p12l1157t2713r1270b2738],
22	--	:	O	--	_	0	SENT_179	[p12l1418t2713r1483b2740],
23	9.4	CD	NUMBER	9.4	num	24	SENT_179	[p12l1418t2713r1483b2740],
24	(	NN	O	(	dep	8	SENT_179	[p12l1495t2712r1557b2742],
25	2.9	CD	NUMBER	2.9	number	26	SENT_179	[p12l1495t2712r1557b2742],
26	)	CD	NUMBER	)	num	28	SENT_179	[p12l1495t2712r1557b2742],
27	0.001	CD	NUMBER	0.001	number	28	SENT_179	[p12l1729t2713r1800b2738],
28	2	CD	NUMBER	2	dep	24	SENT_179	[p12l364t2751r378b2775],
29	and	CC	O	and	_	0	SENT_179	[p12l392t2750r440b2776],
30	3	CD	NUMBER	3	num	31	SENT_179	[p12l452t2751r466b2776],
31	n	NN	O	n	conj_and	24	SENT_179	[p12l524t2760r542b2775],
32	=	JJ	O	=	amod	31	SENT_179	[p12l554t2760r575b2768],
33	208	CD	PERCENT	208	number	34	SENT_179	[p12l588t2751r635b2776],
34	(	CD	PERCENT	(	prep	32	SENT_179	[p12l648t2750r729b2780],
35	52	CD	PERCENT	52	num	36	SENT_179	[p12l648t2750r729b2780],
36	%	NN	PERCENT	%	dep	34	SENT_179	[p12l648t2750r729b2780],
37	)	CD	NUMBER	)	tmod	32	SENT_179	[p12l648t2750r729b2780],
38	0.32	CD	NUMBER	0.32	num	39	SENT_179	[p12l879t2751r935b2776],
39	(	NN	O	(	dep	40	SENT_179	[p12l947t2750r1027b2780],
40	0.10	CD	NUMBER	0.10	dep	71	SENT_179	[p12l947t2750r1027b2780],
41	)	CD	NUMBER	)	num	42	SENT_179	[p12l947t2750r1027b2780],
42	0.001	CD	NUMBER	0.001	dep	40	SENT_179	[p12l1183t2751r1253b2776],
43	--	:	O	--	_	0	SENT_179	[p12l1418t2751r1482b2777],
44	7.8	CD	NUMBER	7.8	number	45	SENT_179	[p12l1418t2751r1482b2777],
45	(	CD	NUMBER	(	dep	42	SENT_179	[p12l1495t2750r1557b2780],
46	2.7	CD	NUMBER	2.7	num	47	SENT_179	[p12l1495t2750r1557b2780],
47	)	NN	O	)	dep	59	SENT_179	[p12l1495t2750r1557b2780],
48	0.003	CD	NUMBER	0.003	number	49	SENT_179	[p12l1729t2751r1800b2776],
49	4	CD	NUMBER	4	num	50	SENT_179	[p12l363t2789r379b2816],
50	n	NN	O	n	dep	47	SENT_179	[p12l524t2798r542b2813],
51	=	JJ	O	=	amod	50	SENT_179	[p12l554t2798r574b2806],
52	116	CD	PERCENT	116	number	53	SENT_179	[p12l590t2789r636b2814],
53	(	CD	PERCENT	(	prep	51	SENT_179	[p12l648t2788r729b2818],
54	29	CD	PERCENT	29	num	55	SENT_179	[p12l648t2788r729b2818],
55	%	NN	PERCENT	%	dep	53	SENT_179	[p12l648t2788r729b2818],
56	)	CD	NUMBER	)	tmod	51	SENT_179	[p12l648t2788r729b2818],
57	0.31	CD	NUMBER	0.31	num	58	SENT_179	[p12l879t2789r933b2814],
58	(	NN	O	(	dep	59	SENT_179	[p12l947t2788r1027b2818],
59	0.10	CD	NUMBER	0.10	dep	42	SENT_179	[p12l947t2788r1027b2818],
60	)	CD	NUMBER	)	number	61	SENT_179	[p12l947t2788r1027b2818],
61	0.002	CD	NUMBER	0.002	dep	59	SENT_179	[p12l1183t2789r1255b2814],
62	--	:	O	--	_	0	SENT_179	[p12l1418t2789r1482b2815],
63	7.2	CD	NUMBER	7.2	number	64	SENT_179	[p12l1418t2789r1482b2815],
64	(	CD	NUMBER	(	dep	61	SENT_179	[p12l1494t2788r1557b2818],
65	2.7	CD	NUMBER	2.7	num	66	SENT_179	[p12l1494t2788r1557b2818],
66	)	NN	O	)	dep	64	SENT_179	[p12l1494t2788r1557b2818],
67	0.008	CD	NUMBER	0.008	number	68	SENT_179	[p12l1729t2789r1802b2814],
68	5	CD	NUMBER	5	num	69	SENT_179	[p12l364t2826r377b2852],
69	n	NN	O	n	npadvmod	70	SENT_179	[p12l524t2836r542b2852],
70	=	JJ	O	=	amod	42	SENT_179	[p12l554t2836r574b2844],
71	33	CD	PERCENT	33	dep	77	SENT_179	[p12l587t2827r617b2852],
72	(	CD	PERCENT	(	num	74	SENT_179	[p12l631t2826r721b2856],
73	8.3	CD	PERCENT	8.3	num	74	SENT_179	[p12l631t2826r721b2856],
74	%	NN	PERCENT	%	dep	71	SENT_179	[p12l631t2826r721b2856],
75	)	CD	NUMBER	)	number	76	SENT_179	[p12l631t2826r721b2856],
76	0.29	CD	NUMBER	0.29	dep	74	SENT_179	[p12l879t2827r935b2852],
77	(	NN	O	(	dep	80	SENT_179	[p12l947t2826r1026b2856],
78	0.11	CD	NUMBER	0.11	num	77	SENT_179	[p12l947t2826r1026b2856],
79	)	CD	NUMBER	)	num	80	SENT_179	[p12l947t2826r1026b2856],
80	0.008	CD	NUMBER	0.008	_	0	SENT_179	[p12l1183t2827r1255b2852],
81	--	:	O	--	_	0	SENT_179	[p12l1418t2827r1482b2852],
82	6.9	CD	NUMBER	6.9	num	83	SENT_179	[p12l1418t2827r1482b2852],
83	(	NN	O	(	dep	93	SENT_179	[p12l1494t2826r1557b2856],
84	2.9	CD	NUMBER	2.9	num	85	SENT_179	[p12l1494t2826r1557b2856],
85	)	CD	NUMBER	)	dep	83	SENT_179	[p12l1494t2826r1557b2856],
86	0.018	CD	NUMBER	0.018	number	87	SENT_179	[p12l1729t2827r1802b2852],
87	6	CD	NUMBER	6	num	88	SENT_179	[p12l364t2866r378b2890],
88	n	NN	O	n	npadvmod	89	SENT_179	[p12l524t2875r542b2890],
89	=	JJ	O	=	amod	85	SENT_179	[p12l554t2875r574b2883],
90	8	CD	NUMBER	8	num	91	SENT_179	[p12l588t2866r602b2890],
91	(	NN	O	(	dep	93	SENT_179	[p12l614t2865r679b2895],
92	2	CD	PERCENT	2	num	93	SENT_179	[p12l614t2865r679b2895],
93	%	NN	PERCENT	%	dep	99	SENT_179	[p12l614t2865r679b2895],
94	)	CD	NUMBER	)	num	96	SENT_179	[p12l614t2865r679b2895],
95	o.	NN	O	o.	nn	96	SENT_179	[p12l925t2866r982b2890],
96	oo	NN	O	oo	dep	93	SENT_179	[p12l925t2866r982b2890],
97	Reference	NNP	O	Reference	nn	99	SENT_179	[p12l1147t2865r1280b2890],
98	o.o	NNP	O	o.o	nn	99	SENT_179	[p12l1467t2866r1507b2890],
99	Reference	NNP	O	Reference	dep	80	SENT_179	[p12l1693t2865r1826b2890],

1	ARMS2	NN	O	arms2	_	0	SENT_180	[p12l329t2966r435b2990],
2	=	JJ	O	=	amod	7	SENT_180	[p12l455t2975r476b2983],
3	age	NN	O	age	nn	7	SENT_180	[p12l494t2965r630b2997],
4	—	NN	O	—	nn	7	SENT_180	[p12l494t2965r630b2997],
5	related	JJ	O	related	amod	7	SENT_180	[p12l494t2965r630b2997],
6	maculopathy	NN	O	maculopathy	nn	7	SENT_180	[p12l644t2965r802b2997],
7	susceptibility	NN	O	susceptibility	dep	1	SENT_180	[p12l819t2965r974b2997],
8	2	CD	NUMBER	2	num	9	SENT_180	[p12l992t2966r1006b2990],
9	gene	NN	O	gene	dep	7	SENT_180	[p12l1021t2975r1084b2997],
10	;	:	O	;	_	0	SENT_180	[p12l1021t2975r1084b2997],
11	CFH	NN	O	cfh	dep	7	SENT_180	[p12l1101t2966r1169b2990],
12	=	JJ	O	=	amod	15	SENT_180	[p12l1188t2975r1208b2983],
13	complement	NN	O	complement	nn	15	SENT_180	[p12l1227t2965r1377b2997],
14	factor	NN	O	factor	nn	15	SENT_180	[p12l1390t2965r1464b2997],
15	gene	NN	O	gene	dep	11	SENT_180	[p12l1478t2975r1541b2997],
16	;	:	O	;	_	0	SENT_180	[p12l1478t2975r1541b2997],
17	VEGFA	NN	O	vegfa	dep	7	SENT_180	[p12l1558t2966r1668b2991],
18	=	JJ	O	=	amod	24	SENT_180	[p12l1687t2975r1708b2983],
19	vascular	JJ	O	vascular	amod	20	SENT_180	[p12l1727t2965r1830b2990],
20	endothelial	JJ	O	endothelial	amod	24	SENT_180	[p12l330t3002r463b3027],
21	growth	NN	O	growth	nn	24	SENT_180	[p12l473t3002r559b3034],
22	factor	NN	O	factor	nn	24	SENT_180	[p12l568t3002r642b3034],
23	A	NN	O	a	nn	24	SENT_180	[p12l653t3003r677b3027],
24	gene	NN	O	gene	dep	17	SENT_180	[p12l688t3012r750b3034],
25	.	.	O	.	_	0	SENT_180	[p12l688t3012r750b3034],

1	*	NN	O	*	nn	2	SENT_181	[p12l331t3040r424b3064],
2	Mean	NN	O	mean	nsubj	18	SENT_181	[p12l331t3040r424b3064],
3	visual	JJ	O	visual	amod	5	SENT_181	[p12l438t3039r515b3064],
4	acuity	NN	O	acuity	nn	5	SENT_181	[p12l530t3043r610b3071],
5	improvement	NN	O	improvement	dep	2	SENT_181	[p12l625t3043r805b3071],
6	in	IN	O	in	_	0	SENT_181	[p12l820t3043r846b3064],
7	logarithm	NN	O	logarithm	prep_in	5	SENT_181	[p12l861t3039r991b3071],
8	of	IN	O	of	_	0	SENT_181	[p12l1005t3039r1033b3064],
9	the	DT	O	the	det	11	SENT_181	[p12l1045t3039r1087b3064],
10	minimum	JJ	O	minimum	amod	11	SENT_181	[p12l1102t3043r1233b3064],
11	angle	NN	O	angle	prep_of	7	SENT_181	[p12l1248t3039r1318b3071],
12	of	IN	O	of	_	0	SENT_181	[p12l1333t3039r1361b3064],
13	resolution	NN	O	resolution	nn	15	SENT_181	[p12l1372t3039r1507b3064],
14	(	CD	NUMBER	(	num	15	SENT_181	[p12l1523t3039r1662b3071],
15	logMAR	NN	O	logmar	prep_of	11	SENT_181	[p12l1523t3039r1662b3071],
16	)	CD	NUMBER	)	num	17	SENT_181	[p12l1523t3039r1662b3071],
17	units	NNS	O	unit	dep	2	SENT_181	[p12l1679t3043r1744b3064],
18	(	VBP	O	(	_	0	SENT_181	[p12l1761t3039r1828b3069],
19	0.02	CD	NUMBER	0.02	num	20	SENT_181	[p12l1761t3039r1828b3069],
20	logMAR	NN	O	logmar	nsubj	21	SENT_181	[p12l331t3076r448b3108],
21	=	JJ	O	=	ccomp	18	SENT_181	[p12l463t3086r483b3094],
22	1	CD	NUMBER	1	num	24	SENT_181	[p12l501t3077r511b3101],
23	Early	JJ	O	early	amod	24	SENT_181	[p12l526t3076r594b3108],
24	Treatment	NN	O	treatment	iobj	21	SENT_181	[p12l605t3077r749b3101],
25	Diabetic	NNP	O	Diabetic	nn	28	SENT_181	[p12l762t3076r875b3101],
26	Retinopathy	NNP	O	Retinopathy	nn	28	SENT_181	[p12l887t3076r1055b3108],
27	Study	NNP	O	Study	nn	28	SENT_181	[p12l1067t3076r1144b3108],
28	letter	NN	O	letter	dobj	21	SENT_181	[p12l1156t3076r1247b3106],
29	)	CD	NUMBER	)	num	28	SENT_181	[p12l1156t3076r1247b3106],
30	.	.	O	.	_	0	SENT_181	[p12l1156t3076r1247b3106],

1	TPositive	JJ	O	tpositive	amod	3	SENT_182	[p12l331t3109r449b3139],
2	age	NN	O	age	nn	3	SENT_182	[p12l462t3122r504b3145],
3	difference	NN	O	difference	nsubj	4	SENT_182	[p12l517t3113r649b3139],
4	indicates	VBZ	O	indicate	_	0	SENT_182	[p12l662t3113r780b3139],
5	older	JJR	O	older	amod	6	SENT_182	[p12l793t3112r860b3139],
6	age	NN	O	age	dobj	4	SENT_182	[p12l873t3123r915b3145],
7	when	WRB	O	when	advmod	13	SENT_182	[p12l928t3113r1001b3138],
8	the	DT	O	the	det	11	SENT_182	[p12l1013t3113r1056b3138],
9	first	JJ	ORDINAL	first	amod	11	SENT_182	[p12l1068t3113r1118b3139],
10	ranibizumab	NN	O	ranibizumab	nn	11	SENT_182	[p12l1130t3113r1293b3139],
11	injection	NN	O	injection	nsubjpass	13	SENT_182	[p12l1307t3116r1427b3145],
12	was	VBD	O	be	auxpass	13	SENT_182	[p12l1439t3123r1485b3139],
13	given	VBN	O	give	advcl	4	SENT_182	[p12l1498t3116r1578b3145],
14	.	.	O	.	_	0	SENT_182	[p12l1498t3116r1578b3145],

1	have	VB	O	have	_	0	SENT_183	[p13l8t87r174b149],
2	greater	JJR	O	greater	amod	3	SENT_183	[p13l213t96r459b167],
3	consequence	NN	O	consequence	dobj	1	SENT_183	[p13l495t107r947b167],
4	on	IN	O	on	_	0	SENT_183	[p13l986t107r1071b149],
5	the	DT	O	the	det	6	SENT_183	[p13l1108t87r1214b149],
6	response	NN	O	response	prep_on	3	SENT_183	[p13l1251t107r1561b167],
7	to	TO	O	to	_	0	SENT_183	[p13l1599t96r1664b149],
8	ranibizumab	NN	O	ranibizumab	nn	9	SENT_183	[p13l1702t87r2145b149],
9	treatment	NN	O	treatment	prep_to	6	SENT_183	[p13l9t193r344b246],
10	than	IN	O	than	_	0	SENT_183	[p13l375t184r526b246],
11	the	DT	O	the	det	13	SENT_183	[p13l558t184r664b246],
12	VEGFA	NN	O	vegfa	nn	13	SENT_183	[p13l702t185r974b246],
13	gene	NN	O	gene	prep_than	9	SENT_183	[p13l1010t203r1192b264],
14	.	.	O	.	_	0	SENT_183	[p13l1010t203r1192b264],

1	Although	IN	O	although	mark	4	SENT_184	[p13l115t280r450b361],
2	this	DT	O	this	det	3	SENT_184	[p13l487t280r611b342],
3	study	NN	O	study	nsubj	4	SENT_184	[p13l653t280r840b361],
4	indicates	VBZ	O	indicate	advcl	41	SENT_184	[p13l877t280r1190b342],
5	that	IN	O	that	complm	19	SENT_184	[p13l1229t280r1361b342],
6	an	DT	O	a	det	8	SENT_184	[p13l1399t300r1479b342],
7	additive	JJ	O	additive	amod	8	SENT_184	[p13l1517t280r1800b343],
8	effect	NN	O	effect	nsubj	19	SENT_184	[p13l1837t280r2039b342],
9	of	IN	O	of	_	0	SENT_184	[p13l2075t280r2152b342],
10	CFH	NNP	O	CFH	prep_of	8	SENT_184	[p13l13t379r203b451],
11	,	,	O	,	_	0	SENT_184	[p13l13t379r203b451],
12	ARMS2	NN	O	arms2	conj_and	10	SENT_184	[p13l230t379r525b452],
13	,	,	O	,	_	0	SENT_184	[p13l230t379r525b452],
14	and	CC	O	and	_	0	SENT_184	[p13l559t378r685b440],
15	VEGFA	NN	O	vegfa	nn	16	SENT_184	[p13l718t379r991b441],
16	genotypes	NNS	O	genotype	conj_and	10	SENT_184	[p13l1024t387r1380b458],
17	is	VBZ	O	be	cop	19	SENT_184	[p13l1411t378r1466b440],
18	partially	RB	O	partially	advmod	19	SENT_184	[p13l1496t378r1792b458],
19	responsible	JJ	O	responsible	ccomp	4	SENT_184	[p13l1820t378r2143b458, p13l7t475r114b537],
20	for	IN	O	for	_	0	SENT_184	[p13l149t475r252b537],
21	a	DT	O	a	det	24	SENT_184	[p13l285t494r322b537],
22	decreased	VBN	O	decrease	amod	24	SENT_184	[p13l355t475r704b537],
23	response	NN	O	response	nn	24	SENT_184	[p13l735t494r1045b555],
24	rate	NN	O	rate	prep_for	19	SENT_184	[p13l1078t484r1210b537],
25	to	TO	O	to	_	0	SENT_184	[p13l1244t484r1309b537],
26	the	DT	O	the	det	28	SENT_184	[p13l1344t475r1450b537],
27	ranibizumab	NN	O	ranibizumab	nn	28	SENT_184	[p13l1483t475r1926b537],
28	treatment	NN	O	treatment	prep_to	24	SENT_184	[p13l1960t484r2144b537, p13l9t580r203b645],
29	,	,	O	,	_	0	SENT_184	[p13l1960t484r2144b537, p13l9t580r203b645],
30	the	DT	O	the	det	31	SENT_184	[p13l253t571r359b633],
31	mechanism	NN	O	mechanism	nsubj	41	SENT_184	[p13l405t571r810b633],
32	by	IN	O	by	_	0	SENT_184	[p13l854t571r941b652],
33	which	WDT	O	which	rel	36	SENT_184	[p13l988t571r1203b634],
34	these	DT	O	these	det	35	SENT_184	[p13l1249t571r1430b633],
35	genotypes	NNS	O	genotype	nsubj	36	SENT_184	[p13l1477t580r1833b652],
36	interact	VBP	O	interact	rcmod	31	SENT_184	[p13l1881t571r2147b633],
37	with	IN	O	with	_	0	SENT_184	[p13l9t669r165b731],
38	anti-VEGF	JJ	O	anti-vegf	amod	39	SENT_184	[p13l217t669r609b731],
39	therapy	NN	O	therapy	prep_with	36	SENT_184	[p13l659t669r923b749],
40	is	VBZ	O	be	cop	41	SENT_184	[p13l974t669r1029b731],
41	unknown	JJ	O	unknown	_	0	SENT_184	[p13l1081t669r1428b731],
42	.	.	O	.	_	0	SENT_184	[p13l1081t669r1428b731],

1	Because	IN	O	because	mark	6	SENT_185	[p13l1483t671r1778b731],
2	the	DT	O	the	det	4	SENT_185	[p13l1828t669r1934b731],
3	antiVEGF	NN	O	antivegf	nn	4	SENT_185	[p13l1987t669r2143b731, p13l9t766r239b828],
4	drug	NN	O	drug	nsubjpass	6	SENT_185	[p13l274t766r433b846],
5	is	VBZ	O	be	auxpass	6	SENT_185	[p13l468t766r523b828],
6	injected	VBN	O	inject	advcl	11	SENT_185	[p13l559t766r840b846],
7	locally	RB	O	locally	advmod	6	SENT_185	[p13l873t766r1132b846],
8	,	,	O	,	_	0	SENT_185	[p13l873t766r1132b846],
9	it	PRP	O	it	nsubj	11	SENT_185	[p13l1170t766r1218b828],
10	is	VBZ	O	be	cop	11	SENT_185	[p13l1251t766r1306b828],
11	unlikely	JJ	O	unlikely	_	0	SENT_185	[p13l1341t766r1631b846],
12	that	IN	O	that	complm	17	SENT_185	[p13l1666t766r1798b828],
13	inherited	VBN	O	inherit	amod	15	SENT_185	[p13l1831t766r2147b828],
14	pharmacokinetic	JJ	O	pharmacokinetic	amod	15	SENT_185	[p13l8t862r599b943],
15	effects	NNS	O	effect	nsubj	17	SENT_185	[p13l631t862r864b924],
16	are	VBP	O	be	cop	17	SENT_185	[p13l898t882r1002b924],
17	responsible	JJ	O	responsible	ccomp	11	SENT_185	[p13l1032t862r1436b943],
18	for	IN	O	for	_	0	SENT_185	[p13l1467t862r1569b924],
19	the	DT	O	the	det	20	SENT_185	[p13l1598t862r1704b924],
20	variation	NN	O	variation	prep_for	17	SENT_185	[p13l1735t862r2049b925],
21	in	IN	O	in	_	0	SENT_185	[p13l2079t862r2146b924],
22	the	DT	O	the	det	23	SENT_185	[p13l9t960r115b1022],
23	concentration	NN	O	concentration	prep_in	20	SENT_185	[p13l155t960r637b1022],
24	of	IN	O	of	_	0	SENT_185	[p13l677t960r753b1022],
25	the	DT	O	the	det	26	SENT_185	[p13l786t960r892b1022],
26	drug	NN	O	drug	prep_of	23	SENT_185	[p13l932t960r1091b1040],
27	reaching	VBG	O	reach	partmod	26	SENT_185	[p13l1130t960r1434b1040],
28	its	PRP$	O	its	poss	29	SENT_185	[p13l1474t960r1554b1022],
29	target	NN	O	target	dobj	27	SENT_185	[p13l1595t969r1813b1040],
30	.	.	O	.	_	0	SENT_185	[p13l1595t969r1813b1040],

1	Furthermore	RB	O	furthermore	advmod	5	SENT_186	[p13l1856t960r2143b1022, p13l9t1076r208b1130],
2	,	,	O	,	_	0	SENT_186	[p13l1856t960r2143b1022, p13l9t1076r208b1130],
3	AMD	NNP	ORGANIZATION	AMD	nsubjpass	5	SENT_186	[p13l248t1057r452b1118],
4	is	VBZ	O	be	auxpass	5	SENT_186	[p13l489t1057r544b1119],
5	associated	VBN	O	associate	_	0	SENT_186	[p13l585t1057r948b1119],
6	strongly	RB	O	strongly	advmod	5	SENT_186	[p13l986t1057r1272b1137],
7	with	IN	O	with	_	0	SENT_186	[p13l1310t1057r1465b1119],
8	CFH	NN	O	cfh	nn	11	SENT_186	[p13l1506t1058r1683b1119],
9	and	CC	O	and	_	0	SENT_186	[p13l1715t1057r1841b1119],
10	ARMS2	NN	O	arms2	nn	11	SENT_186	[p13l1870t1057r2143b1119],
11	polymorphisms	NNS	O	polymorphism	prep_with	5	SENT_186	[p13l8t1153r580b1234],
12	,	,	O	,	_	0	SENT_186	[p13l8t1153r580b1234],
13	and	CC	O	and	_	0	SENT_186	[p13l608t1153r734b1215],
14	both	DT	O	both	det	15	SENT_186	[p13l755t1153r913b1215],
15	genes	NNS	O	gene	nsubj	17	SENT_186	[p13l937t1173r1134b1234],
16	are	VBP	O	be	cop	17	SENT_186	[p13l1161t1173r1266b1215],
17	related	JJ	O	related	conj_and	5	SENT_186	[p13l1289t1153r1530b1215],
18	independently	RB	O	independently	advmod	17	SENT_186	[p13l1553t1153r2055b1234],
19	to	TO	O	to	_	0	SENT_186	[p13l2079t1163r2145b1215],
20	the	DT	O	the	det	21	SENT_186	[p13l8t1251r114b1313],
21	progression	NN	O	progression	prep_to	17	SENT_186	[p13l150t1251r565b1331],
22	of	IN	O	of	_	0	SENT_186	[p13l602t1251r678b1313],
23	AMD	NNP	ORGANIZATION	AMD	prep_of	21	SENT_186	[p13l708t1252r912b1312],
24	from	IN	O	from	_	0	SENT_186	[p13l950t1251r1122b1313],
25	early	JJ	O	early	amod	27	SENT_186	[p13l1157t1251r1332b1331],
26	to	TO	O	to	dep	27	SENT_186	[p13l1368t1260r1434b1313],
27	advanced	JJ	O	advanced	amod	28	SENT_186	[p13l1473t1251r1806b1313],
28	stages	NNS	O	stage	prep_from	17	SENT_186	[p13l1845t1239r2146b1331],
29	.	.	O	.	_	0	SENT_186	[p13l1845t1239r2146b1331],

1	“	NN	O	“	nsubj	8	SENT_187	[p13l1845t1239r2146b1331],
2	Also	RB	O	also	advmod	8	SENT_187	[p13l8t1348r193b1421],
3	,	,	O	,	_	0	SENT_187	[p13l8t1348r193b1421],
4	CFH	NNP	O	CFH	nsubj	8	SENT_187	[p13l229t1348r399b1410],
5	is	VBZ	O	be	cop	8	SENT_187	[p13l429t1348r484b1410],
6	the	DT	O	the	det	8	SENT_187	[p13l517t1348r623b1410],
7	main	JJ	O	main	amod	8	SENT_187	[p13l654t1348r831b1410],
8	regulator	NN	O	regulator	_	0	SENT_187	[p13l860t1348r1182b1428],
9	of	IN	O	of	_	0	SENT_187	[p13l1212t1348r1289b1410],
10	the	DT	O	the	det	13	SENT_187	[p13l1314t1348r1420b1410],
11	alternative	JJ	O	alternative	amod	13	SENT_187	[p13l1453t1348r1825b1410],
12	complement	NN	O	complement	nn	13	SENT_187	[p13l1857t1348r2143b1428, p13l9t1453r186b1506],
13	pathway	NN	O	pathway	prep_of	8	SENT_187	[p13l207t1444r527b1525],
14	,	,	O	,	_	0	SENT_187	[p13l207t1444r527b1525],
15	and	CC	O	and	_	0	SENT_187	[p13l556t1444r681b1506],
16	the	DT	O	the	det	19	SENT_187	[p13l703t1444r810b1506],
17	CFH	NNP	O	CFH	nn	19	SENT_187	[p13l838t1446r1015b1507],
18	402H	NN	O	402h	nn	19	SENT_187	[p13l1033t1445r1229b1507],
19	variant	NN	O	variant	nsubjpass	21	SENT_187	[p13l1253t1444r1499b1507],
20	is	VBZ	O	be	auxpass	21	SENT_187	[p13l1522t1444r1577b1506],
21	associated	VBN	O	associate	conj_and	8	SENT_187	[p13l1604t1444r1967b1506],
22	with	IN	O	with	_	0	SENT_187	[p13l1990t1444r2147b1507],
23	an	DT	O	a	det	25	SENT_187	[p13l10t1562r91b1604],
24	altered	JJ	O	altered	amod	25	SENT_187	[p13l123t1542r362b1604],
25	function	NN	O	function	prep_with	21	SENT_187	[p13l393t1542r688b1604],
26	of	IN	O	of	_	0	SENT_187	[p13l719t1542r796b1604],
27	the	DT	O	the	det	29	SENT_187	[p13l821t1542r927b1604],
28	CFH	NNP	O	CFH	nn	29	SENT_187	[p13l959t1542r1129b1604],
29	protein	NN	O	protein	prep_of	25	SENT_187	[p13l1159t1542r1429b1622],
30	,	,	O	,	_	0	SENT_187	[p13l1159t1542r1429b1622],
31	leading	VBG	O	lead	xcomp	21	SENT_187	[p13l1464t1542r1723b1622],
32	to	TO	O	to	_	0	SENT_187	[p13l1754t1551r1820b1604],
33	a	DT	O	a	det	34	SENT_187	[p13l1854t1562r1891b1604],
34	deregulation	NN	O	deregulation	prep_to	31	SENT_187	[p13l1922t1542r2143b1622, p13l8t1639r254b1701],
35	and	CC	O	and	_	0	SENT_187	[p13l282t1639r407b1701],
36	an	DT	O	a	det	37	SENT_187	[p13l435t1658r515b1701],
37	overactivation	NN	O	overactivation	conj_and	34	SENT_187	[p13l543t1639r1049b1701],
38	of	IN	O	of	_	0	SENT_187	[p13l1077t1639r1154b1701],
39	the	DT	O	the	det	42	SENT_187	[p13l1174t1639r1280b1701],
40	alternative	JJ	O	alternative	amod	42	SENT_187	[p13l1309t1639r1681b1701],
41	complement	NN	O	complement	nn	42	SENT_187	[p13l1709t1639r2148b1719],
42	pathway	NN	O	pathway	prep_of	37	SENT_187	[p13l8t1723r394b1816],
43	.	.	O	.	_	0	SENT_187	[p13l8t1723r394b1816],

1	”	NN	O	”	nn	2	SENT_188	[p13l8t1723r394b1816],
2	A	NN	O	a	nsubj	5	SENT_188	[p13l420t1736r482b1797],
3	recent	JJ	O	recent	amod	4	SENT_188	[p13l503t1744r721b1797],
4	study	NN	O	study	dep	2	SENT_188	[p13l745t1735r932b1816],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_188	[p13l956t1735r1433b1797],
6	that	IN	O	that	complm	13	SENT_188	[p13l1455t1735r1587b1797],
7	increased	VBN	O	increase	amod	9	SENT_188	[p13l1608t1735r1944b1797],
8	complement	NN	O	complement	nn	9	SENT_188	[p13l1966t1755r2143b1797, p13l8t1833r295b1913],
9	activation	NN	O	activation	nsubjpass	13	SENT_188	[p13l329t1833r676b1895],
10	in	IN	O	in	_	0	SENT_188	[p13l710t1833r776b1894],
11	serum	NN	O	serum	prep_in	9	SENT_188	[p13l813t1853r1027b1895],
12	is	VBZ	O	be	auxpass	13	SENT_188	[p13l1059t1833r1114b1895],
13	associated	VBN	O	associate	ccomp	5	SENT_188	[p13l1151t1833r1514b1895],
14	with	IN	O	with	_	0	SENT_188	[p13l1547t1833r1703b1895],
15	the	DT	O	the	det	18	SENT_188	[p13l1736t1833r1842b1895],
16	ARMS2	NN	O	arms2	nn	18	SENT_188	[p13l1870t1834r2143b1896],
17	high-risk	JJ	O	high-risk	amod	18	SENT_188	[p13l8t1930r330b2010],
18	allele	NN	O	allele	prep_with	13	SENT_188	[p13l353t1930r560b2003],
19	,	,	O	,	_	0	SENT_188	[p13l353t1930r560b2003],
20	suggesting	VBG	O	suggest	xcomp	5	SENT_188	[p13l590t1930r965b2010],
21	that	IN	O	that	complm	26	SENT_188	[p13l989t1930r1122b1992],
22	this	DT	O	this	det	23	SENT_188	[p13l1144t1930r1268b1992],
23	locus	NN	O	locus	nsubjpass	26	SENT_188	[p13l1294t1930r1477b1992],
24	also	RB	O	also	advmod	26	SENT_188	[p13l1504t1930r1642b1992],
25	is	VBZ	O	be	auxpass	26	SENT_188	[p13l1666t1930r1721b1992],
26	involved	VBN	O	involve	ccomp	20	SENT_188	[p13l1747t1930r2057b1992],
27	in	IN	O	in	_	0	SENT_188	[p13l2079t1930r2147b1991],
28	complement	NN	O	complement	nn	29	SENT_188	[p13l9t2026r448b2107],
29	activation	NN	O	activation	prep_in	26	SENT_188	[p13l481t2014r917b2089],
30	.26	CD	NUMBER	.26	num	29	SENT_188	[p13l481t2014r917b2089],

1	At	IN	O	at	_	0	SENT_189	[p13l115t2125r204b2186],
2	the	DT	O	the	det	4	SENT_189	[p13l232t2124r338b2186],
3	biochemical	JJ	O	biochemical	amod	4	SENT_189	[p13l367t2124r801b2186],
4	level	NN	O	level	prep_at	12	SENT_189	[p13l831t2124r1021b2197],
5	,	,	O	,	_	0	SENT_189	[p13l831t2124r1021b2197],
6	bioactive	JJ	O	bioactive	amod	9	SENT_189	[p13l1053t2124r1378b2186],
7	complement	NN	O	complement	nn	9	SENT_189	[p13l1409t2124r1847b2204],
8	components	NNS	O	component	nn	9	SENT_189	[p13l1877t2144r2143b2204, p13l9t2230r192b2283],
9	C3a	NN	O	c3a	nsubj	12	SENT_189	[p13l246t2221r388b2283],
10	and	CC	O	and	_	0	SENT_189	[p13l439t2221r564b2283],
11	C5a	NN	O	c5a	conj_and	9	SENT_189	[p13l615t2221r757b2283],
12	induce	VBP	O	induce	_	0	SENT_189	[p13l806t2221r1041b2283],
13	VEGF	NN	O	vegf	nn	14	SENT_189	[p13l1092t2221r1323b2283],
14	expression	NN	O	expression	dobj	12	SENT_189	[p13l1374t2221r1752b2301],
15	in	IN	O	in	_	0	SENT_189	[p13l1803t2221r1870b2282],
16	retinal	JJ	O	retinal	amod	17	SENT_189	[p13l1920t2221r2146b2283],
17	pigment	NN	O	pigment	prep_in	12	SENT_189	[p13l8t2317r300b2398],
18	epithelial	JJ	O	epithelial	amod	19	SENT_189	[p13l324t2317r652b2398],
19	cells	NNS	O	cell	dep	17	SENT_189	[p13l678t2317r835b2379],
20	and	CC	O	and	_	0	SENT_189	[p13l864t2317r989b2379],
21	cause	VB	O	cause	conj_and	12	SENT_189	[p13l1014t2337r1208b2379],
22	a	DT	O	a	det	23	SENT_189	[p13l1235t2337r1272b2379],
23	reduction	NN	O	reduction	dobj	21	SENT_189	[p13l1294t2317r1629b2379],
24	in	IN	O	in	_	0	SENT_189	[p13l1653t2317r1721b2379],
25	CNV	NNP	O	CNV	prep_in	21	SENT_189	[p13l1746t2318r1930b2380],
26	when	WRB	O	when	advmod	33	SENT_189	[p13l1955t2317r2146b2380],
27	neutralized	VBN	O	neutralize	csubj	33	SENT_189	[p13l9t2403r573b2477],
28	.27	CD	NUMBER	.27	number	29	SENT_189	[p13l9t2403r573b2477],
29	’28	CD	NUMBER	’28	num	32	SENT_189	[p13l9t2403r573b2477],
30	Another	DT	O	another	det	32	SENT_189	[p13l614t2415r906b2477],
31	important	JJ	O	important	amod	32	SENT_189	[p13l943t2415r1289b2495],
32	ﬁnding	NN	O	ﬁnding	dobj	27	SENT_189	[p13l1328t2415r1576b2495],
33	is	VBZ	O	be	advcl	21	SENT_189	[p13l1617t2415r1672b2477],
34	that	IN	O	that	complm	55	SENT_189	[p13l1713t2415r1846b2477],
35	the	DT	O	the	det	37	SENT_189	[p13l1883t2415r1990b2477],
36	CC	NN	O	cc	nn	37	SENT_189	[p13l2031t2415r2145b2477],
37	genotype	NN	O	genotype	nsubjpass	55	SENT_189	[p13l10t2521r332b2592],
38	of	IN	O	of	_	0	SENT_189	[p13l378t2512r454b2574],
39	the	DT	O	the	det	42	SENT_189	[p13l492t2512r598b2574],
40	VEGFA	NNP	O	VEGFA	nn	42	SENT_189	[p13l648t2513r920b2575],
41	rs699947	CD	NUMBER	rs699947	num	42	SENT_189	[p13l965t2512r1292b2575],
42	SNP	NN	ORGANIZATION	snp	prep_of	37	SENT_189	[p13l1341t2512r1519b2585],
43	,	,	O	,	_	0	SENT_189	[p13l1341t2512r1519b2585],
44	localized	JJ	O	localized	amod	37	SENT_189	[p13l1566t2512r1886b2574],
45	in	IN	O	in	_	0	SENT_189	[p13l1929t2512r1996b2573],
46	the	DT	O	the	det	48	SENT_189	[p13l2039t2512r2145b2574],
47	promoter	NN	O	promoter	nn	48	SENT_189	[p13l8t2617r335b2689],
48	region	NN	O	region	prep_in	44	SENT_189	[p13l368t2608r595b2689],
49	of	IN	O	of	_	0	SENT_189	[p13l632t2608r709b2670],
50	the	DT	O	the	det	52	SENT_189	[p13l739t2608r845b2670],
51	VEGFA	NN	O	vegfa	nn	52	SENT_189	[p13l887t2610r1159b2671],
52	gene	NN	O	gene	prep_of	48	SENT_189	[p13l1199t2628r1383b2689],
53	,	,	O	,	_	0	SENT_189	[p13l1199t2628r1383b2689],
54	is	VBZ	O	be	auxpass	55	SENT_189	[p13l1422t2608r1478b2670],
55	associated	VBN	O	associate	ccomp	33	SENT_189	[p13l1518t2608r1880b2670],
56	with	IN	O	with	_	0	SENT_189	[p13l1917t2608r2073b2671],
57	a	DT	O	a	det	60	SENT_189	[p13l2110t2628r2147b2670],
58	higher	JJR	O	higher	amod	60	SENT_189	[p13l8t2706r236b2786],
59	VEGF	NN	O	vegf	nn	60	SENT_189	[p13l273t2706r504b2768],
60	production	NN	O	production	prep_with	55	SENT_189	[p13l541t2694r1014b2786],
61	.	.	O	.	_	0	SENT_189	[p13l541t2694r1014b2786],

1	”	NN	O	”	nsubj	35	SENT_190	[p13l541t2694r1014b2786],
2	Taking	VBG	O	take	partmod	1	SENT_190	[p13l1054t2706r1303b2786],
3	these	DT	O	these	det	4	SENT_190	[p13l1342t2706r1523b2768],
4	observations	NNS	O	observation	dobj	2	SENT_190	[p13l1563t2706r2009b2768],
5	together	RB	O	together	advmod	9	SENT_190	[p13l2049t2715r2144b2768, p13l10t2803r248b2883],
6	,	,	O	,	_	0	SENT_190	[p13l2049t2715r2144b2768, p13l10t2803r248b2883],
7	the	DT	O	the	det	8	SENT_190	[p13l287t2803r393b2865],
8	authors	NNS	O	author	nsubj	9	SENT_190	[p13l432t2803r688b2865],
9	propose	VBP	O	propose	rcmod	4	SENT_190	[p13l725t2822r1005b2883],
10	that	IN	O	that	complm	16	SENT_190	[p13l1042t2803r1175b2865],
11	CFH	NNP	O	CFH	nsubjpass	16	SENT_190	[p13l1214t2804r1391b2865],
12	and	CC	O	and	_	0	SENT_190	[p13l1423t2803r1548b2865],
13	ARMS2/HTRA1	NN	O	arms2/htra1	nsubjpass	16	SENT_190	[p13l1578t2803r2139b2866],
14	are	VBP	O	be	auxpass	16	SENT_190	[p13l10t2919r115b2961],
15	both	DT	O	both	advmod	16	SENT_190	[p13l141t2899r298b2961],
16	associated	VBN	O	associate	ccomp	9	SENT_190	[p13l327t2899r689b2961],
17	with	IN	O	with	_	0	SENT_190	[p13l716t2899r872b2962],
18	an	DT	O	a	det	19	SENT_190	[p13l900t2919r980b2961],
19	overactivation	NN	O	overactivation	prep_with	16	SENT_190	[p13l1007t2899r1514b2962],
20	of	IN	O	of	_	0	SENT_190	[p13l1542t2899r1618b2961],
21	the	DT	O	the	det	24	SENT_190	[p13l1639t2899r1746b2961],
22	alternative	JJ	O	alternative	amod	24	SENT_190	[p13l1774t2899r2146b2962],
23	complement	NN	O	complement	nn	24	SENT_190	[p13l9t2997r448b3077],
24	pathway	NN	O	pathway	prep_of	19	SENT_190	[p13l474t2997r774b3077],
25	and	CC	O	and	_	0	SENT_190	[p13l805t2997r948b3071],
26	,	,	O	,	_	0	SENT_190	[p13l805t2997r948b3071],
27	in	IN	O	in	conj_and	9	SENT_190	[p13l980t2997r1047b3058],
28	combination	NN	O	combination	pobj	27	SENT_190	[p13l1076t2997r1519b3059],
29	with	IN	O	with	_	0	SENT_190	[p13l1547t2997r1704b3059],
30	the	DT	O	the	det	32	SENT_190	[p13l1731t2997r1837b3059],
31	VEGFA	NNP	O	VEGFA	nn	32	SENT_190	[p13l1871t2998r2144b3060],
32	polymorphism	NN	O	polymorphism	prep_with	28	SENT_190	[p13l8t3094r545b3174],
33	,	,	O	,	_	0	SENT_190	[p13l8t3094r545b3174],
34	may	MD	O	may	aux	35	SENT_190	[p13l599t3113r749b3174],
35	lead	VB	O	lead	_	0	SENT_190	[p13l801t3094r947b3156],
36	to	TO	O	to	_	0	SENT_190	[p13l996t3103r1062b3156],
37	potentially	RB	O	potentially	advmod	38	SENT_190	[p13l1113t3094r1492b3174],
38	higher	JJR	O	higher	amod	39	SENT_190	[p13l1542t3094r1770b3174],
39	levels	NNS	O	level	prep_to	35	SENT_190	[p13l1818t3094r2022b3156],
40	of	IN	O	of	prep	39	SENT_190	[p13l2075t3094r2152b3156],

1	(	NN	O	(	_	0	SENT_191	[p14l16t24r240b101],
2	local	JJ	O	local	amod	1	SENT_191	[p14l16t24r240b101],
3	)	CD	NUMBER	)	num	5	SENT_191	[p14l16t24r240b101],
4	VEGF	NN	O	vegf	nn	5	SENT_191	[p14l281t24r511b86],
5	production	NN	O	production	dep	1	SENT_191	[p14l548t24r950b104],
6	.	.	O	.	_	0	SENT_191	[p14l548t24r950b104],

1	As	IN	O	as	_	0	SENT_192	[p14l992t25r1087b86],
2	a	DT	O	a	det	3	SENT_192	[p14l1129t44r1165b86],
3	result	NN	O	result	prep_as	11	SENT_192	[p14l1201t24r1399b86],
4	of	IN	O	of	_	0	SENT_192	[p14l1437t24r1513b86],
5	increased	VBN	O	increase	amod	7	SENT_192	[p14l1545t24r1880b86],
6	VEGF	NN	O	vegf	nn	7	SENT_192	[p14l1917t24r2148b86],
7	production	NN	O	production	prep_of	3	SENT_192	[p14l12t121r415b201],
8	,	,	O	,	_	0	SENT_192	[p14l12t121r415b201],
9	CNV	NN	ORGANIZATION	cnv	nsubj	11	SENT_192	[p14l455t121r639b183],
10	may	MD	O	may	aux	11	SENT_192	[p14l675t140r825b201],
11	develop	VB	O	develop	_	0	SENT_192	[p14l862t121r1139b201],
12	sooner	RBR	O	sooner	advmod	11	SENT_192	[p14l1179t140r1430b194],
13	,	,	O	,	_	0	SENT_192	[p14l1179t140r1430b194],
14	consequently	RB	O	consequently	advmod	11	SENT_192	[p14l1469t121r1935b201],
15	leading	VBG	O	lead	xcomp	11	SENT_192	[p14l1972t121r2144b183, p14l13t217r123b298],
16	to	TO	O	to	_	0	SENT_192	[p14l152t226r218b279],
17	CNV	NNP	ORGANIZATION	CNV	nn	18	SENT_192	[p14l247t218r431b280],
18	formation	NN	O	formation	prep_to	15	SENT_192	[p14l459t217r808b279],
19	at	IN	O	at	_	0	SENT_192	[p14l837t227r898b279],
20	a	DT	O	a	det	22	SENT_192	[p14l926t237r963b279],
21	younger	JJR	O	younger	amod	22	SENT_192	[p14l989t237r1280b298],
22	age	NN	O	age	prep_at	15	SENT_192	[p14l1308t237r1446b298],
23	,	,	O	,	_	0	SENT_192	[p14l1308t237r1446b298],
24	as	IN	O	as	mark	25	SENT_192	[p14l1478t237r1546b279],
25	demonstrated	VBN	O	demonstrate	dep	22	SENT_192	[p14l1577t217r2053b279],
26	in	IN	O	in	_	0	SENT_192	[p14l2080t217r2147b279],
27	this	DT	O	this	det	28	SENT_192	[p14l13t315r137b377],
28	study	NN	O	study	prep_in	25	SENT_192	[p14l174t315r379b395],
29	.	.	O	.	_	0	SENT_192	[p14l174t315r379b395],

1	It	PRP	O	it	nsubj	4	SENT_193	[p14l120t413r173b474],
2	is	VBZ	O	be	cop	4	SENT_193	[p14l212t412r267b474],
3	not	RB	O	not	neg	4	SENT_193	[p14l309t421r422b474],
4	clear	JJ	O	clear	_	0	SENT_193	[p14l461t412r632b474],
5	whether	IN	O	whether	complm	12	SENT_193	[p14l671t412r957b474],
6	AMD	NNP	ORGANIZATION	AMD	nn	7	SENT_193	[p14l995t412r1199b473],
7	patients	NNS	O	patient	nsubj	12	SENT_193	[p14l1240t412r1513b492],
8	with	IN	O	with	_	0	SENT_193	[p14l1556t412r1711b474],
9	a	DT	O	a	det	11	SENT_193	[p14l1753t431r1790b474],
10	high	JJ	O	high	amod	11	SENT_193	[p14l1828t412r2149b492],
11	—	NN	O	—	prep_with	7	SENT_193	[p14l1828t412r2149b492],
12	risk	NN	O	risk	ccomp	4	SENT_193	[p14l1828t412r2149b492],
13	genetic	JJ	O	genetic	amod	14	SENT_193	[p14l14t508r266b589],
14	background	NN	O	background	nsubj	15	SENT_193	[p14l315t508r735b589],
15	develop	VB	O	develop	ccomp	12	SENT_193	[p14l783t508r1061b589],
16	a	DT	O	a	det	19	SENT_193	[p14l1112t528r1149b570],
17	more	RBR	O	more	advmod	18	SENT_193	[p14l1196t528r1376b570],
18	devastating	JJ	O	devastating	amod	19	SENT_193	[p14l1425t508r1827b589],
19	type	NN	O	type	dobj	15	SENT_193	[p14l1876t518r2027b589],
20	of	IN	O	of	_	0	SENT_193	[p14l2077t508r2153b570],
21	AMD	NNP	ORGANIZATION	AMD	prep_of	19	SENT_193	[p14l13t607r217b667],
22	or	CC	O	or	_	0	SENT_193	[p14l247t626r319b668],
23	less	JJR	O	less	amod	25	SENT_193	[p14l345t606r474b668],
24	anti-VEGF	JJ	O	anti-vegf	amod	25	SENT_193	[p14l506t606r897b668],
25	responsiveness	NN	O	responsiveness	conj_or	21	SENT_193	[p14l923t606r1474b686],
26	.	.	O	.	_	0	SENT_193	[p14l923t606r1474b686],

1	It	PRP	O	it	nsubj	3	SENT_194	[p14l1506t608r1559b668],
2	is	VBZ	O	be	cop	3	SENT_194	[p14l1585t606r1640b668],
3	plausible	JJ	O	plausible	_	0	SENT_194	[p14l1669t606r1988b686],
4	that	IN	O	that	complm	10	SENT_194	[p14l2016t606r2149b668],
5	high	JJ	O	high	amod	8	SENT_194	[p14l12t703r169b783],
6	VEGF	NN	O	vegf	nn	8	SENT_194	[p14l191t703r422b765],
7	expression	NN	O	expression	nn	8	SENT_194	[p14l444t703r822b783],
8	levels	NNS	O	level	nsubj	10	SENT_194	[p14l844t703r1047b765],
9	may	MD	O	may	aux	10	SENT_194	[p14l1072t722r1222b783],
10	cause	VB	O	cause	ccomp	3	SENT_194	[p14l1245t722r1440b765],
11	speciﬁc	JJ	O	speciﬁc	amod	14	SENT_194	[p14l1465t703r1730b783],
12	phenotypic	JJ	O	phenotypic	amod	14	SENT_194	[p14l1753t703r2146b783],
13	CNV	NN	O	cnv	nn	14	SENT_194	[p14l14t800r198b862],
14	characteristics	NNS	O	characteristic	dobj	10	SENT_194	[p14l223t799r727b861],
15	or	CC	O	or	_	0	SENT_194	[p14l755t819r827b861],
16	submacular	JJ	O	submacular	amod	17	SENT_194	[p14l852t799r1259b861],
17	ﬁbrosis	NN	O	ﬁbrosis	conj_or	14	SENT_194	[p14l1282t799r1559b873],
18	,	,	O	,	_	0	SENT_194	[p14l1282t799r1559b873],
19	which	WDT	O	which	nsubj	21	SENT_194	[p14l1588t799r1803b862],
20	may	MD	O	may	aux	21	SENT_194	[p14l1826t819r1977b880],
21	lead	VB	O	lead	rcmod	14	SENT_194	[p14l2001t799r2148b861],
22	to	TO	O	to	_	0	SENT_194	[p14l13t906r79b959],
23	a	DT	O	a	det	25	SENT_194	[p14l110t917r147b959],
24	decreased	VBN	O	decrease	amod	25	SENT_194	[p14l175t897r523b959],
25	response	NN	O	response	prep_to	21	SENT_194	[p14l550t917r860b977],
26	to	TO	O	to	_	0	SENT_194	[p14l889t906r955b959],
27	anti-VEGF	JJ	O	anti-vegf	amod	28	SENT_194	[p14l986t897r1378b959],
28	therapy	NN	O	therapy	prep_to	25	SENT_194	[p14l1406t897r1688b977],
29	.	.	O	.	_	0	SENT_194	[p14l1406t897r1688b977],

1	It	PRP	O	it	nsubj	3	SENT_195	[p14l1721t899r1775b959],
2	is	VBZ	O	be	cop	3	SENT_195	[p14l1802t897r1857b959],
3	unclear	JJ	O	unclear	_	0	SENT_195	[p14l1887t897r2149b959],
4	whether	IN	O	whether	complm	8	SENT_195	[p14l13t994r299b1056],
5	such	JJ	O	such	amod	7	SENT_195	[p14l336t994r494b1056],
6	phenotypic	JJ	O	phenotypic	amod	7	SENT_195	[p14l528t994r921b1074],
7	characteristics	NNS	O	characteristic	nsubj	8	SENT_195	[p14l959t994r1462b1056],
8	correlate	VBP	O	correlate	ccomp	3	SENT_195	[p14l1501t994r1808b1056],
9	with	IN	O	with	_	0	SENT_195	[p14l1845t994r2001b1056],
10	genetic	JJ	O	genetic	amod	11	SENT_195	[p14l2037t1013r2145b1074, p14l13t1090r182b1152],
11	background	NN	O	background	prep_with	8	SENT_195	[p14l230t1090r666b1171],
12	.	.	O	.	_	0	SENT_195	[p14l230t1090r666b1171],

1	One	CD	NUMBER	one	num	2	SENT_196	[p14l720t1091r864b1153],
2	study	NN	O	study	nsubj	3	SENT_196	[p14l915t1090r1101b1171],
3	suggested	VBD	O	suggest	_	0	SENT_196	[p14l1152t1090r1498b1171],
4	that	IN	O	that	complm	12	SENT_196	[p14l1545t1090r1678b1152],
5	the	DT	O	the	det	6	SENT_196	[p14l1723t1090r1830b1152],
6	type	NN	O	type	nsubjpass	12	SENT_196	[p14l1877t1100r2028b1171],
7	of	IN	O	of	_	0	SENT_196	[p14l2076t1090r2153b1152],
8	neovascular	JJ	O	neovascular	amod	9	SENT_196	[p14l13t1188r438b1250],
9	membranes	NNS	O	membrane	prep_of	6	SENT_196	[p14l461t1188r867b1250],
10	may	MD	O	may	aux	12	SENT_196	[p14l895t1208r1045b1268],
11	be	VB	O	be	auxpass	12	SENT_196	[p14l1071t1188r1153b1250],
12	inﬂuenced	VBN	O	inﬂuenced	ccomp	3	SENT_196	[p14l1180t1188r1549b1250],
13	by	IN	O	by	_	0	SENT_196	[p14l1573t1188r1660b1268],
14	the	DT	O	the	det	15	SENT_196	[p14l1687t1188r1793b1250],
15	CFH	NNP	O	CFH	agent	12	SENT_196	[p14l1824t1189r2000b1251],
16	and	CC	O	and	_	0	SENT_196	[p14l2023t1188r2148b1250],
17	HT	NNP	O	HT	nn	21	SENT_196	[p14l11t1287r133b1346],
18	RA	NN	O	ra	nn	21	SENT_196	[p14l124t1285r271b1346],
19	]	CD	NUMBER	]	num	21	SENT_196	[p14l124t1285r271b1346],
20	genetic	JJ	O	genetic	amod	21	SENT_196	[p14l307t1285r559b1365],
21	variations	NNS	O	variation	agent	12	SENT_196	[p14l588t1273r1025b1347],
22	.	.	O	.	_	0	SENT_196	[p14l588t1273r1025b1347],

1	”	NN	O	”	nsubj	5	SENT_197	[p14l588t1273r1025b1347],
2	Yet	RB	O	yet	advmod	5	SENT_197	[p14l1054t1286r1181b1347],
3	another	DT	O	another	det	4	SENT_197	[p14l1210t1285r1474b1347],
4	study	NN	O	study	nsubj	5	SENT_197	[p14l1503t1285r1690b1365],
5	showed	VBD	O	show	_	0	SENT_197	[p14l1721t1285r1989b1347],
6	that	IN	O	that	complm	11	SENT_197	[p14l2015t1285r2148b1347],
7	it	PRP	O	it	nsubj	11	SENT_197	[p14l13t1381r61b1443],
8	is	VBZ	O	be	cop	11	SENT_197	[p14l102t1381r157b1443],
9	not	RB	O	not	neg	11	SENT_197	[p14l200t1391r313b1443],
10	the	DT	O	the	det	11	SENT_197	[p14l353t1381r459b1443],
11	type	NN	O	type	ccomp	5	SENT_197	[p14l500t1391r651b1462],
12	of	IN	O	of	_	0	SENT_197	[p14l694t1381r771b1443],
13	neovascularization	NN	O	neovascularization	prep_of	11	SENT_197	[p14l806t1381r1472b1444],
14	that	WDT	O	that	nsubjpass	16	SENT_197	[p14l1513t1381r1645b1443],
15	is	VBZ	O	be	auxpass	16	SENT_197	[p14l1685t1381r1740b1443],
16	associated	VBN	O	associate	rcmod	11	SENT_197	[p14l1785t1381r2148b1443],
17	with	IN	O	with	_	0	SENT_197	[p14l13t1480r170b1542],
18	worse	JJR	O	worse	amod	20	SENT_197	[p14l195t1500r405b1542],
19	visual	JJ	O	visual	amod	20	SENT_197	[p14l432t1480r642b1542],
20	outcome	NN	O	outcome	prep_with	16	SENT_197	[p14l669t1490r971b1542],
21	after	IN	O	after	_	0	SENT_197	[p14l1000t1480r1160b1542],
22	ranibizumab	NN	O	ranibizumab	nn	23	SENT_197	[p14l1184t1480r1626b1542],
23	treatment	NN	O	treatment	prep_after	16	SENT_197	[p14l1653t1489r2006b1554],
24	,	,	O	,	_	0	SENT_197	[p14l1653t1489r2006b1554],
25	but	CC	O	but	_	0	SENT_197	[p14l2034t1480r2149b1542],
26	rather	RB	O	rather	_	0	SENT_197	[p14l12t1577r220b1639],
27	the	DT	O	the	det	28	SENT_197	[p14l246t1577r352b1639],
28	size	NN	O	size	ccomp	5	SENT_197	[p14l384t1577r516b1639],
29	of	IN	O	of	_	0	SENT_197	[p14l546t1577r622b1639],
30	the	DT	O	the	det	34	SENT_197	[p14l645t1577r751b1639],
31	retinal	JJ	O	retinal	amod	34	SENT_197	[p14l778t1577r1004b1639],
32	pigment	NN	O	pigment	nn	34	SENT_197	[p14l1031t1577r1323b1657],
33	epithelium	NN	O	epithelium	nn	34	SENT_197	[p14l1351t1577r1730b1657],
34	area	NN	O	area	prep_of	28	SENT_197	[p14l1758t1596r1903b1639],
35	that	WDT	O	that	nsubjpass	37	SENT_197	[p14l1930t1577r2063b1639],
36	is	VBZ	O	be	auxpass	37	SENT_197	[p14l2090t1577r2145b1639],
37	affected	VBN	O	affect	rcmod	28	SENT_197	[p14l15t1661r380b1735],
38	.	.	O	.	_	0	SENT_197	[p14l15t1661r380b1735],

1	“	NN	O	“	nsubj	12	SENT_198	[p14l15t1661r380b1735],
2	Consistent	JJ	O	consistent	amod	1	SENT_198	[p14l413t1673r786b1736],
3	with	IN	O	with	_	0	SENT_198	[p14l811t1673r967b1736],
4	previous	JJ	O	previous	amod	5	SENT_198	[p14l991t1673r1293b1754],
5	ﬁndings	NNS	O	ﬁndings	prep_with	1	SENT_198	[p14l1323t1673r1624b1754],
6	,	,	O	,	_	0	SENT_198	[p14l1323t1673r1624b1754],
7	the	DT	O	the	det	9	SENT_198	[p14l1653t1673r1759b1735],
8	CNV	NNP	ORGANIZATION	CNV	nn	9	SENT_198	[p14l1786t1674r1970b1736],
9	type	NN	O	type	appos	5	SENT_198	[p14l1996t1683r2147b1754],
10	did	VBD	O	do	aux	12	SENT_198	[p14l14t1771r125b1833],
11	not	RB	O	not	neg	12	SENT_198	[p14l165t1780r278b1833],
12	show	VB	O	show	_	0	SENT_198	[p14l320t1771r502b1833],
13	an	DT	O	a	det	14	SENT_198	[p14l545t1791r625b1833],
14	association	NN	O	association	dobj	12	SENT_198	[p14l668t1771r1059b1833],
15	with	IN	O	with	_	0	SENT_198	[p14l1100t1771r1256b1833],
16	response	NN	O	response	prep_with	14	SENT_198	[p14l1295t1791r1605b1851],
17	to	TO	O	to	_	0	SENT_198	[p14l1646t1780r1712b1833],
18	anti-VEGF	JJ	O	anti-vegf	amod	19	SENT_198	[p14l1756t1771r2148b1833],
19	treatment	NN	O	treatment	prep_to	12	SENT_198	[p14l13t1877r348b1930],
20	in	IN	O	in	_	0	SENT_198	[p14l369t1868r436b1929],
21	this	DT	O	this	det	23	SENT_198	[p14l458t1868r582b1930],
22	study	NN	O	study	nn	23	SENT_198	[p14l609t1868r796b1948],
23	population	NN	O	population	prep_in	19	SENT_198	[p14l818t1856r1280b1948],
24	.	.	O	.	_	0	SENT_198	[p14l818t1856r1280b1948],

1	“	NN	O	“	nn	3	SENT_199	[p14l818t1856r1280b1948],
2	Conﬂicting	NN	O	conﬂicting	nn	3	SENT_199	[p14l1310t1867r1706b1948],
3	results	NNS	O	result	nsubjpass	6	SENT_199	[p14l1729t1868r1957b1930],
4	have	VBP	O	have	aux	6	SENT_199	[p14l1981t1868r2147b1930],
5	been	VBN	O	be	auxpass	6	SENT_199	[p14l12t1964r179b2026],
6	reported	VBN	O	report	ccomp	40	SENT_199	[p14l208t1964r504b2045],
7	concerning	VBG	O	concern	xcomp	6	SENT_199	[p14l533t1964r925b2045],
8	an	DT	O	a	det	9	SENT_199	[p14l958t1984r1038b2026],
9	association	NN	O	association	dobj	7	SENT_199	[p14l1069t1964r1461b2026],
10	between	IN	O	between	_	0	SENT_199	[p14l1489t1964r1785b2027],
11	CFH	NNP	O	CFH	prep_between	9	SENT_199	[p14l1820t1966r1996b2027],
12	and	CC	O	and	_	0	SENT_199	[p14l2023t1964r2148b2026],
13	ARMS2/HTRAI	NN	O	arms2/htrai	nn	14	SENT_199	[p14l7t2063r568b2125],
14	genotypes	NNS	O	genotype	conj_and	11	SENT_199	[p14l624t2071r979b2142],
15	and	CC	O	and	_	0	SENT_199	[p14l1032t2062r1157b2124],
16	the	DT	O	the	det	17	SENT_199	[p14l1205t2062r1311b2124],
17	size	NN	O	size	conj_and	9	SENT_199	[p14l1363t2062r1496b2124],
18	of	IN	O	of	_	0	SENT_199	[p14l1546t2062r1623b2124],
19	the	DT	O	the	det	21	SENT_199	[p14l1666t2062r1772b2124],
20	CNV	NN	O	cnv	nn	21	SENT_199	[p14l1822t2062r2006b2124],
21	lesion	NN	O	lesion	prep_of	17	SENT_199	[p14l2056t2062r2144b2124, p14l16t2146r345b2221],
22	.32	CD	NUMBER	.32	number	23	SENT_199	[p14l2056t2062r2144b2124, p14l16t2146r345b2221],
23	'35	CD	NUMBER	'35	num	21	SENT_199	[p14l2056t2062r2144b2124, p14l16t2146r345b2221],
24	Nevertheless	RB	O	nevertheless	advmod	7	SENT_199	[p14l378t2159r855b2232],
25	,	,	O	,	_	0	SENT_199	[p14l378t2159r855b2232],
26	further	JJ	O	further	amod	27	SENT_199	[p14l889t2159r1131b2221],
27	investigation	NN	O	investigation	nsubjpass	40	SENT_199	[p14l1160t2159r1617b2239],
28	of	IN	O	of	_	0	SENT_199	[p14l1649t2159r1726b2221],
29	the	DT	O	the	det	30	SENT_199	[p14l1750t2159r1856b2221],
30	mechanism	NN	O	mechanism	prep_of	27	SENT_199	[p14l1887t2159r2144b2221, p14l13t2255r185b2317],
31	by	IN	O	by	_	0	SENT_199	[p14l227t2255r314b2336],
32	which	WDT	O	which	rel	35	SENT_199	[p14l359t2255r574b2318],
33	these	DT	O	these	det	34	SENT_199	[p14l618t2255r798b2317],
34	genotypes	NNS	O	genotype	nsubj	35	SENT_199	[p14l843t2264r1199b2336],
35	interact	VBP	O	interact	rcmod	30	SENT_199	[p14l1245t2255r1511b2317],
36	with	IN	O	with	_	0	SENT_199	[p14l1554t2255r1710b2318],
37	anti-VEGF	JJ	O	anti-vegf	amod	38	SENT_199	[p14l1756t2255r2148b2318],
38	therapy	NN	O	therapy	prep_with	35	SENT_199	[p14l13t2353r276b2433],
39	is	VBZ	O	be	auxpass	40	SENT_199	[p14l309t2353r364b2415],
40	required	VBN	O	require	_	0	SENT_199	[p14l398t2353r710b2433],
41	.	.	O	.	_	0	SENT_199	[p14l398t2353r710b2433],

1	The	DT	O	the	det	5	SENT_200	[p14l120t2450r255b2512],
2	high	JJ	O	high	amod	5	SENT_200	[p14l289t2450r610b2530],
3	—	NN	O	—	nn	5	SENT_200	[p14l289t2450r610b2530],
4	risk	NN	O	risk	nn	5	SENT_200	[p14l289t2450r610b2530],
5	genotypes	NNS	O	genotype	nsubj	11	SENT_200	[p14l643t2459r998b2530],
6	tested	VBN	O	test	partmod	5	SENT_200	[p14l1034t2450r1240b2512],
7	in	IN	O	in	_	0	SENT_200	[p14l1273t2450r1340b2511],
8	this	DT	O	this	det	9	SENT_200	[p14l1373t2450r1497b2512],
9	study	NN	O	study	prep_in	6	SENT_200	[p14l1537t2450r1723b2530],
10	are	VBP	O	be	cop	11	SENT_200	[p14l1760t2469r1864b2512],
11	predictive	JJ	O	predictive	_	0	SENT_200	[p14l1896t2450r2145b2530, p14l13t2546r144b2609],
12	for	IN	O	for	_	0	SENT_200	[p14l184t2546r287b2608],
13	progression	NN	O	progression	prep_for	11	SENT_200	[p14l323t2546r738b2627],
14	of	IN	O	of	_	0	SENT_200	[p14l778t2546r854b2608],
15	AMD	NNP	ORGANIZATION	AMD	prep_of	13	SENT_200	[p14l888t2547r1091b2608],
16	and	CC	O	and	_	0	SENT_200	[p14l1135t2546r1260b2608],
17	response	NN	O	response	conj_and	13	SENT_200	[p14l1297t2566r1607b2627],
18	to	TO	O	to	_	0	SENT_200	[p14l1647t2556r1713b2608],
19	anti-VEGF	JJ	O	anti-vegf	amod	20	SENT_200	[p14l1755t2546r2148b2609],
20	treatment	NN	O	treatment	prep_to	17	SENT_200	[p14l13t2653r365b2717],
21	,	,	O	,	_	0	SENT_200	[p14l13t2653r365b2717],
22	which	WDT	O	which	nsubj	23	SENT_200	[p14l398t2644r613b2706],
23	underlines	VBZ	O	underline	rcmod	20	SENT_200	[p14l640t2644r1007b2706],
24	the	DT	O	the	det	25	SENT_200	[p14l1037t2644r1144b2706],
25	potential	NN	O	potential	dobj	23	SENT_200	[p14l1171t2644r1481b2724],
26	of	IN	O	of	_	0	SENT_200	[p14l1511t2644r1587b2706],
27	genetic	JJ	O	genetic	amod	28	SENT_200	[p14l1611t2644r1863b2724],
28	screening	NN	O	screening	prep_of	25	SENT_200	[p14l1895t2664r2145b2706, p14l13t2741r123b2821],
29	in	IN	O	in	_	0	SENT_200	[p14l150t2741r218b2802],
30	predicting	VBG	O	predict	prepc_in	23	SENT_200	[p14l243t2741r601b2821],
31	the	DT	O	the	det	32	SENT_200	[p14l628t2741r734b2803],
32	development	NN	O	development	dobj	30	SENT_200	[p14l762t2741r1220b2821],
33	of	IN	O	of	_	0	SENT_200	[p14l1246t2741r1322b2803],
34	end-stage	JJ	O	end-stage	amod	35	SENT_200	[p14l1343t2741r1681b2821],
35	AMD	NNP	O	AMD	prep_of	32	SENT_200	[p14l1707t2741r1931b2803],
36	.	.	O	.	_	0	SENT_200	[p14l1707t2741r1931b2803],

1	Identifying	VBG	O	identify	_	0	SENT_201	[p14l1962t2741r2144b2803, p14l13t2837r247b2918],
2	high	JJ	O	high	amod	5	SENT_201	[p14l287t2837r608b2918],
3	—	NN	O	—	nn	5	SENT_201	[p14l287t2837r608b2918],
4	risk	NN	O	risk	nn	5	SENT_201	[p14l287t2837r608b2918],
5	individuals	NNS	O	individual	dobj	1	SENT_201	[p14l646t2837r1037b2900],
6	during	IN	O	during	_	0	SENT_201	[p14l1079t2837r1307b2918],
7	the	DT	O	the	det	9	SENT_201	[p14l1348t2837r1454b2899],
8	early	JJ	O	early	amod	9	SENT_201	[p14l1495t2837r1669b2918],
9	stage	NN	O	stage	prep_during	1	SENT_201	[p14l1712t2847r1889b2918],
10	of	IN	O	of	_	0	SENT_201	[p14l1930t2837r2007b2899],
11	the	DT	O	the	det	12	SENT_201	[p14l2041t2837r2147b2899],
12	disease	NN	O	disease	prep_of	9	SENT_201	[p14l14t2935r267b2997],
13	could	MD	O	could	aux	14	SENT_201	[p14l306t2935r502b2997],
14	lead	VB	O	lead	dep	1	SENT_201	[p14l539t2935r685b2997],
15	to	TO	O	to	_	0	SENT_201	[p14l723t2945r788b2997],
16	an	DT	O	a	det	17	SENT_201	[p14l829t2955r909b2997],
17	awareness	NN	O	awareness	prep_to	14	SENT_201	[p14l949t2955r1308b2997],
18	of	IN	O	of	prep	17	SENT_201	[p14l1349t2935r1439b3008],
19	,	,	O	,	_	0	SENT_201	[p14l1349t2935r1439b3008],
20	and	CC	O	and	_	0	SENT_201	[p14l1482t2935r1607b2997],
21	more	RBR	O	more	advmod	14	SENT_201	[p14l1644t2955r1824b2997],
22	targeted	VBN	O	target	conj_and	14	SENT_201	[p14l1862t2935r2148b3015],
23	education	NN	O	education	nsubj	1	SENT_201	[p14l13t3032r356b3094],
24	about	RB	O	about	advmod	23	SENT_201	[p14l388t3032r601b3105],
25	,	,	O	,	_	0	SENT_201	[p14l388t3032r601b3105],
26	the	DT	O	the	det	27	SENT_201	[p14l634t3032r740b3094],
27	adoption	NN	O	adoption	appos	23	SENT_201	[p14l773t3032r1080b3112],
28	of	IN	O	of	_	0	SENT_201	[p14l1111t3032r1188b3094],
29	a	DT	O	a	det	31	SENT_201	[p14l1214t3051r1251b3094],
30	healthy	JJ	O	healthy	amod	31	SENT_201	[p14l1279t3032r1539b3112],
31	lifestyle	NN	O	lifestyle	prep_of	27	SENT_201	[p14l1570t3032r1853b3112],
32	and	CC	O	and	_	0	SENT_201	[p14l1886t3032r2011b3094],
33	the	DT	O	the	prep_of	27	SENT_201	[p14l2040t3032r2146b3094],

1	Smailhodzic	JJ	MISC	smailhodzic	_	0	SENT_202	[p14l468t3187r670b3226],
2	et	FW	MISC	et	dep	1	SENT_202	[p14l686t3198r716b3222],
3	al	FW	MISC	al	nn	4	SENT_202	[p14l732t3187r762b3222],
4	°	FW	MISC	°	amod	6	SENT_202	[p14l788t3202r796b3209],
5	Risk	NN	MISC	risk	nn	6	SENT_202	[p14l823t3187r904b3222],
6	Alleles	NNS	MISC	allele	dep	1	SENT_202	[p14l919t3187r1047b3222],
7	on	IN	O	on	_	0	SENT_202	[p14l1065t3201r1112b3222],
8	Treatment	NN	O	treatment	nn	9	SENT_202	[p14l1128t3189r1326b3222],
9	Response	NN	O	response	prep_on	6	SENT_202	[p14l1342t3189r1513b3231],
10	in	IN	O	in	_	0	SENT_202	[p14l1532t3192r1568b3222],
11	AMD	NNP	ORGANIZATION	AMD	prep_in	9	SENT_202	[p14l1584t3188r1692b3222],

1	+	CC	O	+	_	0	SENT_203	[p15l1340t707r1561b729],
2	¢	CD	NUMBER	¢	num	4	SENT_203	[p15l1340t707r1561b729],
3	§	NN	O	§	nn	4	SENT_203	[p15l1340t707r1561b729],
4	o	NN	O	o	dep	12	SENT_203	[p15l1340t707r1561b729],
5	+	CC	O	+	_	0	SENT_203	[p15l1340t707r1561b729],
6	§	NN	O	§	conj_+	4	SENT_203	[p15l1340t707r1561b729],
7	4	CD	NUMBER	4	num	6	SENT_203	[p15l1340t707r1561b729],
8	+	CC	O	+	_	0	SENT_203	[p15l1340t707r1561b729],
9	t9	NN	O	t9	conj_+	4	SENT_203	[p15l1340t707r1561b729],
10	'	''	O	'	_	0	SENT_203	[p15l1340t707r1561b729],
11	‘	CD	NUMBER	‘	number	12	SENT_203	[p15l1382t752r1520b774],
12	carom	NN	O	carom	_	0	SENT_203	[p15l1382t752r1520b774],
13	:	:	O	:	_	0	SENT_203	[p15l1382t752r1520b774],
14	*	CD	NUMBER	*	num	15	SENT_203	[p15l1443t794r1459b809],
15	¢	CD	NUMBER	¢	dep	12	SENT_203	[p15l1485t803r1500b816],
16	4.	LS	NUMBER	4.	dep	15	SENT_203	[p15l1423t809r1478b835],
17	:	:	O	:	_	0	SENT_203	[p15l1423t809r1478b835],
18	i	FW	O	i	dep	15	SENT_203	[p15l1404t858r1478b874],
19	¢	FW	O	¢	nn	20	SENT_203	[p15l1404t858r1478b874],
20	¢	FW	O	¢	dep	18	SENT_203	[p15l1404t858r1478b874],
21	a	DT	O	a	dep	20	SENT_203	[p15l1404t858r1478b874],

1	Change	NNP	O	Change	_	0	SENT_204	[p15l29t867r78b1044],
2	In	IN	O	in	dep	1	SENT_204	[p15l39t813r68b848],
3	wsuall	JJ	O	wsuall	amod	4	SENT_204	[p15l29t665r68b797],
4	El	NNP	O	El	pobj	2	SENT_204	[p15l29t514r78b646],
5	:	:	O	:	_	0	SENT_204	[p15l29t514r78b646],
6	-	:	O	-	_	0	SENT_204	[p15l29t514r78b646],
7	llllif	NN	O	llllif	nn	8	SENT_204	[p15l29t514r78b646],
8	scare	NN	O	scare	dep	1	SENT_204	[p15l39t376r68b499],
9	from	IN	O	from	dep	8	SENT_204	[p15l87t874r126b974],
10	Baseline	NN	O	baseline	pobj	9	SENT_204	[p15l87t659r126b855],
11	(	CD	NUMBER	(	num	10	SENT_204	[p15l87t431r136b643],
12	In	IN	O	in	dep	8	SENT_204	[p15l87t431r136b643],
13	-	:	O	-	_	0	SENT_204	[p15l87t431r136b643],
14	,	,	O	,	_	0	SENT_204	[p15l87t431r136b643],
15	gMAR	NN	O	gmar	nn	16	SENT_204	[p15l87t431r136b643],
16	}	NN	O	}	dep	8	SENT_204	[p15l87t431r136b643],

1	H	NN	O	h	_	0	SENT_205	[p15l215t681r251b713],
2	:	:	O	:	_	0	SENT_205	[p15l215t681r251b713],

1	4	CD	NUMBER	4	num	2	SENT_206	[p15l530t1326r562b1368],
2	3	CD	NUMBER	3	_	0	SENT_206	[p15l982t1326r1012b1368],
3	2-1	CD	NUMBER	2-1	dep	2	SENT_206	[p15l1404t1326r1478b1368],
4	in	IN	O	in	prep	3	SENT_206	[p15l1876t1326r1905b1368],

1	Number	NN	O	number	_	0	SENT_207	[p15l585t1397r765b1433],
2	of	IN	O	of	_	0	SENT_207	[p15l780t1397r823b1433],
3	higharisk	JJ	O	higharisk	amod	4	SENT_207	[p15l838t1397r1031b1442],
4	alleles	NNS	O	allele	prep_of	1	SENT_207	[p15l1047t1397r1193b1433],
5	i-n	JJ	O	i-n	amod	4	SENT_207	[p15l1211t1397r1247b1433],
6	-	:	O	-	_	0	SENT_207	[p15l1266t1397r1372b1433],
7	CFH	NN	O	cfh	dep	1	SENT_207	[p15l1266t1397r1372b1433],
8	and	CC	O	and	_	0	SENT_207	[p15l1382t1397r1465b1433],
9	ARMS	NNS	O	arm	dep	1	SENT_207	[p15l1481t1397r1661b1433],
10	}	CD	NUMBER	}	num	9	SENT_207	[p15l1481t1397r1661b1433],
11	?	.	O	?	_	0	SENT_207	[p15l1481t1397r1661b1433],

1	genes	NNS	O	gene	_	0	SENT_208	[p15l1671t1403r1809b1442],

1	100	CD	NUMBER	100	num	2	SENT_209	[p15l216t1566r314b1607],
2	p	NN	O	p	_	0	SENT_209	[p15l1154t1550r1177b1586],
3	=	JJ	O	=	amod	4	SENT_209	[p15l1192t1551r1215b1570],
4	l1	NN	O	l1	dep	2	SENT_209	[p15l1231t1541r1317b1577],
5	.	.	O	.	_	0	SENT_209	[p15l1231t1541r1317b1577],

1	‘	NN	O	‘	nn	2	SENT_210	[p15l1231t1541r1317b1577],
2	l9	NN	O	l9	_	0	SENT_210	[p15l1231t1541r1317b1577],

1	Uo	NN	O	uo	_	0	SENT_211	[p15l49t1560r100b1627],

1	ID	NN	O	id	_	0	SENT_212	[p15l244t1806r274b1848],
2	5	CD	NUMBER	5	num	1	SENT_212	[p15l276t1806r306b1848],

1	Age	NN	O	age	_	0	SENT_213	[p15l87t2474r135b2567],
2	of	IN	O	of	_	0	SENT_213	[p15l87t2413r126b2461],
3	ﬁlrst	NN	O	ﬁlrst	nn	5	SENT_213	[p15l87t2316r126b2403],
4	ranibizumab	NN	O	ranibizumab	nn	5	SENT_213	[p15l87t2024r126b2301],
5	sinjectikmn	NN	O	sinjectikmn	prep_of	1	SENT_213	[p15l87t1822r135b2008],

1	4	CD	NUMBER	4	num	2	SENT_214	[p15l536t2820r566b2862],
2	3	CD	NUMBER	3	_	0	SENT_214	[p15l986t2820r1015b2862],
3	2-1	CD	NUMBER	2-1	dep	2	SENT_214	[p15l1407t2795r1481b2862],
4	or	CC	O	or	cc	3	SENT_214	[p15l1882t2820r1911b2862],

1	Number	NN	O	number	nn	2	SENT_215	[p15l613t2894r793b2932],
2	nf	NN	O	nf	_	0	SENT_215	[p15l806t2894r851b2932],
3	thigh-risk	JJ	O	thigh-risk	amod	4	SENT_215	[p15l864t2894r1061b2942],
4	anaias	NNS	O	anaia	dep	2	SENT_215	[p15l1077t2894r1221b2932],
5	in	IN	O	in	_	0	SENT_215	[p15l1237t2894r1276b2930],
6	CFH	NNP	O	CFH	prep_in	4	SENT_215	[p15l1295t2894r1398b2932],
7	and	CC	O	and	_	0	SENT_215	[p15l1410t2894r1494b2932],
8	:	:	O	:	_	0	SENT_215	[p15l1410t2894r1494b2932],
9	AHM52	NN	O	ahm52	dep	6	SENT_215	[p15l1510t2894r1687b2932],
10	genes	NNS	O	gene	prep_in	4	SENT_215	[p15l1699t2900r1838b2942],

1	Figure	NNP	O	Figure	_	0	SENT_216	[p15l7t3019r196b3084],
2	1	CD	NUMBER	1	dep	1	SENT_216	[p15l233t3021r280b3070],
3	.	.	O	.	_	0	SENT_216	[p15l233t3021r280b3070],

1	Graphs	NNS	O	graph	nsubj	26	SENT_217	[p15l321t3016r528b3084],
2	showing	VBG	O	show	partmod	1	SENT_217	[p15l558t3016r794b3084],
3	the	DT	O	the	det	5	SENT_217	[p15l823t3016r914b3070],
4	cumulative	JJ	O	cumulative	amod	5	SENT_217	[p15l945t3016r1262b3070],
5	effect	NN	O	effect	dobj	2	SENT_217	[p15l1293t3017r1449b3070],
6	of	IN	O	of	_	0	SENT_217	[p15l1478t3017r1537b3070],
7	complement	NN	O	complement	nn	12	SENT_217	[p15l1560t3016r1884b3084],
8	factor	NN	O	factor	nn	12	SENT_217	[p15l1907t3017r2065b3084],
9	H	NN	O	h	nn	12	SENT_217	[p15l2093t3019r2146b3070],
10	(	CD	NUMBER	(	num	12	SENT_217	[p15l13t3104r204b3167],
11	CFH	NNP	O	CFH	nn	12	SENT_217	[p15l13t3104r204b3167],
12	)	NN	O	)	prep_of	5	SENT_217	[p15l13t3104r204b3167],
13	and	CC	O	and	_	0	SENT_217	[p15l233t3104r337b3157],
14	agexrelated	JJ	O	agexrelated	amod	16	SENT_217	[p15l359t3104r648b3171],
15	maculopathy	NN	O	maculopathy	nn	16	SENT_217	[p15l668t3104r1005b3171],
16	susceptibility	NN	O	susceptibility	prep_of	5	SENT_217	[p15l1030t3104r1363b3171],
17	2	CD	NUMBER	2	number	18	SENT_217	[p15l1389t3106r1419b3157],
18	(	CD	NUMBER	(	num	22	SENT_217	[p15l1449t3104r1723b3167],
19	ARMS2	NN	O	arms2	nn	22	SENT_217	[p15l1449t3104r1723b3167],
20	)	NN	O	)	nn	22	SENT_217	[p15l1449t3104r1723b3167],
21	risk	NN	O	risk	nn	22	SENT_217	[p15l1751t3104r1853b3157],
22	alleles	NNS	O	allele	dep	16	SENT_217	[p15l1876t3104r2050b3157],
23	on	IN	O	on	_	0	SENT_217	[p15l2074t3125r2148b3158],
24	(	NN	O	(	nn	25	SENT_217	[p15l13t3191r113b3255],
25	A	NN	O	a	prep_on	2	SENT_217	[p15l13t3191r113b3255],
26	)	VBD	O	)	_	0	SENT_217	[p15l13t3191r113b3255],
27	the	DT	O	the	det	34	SENT_217	[p15l138t3191r229b3245],
28	change	NN	O	change	dep	34	SENT_217	[p15l249t3191r451b3259],
29	in	IN	O	in	_	0	SENT_217	[p15l474t3199r529b3244],
30	Visual	JJ	O	visual	amod	33	SENT_217	[p15l548t3191r712b3245],
31	acuity	NN	O	acuity	nn	33	SENT_217	[p15l733t3199r904b3259],
32	(	CD	NUMBER	(	num	33	SENT_217	[p15l927t3191r1078b3255],
33	VA	NN	ORGANIZATION	va	prep_in	28	SENT_217	[p15l927t3191r1078b3255],
34	)	NN	O	)	dobj	26	SENT_217	[p15l927t3191r1078b3255],
35	after	IN	O	after	_	0	SENT_217	[p15l1103t3192r1231b3245],
36	ranibizumab	NN	O	ranibizumab	nn	37	SENT_217	[p15l1250t3191r1599b3245],
37	treatment	NN	O	treatment	prep_after	26	SENT_217	[p15l1620t3208r1903b3245],
38	and	CC	O	and	_	0	SENT_217	[p15l1923t3191r2026b3245],
39	(	NN	O	(	nn	41	SENT_217	[p15l2050t3191r2142b3255],
40	B	NN	O	b	nn	41	SENT_217	[p15l2050t3191r2142b3255],
41	)	NN	O	)	conj_and	37	SENT_217	[p15l2050t3191r2142b3255],
42	on	IN	O	on	_	0	SENT_217	[p15l9t3299r82b3331],
43	the	DT	O	the	det	44	SENT_217	[p15l111t3277r202b3331],
44	age	NN	O	age	prep_on	37	SENT_217	[p15l232t3298r323b3345],
45	of	IN	O	of	_	0	SENT_217	[p15l352t3278r411b3331],
46	neovascular	JJ	O	neovascular	amod	47	SENT_217	[p15l433t3277r772b3331],
47	onset	NN	O	onset	prep_of	44	SENT_217	[p15l800t3294r966b3331],
48	.	.	O	.	_	0	SENT_217	[p15l800t3294r966b3331],

1	A	DT	O	a	det	17	SENT_218	[p15l997t3279r1065b3341],
2	,	,	O	,	_	0	SENT_218	[p15l997t3279r1065b3341],
3	Visual	JJ	O	visual	amod	5	SENT_218	[p15l1096t3277r1277b3332],
4	acuity	NN	O	acuity	nn	5	SENT_218	[p15l1306t3285r1477b3345],
5	change	NN	O	change	dep	6	SENT_218	[p15l1505t3277r1707b3345],
6	after	IN	O	after	dep	17	SENT_218	[p15l1738t3278r1866b3331],
7	3	CD	NUMBER	3	num	11	SENT_218	[p15l1893t3280r1922b3331],
8	ranibi	NN	O	ranibus	nn	11	SENT_218	[p15l1954t3277r2144b3331],
9	—	NN	O	—	nn	11	SENT_218	[p15l1954t3277r2144b3331],
10	zumab	NN	O	zumab	nn	11	SENT_218	[p15l9t3365r188b3418],
11	injections	NNS	O	injection	pobj	6	SENT_218	[p15l232t3372r512b3432],
12	from	IN	O	from	_	0	SENT_218	[p15l553t3365r687b3418],
13	baseline	NN	O	baseline	nn	15	SENT_218	[p15l727t3365r958b3418],
14	(	CD	NUMBER	(	num	15	SENT_218	[p15l1004t3365r1206b3432],
15	y	NN	O	y	prep_from	11	SENT_218	[p15l1004t3365r1206b3432],
16	—	CD	NUMBER	—	num	15	SENT_218	[p15l1004t3365r1206b3432],
17	axis	NN	O	axis	nsubj	33	SENT_218	[p15l1004t3365r1206b3432],
18	,	,	O	,	_	0	SENT_218	[p15l1004t3365r1206b3432],
19	0.20	CD	NUMBER	0.20	nsubj	33	SENT_218	[p15l1251t3367r1372b3419],
20	corresponds	VBZ	O	correspond	rcmod	19	SENT_218	[p15l1415t3365r1752b3432],
21	to	TO	O	to	_	0	SENT_218	[p15l1795t3381r1850b3418],
22	10	CD	NUMBER	10	num	28	SENT_218	[p15l1898t3367r1960b3418],
23	Early	JJ	O	early	amod	28	SENT_218	[p15l2002t3365r2147b3432],
24	Treatment	NN	O	treatment	nn	28	SENT_218	[p15l8t3455r316b3506],
25	Diabetic	NNP	O	Diabetic	nn	28	SENT_218	[p15l336t3452r578b3506],
26	Retinopathy	NNP	O	Retinopathy	nn	28	SENT_218	[p15l598t3452r957b3520],
27	Study	NNP	O	Study	nn	28	SENT_218	[p15l978t3452r1141b3520],
28	letters	NNS	O	letter	prep_to	20	SENT_218	[p15l1162t3452r1352b3516],
29	,	,	O	,	_	0	SENT_218	[p15l1162t3452r1352b3516],
30	a	DT	O	a	det	32	SENT_218	[p15l1376t3474r1405b3506],
31	positive	JJ	O	positive	amod	32	SENT_218	[p15l1423t3460r1647b3520],
32	change	NN	O	change	appos	28	SENT_218	[p15l1668t3452r1871b3520],
33	indicates	VBZ	O	indicate	_	0	SENT_218	[p15l1894t3452r2146b3506],
34	VA	NNP	ORGANIZATION	VA	nn	35	SENT_218	[p15l8t3540r114b3593],
35	gain	NN	O	gain	dobj	33	SENT_218	[p15l141t3546r276b3606],
36	,	,	O	,	_	0	SENT_218	[p15l141t3546r276b3606],
37	and	CC	O	and	_	0	SENT_218	[p15l308t3538r412b3592],
38	a	DT	O	a	det	40	SENT_218	[p15l440t3560r469b3592],
39	negative	JJ	O	negative	amod	40	SENT_218	[p15l496t3546r739b3606],
40	change	NN	O	change	nsubj	41	SENT_218	[p15l768t3538r970b3606],
41	indicates	VBZ	O	indicate	conj_and	33	SENT_218	[p15l1001t3538r1253b3592],
42	VA	NNP	O	VA	nn	44	SENT_218	[p15l1280t3540r1386b3593],
43	loss	NN	O	loss	nn	44	SENT_218	[p15l1415t3538r1537b3602],
44	)	NN	O	)	dobj	41	SENT_218	[p15l1415t3538r1537b3602],
45	clustered	VBN	O	cluster	partmod	44	SENT_218	[p15l1570t3538r1825b3592],
46	by	IN	O	by	_	0	SENT_218	[p15l1851t3538r1918b3606],
47	a	DT	O	a	det	48	SENT_218	[p15l1946t3560r1975b3592],
48	CFH	NNP	O	CFH	agent	45	SENT_218	[p15l2002t3540r2146b3592],
49	and	CC	O	and	_	0	SENT_218	[p15l10t3626r114b3679],
50	ARMS2	NN	O	arms2	nn	52	SENT_218	[p15l142t3628r369b3680],
51	allelic	JJ	O	allelic	amod	52	SENT_218	[p15l404t3626r574b3679],
52	composition	NN	O	composition	conj_and	44	SENT_218	[p15l606t3633r960b3693],
53	(	CD	NUMBER	(	dep	52	SENT_218	[p15l994t3626r1229b3689],
54	x	CC	O	x	_	0	SENT_218	[p15l994t3626r1229b3689],
55	~	CD	NUMBER	~	num	56	SENT_218	[p15l994t3626r1229b3689],
56	axis	NN	O	axis	conj_and	44	SENT_218	[p15l994t3626r1229b3689],
57	)	CD	NUMBER	)	dep	56	SENT_218	[p15l994t3626r1229b3689],
58	:	:	O	:	_	0	SENT_218	[p15l994t3626r1229b3689],
59	(	CD	NUMBER	(	number	60	SENT_218	[p15l1267t3626r1347b3689],
60	4	CD	NUMBER	4	num	62	SENT_218	[p15l1267t3626r1347b3689],
61	)	NN	O	)	nn	62	SENT_218	[p15l1267t3626r1347b3689],
62	participants	NNS	O	participant	nsubj	70	SENT_218	[p15l1381t3633r1719b3693],
63	carrying	VBG	O	carry	partmod	62	SENT_218	[p15l1752t3633r1982b3693],
64	all	DT	O	all	det	69	SENT_218	[p15l2014t3626r2082b3679],
65	4	CD	NUMBER	4	num	69	SENT_218	[p15l2113t3628r2145b3684],
66	high	JJ	O	high	amod	69	SENT_218	[p15l8t3713r265b3781],
67	»	NN	O	»	nn	69	SENT_218	[p15l8t3713r265b3781],
68	risk	NN	O	risk	nn	69	SENT_218	[p15l8t3713r265b3781],
69	alleles	NNS	O	allele	dobj	63	SENT_218	[p15l299t3713r473b3767],
70	(	VBP	O	(	parataxis	33	SENT_218	[p15l512t3713r574b3777],
71	n	NN	O	n	nn	73	SENT_218	[p15l512t3713r574b3777],
72	=	JJ	O	=	amod	73	SENT_218	[p15l614t3735r657b3751],
73	Z9	NN	O	z9	dobj	70	SENT_218	[p15l700t3716r766b3767],
74	[	CD	PERCENT	[	number	75	SENT_218	[p15l805t3713r1030b3777],
75	6.9	CD	PERCENT	6.9	num	76	SENT_218	[p15l805t3713r1030b3777],
76	%	NN	PERCENT	%	dep	73	SENT_218	[p15l805t3713r1030b3777],
77	]	CD	NUMBER	]	number	78	SENT_218	[p15l805t3713r1030b3777],
78	)	CD	NUMBER	)	num	76	SENT_218	[p15l805t3713r1030b3777],
79	,	,	O	,	_	0	SENT_218	[p15l805t3713r1030b3777],
80	(	CD	NUMBER	(	number	81	SENT_218	[p15l1071t3713r1151b3777],
81	3	CD	NUMBER	3	num	83	SENT_218	[p15l1071t3713r1151b3777],
82	)	NN	O	)	nn	83	SENT_218	[p15l1071t3713r1151b3777],
83	patients	NNS	O	patient	appos	73	SENT_218	[p15l1189t3721r1416b3781],
84	with	IN	O	with	_	0	SENT_218	[p15l1451t3713r1581b3767],
85	3	CD	NUMBER	3	num	88	SENT_218	[p15l1613t3716r1643b3767],
86	high	JJ	O	high	amod	88	SENT_218	[p15l1680t3713r1937b3781],
87	»	NN	O	»	nn	88	SENT_218	[p15l1680t3713r1937b3781],
88	risl	NN	O	risl	prep_with	83	SENT_218	[p15l1680t3713r1937b3781],
89	<	JJR	O	<	amod	90	SENT_218	[p15l1680t3713r1937b3781],
90	alleles	NNS	O	allele	dep	88	SENT_218	[p15l1971t3713r2145b3767],

1	(	NN	O	(	nn	2	SENT_219	[p16l13t17r75b80],
2	n	NN	O	n	dep	7	SENT_219	[p16l13t17r75b80],
3	=	JJ	O	=	amod	4	SENT_219	[p16l110t38r153b55],
4	lO4	NN	O	lo4	dep	2	SENT_219	[p16l195t19r293b75],
5	[	CD	PERCENT	[	dep	7	SENT_219	[p16l328t16r587b80],
6	24.8	CD	PERCENT	24.8	num	7	SENT_219	[p16l328t16r587b80],
7	%	NN	PERCENT	%	dep	23	SENT_219	[p16l328t16r587b80],
8	]	CD	NUMBER	]	num	9	SENT_219	[p16l328t16r587b80],
9	)	NN	O	)	dep	7	SENT_219	[p16l328t16r587b80],
10	,	,	O	,	_	0	SENT_219	[p16l328t16r587b80],
11	(	NN	O	(	nn	14	SENT_219	[p16l624t17r763b80],
12	2	CD	NUMBER	2	num	14	SENT_219	[p16l624t17r763b80],
13	—	NN	O	—	nn	14	SENT_219	[p16l624t17r763b80],
14	l	NN	O	l	appos	9	SENT_219	[p16l624t17r763b80],
15	)	CD	NUMBER	)	num	16	SENT_219	[p16l624t17r763b80],
16	patients	NNS	O	patient	nsubj	23	SENT_219	[p16l796t24r1023b84],
17	carrying	VBG	O	carry	partmod	16	SENT_219	[p16l1054t24r1285b84],
18	l	NN	O	l	dobj	17	SENT_219	[p16l1320t19r1341b70],
19	or	CC	O	or	_	0	SENT_219	[p16l1377t38r1434b70],
20	2	CD	NUMBER	2	num	22	SENT_219	[p16l1465t19r1494b69],
21	risk	NN	O	risk	nn	22	SENT_219	[p16l1525t16r1627b70],
22	alleles	NNS	O	allele	dobj	17	SENT_219	[p16l1657t16r1830b70],
23	(	VBP	O	(	dep	47	SENT_219	[p16l1865t17r1926b80],
24	n	NN	O	n	dobj	23	SENT_219	[p16l1865t17r1926b80],
25	=	JJ	O	=	amod	24	SENT_219	[p16l1962t38r2005b55],
26	267	CD	PERCENT	267	tmod	25	SENT_219	[p16l2044t18r2143b73],
27	[	CD	PERCENT	[	number	28	SENT_219	[p16l13t103r272b167],
28	63.5	CD	PERCENT	63.5	num	29	SENT_219	[p16l13t103r272b167],
29	%	NN	PERCENT	%	dep	24	SENT_219	[p16l13t103r272b167],
30	]	CD	NUMBER	]	num	31	SENT_219	[p16l13t103r272b167],
31	)	NN	O	)	dep	29	SENT_219	[p16l13t103r272b167],
32	,	,	O	,	_	0	SENT_219	[p16l13t103r272b167],
33	and	CC	O	and	_	0	SENT_219	[p16l311t104r414b157],
34	(	NN	O	(	nn	37	SENT_219	[p16l452t104r532b167],
35	o	NN	O	o	nn	37	SENT_219	[p16l452t104r532b167],
36	)	NN	O	)	nn	37	SENT_219	[p16l452t104r532b167],
37	participants	NNS	O	participant	conj_and	24	SENT_219	[p16l569t111r908b171],
38	without	IN	O	without	_	0	SENT_219	[p16l942t104r1166b157],
39	high	JJ	O	high	amod	41	SENT_219	[p16l1198t104r1456b171],
40	—	NN	O	—	nn	41	SENT_219	[p16l1198t104r1456b171],
41	risl	NN	O	risl	prep_without	37	SENT_219	[p16l1198t104r1456b171],
42	<	JJR	O	<	amod	43	SENT_219	[p16l1198t104r1456b171],
43	alleles	NNS	O	allele	nsubj	47	SENT_219	[p16l1489t104r1663b157],
44	in	IN	O	in	_	0	SENT_219	[p16l1700t111r1755b157],
45	either	DT	O	either	det	46	SENT_219	[p16l1789t104r1957b157],
46	genes	NNS	O	gene	prep_in	43	SENT_219	[p16l1990t124r2145b171],
47	(	VBP	O	(	_	0	SENT_219	[p16l13t191r74b255],
48	n	NN	O	n	dobj	47	SENT_219	[p16l13t191r74b255],
49	=	JJ	O	=	amod	51	SENT_219	[p16l106t213r148b229],
50	Zo	NN	O	zo	nn	51	SENT_219	[p16l183t194r249b245],
51	[	NN	O	[	dep	48	SENT_219	[p16l280t191r504b255],
52	4.8	CD	PERCENT	4.8	num	53	SENT_219	[p16l280t191r504b255],
53	%	NN	PERCENT	%	tmod	47	SENT_219	[p16l280t191r504b255],
54	]	CD	NUMBER	]	num	55	SENT_219	[p16l280t191r504b255],
55	)	NN	O	)	dep	53	SENT_219	[p16l280t191r504b255],
56	.	.	O	.	_	0	SENT_219	[p16l280t191r504b255],

1	The	DT	O	the	det	2	SENT_220	[p16l531t191r648b245],
2	carriers	NNS	O	carrier	nsubj	14	SENT_220	[p16l674t199r880b245],
3	of	IN	O	of	_	0	SENT_220	[p16l907t192r966b245],
4	all	DT	O	all	det	6	SENT_220	[p16l986t191r1054b245],
5	4	CD	NUMBER	4	num	6	SENT_220	[p16l1079t194r1111b250],
6	CFH	NN	O	cfh	prep_of	2	SENT_220	[p16l1138t193r1282b245],
7	and	CC	O	and	_	0	SENT_220	[p16l1309t191r1412b245],
8	ARMS2	NN	O	arms2	nn	10	SENT_220	[p16l1435t193r1662b245],
9	high	JJ	O	high	amod	10	SENT_220	[p16l1689t191r1946b259],
10	»	NN	O	»	nn	11	SENT_220	[p16l1689t191r1946b259],
11	risl	NN	O	risl	conj_and	2	SENT_220	[p16l1689t191r1946b259],
12	<	JJR	O	<	amod	13	SENT_220	[p16l1689t191r1946b259],
13	alleles	NNS	O	allele	dep	11	SENT_220	[p16l1972t191r2145b245],
14	demonstrated	VBD	O	demonstrate	_	0	SENT_220	[p16l9t277r399b331],
15	a	DT	O	a	det	19	SENT_220	[p16l421t300r449b331],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_220	[p16l470t278r816b345],
17	lower	JJR	O	lower	amod	19	SENT_220	[p16l838t277r994b331],
18	mean	NN	O	mean	nn	19	SENT_220	[p16l1015t299r1171b331],
19	VA	NN	O	va	dobj	14	SENT_220	[p16l1190t279r1296b332],
20	than	IN	O	than	_	0	SENT_220	[p16l1318t277r1449b331],
21	the	DT	O	the	det	23	SENT_220	[p16l1471t277r1562b331],
22	age	NN	O	age	nn	23	SENT_220	[p16l1585t277r1898b345],
23	—	NN	O	—	prep_than	19	SENT_220	[p16l1585t277r1898b345],
24	related	JJ	O	related	rcmod	19	SENT_220	[p16l1585t277r1898b345],
25	macular	JJ	O	macular	amod	26	SENT_220	[p16l1920t277r2147b331],
26	degeneration	NN	O	degeneration	iobj	24	SENT_220	[p16l9t365r383b432],
27	(	CD	NUMBER	(	num	30	SENT_220	[p16l421t365r636b428],
28	AMD	NNP	O	AMD	nn	30	SENT_220	[p16l421t365r636b428],
29	)	CD	NUMBER	)	num	30	SENT_220	[p16l421t365r636b428],
30	patients	NNS	O	patient	dobj	24	SENT_220	[p16l674t372r902b432],
31	carrying	VBG	O	carry	xcomp	14	SENT_220	[p16l938t372r1168b432],
32	Z	NN	O	z	dobj	31	SENT_220	[p16l1205t367r1251b428],
33	,	,	O	,	_	0	SENT_220	[p16l1205t367r1251b428],
34	l	NN	O	l	appos	32	SENT_220	[p16l1295t367r1337b428],
35	,	,	O	,	_	0	SENT_220	[p16l1295t367r1337b428],
36	or	CC	O	or	_	0	SENT_220	[p16l1375t386r1432b418],
37	no	DT	O	no	det	40	SENT_220	[p16l1465t386r1538b418],
38	high	JJ	O	high	amod	40	SENT_220	[p16l1572t365r1829b432],
39	—	NN	O	—	nn	40	SENT_220	[p16l1572t365r1829b432],
40	risl	NN	O	risl	dep	41	SENT_220	[p16l1572t365r1829b432],
41	<	JJR	O	<	conj_or	32	SENT_220	[p16l1572t365r1829b432],
42	CFH	CD	NUMBER	cfh	dep	32	SENT_220	[p16l1863t367r2007b418],
43	and	CC	O	and	_	0	SENT_220	[p16l2043t365r2147b418],
44	ARMSZ	NN	O	armsz	nn	45	SENT_220	[p16l7t454r234b506],
45	alleles	NNS	O	allele	dep	32	SENT_220	[p16l272t452r461b506],
46	.	.	O	.	_	0	SENT_220	[p16l272t452r461b506],

1	B	NN	O	b	_	0	SENT_221	[p16l497t455r559b516],
2	,	,	O	,	_	0	SENT_221	[p16l497t455r559b516],
3	The	DT	O	the	det	4	SENT_221	[p16l595t452r712b506],
4	age	NN	O	age	appos	1	SENT_221	[p16l748t473r839b520],
5	when	WRB	O	when	advmod	11	SENT_221	[p16l874t452r1031b506],
6	ﬁrst	NN	O	ﬁrst	nn	8	SENT_221	[p16l1065t453r1170b506],
7	ranibizumab	NN	O	ranibizumab	nn	8	SENT_221	[p16l1204t452r1553b506],
8	injection	NN	O	injection	nsubjpass	11	SENT_221	[p16l1591t460r1849b519],
9	has	VBZ	O	have	aux	11	SENT_221	[p16l1882t452r1975b506],
10	been	VBN	O	be	auxpass	11	SENT_221	[p16l2010t452r2147b506],
11	administrated	VBN	O	administrate	dep	4	SENT_221	[p16l10t538r403b592],
12	(	CD	NUMBER	(	num	13	SENT_221	[p16l432t538r643b606],
13	y	NN	O	y	nsubj	16	SENT_221	[p16l432t538r643b606],
14	—	CD	NUMBER	—	num	15	SENT_221	[p16l432t538r643b606],
15	aXis	NN	O	axis	dep	13	SENT_221	[p16l432t538r643b606],
16	)	CD	NUMBER	)	xcomp	11	SENT_221	[p16l432t538r643b606],
17	clustered	VBN	O	cluster	partmod	16	SENT_221	[p16l673t538r928b592],
18	by	IN	O	by	_	0	SENT_221	[p16l952t538r1018b606],
19	CFH	NNP	O	CFH	agent	17	SENT_221	[p16l1043t541r1187b592],
20	and	CC	O	and	_	0	SENT_221	[p16l1214t538r1318b592],
21	ARMS2	NN	O	arms2	nn	23	SENT_221	[p16l1340t541r1567b592],
22	allelic	JJ	O	allelic	amod	23	SENT_221	[p16l1596t538r1767b592],
23	composition	NN	O	composition	agent	17	SENT_221	[p16l1792t546r2147b606],
24	as	IN	O	as	mark	25	SENT_221	[p16l10t648r61b680],
25	mentioned	VBN	O	mention	advcl	17	SENT_221	[p16l96t626r406b680],
26	above	IN	O	above	prep	25	SENT_221	[p16l440t626r622b680],
27	.	.	O	.	_	0	SENT_221	[p16l440t626r622b680],

1	The	DT	O	the	det	2	SENT_222	[p16l657t626r774b680],
2	carriers	NNS	O	carrier	nsubj	11	SENT_222	[p16l808t633r1015b680],
3	of	IN	O	of	_	0	SENT_222	[p16l1049t626r1108b680],
4	all	DT	O	all	det	6	SENT_222	[p16l1137t626r1204b680],
5	4	CD	NUMBER	4	num	6	SENT_222	[p16l1237t628r1270b684],
6	alleles	NNS	O	allele	prep_of	2	SENT_222	[p16l1306t626r1479b680],
7	in	IN	O	in	_	0	SENT_222	[p16l1515t633r1571b680],
8	CFH	NNP	O	CFH	prep_in	6	SENT_222	[p16l1603t628r1748b680],
9	and	CC	O	and	_	0	SENT_222	[p16l1783t626r1886b680],
10	ARMS2	NN	O	arms2	prep_in	6	SENT_222	[p16l1917t628r2144b680],
11	received	VBD	O	receive	_	0	SENT_222	[p16l9t714r248b768],
12	their	PRP$	O	they	poss	15	SENT_222	[p16l281t714r417b768],
13	first	JJ	ORDINAL	first	amod	15	SENT_222	[p16l447t715r552b768],
14	ranibizumab	NN	O	ranibizumab	nn	15	SENT_222	[p16l583t714r932b768],
15	injection	NN	O	injection	dobj	11	SENT_222	[p16l967t722r1224b781],
16	at	IN	O	at	_	0	SENT_222	[p16l1256t731r1308b768],
17	a	DT	O	a	det	20	SENT_222	[p16l1341t736r1370b768],
18	signiﬁcantly	JJ	O	signiﬁcantly	amod	20	SENT_222	[p16l1401t714r1746b782],
19	younger	JJR	O	younger	amod	20	SENT_222	[p16l1777t735r2006b782],
20	age	NN	O	age	prep_at	11	SENT_222	[p16l2037t735r2144b782],
21	,	,	O	,	_	0	SENT_222	[p16l2037t735r2144b782],
22	indicating	VBG	O	indicate	partmod	11	SENT_222	[p16l11t800r300b868],
23	that	IN	O	that	complm	30	SENT_222	[p16l319t801r435b854],
24	those	DT	O	those	det	27	SENT_222	[p16l454t800r604b854],
25	high	JJ	O	high	amod	27	SENT_222	[p16l622t800r879b868],
26	—	NN	O	—	nn	27	SENT_222	[p16l622t800r879b868],
27	risl	NN	O	risl	nsubj	30	SENT_222	[p16l622t800r879b868],
28	<	JJR	O	<	amod	29	SENT_222	[p16l622t800r879b868],
29	genes	NNS	O	gene	dep	27	SENT_222	[p16l897t821r1052b868],
30	lead	VBP	O	lead	ccomp	22	SENT_222	[p16l1072t800r1188b854],
31	to	TO	O	to	_	0	SENT_222	[p16l1207t817r1262b854],
32	an	DT	O	a	det	34	SENT_222	[p16l1282t822r1351b854],
33	earlier	JJR	O	earlier	amod	34	SENT_222	[p16l1369t800r1549b854],
34	onset	NN	O	onset	prep_to	30	SENT_222	[p16l1567t817r1719b854],
35	of	IN	O	of	_	0	SENT_222	[p16l1737t801r1796b854],
36	neovascular	JJ	O	neovascular	amod	37	SENT_222	[p16l1808t800r2147b854],
37	AMD	NNP	O	AMD	prep_of	34	SENT_222	[p16l8t889r191b941],
38	.	.	O	.	_	0	SENT_222	[p16l8t889r191b941],

1	logMAR	NN	O	logmar	nn	3	SENT_223	[p16l222t888r473b955],
2	=	JJ	O	=	amod	3	SENT_223	[p16l505t909r548b926],
3	logarithm	NN	O	logarithm	_	0	SENT_223	[p16l582t888r861b955],
4	of	IN	O	of	_	0	SENT_223	[p16l887t888r945b941],
5	the	DT	O	the	det	7	SENT_223	[p16l967t888r1057b941],
6	minimum	JJ	O	minimum	amod	7	SENT_223	[p16l1085t895r1364b941],
7	angle	NN	O	angle	prep_of	3	SENT_223	[p16l1391t888r1541b955],
8	of	IN	O	of	_	0	SENT_223	[p16l1569t888r1627b941],
9	resolution	NN	O	resolution	prep_of	3	SENT_223	[p16l1647t888r1949b941],
10	.	.	O	.	_	0	SENT_223	[p16l1647t888r1949b941],

1	beneﬁcial	JJ	O	beneﬁcial	amod	2	SENT_224	[p16l7t1117r352b1179],
2	use	NN	O	use	nsubjpass	38	SENT_224	[p16l388t1136r504b1179],
3	of	IN	O	of	_	0	SENT_224	[p16l541t1116r617b1179],
4	antioxidants	NNS	O	antioxidant	prep_of	2	SENT_224	[p16l648t1116r1078b1179],
5	and	CC	O	and	_	0	SENT_224	[p16l1117t1117r1242b1179],
6	zinc	NN	O	zinc	nn	7	SENT_224	[p16l1277t1116r1421b1179],
7	supplementation	NN	O	supplementation	prep_of	2	SENT_224	[p16l1460t1117r2044b1197],
8	in	IN	O	in	_	0	SENT_224	[p16l2079t1117r2146b1178],
9	slowing	VBG	O	slow	prepc_in	2	SENT_224	[p16l12t1213r287b1294],
10	down	RP	O	down	prt	9	SENT_224	[p16l317t1213r512b1275],
11	the	DT	O	the	det	12	SENT_224	[p16l540t1213r646b1275],
12	progression	NN	O	progression	dobj	9	SENT_224	[p16l673t1213r1088b1294],
13	of	IN	O	of	_	0	SENT_224	[p16l1117t1213r1194b1275],
14	AMD	NNP	ORGANIZATION	AMD	prep_of	12	SENT_224	[p16l1216t1201r1510b1275],
15	.36	CD	NUMBER	.36	num	14	SENT_224	[p16l1216t1201r1510b1275],
16	Identifying	VBG	O	identify	xcomp	9	SENT_224	[p16l1539t1213r1931b1294],
17	highrisk	JJ	O	highrisk	amod	18	SENT_224	[p16l1960t1213r2143b1294, p16l8t1311r142b1373],
18	individuals	NNS	O	individual	dobj	16	SENT_224	[p16l165t1311r557b1373],
19	during	IN	O	during	_	0	SENT_224	[p16l586t1311r814b1391],
20	advanced	JJ	O	advanced	amod	21	SENT_224	[p16l842t1311r1175b1373],
21	stages	NNS	O	stage	prep_during	16	SENT_224	[p16l1203t1320r1413b1391],
22	of	IN	O	of	_	0	SENT_224	[p16l1442t1311r1519b1373],
23	the	DT	O	the	det	24	SENT_224	[p16l1538t1311r1644b1373],
24	disease	NN	O	disease	prep_of	21	SENT_224	[p16l1671t1311r1925b1373],
25	could	MD	O	could	aux	26	SENT_224	[p16l1951t1311r2147b1373],
26	lead	VB	O	lead	_	0	SENT_224	[p16l9t1408r156b1470],
27	to	TO	O	to	_	0	SENT_224	[p16l186t1417r252b1470],
28	more	JJR	O	more	dep	29	SENT_224	[p16l285t1427r465b1470],
29	frequent	JJ	O	frequent	amod	31	SENT_224	[p16l498t1408r793b1488],
30	clinical	JJ	O	clinical	amod	31	SENT_224	[p16l824t1408r1083b1470],
31	surveillance	NN	O	surveillance	prep_to	26	SENT_224	[p16l1118t1408r1543b1470],
32	in	IN	O	in	_	0	SENT_224	[p16l1575t1408r1642b1469],
33	such	JJ	O	such	amod	34	SENT_224	[p16l1677t1408r1835b1470],
34	individuals	NNS	O	individual	prep_in	31	SENT_224	[p16l1866t1408r2143b1470, p16l8t1504r147b1566],
35	and	CC	O	and	_	0	SENT_224	[p16l191t1504r316b1566],
36	could	MD	O	could	aux	38	SENT_224	[p16l356t1504r551b1566],
37	be	VB	O	be	auxpass	38	SENT_224	[p16l589t1504r671b1566],
38	used	VBN	O	use	conj_and	26	SENT_224	[p16l710t1504r872b1566],
39	for	IN	O	for	_	0	SENT_224	[p16l911t1504r1014b1566],
40	identifying	VBG	O	identify	prepc_for	38	SENT_224	[p16l1052t1504r1440b1585],
41	patients	NNS	O	patient	dobj	40	SENT_224	[p16l1479t1504r1753b1585],
42	for	IN	O	for	_	0	SENT_224	[p16l1795t1504r1898b1566],
43	future	JJ	DATE	future	amod	45	SENT_224	[p16l1936t1504r2146b1566],
44	clinical	JJ	O	clinical	amod	45	SENT_224	[p16l9t1602r268b1664],
45	trials	NNS	O	trial	prep_for	41	SENT_224	[p16l305t1602r478b1664],
46	designed	VBN	O	design	partmod	45	SENT_224	[p16l518t1602r832b1682],
47	to	TO	O	to	aux	48	SENT_224	[p16l867t1611r933b1664],
48	evaluate	VB	O	evaluate	xcomp	46	SENT_224	[p16l971t1602r1265b1664],
49	new	JJ	O	new	amod	50	SENT_224	[p16l1301t1622r1446b1664],
50	treatments	NNS	O	treatment	dobj	48	SENT_224	[p16l1483t1611r1870b1664],
51	.	.	O	.	_	0	SENT_224	[p16l1483t1611r1870b1664],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_225	[p16l1911t1602r2143b1664, p16l8t1699r222b1779],
2	options	NNS	O	option	nsubjpass	8	SENT_225	[p16l270t1699r527b1779],
3	for	IN	O	for	_	0	SENT_225	[p16l575t1699r677b1761],
4	late-stage	JJ	O	late-stage	amod	5	SENT_225	[p16l721t1699r1059b1779],
5	AMD	NNP	ORGANIZATION	AMD	prep_for	2	SENT_225	[p16l1105t1699r1308b1760],
6	currently	RB	DATE	currently	advmod	8	SENT_225	[p16l1356t1699r1674b1779],
7	are	VBP	O	be	auxpass	8	SENT_225	[p16l1722t1718r1826b1761],
8	limited	VBN	O	limit	_	0	SENT_225	[p16l1871t1699r2142b1772],
9	;	:	O	;	_	0	SENT_225	[p16l1871t1699r2142b1772],
10	however	RB	O	however	advmod	14	SENT_225	[p16l8t1795r332b1869],
11	,	,	O	,	_	0	SENT_225	[p16l8t1795r332b1869],
12	this	DT	O	this	nsubj	14	SENT_225	[p16l382t1795r506b1857],
13	could	MD	O	could	aux	14	SENT_225	[p16l556t1795r751b1857],
14	change	VB	O	change	parataxis	8	SENT_225	[p16l798t1795r1047b1876],
15	in	IN	O	in	_	0	SENT_225	[p16l1093t1795r1160b1857],
16	the	DT	DATE	the	det	18	SENT_225	[p16l1207t1795r1313b1857],
17	near	JJ	DATE	near	amod	18	SENT_225	[p16l1360t1815r1512b1857],
18	future	NN	DATE	future	prep_in	14	SENT_225	[p16l1558t1795r1785b1857],
19	.	.	O	.	_	0	SENT_225	[p16l1558t1795r1785b1857],

1	Ongoing	JJ	O	ongoing	amod	3	SENT_226	[p16l1838t1795r2145b1876],
2	clinical	JJ	O	clinical	amod	3	SENT_226	[p16l9t1893r268b1955],
3	trials	NNS	O	trial	nsubj	6	SENT_226	[p16l317t1893r491b1955],
4	currently	RB	DATE	currently	advmod	6	SENT_226	[p16l542t1893r860b1973],
5	are	VBP	O	be	aux	6	SENT_226	[p16l911t1913r1015b1955],
6	testing	VBG	O	test	_	0	SENT_226	[p16l1064t1893r1298b1973],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_226	[p16l1348t1893r1740b1973],
8	effects	NNS	O	effect	dobj	6	SENT_226	[p16l1791t1893r2024b1955],
9	of	IN	O	of	_	0	SENT_226	[p16l2075t1893r2152b1955],
10	complement	NN	O	complement	nn	11	SENT_226	[p16l9t1990r448b2070],
11	inhibition	NN	O	inhibition	prep_of	8	SENT_226	[p16l499t1990r844b2052],
12	in	IN	O	in	_	0	SENT_226	[p16l895t1990r962b2051],
13	neovascular	JJ	O	neovascular	amod	16	SENT_226	[p16l1014t1990r1439b2052],
14	and	CC	O	and	_	0	SENT_226	[p16l1492t1990r1616b2052],
15	nonexudative	JJ	O	nonexudative	conj_and	13	SENT_226	[p16l1668t1990r2145b2052],
16	AMD	NNP	O	AMD	prep_in	6	SENT_226	[p16l8t2086r301b2160],
17	.37	CD	NUMBER	.37	num	16	SENT_226	[p16l8t2086r301b2160],
18	One	CD	NUMBER	one	num	20	SENT_226	[p16l339t2099r483b2161],
19	clinical	JJ	O	clinical	amod	20	SENT_226	[p16l518t2098r777b2160],
20	trial	NN	O	trial	nsubj	22	SENT_226	[p16l811t2098r952b2160],
21	is	VBZ	O	be	aux	22	SENT_226	[p16l986t2098r1041b2160],
22	using	VBG	O	use	rcmod	16	SENT_226	[p16l1076t2098r1266b2179],
23	a	DT	O	a	det	24	SENT_226	[p16l1303t2118r1340b2160],
24	combination	NN	O	combination	dobj	22	SENT_226	[p16l1373t2098r1816b2160],
25	of	IN	O	of	_	0	SENT_226	[p16l1850t2098r1927b2160],
26	intravitreal	JJ	O	intravitreal	amod	27	SENT_226	[p16l1955t2098r2143b2160, p16l9t2196r234b2258],
27	therapy	NN	O	therapy	prep_of	24	SENT_226	[p16l270t2196r534b2276],
28	of	IN	O	of	_	0	SENT_226	[p16l571t2196r648b2258],
29	anti-C5	JJ	O	anti-c5	amod	34	SENT_226	[p16l679t2196r1261b2276],
30	—	NN	O	—	nn	34	SENT_226	[p16l679t2196r1261b2276],
31	aptamer	NN	O	aptamer	nn	34	SENT_226	[p16l679t2196r1261b2276],
32	(	CD	NUMBER	(	num	34	SENT_226	[p16l1298t2196r1711b2273],
33	ARCl905	NN	O	arcl905	nn	34	SENT_226	[p16l1298t2196r1711b2273],
34	)	NN	O	)	prep_of	27	SENT_226	[p16l1298t2196r1711b2273],
35	and	CC	O	and	_	0	SENT_226	[p16l1751t2196r1876b2258],
36	ranibizumab	NN	O	ranibizumab	prep_of	27	SENT_226	[p16l1910t2196r2144b2258, p16l10t2281r331b2355],
37	.37	CD	NUMBER	.37	num	36	SENT_226	[p16l1910t2196r2144b2258, p16l10t2281r331b2355],
38	Those	DT	O	those	det	40	SENT_226	[p16l355t2293r570b2355],
39	AMD	NN	O	amd	nn	40	SENT_226	[p16l593t2293r797b2354],
40	patients	NNS	O	patient	dep	36	SENT_226	[p16l820t2293r1094b2373],
41	with	IN	O	with	_	0	SENT_226	[p16l1119t2293r1275b2355],
42	high-risk	JJ	O	high-risk	amod	43	SENT_226	[p16l1296t2293r1618b2373],
43	genotypes	NNS	O	genotype	prep_with	22	SENT_226	[p16l1639t2302r1996b2373],
44	and	CC	O	and	_	0	SENT_226	[p16l2022t2293r2147b2355],
45	decreased	VBD	O	decrease	conj_and	22	SENT_226	[p16l10t2389r358b2451],
46	response	NN	O	response	nn	47	SENT_226	[p16l409t2409r720b2470],
47	rates	NNS	O	rate	nsubj	52	SENT_226	[p16l772t2399r937b2451],
48	to	TO	O	to	_	0	SENT_226	[p16l992t2398r1058b2451],
49	ranibizumab	JJ	O	ranibizumab	amod	50	SENT_226	[p16l1111t2389r1553b2451],
50	treatment	NN	O	treatment	prep_to	47	SENT_226	[p16l1607t2398r1943b2451],
51	may	MD	O	may	aux	52	SENT_226	[p16l1995t2409r2145b2470],
52	demonstrate	VB	O	demonstrate	ccomp	45	SENT_226	[p16l10t2487r442b2549],
53	greater	JJR	O	greater	amod	54	SENT_226	[p16l494t2496r739b2567],
54	beneﬁt	NN	O	beneﬁt	dobj	52	SENT_226	[p16l787t2487r1029b2549],
55	from	IN	O	from	_	0	SENT_226	[p16l1079t2487r1251b2549],
56	a	DT	O	a	det	58	SENT_226	[p16l1301t2507r1338b2549],
57	combination	NN	O	combination	nn	58	SENT_226	[p16l1388t2487r1831b2549],
58	therapy	NN	O	therapy	prep_from	52	SENT_226	[p16l1881t2487r2145b2567],
59	with	IN	O	with	_	0	SENT_226	[p16l9t2584r165b2646],
60	complement	NN	O	complement	nn	61	SENT_226	[p16l191t2584r630b2664],
61	inhibition	NN	O	inhibition	prep_with	58	SENT_226	[p16l654t2584r998b2646],
62	and	CC	O	and	_	0	SENT_226	[p16l1025t2584r1151b2646],
63	anti-VEGF	NN	O	anti-vegf	conj_and	61	SENT_226	[p16l1177t2584r1587b2646],
64	.	.	O	.	_	0	SENT_226	[p16l1177t2584r1587b2646],

1	A	DT	O	a	det	2	SENT_227	[p16l1617t2584r1679b2645],
2	limitation	NN	O	limitation	_	0	SENT_227	[p16l1705t2584r2049b2646],
3	of	IN	O	of	prep	2	SENT_227	[p16l2075t2584r2152b2646],

1	E	NN	O	e	_	0	SENT_228	[p17l280t93r360b126],

1	vi	LS	O	vi	dep	4	SENT_229	[p17l1593t145r1609b161],
2	III	CD	NUMBER	iii	number	3	SENT_229	[p17l276t206r299b238],
3	75	CD	NUMBER	75	num	4	SENT_229	[p17l315t206r370b238],
4	‘	CD	NUMBER	‘	_	0	SENT_229	[p17l1574t187r1629b222],
5	*	NN	O	*	dep	9	SENT_229	[p17l1574t187r1629b222],
6	'	''	O	'	_	0	SENT_229	[p17l1574t187r1629b222],
7	i	FW	O	i	dep	5	SENT_229	[p17l286t239r290b241],
8	E	NN	O	e	dep	9	SENT_229	[p17l302t234r309b241],
9	I	PRP	O	I	dep	4	SENT_229	[p17l347t239r350b241],
10	9	CD	NUMBER	9	dep	9	SENT_229	[p17l896t241r909b257],
11	'	''	O	'	_	0	SENT_229	[p17l896t241r909b257],
12	o	NN	O	o	dobj	4	SENT_229	[p17l1244t250r1257b264],
13	-	:	O	-	_	0	SENT_229	[p17l1593t250r1629b264],
14	I-It	NN	O	i-it	nn	16	SENT_229	[p17l1593t250r1629b264],
15	V	NN	O	v	nn	16	SENT_229	[p17l1985t270r1988b271],
16	Y	NN	O	y	dep	12	SENT_229	[p17l36t270r68b315],
17	*	CD	NUMBER	*	dep	16	SENT_229	[p17l36t270r68b315],
18	vi	LS	O	vi	dep	4	SENT_229	[p17l1244t286r1257b302],
19	1	CD	NUMBER	1	dobj	4	SENT_229	[p17l1552t286r1648b302],
20	--	:	O	--	_	0	SENT_229	[p17l1552t286r1648b302],
21	ii-am	JJ	O	ii-am	amod	28	SENT_229	[p17l1552t286r1648b302],
22	um	NN	O	um	nn	28	SENT_229	[p17l1921t273r1995b302],
23	‘	NN	O	‘	nn	28	SENT_229	[p17l1921t273r1995b302],
24	ig	NN	O	ig	nn	28	SENT_229	[p17l36t318r68b398],
25	Y	NN	O	y	nn	28	SENT_229	[p17l87t328r139b379],
26	*	CD	NUMBER	*	num	28	SENT_229	[p17l87t328r139b379],
27	U.	NNP	O	U.	nn	28	SENT_229	[p17l276t328r370b360],
28	5l	NN	O	5l	dep	19	SENT_229	[p17l276t328r370b360],
29	.	.	O	.	_	0	SENT_229	[p17l276t328r370b360],
30	'	''	O	'	_	0	SENT_229	[p17l276t328r370b360],

1	.	.	O	.	_	0	SENT_230	[p17l276t328r370b360],

1	l	NN	O	l	_	0	SENT_231	[p17l276t328r370b360],
2	II	CD	NUMBER	ii	dep	1	SENT_231	[p17l896t344r909b360],
3	!	.	O	!	_	0	SENT_231	[p17l1202t331r1298b386],

1	:	:	O	:	_	0	SENT_232	[p17l1202t331r1298b386],
2	:	:	O	:	_	0	SENT_232	[p17l1202t331r1298b386],
3	'	''	O	'	_	0	SENT_232	[p17l1202t331r1298b386],
4	:	:	O	:	_	0	SENT_232	[p17l1202t331r1298b386],
5	+	CC	O	+	_	0	SENT_232	[p17l1202t331r1298b386],
6	"	``	O	"	punct	3	SENT_232	[p17l1513t337r1687b379],
7	-	:	O	-	_	0	SENT_232	[p17l1513t337r1687b379],
8	"	``	O	"	punct	3	SENT_232	[p17l1513t337r1687b379],
9	"	``	O	"	punct	10	SENT_232	[p17l1513t337r1687b379],
10	vii	LS	O	vii	conj_+	3	SENT_232	[p17l1513t337r1687b379],
11	,	,	O	,	_	0	SENT_232	[p17l1513t337r1687b379],
12	:1	CD	NUMBER	:1	appos	10	SENT_232	[p17l1513t337r1687b379],
13	.	.	O	.	_	0	SENT_232	[p17l1513t337r1687b379],

1	r	NN	O	r	_	0	SENT_233	[p17l1513t337r1687b379],
2	*	CD	NUMBER	*	dep	1	SENT_233	[p17l1513t337r1687b379],
3	"	``	O	"	prep	2	SENT_233	[p17l1513t337r1687b379],
4	'	''	O	'	_	0	SENT_233	[p17l1921t327r1956b360],
5	1	CD	NUMBER	1	num	6	SENT_233	[p17l1921t327r1956b360],
6	»	CD	NUMBER	»	dep	3	SENT_233	[p17l1921t327r1956b360],
7	i	FW	O	i	nn	9	SENT_233	[p17l36t385r37b388],
8	‘	FW	O	‘	nn	9	SENT_233	[p17l87t382r126b418],
9	E	NN	O	e	dep	1	SENT_233	[p17l87t382r126b418],
10	in	IN	O	in	prep	9	SENT_233	[p17l896t382r909b395],
11	in	IN	O	in	pcomp	10	SENT_233	[p17l1244t379r1272b410],
12	V	NN	O	v	nn	14	SENT_233	[p17l1571t402r1573b405],
13	4	CD	NUMBER	4	num	14	SENT_233	[p17l1593t379r1648b411],
14	*	NN	O	*	pobj	11	SENT_233	[p17l1593t379r1648b411],
15	,	,	O	,	_	0	SENT_233	[p17l1593t379r1648b411],
16	an	DT	O	a	det	18	SENT_233	[p17l1940t379r1976b395],
17	pm	NN	O	pm	nn	18	SENT_233	[p17l29t414r126b466],
18	Y	NN	O	y	appos	1	SENT_233	[p17l29t414r126b466],
19	*	CD	NUMBER	*	num	20	SENT_233	[p17l29t414r126b466],
20	U	NNP	O	U	dep	18	SENT_233	[p17l276t440r299b472],
21	25	CD	NUMBER	25	num	20	SENT_233	[p17l315t440r360b472],
22	--	:	O	--	_	0	SENT_233	[p17l514t424r562b444],
23	it	PRP	O	it	dep	18	SENT_233	[p17l514t424r562b444],
24	-9	CD	NUMBER	-9	dep	23	SENT_233	[p17l874t427r928b469],
25	;	:	O	;	_	0	SENT_233	[p17l874t427r928b469],
26	‘	CD	NUMBER	‘	num	27	SENT_233	[p17l874t427r928b469],
27	~	NN	O	~	dep	18	SENT_233	[p17l1144t408r1359b469],
28	I	PRP	O	I	dep	27	SENT_233	[p17l1144t408r1359b469],
29	,	,	O	,	_	0	SENT_233	[p17l1144t408r1359b469],
30	a4	NN	O	a4	appos	1	SENT_233	[p17l1144t408r1359b469],
31	.	.	O	.	_	0	SENT_233	[p17l1144t408r1359b469],

1	~	NN	O	~	_	0	SENT_234	[p17l1144t408r1359b469],
2	+	CC	O	+	nsubj	3	SENT_234	[p17l1144t408r1359b469],
3	-	:	O	-	_	0	SENT_234	[p17l1144t408r1359b469],
4	;	:	O	;	_	0	SENT_234	[p17l1144t408r1359b469],
5	-	:	O	-	_	0	SENT_234	[p17l1144t408r1359b469],
6	i	FW	O	i	dep	3	SENT_234	[p17l1144t408r1359b469],
7	:	:	O	:	_	0	SENT_234	[p17l1144t408r1359b469],
8	€	CD	NUMBER	€	num	9	SENT_234	[p17l1144t408r1359b469],
9	nr.M-q	NN	O	nr.m-q	dep	6	SENT_234	[p17l1144t408r1359b469],
10	-	:	O	-	_	0	SENT_234	[p17l1144t408r1359b469],
11	$	$	MONEY	$	amod	13	SENT_234	[p17l1494t408r1709b469],
12	3	CD	MONEY	3	number	11	SENT_234	[p17l1494t408r1709b469],
13	?!	NN	O	?!	dep	9	SENT_234	[p17l1494t408r1709b469],

1	-	:	O	-	_	0	SENT_235	[p17l1494t408r1709b469],
2	ip	NN	O	ip	_	0	SENT_235	[p17l1494t408r1709b469],
3	:	:	O	:	_	0	SENT_235	[p17l1494t408r1709b469],
4	ﬂ	VB	O	ﬂ	dep	7	SENT_235	[p17l1494t408r1709b469],
5	*	NN	O	*	dobj	4	SENT_235	[p17l1494t408r1709b469],
6	1	CD	NUMBER	1	num	5	SENT_235	[p17l1494t408r1709b469],
7	page	NN	O	page	dep	2	SENT_235	[p17l1901t427r1995b456],
8	‘	NN	O	‘	dep	7	SENT_235	[p17l1901t427r1995b456],
9	!	.	O	!	_	0	SENT_235	[p17l1901t427r1995b456],

1	|	NN	O	|	_	0	SENT_236	[p17l97t463r99b469],
2	I	CD	NUMBER	i	num	1	SENT_236	[p17l302t466r309b472],
3	Y	NN	O	y	dep	1	SENT_236	[p17l1244t462r1257b482],
4	*	CD	NUMBER	*	num	3	SENT_236	[p17l1244t462r1257b482],
5	.	.	O	.	_	0	SENT_236	[p17l1331t472r1333b474],

1	I	PRP	O	I	_	0	SENT_237	[p17l1508t479r1510b482],
2	V	NN	O	v	dep	1	SENT_237	[p17l1707t476r1709b482],

1	E	NN	O	e	nn	2	SENT_238	[p17l36t472r68b524],
2	E	NN	O	e	_	0	SENT_238	[p17l97t462r139b517],
3	?	.	O	?	_	0	SENT_238	[p17l97t462r139b517],

1	T	NN	O	t	nn	2	SENT_239	[p17l899t508r902b509],
2	M.i.	NN	O	m.i.	_	0	SENT_239	[p17l1144t472r1356b501],
3	:	:	O	:	_	0	SENT_239	[p17l1144t472r1356b501],
4	.	.	O	.	_	0	SENT_239	[p17l1144t472r1356b501],

1	*	NN	O	*	_	0	SENT_240	[p17l1144t472r1356b501],
2	.	.	O	.	_	0	SENT_240	[p17l1144t472r1356b501],

1	.	.	O	.	_	0	SENT_241	[p17l1144t472r1356b501],

1	+	CC	O	+	dep	3	SENT_242	[p17l1144t472r1356b501],
2	--	:	O	--	_	0	SENT_242	[p17l1144t472r1356b501],
3	:53	CD	NUMBER	:53	_	0	SENT_242	[p17l1494t459r1549b501],
4	_	CD	NUMBER	_	num	6	SENT_242	[p17l1658t499r1680b501],
5	>	JJR	O	>	amod	6	SENT_242	[p17l1658t499r1680b501],
6	c	NN	O	c	dep	3	SENT_242	[p17l1699t491r1709b501],
7	Y	NN	O	y	nn	9	SENT_242	[p17l1699t491r1709b501],
8	*	CD	NUMBER	*	num	9	SENT_242	[p17l1699t491r1709b501],
9	Kauai	NNP	LOCATION	Kauai	dep	3	SENT_242	[p17l1825t472r2072b508],
10	:	:	O	:	_	0	SENT_242	[p17l1825t472r2072b508],
11	W	NNP	O	W	nn	12	SENT_242	[p17l36t526r68b553],
12	E	NNP	O	E	dep	9	SENT_242	[p17l87t520r139b549],
13	!	.	O	!	_	0	SENT_242	[p17l87t520r139b549],

1	I	PRP	O	I	nsubj	9	SENT_243	[p17l543t507r562b527],
2	‘	SYM	O	‘	dep	9	SENT_243	[p17l543t507r562b527],
3	-	:	O	-	_	0	SENT_243	[p17l816t510r989b543],
4	Ii	NN	O	ii	dobj	9	SENT_243	[p17l816t510r989b543],
5	-	:	O	-	_	0	SENT_243	[p17l816t510r989b543],
6	+	CC	O	+	cc	7	SENT_243	[p17l816t510r989b543],
7	np	NN	O	np	dep	4	SENT_243	[p17l816t510r989b543],
8	:	:	O	:	_	0	SENT_243	[p17l816t510r989b543],
9	,	,	O	,	_	0	SENT_243	[p17l816t510r989b543],
10	.	.	O	.	_	0	SENT_243	[p17l816t510r989b543],

1	,1	NN	O	,1	nsubj	9	SENT_244	[p17l816t510r989b543],
2	--	:	O	--	_	0	SENT_244	[p17l816t510r989b543],
3	Qvt	SYM	O	qvt	dep	1	SENT_244	[p17l816t510r989b543],
4	-	:	O	-	_	0	SENT_244	[p17l1128t504r1375b562],
5	i	FW	O	i	dep	1	SENT_244	[p17l1475t533r1476b536],
6	'	''	O	'	_	0	SENT_244	[p17l1508t514r1510b517],
7	'	''	O	'	_	0	SENT_244	[p17l1558t514r1562b516],
8	"	``	O	"	punct	9	SENT_244	[p17l1638t521r1661b522],
9	V.	NNP	O	V.	_	0	SENT_244	[p17l1982t552r2017b565],
10	‘	CD	NUMBER	‘	number	11	SENT_244	[p17l1982t552r2017b565],
11	3	CD	NUMBER	3	dep	12	SENT_244	[p17l29t571r68b610],
12	m	NN	O	m	amod	9	SENT_244	[p17l97t565r129b594],
13	a	DT	O	a	dep	14	SENT_244	[p17l276t552r299b585],
14	no	DT	O	no	advmod	12	SENT_244	[p17l315t552r360b585],
15	-	:	O	-	_	0	SENT_244	[p17l524t562r527b564],
16	F	NN	O	f	nn	17	SENT_244	[p17l560t569r818b570],
17	s	NNS	O	s	dep	36	SENT_244	[p17l899t565r902b567],
18	e	LS	O	e	prep	17	SENT_244	[p17l1158t569r1165b570],
19	e	SYM	O	e	dep	20	SENT_244	[p17l1197t569r1204b570],
20	~	CD	NUMBER	~	dep	18	SENT_244	[p17l1998t569r2009b570],
21	:	:	O	:	_	0	SENT_244	[p17l39t613r68b639],
22	p	NN	O	p	dep	29	SENT_244	[p17l87t597r126b646],
23	#	#	O	#	prep	22	SENT_244	[p17l87t597r126b646],
24	Y	NN	O	y	nn	27	SENT_244	[p17l87t597r126b646],
25	*	CD	NUMBER	*	num	27	SENT_244	[p17l87t597r126b646],
26	'	''	O	'	_	0	SENT_244	[p17l1494t601r1687b633],
27	*	NN	O	*	dep	23	SENT_244	[p17l1494t601r1687b633],
28	'	''	O	'	_	0	SENT_244	[p17l1494t601r1687b633],
29	+	CC	O	+	dep	18	SENT_244	[p17l1494t601r1687b633],
30	¢	SYM	O	¢	dep	17	SENT_244	[p17l1494t601r1687b633],
31	-	:	O	-	_	0	SENT_244	[p17l1494t601r1687b633],
32	in	IN	O	in	dep	17	SENT_244	[p17l1494t601r1687b633],
33	-	:	O	-	_	0	SENT_244	[p17l1494t601r1687b633],
34	,	,	O	,	_	0	SENT_244	[p17l1494t601r1687b633],
35	¢	NN	O	¢	appos	17	SENT_244	[p17l1494t601r1687b633],
36	+	CC	O	+	dep	9	SENT_244	[p17l1494t601r1687b633],
37	e	SYM	O	e	dep	9	SENT_244	[p17l1494t601r1687b633],
38	'	''	O	'	_	0	SENT_244	[p17l1494t601r1687b633],
39	|	NN	O	|	dobj	9	SENT_244	[p17l1494t601r1687b633],
40	'	''	O	'	_	0	SENT_244	[p17l1494t601r1687b633],
41	.1	CD	NUMBER	.1	num	43	SENT_244	[p17l1921t613r1956b636, p17l29t642r68b683],
42	QE	NN	O	qe	nn	43	SENT_244	[p17l1921t613r1956b636, p17l29t642r68b683],
43	w	NN	O	w	rcmod	39	SENT_244	[p17l97t649r129b703],
44	‘	CD	NUMBER	‘	advmod	45	SENT_244	[p17l358t674r360b678],
45	T	NN	O	t	dep	43	SENT_244	[p17l431t658r678b678],
46	:35	CD	NUMBER	:35	number	47	SENT_244	[p17l1244t649r1279b684],
47	*	CD	NUMBER	*	dobj	45	SENT_244	[p17l1533t639r1668b687],
48	‘	NN	O	‘	dep	47	SENT_244	[p17l1533t639r1668b687],
49	''	''	O	''	_	0	SENT_244	[p17l1533t639r1668b687],
50	'	''	O	'	_	0	SENT_244	[p17l1533t639r1668b687],
51	-	:	O	-	_	0	SENT_244	[p17l1533t639r1668b687],
52	I	PRP	O	I	dep	47	SENT_244	[p17l1533t639r1668b687],
53	:	:	O	:	_	0	SENT_244	[p17l1533t639r1668b687],
54	’‘	NN	O	’‘	dep	52	SENT_244	[p17l1533t639r1668b687],
55	'	''	O	'	_	0	SENT_244	[p17l1533t639r1668b687],
56	*	CD	NUMBER	*	number	57	SENT_244	[p17l1533t639r1668b687],
57	‘	CD	NUMBER	‘	num	59	SENT_244	[p17l36t677r68b735],
58	h	NN	O	h	nn	59	SENT_244	[p17l36t677r68b735],
59	E	NN	O	e	dep	47	SENT_244	[p17l97t706r129b732],
60	‘	SYM	O	‘	dep	47	SENT_244	[p17l97t706r129b732],
61	-	:	O	-	_	0	SENT_244	[p17l261t674r360b707],
62	a	DT	O	a	det	64	SENT_244	[p17l261t674r360b707],
63	'25	CD	NUMBER	'25	num	64	SENT_244	[p17l261t674r360b707],
64	Oi	NN	O	ous	dep	43	SENT_244	[p17l1205t706r1279b729],
65	-	:	O	-	_	0	SENT_244	[p17l1205t706r1279b729],
66	,	,	O	,	_	0	SENT_244	[p17l1205t706r1279b729],
67	.	.	O	.	_	0	SENT_244	[p17l1205t706r1279b729],
68	'	''	O	'	_	0	SENT_244	[p17l1205t706r1279b729],

1	,	,	O	,	_	0	SENT_245	[p17l1205t706r1279b729],
2	.	.	O	.	_	0	SENT_245	[p17l1205t706r1279b729],
3	'	''	O	'	_	0	SENT_245	[p17l1205t706r1279b729],

1	I	PRP	O	I	_	0	SENT_246	[p17l1205t706r1279b729],
2	!	.	O	!	_	0	SENT_246	[p17l1205t706r1279b729],

1	I	PRP	O	I	nsubj	2	SENT_247	[p17l1205t706r1279b729],
2	I-Ariluulo-Hi-II	VBP	O	i-ariluulo-hi-ii	_	0	SENT_247	[p17l1494t697r1709b722],
3	!	.	O	!	_	0	SENT_247	[p17l1494t697r1709b722],

1	--	:	O	--	_	0	SENT_248	[p17l1494t697r1709b722],
2	II	CD	NUMBER	ii	dep	5	SENT_248	[p17l1494t697r1709b722],
3	»	NN	O	»	dep	2	SENT_248	[p17l1494t697r1709b722],
4	2	CD	NUMBER	2	dep	5	SENT_248	[p17l29t722r68b779],
5	Y	NN	O	y	dep	8	SENT_248	[p17l29t722r68b779],
6	*	CD	NUMBER	*	num	7	SENT_248	[p17l29t722r68b779],
7	CE	NN	O	ce	dep	5	SENT_248	[p17l87t735r126b764],
8	-9	CD	NUMBER	-9	_	0	SENT_248	[p17l874t748r909b764],
9	.	.	O	.	_	0	SENT_248	[p17l874t748r909b764],

1	.	.	O	.	_	0	SENT_249	[p17l874t748r909b764],

1	o	NN	O	o	_	0	SENT_250	[p17l1244t748r1257b764],
2	duh	SYM	O	duh	dep	1	SENT_250	[p17l1513t742r1687b765],
3	-	:	O	-	_	0	SENT_250	[p17l1513t742r1687b765],
4	‘	NN	O	‘	dep	1	SENT_250	[p17l1513t742r1687b765],
5	I	PRP	O	I	dep	4	SENT_250	[p17l1513t742r1687b765],
6	--	:	O	--	_	0	SENT_250	[p17l1513t742r1687b765],
7	I-9	NN	O	i-9	dep	5	SENT_250	[p17l1513t742r1687b765],
8	’	SYM	O	’	dep	5	SENT_250	[p17l1513t742r1687b765],
9	-	:	O	-	_	0	SENT_250	[p17l1513t742r1687b765],
10	I-4-i	NNS	O	i-4-i	dep	5	SENT_250	[p17l1513t742r1687b765],
11	"	``	O	"	punct	13	SENT_250	[p17l1513t742r1687b765],
12	g	NN	O	g	nn	13	SENT_250	[p17l36t780r78b835],
13	E	NN	O	e	dep	10	SENT_250	[p17l97t784r126b825],
14	--	:	O	--	_	0	SENT_250	[p17l260t787r360b819],
15	1513	CD	DATE	1513	dep	13	SENT_250	[p17l260t787r360b819],
16	1	LS	NUMBER	1	dep	15	SENT_250	[p17l1244t783r1279b825],
17	-	:	O	-	_	0	SENT_250	[p17l1244t783r1279b825],
18	»	CD	NUMBER	»	num	19	SENT_250	[p17l1244t783r1279b825],
19	Y	NN	O	y	dep	15	SENT_250	[p17l1574t793r1629b816],
20	*	CD	NUMBER	*	num	21	SENT_250	[p17l1574t793r1629b816],
21	E	NN	O	e	dep	19	SENT_250	[p17l36t838r68b864],
22	'	''	O	'	_	0	SENT_250	[p17l127t838r129b845],
23	.	.	O	.	_	0	SENT_250	[p17l1244t848r1246b850],

1	-	:	O	-	_	0	SENT_251	[p17l29t867r68b922],
2	E	NN	O	e	nn	3	SENT_251	[p17l29t867r68b922],
3	E	NN	O	e	_	0	SENT_251	[p17l87t828r126b890],
4	9	CD	NUMBER	9	dep	3	SENT_251	[p17l1224t845r1260b860],
5	+	CC	O	+	_	0	SENT_251	[p17l1224t845r1260b860],
6	9	CD	NUMBER	9	conj_+	3	SENT_251	[p17l1593t844r1609b861],
7	in	IN	O	in	_	0	SENT_251	[p17l1940t847r1956b864],
8	D	NN	O	d	prep_in	6	SENT_251	[p17l26t925r68b960],
9	-0.75	CD	NUMBER	-0.75	dep	3	SENT_251	[p17l261t908r360b941],

1	lhlurrnrber	NN	O	lhlurrnrber	_	0	SENT_252	[p17l534t1419r720b1458],
2	of	IN	O	of	_	0	SENT_252	[p17l735t1419r781b1458],
3	l'lIllQll	NN	O	l'lillqll	prep_of	1	SENT_252	[p17l796t1419r996b1467],
4	'	''	O	'	_	0	SENT_252	[p17l796t1419r996b1467],
5	I-I	NN	O	i-i	dep	1	SENT_252	[p17l796t1419r996b1467],
6	'	''	O	'	_	0	SENT_252	[p17l796t1419r996b1467],
7	l5lI	NN	O	l5lus	dep	5	SENT_252	[p17l796t1419r996b1467],
8	'	''	O	'	_	0	SENT_252	[p17l796t1419r996b1467],
9	.	.	O	.	_	0	SENT_252	[p17l796t1419r996b1467],

1	alleles	NNS	O	allele	_	0	SENT_253	[p17l1012t1419r1164b1458],
2	llI1	NN	O	lli1	nn	3	SENT_253	[p17l1182t1419r1218b1458],
3	GFH	NN	O	gfh	dep	1	SENT_253	[p17l1240t1419r1356b1464],
4	,	,	O	,	_	0	SENT_253	[p17l1240t1419r1356b1464],
5	ARMS2	NN	O	arms2	nn	9	SENT_253	[p17l1375t1419r1558b1458],
6	and	CC	O	and	_	0	SENT_253	[p17l1571t1419r1655b1458],
7	VEGFA	NN	O	vegfa	conj_and	5	SENT_253	[p17l1680t1419r1850b1458],
8	genes	NNS	O	gene	nn	9	SENT_253	[p17l1863t1428r2005b1467],
9	lp	NN	O	lp	appos	1	SENT_253	[p17l1125t1578r1148b1610],
10	=	JJ	O	=	amod	13	SENT_253	[p17l1163t1578r1183b1595],
11	n.	NN	O	n.	nn	13	SENT_253	[p17l1198t1569r1298b1601],
12	n	NN	O	n	nn	13	SENT_253	[p17l1198t1569r1298b1601],
13	~	NN	O	~	dep	9	SENT_253	[p17l1198t1569r1298b1601],
14	:	:	O	:	_	0	SENT_253	[p17l1198t1569r1298b1601],
15	:	:	O	:	_	0	SENT_253	[p17l1198t1569r1298b1601],
16	u1	NN	O	u1	dep	1	SENT_253	[p17l1198t1569r1298b1601],

1	W	NN	O	w	_	0	SENT_254	[p17l55t1575r110b1642],

1	mu	NN	O	mu	_	0	SENT_255	[p17l267t1598r360b1639],
2	.	.	O	.	_	0	SENT_255	[p17l543t1616r1908b1648],

1	|	NN	O	|	nn	2	SENT_256	[p17l957t1648r1112b1687],
2	p	NN	O	p	dep	3	SENT_256	[p17l957t1648r1112b1687],
3	=	JJ	O	=	_	0	SENT_256	[p17l957t1648r1112b1687],
4	El	NNP	O	El	nn	6	SENT_256	[p17l957t1648r1112b1687],
5	,	,	O	,	_	0	SENT_256	[p17l957t1648r1112b1687],
6	lJ	NNP	O	lJ	nsubj	7	SENT_256	[p17l957t1648r1112b1687],
7	|	VBD	O	|	ccomp	3	SENT_256	[p17l957t1648r1112b1687],
8	J3	NN	O	j3	dobj	7	SENT_256	[p17l957t1648r1112b1687],

1	I	PRP	O	I	dep	2	SENT_257	[p17l543t1693r547b1728],
2	E	NN	O	e	_	0	SENT_257	[p17l784t1738r806b1772],
3	;	:	O	;	_	0	SENT_257	[p17l822t1738r845b1754],
4	»	CD	NUMBER	»	num	5	SENT_257	[p17l858t1728r967b1761],
5	u-ma	NN	O	u-ma	dep	2	SENT_257	[p17l858t1728r967b1761],
6	.	.	O	.	_	0	SENT_257	[p17l1221t1754r1237b1770],

1	__	NN	O	__	_	0	SENT_258	[p17l1221t1754r1237b1770],
2	'	''	O	'	_	0	SENT_258	[p17l1552t1693r1558b1728],

1	Age	NNP	O	Age	_	0	SENT_259	[p17l90t2495r139b2588],
2	nfﬁrst	NN	O	nfﬁrst	nn	4	SENT_259	[p17l90t2331r129b2479],
3	ranihizumah	NN	O	ranihizumah	nn	4	SENT_259	[p17l90t2030r129b2313],
4	injeetilnn	NN	O	injeetilnn	dep	1	SENT_259	[p17l90t1818r139b2011],

1	6	CD	NUMBER	6	_	0	SENT_260	[p17l530t2774r562b2816],
2	-	:	O	-	_	0	SENT_260	[p17l530t2774r562b2816],
3	5	CD	NUMBER	5	number	4	SENT_260	[p17l871t2771r902b2816],
4	4	CD	NUMBER	4	dep	1	SENT_260	[p17l1208t2774r1241b2816],
5	3-2	CD	NUMBER	3-2	num	6	SENT_260	[p17l1526t2771r1610b2816],
6	1l	NN	O	1l	dep	4	SENT_260	[p17l1866t2774r1944b2816],
7	--	:	O	--	_	0	SENT_260	[p17l1866t2774r1944b2816],
8	0	CD	NUMBER	0	dep	1	SENT_260	[p17l1866t2774r1944b2816],

1	Humhezr	NNP	PERSON	Humhezr	dep	4	SENT_261	[p17l562t2883r748b2921],
2	all	DT	O	all	det	4	SENT_261	[p17l761t2883r809b2921],
3	high-riisk	JJ	O	high-riisk	amod	4	SENT_261	[p17l822t2883r1022b2931],
4	alleles	NNS	O	allele	_	0	SENT_261	[p17l1040t2883r1192b2921],
5	in	IN	O	in	prep	4	SENT_261	[p17l1208t2883r1247b2921],
6	:	:	O	:	_	0	SENT_261	[p17l1208t2883r1247b2921],
7	GFH	NN	O	gfh	dep	4	SENT_261	[p17l1269t2883r1385b2928],
8	.	.	O	.	_	0	SENT_261	[p17l1269t2883r1385b2928],

1	ARMS	NNS	O	arm	_	0	SENT_262	[p17l1401t2883r1584b2921],
2	:	:	O	:	_	0	SENT_262	[p17l1401t2883r1584b2921],
3	and	CC	O	and	_	0	SENT_262	[p17l1600t2883r1683b2921],
4	VEGFA	JJ	O	vegfa	amod	5	SENT_262	[p17l1706t2883r1876b2921],
5	genes	NNS	O	gene	conj_and	1	SENT_262	[p17l1892t2889r2033b2931],

1	Figure	NN	O	figure	_	0	SENT_263	[p17l7t3011r196b3076],
2	2	CD	NUMBER	2	dep	1	SENT_263	[p17l227t3013r281b3062],
3	.	.	O	.	_	0	SENT_263	[p17l227t3013r281b3062],

1	Graphs	NNS	O	graph	nsubj	37	SENT_264	[p17l321t3008r528b3076],
2	showing	VBG	O	show	partmod	1	SENT_264	[p17l559t3008r794b3076],
3	the	DT	O	the	det	5	SENT_264	[p17l825t3008r916b3062],
4	cumulative	JJ	O	cumulative	amod	5	SENT_264	[p17l946t3008r1264b3062],
5	effect	NN	O	effect	iobj	2	SENT_264	[p17l1295t3009r1451b3062],
6	of	IN	O	of	_	0	SENT_264	[p17l1481t3009r1539b3062],
7	complement	NN	O	complement	nn	9	SENT_264	[p17l1563t3008r1883b3076],
8	factor	NN	O	factor	nn	9	SENT_264	[p17l1906t3009r2065b3076],
9	H	NN	O	h	prep_of	5	SENT_264	[p17l2093t3011r2147b3062],
10	(	CD	NUMBER	(	num	11	SENT_264	[p17l13t3095r223b3158],
11	CFH	NNP	O	CFH	dep	9	SENT_264	[p17l13t3095r223b3158],
12	)	CD	NUMBER	)	num	11	SENT_264	[p17l13t3095r223b3158],
13	,	,	O	,	_	0	SENT_264	[p17l13t3095r223b3158],
14	agewelated	JJ	O	agewelated	amod	20	SENT_264	[p17l253t3095r542b3162],
15	maculopathy	NN	O	maculopathy	nn	20	SENT_264	[p17l566t3095r904b3162],
16	susceptibility	NN	O	susceptibility	nn	20	SENT_264	[p17l932t3095r1265b3162],
17	Z	NN	O	z	nn	20	SENT_264	[p17l1296t3097r1325b3148],
18	(	CD	NUMBER	(	num	20	SENT_264	[p17l1359t3095r1653b3158],
19	ARMS2	NN	O	arms2	nn	20	SENT_264	[p17l1359t3095r1653b3158],
20	)	NN	O	)	prep_of	5	SENT_264	[p17l1359t3095r1653b3158],
21	,	,	O	,	_	0	SENT_264	[p17l1359t3095r1653b3158],
22	and	CC	O	and	_	0	SENT_264	[p17l1684t3095r1788b3148],
23	vascular	JJ	O	vascular	amod	29	SENT_264	[p17l1816t3095r2036b3148],
24	en	IN	O	en	_	0	SENT_264	[p17l2062t3116r2145b3148],
25	»	CD	NUMBER	»	prep_en	23	SENT_264	[p17l2062t3116r2145b3148],
26	dothelial	JJ	O	dothelial	amod	29	SENT_264	[p17l8t3182r229b3236],
27	growth	NN	O	growth	nn	29	SENT_264	[p17l251t3182r434b3250],
28	factor	NN	O	factor	nn	29	SENT_264	[p17l454t3183r612b3250],
29	A	NN	O	a	conj_and	9	SENT_264	[p17l634t3184r686b3235],
30	(	CD	NUMBER	(	num	36	SENT_264	[p17l715t3182r998b3246],
31	VEGFA	NNP	O	VEGFA	nn	36	SENT_264	[p17l715t3182r998b3246],
32	)	CD	NUMBER	)	num	36	SENT_264	[p17l715t3182r998b3246],
33	high	JJ	O	high	amod	36	SENT_264	[p17l1027t3182r1284b3250],
34	»	NN	O	»	nn	36	SENT_264	[p17l1027t3182r1284b3250],
35	risk	NN	O	risk	nn	36	SENT_264	[p17l1027t3182r1284b3250],
36	alleles	NNS	O	allele	dobj	2	SENT_264	[p17l1309t3182r1483b3236],
37	(	VBP	O	(	_	0	SENT_264	[p17l1514t3182r1614b3246],
38	A	DT	O	a	det	39	SENT_264	[p17l1514t3182r1614b3246],
39	)	NN	O	)	dobj	37	SENT_264	[p17l1514t3182r1614b3246],
40	on	IN	O	on	_	0	SENT_264	[p17l1644t3204r1717b3236],
41	the	DT	O	the	det	48	SENT_264	[p17l1743t3182r1834b3236],
42	change	NN	O	change	dep	48	SENT_264	[p17l1861t3182r2063b3250],
43	in	IN	O	in	_	0	SENT_264	[p17l2092t3190r2147b3235],
44	visual	JJ	O	visual	amod	47	SENT_264	[p17l9t3269r173b3323],
45	acuity	NN	O	acuity	nn	47	SENT_264	[p17l207t3277r378b3337],
46	(	CD	NUMBER	(	num	47	SENT_264	[p17l415t3269r566b3333],
47	VA	NN	ORGANIZATION	va	prep_in	42	SENT_264	[p17l415t3269r566b3333],
48	)	NN	O	)	prep_on	39	SENT_264	[p17l415t3269r566b3333],
49	after	IN	O	after	_	0	SENT_264	[p17l605t3270r733b3323],
50	ranibizumab	NN	O	ranibizumab	nn	51	SENT_264	[p17l765t3269r1114b3323],
51	treatment	NN	O	treatment	prep_after	37	SENT_264	[p17l1149t3286r1432b3323],
52	and	CC	O	and	_	0	SENT_264	[p17l1465t3269r1569b3323],
53	(	NN	O	(	nn	55	SENT_264	[p17l1606t3269r1698b3333],
54	B	NN	O	b	nn	55	SENT_264	[p17l1606t3269r1698b3333],
55	)	NN	O	)	prep_after	37	SENT_264	[p17l1606t3269r1698b3333],
56	on	IN	O	on	_	0	SENT_264	[p17l1736t3291r1810b3323],
57	the	DT	O	the	det	58	SENT_264	[p17l1843t3269r1934b3323],
58	age	NN	O	age	prep_on	51	SENT_264	[p17l1969t3290r2059b3337],
59	of	IN	O	of	_	0	SENT_264	[p17l2093t3270r2152b3323],
60	neovascular	JJ	O	neovascular	amod	61	SENT_264	[p17l8t3356r348b3409],
61	onset	NN	O	onset	prep_of	58	SENT_264	[p17l371t3372r537b3409],
62	.	.	O	.	_	0	SENT_264	[p17l371t3372r537b3409],

1	A	DT	O	a	det	15	SENT_265	[p17l563t3357r631b3419],
2	,	,	O	,	_	0	SENT_265	[p17l563t3357r631b3419],
3	Visual	JJ	O	visual	amod	5	SENT_265	[p17l656t3356r837b3410],
4	acuity	NN	O	acuity	nn	5	SENT_265	[p17l862t3363r1032b3423],
5	change	NN	O	change	dep	6	SENT_265	[p17l1055t3356r1258b3423],
6	after	IN	O	after	dep	15	SENT_265	[p17l1283t3356r1411b3409],
7	3	CD	NUMBER	3	num	9	SENT_265	[p17l1433t3358r1462b3409],
8	ranibizumab	NN	O	ranibizumab	nn	9	SENT_265	[p17l1490t3356r1839b3410],
9	injections	NNS	O	injection	pobj	6	SENT_265	[p17l1865t3363r2145b3423],
10	from	IN	O	from	_	0	SENT_265	[p17l8t3444r142b3497],
11	baseline	NN	O	baseline	nn	13	SENT_265	[p17l172t3443r403b3497],
12	(	CD	NUMBER	(	num	13	SENT_265	[p17l440t3443r642b3511],
13	y	NN	O	y	prep_from	9	SENT_265	[p17l440t3443r642b3511],
14	»	CD	NUMBER	»	num	13	SENT_265	[p17l440t3443r642b3511],
15	aXis	NN	O	axis	nsubj	31	SENT_265	[p17l440t3443r642b3511],
16	,	,	O	,	_	0	SENT_265	[p17l440t3443r642b3511],
17	0.20	CD	NUMBER	0.20	nsubj	31	SENT_265	[p17l677t3446r798b3497],
18	corresponds	VBZ	O	correspond	rcmod	17	SENT_265	[p17l831t3443r1168b3511],
19	to	TO	O	to	_	0	SENT_265	[p17l1201t3460r1257b3497],
20	10	CD	NUMBER	10	num	26	SENT_265	[p17l1295t3446r1357b3497],
21	Early	JJ	O	early	amod	26	SENT_265	[p17l1389t3443r1534b3511],
22	Treatment	NN	O	treatment	nn	26	SENT_265	[p17l1564t3446r1872b3497],
23	Diabetic	NNP	O	Diabetic	nn	26	SENT_265	[p17l1904t3443r2146b3497],
24	Retinopathy	NNP	O	Retinopathy	nn	26	SENT_265	[p17l8t3530r367b3598],
25	Study	NNP	O	Study	nn	26	SENT_265	[p17l401t3530r565b3598],
26	letters	NNS	O	letter	prep_to	18	SENT_265	[p17l599t3530r788b3594],
27	,	,	O	,	_	0	SENT_265	[p17l599t3530r788b3594],
28	a	DT	O	a	det	30	SENT_265	[p17l826t3552r855b3584],
29	positive	JJ	O	positive	amod	30	SENT_265	[p17l887t3538r1110b3598],
30	change	NN	O	change	appos	26	SENT_265	[p17l1145t3530r1347b3598],
31	indicates	VBZ	O	indicate	_	0	SENT_265	[p17l1384t3530r1635b3584],
32	VA	NNP	ORGANIZATION	VA	nn	33	SENT_265	[p17l1669t3532r1775b3585],
33	gain	NN	O	gain	dobj	31	SENT_265	[p17l1808t3538r1943b3598],
34	,	,	O	,	_	0	SENT_265	[p17l1808t3538r1943b3598],
35	and	CC	O	and	_	0	SENT_265	[p17l1981t3530r2085b3584],
36	a	DT	O	a	det	38	SENT_265	[p17l2119t3552r2148b3584],
37	negative	JJ	O	negative	amod	38	SENT_265	[p17l8t3624r251b3684],
38	change	NN	O	change	nsubj	39	SENT_265	[p17l294t3617r496b3684],
39	indicates	VBZ	O	indicate	conj_and	31	SENT_265	[p17l540t3617r792b3670],
40	VA	NNP	O	VA	nn	42	SENT_265	[p17l833t3618r939b3671],
41	loss	NN	O	loss	nn	42	SENT_265	[p17l981t3617r1104b3680],
42	)	NN	O	)	dobj	39	SENT_265	[p17l981t3617r1104b3680],
43	clustered	VBN	O	cluster	partmod	42	SENT_265	[p17l1150t3617r1405b3670],
44	by	IN	O	by	_	0	SENT_265	[p17l1445t3617r1511b3684],
45	CFH	NNP	O	CFH	agent	43	SENT_265	[p17l1552t3619r1711b3680],
46	,	,	O	,	_	0	SENT_265	[p17l1552t3619r1711b3680],
47	ARMS2	NN	O	arms2	agent	43	SENT_265	[p17l1753t3619r1997b3680],
48	,	,	O	,	_	0	SENT_265	[p17l1753t3619r1997b3680],
49	and	CC	O	and	_	0	SENT_265	[p17l2043t3617r2147b3670],
50	VEGFA	NN	O	vegfa	nn	52	SENT_265	[p17l8t3706r245b3758],
51	allelic	JJ	O	allelic	amod	52	SENT_265	[p17l271t3704r441b3758],
52	composition	NN	O	composition	agent	43	SENT_265	[p17l468t3712r822b3772],
53	(	CD	NUMBER	(	dep	52	SENT_265	[p17l851t3704r1085b3768],
54	x	CC	O	x	_	0	SENT_265	[p17l851t3704r1085b3768],
55	»	CD	NUMBER	»	num	56	SENT_265	[p17l851t3704r1085b3768],
56	axis	NN	O	axis	conj_x	52	SENT_265	[p17l851t3704r1085b3768],
57	)	CD	NUMBER	)	dep	56	SENT_265	[p17l851t3704r1085b3768],
58	:	:	O	:	_	0	SENT_265	[p17l851t3704r1085b3768],
59	(	CD	NUMBER	(	number	60	SENT_265	[p17l1118t3704r1198b3768],
60	6	CD	NUMBER	6	num	62	SENT_265	[p17l1118t3704r1198b3768],
61	)	NN	O	)	nn	62	SENT_265	[p17l1118t3704r1198b3768],
62	patients	NNS	O	patient	nsubj	63	SENT_265	[p17l1227t3712r1455b3772],
63	carrying	VBG	O	carry	dep	42	SENT_265	[p17l1481t3712r1712b3772],
64	all	DT	O	all	det	68	SENT_265	[p17l1739t3704r1807b3758],
65	6	CD	NUMBER	6	num	68	SENT_265	[p17l1833t3706r1864b3758],
66	high	JJ	O	high	amod	68	SENT_265	[p17l1890t3704r2148b3772],
67	~	NN	O	~	nn	68	SENT_265	[p17l1890t3704r2148b3772],
68	risl	NN	O	risl	nsubj	69	SENT_265	[p17l1890t3704r2148b3772],
69	<	JJR	O	<	xcomp	63	SENT_265	[p17l1890t3704r2148b3772],

1	alleles	NNS	O	allele	dep	6	SENT_266	[p18l10t16r184b70],
2	(	CD	NUMBER	(	num	3	SENT_266	[p18l220t16r281b80],
3	n	NN	O	n	dep	1	SENT_266	[p18l220t16r281b80],
4	=	JJ	O	=	dep	6	SENT_266	[p18l319t38r362b54],
5	8	CD	NUMBER	8	num	6	SENT_266	[p18l402t19r432b70],
6	[	NN	O	[	dep	30	SENT_266	[p18l469t16r639b80],
7	2	CD	PERCENT	2	num	8	SENT_266	[p18l469t16r639b80],
8	%	NN	PERCENT	%	dep	6	SENT_266	[p18l469t16r639b80],
9	]	CD	NUMBER	]	number	10	SENT_266	[p18l469t16r639b80],
10	)	CD	NUMBER	)	num	8	SENT_266	[p18l469t16r639b80],
11	,	,	O	,	_	0	SENT_266	[p18l469t16r639b80],
12	(	CD	NUMBER	(	number	13	SENT_266	[p18l678t16r758b80],
13	5	CD	NUMBER	5	num	19	SENT_266	[p18l678t16r758b80],
14	)	NN	O	)	nn	19	SENT_266	[p18l678t16r758b80],
15	age	NN	O	age	nn	19	SENT_266	[p18l795t16r1108b84],
16	—	CD	NUMBER	—	num	19	SENT_266	[p18l795t16r1108b84],
17	related	JJ	O	related	amod	18	SENT_266	[p18l795t16r1108b84],
18	macular	JJ	O	macular	amod	19	SENT_266	[p18l1140t16r1367b70],
19	degeneration	NN	O	degeneration	appos	8	SENT_266	[p18l1398t16r1772b84],
20	(	CD	NUMBER	(	num	25	SENT_266	[p18l1807t16r2022b80],
21	AMD	NNP	O	AMD	nn	25	SENT_266	[p18l1807t16r2022b80],
22	)	CD	NUMBER	)	num	25	SENT_266	[p18l1807t16r2022b80],
23	pa	NN	O	pa	nn	25	SENT_266	[p18l2057t38r2144b84],
24	»	NN	O	»	nn	25	SENT_266	[p18l2057t38r2144b84],
25	tients	NNS	O	tient	nsubj	30	SENT_266	[p18l10t110r168b156],
26	carrying	VBG	O	carry	partmod	25	SENT_266	[p18l194t110r425b170],
27	5	CD	NUMBER	5	num	29	SENT_266	[p18l451t103r479b156],
28	risk	NN	O	risk	nn	29	SENT_266	[p18l508t103r610b156],
29	alleles	NNS	O	allele	dobj	26	SENT_266	[p18l635t103r809b156],
30	(	VBP	O	(	dep	48	SENT_266	[p18l839t103r900b166],
31	n	NN	O	n	dobj	30	SENT_266	[p18l839t103r900b166],
32	=	JJ	O	=	dep	31	SENT_266	[p18l932t124r974b141],
33	33	CD	PERCENT	33	iobj	32	SENT_266	[p18l1006t105r1071b156],
34	[	CD	PERCENT	[	number	35	SENT_266	[p18l1105t103r1329b166],
35	8.3	CD	PERCENT	8.3	num	36	SENT_266	[p18l1105t103r1329b166],
36	%	NN	PERCENT	%	dobj	32	SENT_266	[p18l1105t103r1329b166],
37	]	CD	NUMBER	]	number	38	SENT_266	[p18l1105t103r1329b166],
38	)	CD	NUMBER	)	num	36	SENT_266	[p18l1105t103r1329b166],
39	,	,	O	,	_	0	SENT_266	[p18l1105t103r1329b166],
40	(	CD	NUMBER	(	number	41	SENT_266	[p18l1361t103r1441b166],
41	4	CD	NUMBER	4	num	43	SENT_266	[p18l1361t103r1441b166],
42	)	NN	O	)	nn	43	SENT_266	[p18l1361t103r1441b166],
43	participants	NNS	O	participant	nsubj	48	SENT_266	[p18l1470t110r1808b170],
44	with	IN	O	with	_	0	SENT_266	[p18l1833t103r1963b156],
45	4	CD	NUMBER	4	num	47	SENT_266	[p18l1987t105r2020b161],
46	risk	NN	O	risk	nn	47	SENT_266	[p18l2046t103r2148b156],
47	alleles	NNS	O	allele	prep_with	43	SENT_266	[p18l10t190r184b244],
48	(	VBP	O	(	_	0	SENT_266	[p18l208t190r269b254],
49	n	NN	O	n	dobj	48	SENT_266	[p18l208t190r269b254],
50	=	JJ	O	=	quantmod	51	SENT_266	[p18l295t212r338b228],
51	116	CD	NUMBER	116	num	52	SENT_266	[p18l370t192r467b244],
52	[	NN	O	[	dep	49	SENT_266	[p18l492t190r698b254],
53	Z9	CD	PERCENT	z9	num	54	SENT_266	[p18l492t190r698b254],
54	%	NN	PERCENT	%	dep	52	SENT_266	[p18l492t190r698b254],
55	]	CD	NUMBER	]	number	56	SENT_266	[p18l492t190r698b254],
56	)	CD	NUMBER	)	num	54	SENT_266	[p18l492t190r698b254],
57	,	,	O	,	_	0	SENT_266	[p18l492t190r698b254],
58	(	CD	NUMBER	(	num	59	SENT_266	[p18l725t190r864b254],
59	3	CD	NUMBER	3	dobj	48	SENT_266	[p18l725t190r864b254],
60	.	.	O	.	_	0	SENT_266	[p18l725t190r864b254],

1	—	NN	O	—	_	0	SENT_267	[p18l725t190r864b254],
2	.	.	O	.	_	0	SENT_267	[p18l725t190r864b254],

1	Z	NN	O	z	nsubj	10	SENT_268	[p18l725t190r864b254],
2	)	CD	NUMBER	)	num	3	SENT_268	[p18l725t190r864b254],
3	patients	NNS	O	patient	dep	1	SENT_268	[p18l887t198r1114b258],
4	carrying	VBG	O	carry	partmod	1	SENT_268	[p18l1135t198r1366b258],
5	3	CD	NUMBER	3	num	9	SENT_268	[p18l1385t193r1414b244],
6	or	CC	O	or	_	0	SENT_268	[p18l1438t212r1495b244],
7	2	CD	NUMBER	2	num	9	SENT_268	[p18l1516t193r1545b243],
8	risk	NN	O	risk	nn	9	SENT_268	[p18l1566t190r1668b244],
9	alleles	NNS	O	allele	dobj	4	SENT_268	[p18l1687t190r1861b244],
10	(	VBP	O	(	dep	39	SENT_268	[p18l1886t190r1947b254],
11	n	NN	O	n	dobj	10	SENT_268	[p18l1886t190r1947b254],
12	=	JJ	O	=	advmod	25	SENT_268	[p18l1972t212r2015b228],
13	208	CD	PERCENT	208	number	14	SENT_268	[p18l2044t193r2144b244],
14	[	CD	PERCENT	[	dep	12	SENT_268	[p18l13t277r219b341],
15	5Z	CD	PERCENT	5z	num	16	SENT_268	[p18l13t277r219b341],
16	%	NN	PERCENT	%	dep	14	SENT_268	[p18l13t277r219b341],
17	]	CD	NUMBER	]	num	18	SENT_268	[p18l13t277r219b341],
18	)	NN	O	)	dep	14	SENT_268	[p18l13t277r219b341],
19	,	,	O	,	_	0	SENT_268	[p18l13t277r219b341],
20	and	CC	O	and	_	0	SENT_268	[p18l260t277r363b331],
21	(	NN	O	(	conj_and	14	SENT_268	[p18l404t277r543b341],
22	10	CD	NUMBER	10	number	23	SENT_268	[p18l404t277r543b341],
23	)	CD	NUMBER	)	num	24	SENT_268	[p18l404t277r543b341],
24	patients	NNS	O	patient	dep	21	SENT_268	[p18l583t285r810b345],
25	carrying	VBG	O	carry	partmod	11	SENT_268	[p18l848t285r1079b345],
26	l	NN	O	l	tmod	25	SENT_268	[p18l1121t280r1142b331],
27	or	CC	O	or	_	0	SENT_268	[p18l1185t299r1243b331],
28	no	DT	O	no	det	30	SENT_268	[p18l1278t299r1350b331],
29	high-risk	JJ	O	high-risk	amod	30	SENT_268	[p18l1386t277r1643b345],
30	alleles	NNS	O	allele	conj_or	11	SENT_268	[p18l1680t277r1853b331],
31	in	IN	O	in	_	0	SENT_268	[p18l1893t285r1948b331],
32	CFH	NNP	O	CFH	prep_in	30	SENT_268	[p18l1984t279r2143b341],
33	,	,	O	,	_	0	SENT_268	[p18l1984t279r2143b341],
34	ARMS2	NN	O	arms2	conj_and	32	SENT_268	[p18l7t366r251b427],
35	,	,	O	,	_	0	SENT_268	[p18l7t366r251b427],
36	and	CC	O	and	_	0	SENT_268	[p18l276t364r380b417],
37	VEGFA	NN	O	vegfa	nn	38	SENT_268	[p18l400t366r636b418],
38	genes	NNS	O	gene	conj_and	32	SENT_268	[p18l657t384r812b431],
39	(	VBP	O	(	_	0	SENT_268	[p18l838t364r899b427],
40	n	NN	O	n	nsubj	43	SENT_268	[p18l838t364r899b427],
41	=	JJ	O	=	amod	43	SENT_268	[p18l927t385r970b402],
42	35	CD	NUMBER	35	tmod	41	SENT_268	[p18l997t364r1062b417],
43	[	NN	O	[	xcomp	39	SENT_268	[p18l1092t364r1316b427],
44	8.8	CD	PERCENT	8.8	number	45	SENT_268	[p18l1092t364r1316b427],
45	%	NN	PERCENT	%	amod	43	SENT_268	[p18l1092t364r1316b427],
46	]	CD	NUMBER	]	num	47	SENT_268	[p18l1092t364r1316b427],
47	)	NN	O	)	nsubj	39	SENT_268	[p18l1092t364r1316b427],
48	.	.	O	.	_	0	SENT_268	[p18l1092t364r1316b427],

1	Compared	VBN	O	compare	_	0	SENT_269	[p18l1341t364r1639b431],
2	with	IN	O	with	prepc_compared_with	17	SENT_269	[p18l1660t364r1789b417],
3	the	DT	O	the	det	6	SENT_269	[p18l1810t364r1901b417],
4	remaining	VBG	O	remain	amod	6	SENT_269	[p18l1923t371r2144b417, p18l11t459r98b518],
5	AMD	NNP	ORGANIZATION	AMD	nn	6	SENT_269	[p18l127t453r296b504],
6	patients	NNS	O	patient	pobj	17	SENT_269	[p18l325t459r568b519],
7	,	,	O	,	_	0	SENT_269	[p18l325t459r568b519],
8	the	DT	O	the	det	9	SENT_269	[p18l602t451r692b505],
9	carriers	NNS	O	carrier	nsubj	17	SENT_269	[p18l724t459r930b505],
10	of	IN	O	of	_	0	SENT_269	[p18l961t452r1020b505],
11	all	DT	O	all	det	16	SENT_269	[p18l1045t451r1113b505],
12	6	CD	NUMBER	6	num	16	SENT_269	[p18l1144t453r1174b505],
13	high	JJ	O	high	amod	16	SENT_269	[p18l1205t451r1462b519],
14	»	NN	O	»	nn	16	SENT_269	[p18l1205t451r1462b519],
15	risk	NN	O	risk	nn	16	SENT_269	[p18l1205t451r1462b519],
16	alleles	NNS	O	allele	prep_of	9	SENT_269	[p18l1492t451r1666b505],
17	demonstrated	VBD	O	demonstrate	_	0	SENT_269	[p18l1697t451r2087b505],
18	a	DT	O	a	det	20	SENT_269	[p18l2118t473r2147b505],
19	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_269	[p18l9t539r304b606],
20	worsening	NN	O	worsening	dobj	17	SENT_269	[p18l327t546r618b606],
21	of	IN	O	of	_	0	SENT_269	[p18l641t539r700b592],
22	VA.	NNP	O	VA.	prep_of	20	SENT_269	[p18l717t540r837b593],
23	.	.	O	.	_	0	SENT_269	[p18l717t540r837b593],

1	B	NN	O	b	_	0	SENT_270	[p18l862t541r923b602],
2	,	,	O	,	_	0	SENT_270	[p18l862t541r923b602],
3	Age	NNP	O	Age	appos	1	SENT_270	[p18l949t540r1065b606],
4	when	WRB	O	when	advmod	15	SENT_270	[p18l1089t538r1247b592],
5	the	DT	O	the	det	8	SENT_270	[p18l1270t538r1361b592],
6	ﬁrst	NN	O	ﬁrst	nn	8	SENT_270	[p18l1385t539r1491b592],
7	ranibizumab	NN	O	ranibizumab	nn	8	SENT_270	[p18l1513t538r1863b592],
8	injection	NN	O	injection	nsubj	15	SENT_270	[p18l1890t546r2147b605],
9	was	VBD	O	be	cop	15	SENT_270	[p18l8t647r108b678],
10	administrated	JJ	O	administrated	amod	15	SENT_270	[p18l131t625r524b678],
11	(	NN	O	(	nn	15	SENT_270	[p18l548t625r759b692],
12	y	NN	O	y	nn	15	SENT_270	[p18l548t625r759b692],
13	—	CD	NUMBER	—	num	15	SENT_270	[p18l548t625r759b692],
14	axis	NN	O	axis	nn	15	SENT_270	[p18l548t625r759b692],
15	)	NN	O	)	dep	3	SENT_270	[p18l548t625r759b692],
16	clustered	VBN	O	cluster	partmod	15	SENT_270	[p18l785t625r1039b678],
17	by	IN	O	by	_	0	SENT_270	[p18l1059t625r1125b692],
18	CFH	NNP	O	CFH	agent	16	SENT_270	[p18l1145t627r1304b688],
19	,	,	O	,	_	0	SENT_270	[p18l1145t627r1304b688],
20	ARMS2	NN	O	arms2	agent	16	SENT_270	[p18l1326t627r1570b688],
21	,	,	O	,	_	0	SENT_270	[p18l1326t627r1570b688],
22	and	CC	O	and	_	0	SENT_270	[p18l1595t625r1698b678],
23	VEGFA	NN	O	vegfa	nn	25	SENT_270	[p18l1717t627r1954b679],
24	allelic	JJ	O	allelic	amod	25	SENT_270	[p18l1975t625r2146b678],
25	composition	NN	O	composition	agent	16	SENT_270	[p18l9t720r363b780],
26	as	IN	O	as	mark	27	SENT_270	[p18l389t734r440b766],
27	mentioned	VBN	O	mention	advcl	16	SENT_270	[p18l467t712r777b766],
28	above	IN	O	above	prep	27	SENT_270	[p18l803t712r984b766],
29	.	.	O	.	_	0	SENT_270	[p18l803t712r984b766],

1	Adding	VBG	O	add	csubj	12	SENT_271	[p18l1011t712r1228b780],
2	the	DT	O	the	det	7	SENT_271	[p18l1254t712r1345b766],
3	VEGFA	NNP	O	VEGFA	nn	7	SENT_271	[p18l1370t714r1607b766],
4	high	JJ	O	high	amod	7	SENT_271	[p18l1631t712r1888b779],
5	»	NN	O	»	nn	7	SENT_271	[p18l1631t712r1888b779],
6	risk	NN	O	risk	nn	7	SENT_271	[p18l1631t712r1888b779],
7	allele	NN	O	allele	dobj	1	SENT_271	[p18l1913t712r2063b766],
8	to	TO	O	to	_	0	SENT_271	[p18l2090t729r2146b766],
9	the	DT	O	the	det	11	SENT_271	[p18l10t799r100b853],
10	stratiﬁcation	NN	O	stratiﬁcation	nn	11	SENT_271	[p18l136t800r498b853],
11	model	NN	O	model	prep_to	1	SENT_271	[p18l532t799r708b853],
12	demonstrated	VBD	O	demonstrate	_	0	SENT_271	[p18l742t799r1132b853],
13	a	DT	O	a	det	15	SENT_271	[p18l1167t821r1196b853],
14	younger	JJR	O	younger	amod	15	SENT_271	[p18l1229t820r1458b867],
15	age	NN	O	age	dobj	12	SENT_271	[p18l1492t820r1583b867],
16	at	IN	O	at	_	0	SENT_271	[p18l1619t816r1671b853],
17	which	WDT	O	which	rel	23	SENT_271	[p18l1705t799r1882b853],
18	the	DT	O	the	det	21	SENT_271	[p18l1916t799r2007b853],
19	first	JJ	ORDINAL	first	amod	21	SENT_271	[p18l2042t800r2147b853],
20	ranibizumab	NN	O	ranibizumab	nn	21	SENT_271	[p18l9t886r358b939],
21	treatment	NN	O	treatment	nsubjpass	23	SENT_271	[p18l392t902r674b939],
22	was	VBD	O	be	auxpass	23	SENT_271	[p18l705t908r805b939],
23	carried	VBN	O	carry	rcmod	15	SENT_271	[p18l838t886r1033b939],
24	out	IN	O	out	prt	23	SENT_271	[p18l1065t903r1158b939],
25	compared	VBN	O	compare	_	0	SENT_271	[p18l1190t886r1469b953],
26	with	IN	O	with	prepc_compared_with	23	SENT_271	[p18l1499t886r1629b939],
27	the	DT	O	the	det	29	SENT_271	[p18l1661t886r1752b939],
28	stratiﬁcation	NN	O	stratiﬁcation	nn	29	SENT_271	[p18l1785t886r2147b939],
29	model	NN	O	model	pobj	23	SENT_271	[p18l9t973r185b1027],
30	based	VBN	O	base	partmod	29	SENT_271	[p18l210t973r367b1027],
31	on	IN	O	on	_	0	SENT_271	[p18l393t995r466b1027],
32	CFH	NNP	O	CFH	prep_on	30	SENT_271	[p18l491t975r636b1027],
33	and	CC	O	and	_	0	SENT_271	[p18l663t973r767b1027],
34	ARMS2	NN	O	arms2	nn	36	SENT_271	[p18l791t975r1017b1027],
35	risk	NN	O	risk	nn	36	SENT_271	[p18l1046t973r1148b1027],
36	alleles	NNS	O	allele	conj_and	32	SENT_271	[p18l1174t973r1364b1027],
37	.	.	O	.	_	0	SENT_271	[p18l1174t973r1364b1027],

1	The	DT	O	the	det	3	SENT_272	[p18l1391t973r1508b1027],
2	mean	NN	O	mean	nn	3	SENT_272	[p18l1536t995r1692b1027],
3	age	NN	O	age	nsubj	24	SENT_272	[p18l1719t994r1809b1041],
4	among	IN	O	among	_	0	SENT_272	[p18l1837t994r2028b1041],
5	the	DT	O	the	det	6	SENT_272	[p18l2055t973r2146b1027],
6	carriers	NNS	O	carrier	prep_among	3	SENT_272	[p18l9t1068r215b1114],
7	of	IN	O	of	_	0	SENT_272	[p18l240t1061r299b1114],
8	all	DT	O	all	det	13	SENT_272	[p18l318t1060r386b1114],
9	6	CD	NUMBER	6	num	13	SENT_272	[p18l410t1062r441b1114],
10	high	JJ	O	high	amod	13	SENT_272	[p18l465t1060r723b1128],
11	—	NN	O	—	nn	13	SENT_272	[p18l465t1060r723b1128],
12	risk	NN	O	risk	nn	13	SENT_272	[p18l465t1060r723b1128],
13	alleles	NNS	O	allele	prep_of	6	SENT_272	[p18l746t1060r920b1114],
14	in	IN	O	in	_	0	SENT_272	[p18l947t1068r1002b1114],
15	CFH	NNP	O	CFH	prep_in	13	SENT_272	[p18l1025t1062r1185b1124],
16	,	,	O	,	_	0	SENT_272	[p18l1025t1062r1185b1124],
17	ARMS2	NN	O	arms2	prep_in	13	SENT_272	[p18l1209t1062r1454b1124],
18	,	,	O	,	_	0	SENT_272	[p18l1209t1062r1454b1124],
19	and	CC	O	and	_	0	SENT_272	[p18l1482t1060r1585b1114],
20	VEGFA	NNP	O	VEGFA	prep_in	13	SENT_272	[p18l1608t1062r1845b1115],
21	were	VBD	O	be	cop	24	SENT_272	[p18l1867t1082r1999b1114],
22	65	CD	NUMBER	65	number	23	SENT_272	[p18l2025t1061r2089b1114],
23	.9	CD	DURATION	.9	num	24	SENT_272	[p18l2098t1063r2145b1114],
24	years	NNS	NUMBER	year	_	0	SENT_272	[p18l8t1168r148b1214],
25	versus	CC	O	versus	prep	24	SENT_272	[p18l171t1168r342b1200],
26	75.3	CD	DURATION	75.3	num	27	SENT_272	[p18l368t1148r483b1203],
27	years	NNS	NUMBER	year	dep	25	SENT_272	[p18l509t1168r643b1214],
28	in	IN	O	in	_	0	SENT_272	[p18l667t1154r721b1200],
29	the	DT	O	the	det	31	SENT_272	[p18l742t1147r830b1200],
30	AMD	NNP	ORGANIZATION	AMD	nn	31	SENT_272	[p18l851t1148r1017b1200],
31	carriers	NNS	O	carrier	prep_in	27	SENT_272	[p18l1038t1154r1234b1200],
32	of	IN	O	of	_	0	SENT_272	[p18l1257t1147r1314b1200],
33	no	DT	O	no	det	35	SENT_272	[p18l1329t1168r1400b1200],
34	or	CC	O	or	cc	35	SENT_272	[p18l1422t1168r1478b1200],
35	1	CD	NUMBER	1	prep_of	24	SENT_272	[p18l1504t1150r1524b1200],
36	high	JJ	O	high	amod	39	SENT_272	[p18l1551t1147r1797b1214],
37	~	NN	O	~	nn	39	SENT_272	[p18l1551t1147r1797b1214],
38	risk	NN	O	risk	nn	39	SENT_272	[p18l1551t1147r1797b1214],
39	alleles	NNS	O	allele	nsubj	40	SENT_272	[p18l1818t1147r1983b1200],
40	(	VBP	O	(	rcmod	35	SENT_272	[p18l2009t1147r2069b1210],
41	P	NN	O	p	dobj	40	SENT_272	[p18l2009t1147r2069b1210],
42	=	JJ	O	=	advmod	40	SENT_272	[p18l2096t1168r2139b1185],
43	0.001	CD	NUMBER	0.001	num	44	SENT_272	[p18l9t1234r201b1298],
44	)	NN	O	)	dep	42	SENT_272	[p18l9t1234r201b1298],
45	.	.	O	.	_	0	SENT_272	[p18l9t1234r201b1298],

1	logMAR	NN	O	logmar	nn	3	SENT_273	[p18l228t1234r472b1301],
2	=	JJ	O	=	amod	3	SENT_273	[p18l502t1256r544b1272],
3	logarithm	NN	O	logarithm	_	0	SENT_273	[p18l576t1234r844b1302],
4	of	IN	O	of	_	0	SENT_273	[p18l867t1235r924b1288],
5	the	DT	O	the	det	7	SENT_273	[p18l942t1234r1030b1288],
6	minimum	JJ	O	minimum	amod	7	SENT_273	[p18l1055t1242r1326b1288],
7	angle	NN	O	angle	prep_of	3	SENT_273	[p18l1350t1234r1494b1301],
8	of	IN	O	of	_	0	SENT_273	[p18l1519t1235r1576b1288],
9	resolution	NN	O	resolution	prep_of	3	SENT_273	[p18l1593t1234r1881b1288],
10	.	.	O	.	_	0	SENT_273	[p18l1593t1234r1881b1288],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_274	[p18l996t1576r1591b1666],
2	Volume	NN	O	volume	dep	1	SENT_274	[p18l1686t1576r1957b1648],
3	119	CD	NUMBER	119	dep	2	SENT_274	[p18l2001t1580r2153b1660],
4	,	,	O	,	_	0	SENT_274	[p18l2001t1580r2153b1660],

1	the	DT	O	the	det	2	SENT_275	[p18l14t1791r115b1851],
2	study	NN	O	study	nsubj	3	SENT_275	[p18l161t1791r339b1869],
3	is	VBZ	O	be	_	0	SENT_275	[p18l382t1791r435b1851],
4	that	IN	O	that	complm	8	SENT_275	[p18l479t1791r605b1851],
5	the	DT	O	the	det	6	SENT_275	[p18l646t1791r748b1851],
6	conclusions	NNS	O	conclusion	nsubjpass	8	SENT_275	[p18l791t1791r1188b1851],
7	are	VBP	O	be	auxpass	8	SENT_275	[p18l1234t1810r1333b1851],
8	based	VBN	O	base	ccomp	3	SENT_275	[p18l1375t1791r1568b1851],
9	on	IN	O	on	_	0	SENT_275	[p18l1611t1810r1693b1851],
10	a	DT	O	a	det	12	SENT_275	[p18l1737t1810r1772b1851],
11	limited	JJ	O	limited	amod	12	SENT_275	[p18l1813t1791r2052b1851],
12	number	NN	O	number	prep_on	8	SENT_275	[p18l14t1885r272b1944],
13	of	IN	O	of	_	0	SENT_275	[p18l310t1884r383b1944],
14	AMD	NNP	ORGANIZATION	AMD	nn	15	SENT_275	[p18l414t1885r609b1944],
15	patients	NNS	O	patient	prep_of	12	SENT_275	[p18l646t1885r908b1962],
16	with	IN	O	with	_	0	SENT_275	[p18l947t1885r1096b1945],
17	4	CD	NUMBER	4	num	21	SENT_275	[p18l1133t1885r1172b1944],
18	or	CC	O	or	_	0	SENT_275	[p18l1211t1903r1281b1944],
19	6	CD	NUMBER	6	num	21	SENT_275	[p18l1318t1884r1355b1945],
20	high-risk	JJ	O	high-risk	amod	21	SENT_275	[p18l1393t1885r1700b1962],
21	alleles	NNS	O	allele	prep_with	8	SENT_275	[p18l1738t1885r1949b1944],
22	in	IN	O	in	_	0	SENT_275	[p18l1988t1884r2052b1944],
23	CFH	NNP	O	CFH	prep_in	21	SENT_275	[p18l18t1979r199b2047],
24	,	,	O	,	_	0	SENT_275	[p18l18t1979r199b2047],
25	ARMS2	NN	O	arms2	prep_in	21	SENT_275	[p18l229t1978r510b2047],
26	,	,	O	,	_	0	SENT_275	[p18l229t1978r510b2047],
27	and	CC	O	and	_	0	SENT_275	[p18l547t1978r666b2037],
28	VEGFA	NN	O	vegfa	nn	29	SENT_275	[p18l703t1979r962b2037],
29	genes	NNS	O	gene	prep_in	21	SENT_275	[p18l998t1996r1205b2054],
30	.	.	O	.	_	0	SENT_275	[p18l998t1996r1205b2054],

1	Therefore	RB	O	therefore	advmod	7	SENT_276	[p18l1241t1978r1592b2048],
2	,	,	O	,	_	0	SENT_276	[p18l1241t1978r1592b2048],
3	these	DT	O	these	det	4	SENT_276	[p18l1627t1978r1799b2037],
4	results	NNS	O	result	nsubjpass	7	SENT_276	[p18l1831t1978r2049b2037],
5	should	MD	O	should	aux	7	SENT_276	[p18l17t2070r239b2129],
6	be	VB	O	be	auxpass	7	SENT_276	[p18l270t2070r348b2129],
7	validated	VBN	O	validate	_	0	SENT_276	[p18l382t2070r692b2129],
8	in	IN	O	in	_	0	SENT_276	[p18l725t2070r788b2128],
9	other	JJ	O	other	amod	11	SENT_276	[p18l823t2070r995b2129],
10	patient	NN	O	patient	nn	11	SENT_276	[p18l1026t2070r1257b2146],
11	cohorts	NNS	O	cohort	prep_in	7	SENT_276	[p18l1290t2070r1553b2129],
12	.	.	O	.	_	0	SENT_276	[p18l1290t2070r1553b2129],

1	The	DT	O	the	det	3	SENT_277	[p18l1591t2070r1721b2129],
2	vast	JJ	O	vast	amod	3	SENT_277	[p18l1754t2079r1890b2129],
3	majority	NN	O	majority	nsubj	6	SENT_277	[p18l1922t2088r2049b2129, p18l6t2162r195b2238],
4	of	IN	O	of	_	0	SENT_277	[p18l223t2162r296b2221],
5	patients	NNS	O	patient	prep_of	3	SENT_277	[p18l315t2162r576b2238],
6	are	VBP	O	be	_	0	SENT_277	[p18l606t2181r706b2221],
7	in	IN	O	in	_	0	SENT_277	[p18l732t2162r797b2220],
8	the	DT	O	the	det	9	SENT_277	[p18l822t2162r923b2221],
9	middle	NN	O	middle	prep_in	6	SENT_277	[p18l950t2162r1183b2221],
10	of	IN	O	of	_	0	SENT_277	[p18l1211t2162r1284b2221],
11	the	DT	O	the	det	12	SENT_277	[p18l1305t2162r1406b2221],
12	distribution	NN	O	distribution	prep_of	9	SENT_277	[p18l1434t2162r1840b2232],
13	,	,	O	,	_	0	SENT_277	[p18l1434t2162r1840b2232],
14	and	CC	O	and	_	0	SENT_277	[p18l1871t2162r1991b2221],
15	a	DT	O	a	det	17	SENT_277	[p18l2018t2181r2053b2221],
16	wide	JJ	O	wide	amod	17	SENT_277	[p18l14t2255r176b2315],
17	range	NN	O	range	nsubjpass	24	SENT_277	[p18l211t2274r398b2333],
18	in	IN	O	in	_	0	SENT_277	[p18l434t2255r498b2314],
19	response	NN	O	response	prep_in	17	SENT_277	[p18l532t2274r828b2332],
20	to	TO	O	to	_	0	SENT_277	[p18l864t2264r926b2315],
21	ranibizumab	NN	O	ranibizumab	nn	22	SENT_277	[p18l962t2255r1384b2315],
22	treatment	NN	O	treatment	prep_to	19	SENT_277	[p18l1421t2264r1741b2315],
23	was	VBD	O	be	auxpass	24	SENT_277	[p18l1776t2274r1903b2315],
24	observed	VBN	O	observe	conj_and	6	SENT_277	[p18l1942t2255r2049b2315, p18l17t2346r234b2406],
25	among	IN	O	among	_	0	SENT_277	[p18l277t2365r503b2424],
26	allele	NN	O	allele	nn	27	SENT_277	[p18l547t2346r727b2406],
27	groups	NNS	O	group	prep_among	24	SENT_277	[p18l771t2365r1017b2424],
28	,	,	O	,	_	0	SENT_277	[p18l771t2365r1017b2424],
29	indicating	VBG	O	indicate	xcomp	24	SENT_277	[p18l1062t2346r1398b2424],
30	that	IN	O	that	complm	34	SENT_277	[p18l1441t2346r1568b2406],
31	other	JJ	O	other	amod	32	SENT_277	[p18l1609t2346r1782b2406],
32	factors	NNS	O	factor	nsubj	34	SENT_277	[p18l1823t2346r2049b2406],
33	also	RB	O	also	advmod	34	SENT_277	[p18l15t2440r147b2499],
34	contribute	VBP	O	contribute	ccomp	29	SENT_277	[p18l170t2440r511b2499],
35	to	TO	O	to	_	0	SENT_277	[p18l532t2449r596b2499],
36	the	DT	O	the	det	38	SENT_277	[p18l618t2440r718b2499],
37	response	NN	O	response	nn	38	SENT_277	[p18l739t2458r1035b2517],
38	rate	NN	O	rate	prep_to	34	SENT_277	[p18l1055t2448r1198b2499],
39	.	.	O	.	_	0	SENT_277	[p18l1055t2448r1198b2499],

1	Additional	JJ	O	additional	amod	2	SENT_278	[p18l1224t2440r1584b2499],
2	studies	NNS	O	study	nsubj	21	SENT_278	[p18l1609t2440r1838b2499],
3	of	IN	O	of	_	0	SENT_278	[p18l1862t2440r1935b2499],
4	the	DT	O	the	det	5	SENT_278	[p18l1950t2440r2051b2499],
5	effect	NN	O	effect	prep_of	2	SENT_278	[p18l14t2533r206b2592],
6	of	IN	O	of	_	0	SENT_278	[p18l244t2533r317b2592],
7	phenotypic	JJ	O	phenotypic	amod	10	SENT_278	[p18l349t2533r723b2609],
8	and	CC	O	and	_	0	SENT_278	[p18l765t2533r884b2592],
9	environmental	JJ	O	environmental	conj_and	7	SENT_278	[p18l923t2533r1410b2592],
10	parameters	NNS	O	parameter	prep_of	5	SENT_278	[p18l1448t2542r1837b2609],
11	,	,	O	,	_	0	SENT_278	[p18l1448t2542r1837b2609],
12	additional	JJ	O	additional	amod	14	SENT_278	[p18l1881t2533r2048b2592, p18l13t2625r205b2684],
13	genetic	JJ	O	genetic	amod	14	SENT_278	[p18l253t2625r494b2701],
14	variants	NNS	O	variant	prep_of	5	SENT_278	[p18l542t2625r826b2694],
15	,	,	O	,	_	0	SENT_278	[p18l542t2625r826b2694],
16	and	CC	O	and	_	0	SENT_278	[p18l879t2625r998b2684],
17	possibly	RB	O	possibly	advmod	19	SENT_278	[p18l1043t2625r1324b2701],
18	proteomic	JJ	O	proteomic	amod	19	SENT_278	[p18l1371t2625r1713b2701],
19	proﬁling	NN	O	proﬁling	conj_and	10	SENT_278	[p18l1760t2625r2050b2701],
20	may	MD	O	may	aux	21	SENT_278	[p18l14t2736r157b2793],
21	lead	VB	O	lead	_	0	SENT_278	[p18l181t2717r321b2776],
22	to	TO	O	to	_	0	SENT_278	[p18l344t2726r407b2776],
23	a	DT	O	a	det	27	SENT_278	[p18l433t2736r468b2776],
24	more	RBR	O	more	advmod	25	SENT_278	[p18l491t2736r663b2776],
25	accurate	JJ	O	accurate	amod	27	SENT_278	[p18l688t2726r967b2776],
26	prediction	NN	O	prediction	nn	27	SENT_278	[p18l990t2717r1334b2793],
27	model	NN	O	model	prep_to	21	SENT_278	[p18l1357t2717r1585b2787],
28	,	,	O	,	_	0	SENT_278	[p18l1357t2717r1585b2787],
29	which	WDT	O	which	nsubj	31	SENT_278	[p18l1613t2717r1818b2776],
30	would	MD	O	would	aux	31	SENT_278	[p18l1842t2717r2052b2776],
31	provide	VB	O	provide	rcmod	27	SENT_278	[p18l13t2810r271b2887],
32	the	DT	O	the	det	33	SENT_278	[p18l295t2810r397b2870],
33	basis	NN	O	basis	dobj	31	SENT_278	[p18l420t2810r587b2870],
34	for	IN	O	for	_	0	SENT_278	[p18l613t2810r711b2870],
35	personalized	JJ	O	personalized	amod	36	SENT_278	[p18l733t2810r1162b2887],
36	medicine	NN	O	medicine	prep_for	33	SENT_278	[p18l1186t2810r1494b2870],
37	for	IN	O	for	_	0	SENT_278	[p18l1519t2810r1618b2870],
38	treatment	NN	O	treatment	prep_for	31	SENT_278	[p18l1640t2819r1960b2870],
39	of	IN	O	of	_	0	SENT_278	[p18l1984t2810r2057b2870],
40	neovascular	JJ	O	neovascular	amod	41	SENT_278	[p18l14t2902r419b2962],
41	AMD	NNP	ORGANIZATION	AMD	prep_of	38	SENT_278	[p18l448t2903r661b2961],
42	.	.	O	.	_	0	SENT_278	[p18l448t2903r661b2961],

1	In	IN	O	in	_	0	SENT_279	[p18l116t2996r184b3054],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_279	[p18l220t2995r604b3065],
3	,	,	O	,	_	0	SENT_279	[p18l220t2995r604b3065],
4	these	DT	O	these	det	5	SENT_279	[p18l642t2995r814b3054],
5	ﬁndings	NNS	O	ﬁndings	nsubj	6	SENT_279	[p18l851t2994r1120b3072],
6	demonstrate	VBP	O	demonstrate	_	0	SENT_279	[p18l1158t2995r1570b3054],
7	a	DT	O	a	det	9	SENT_279	[p18l1607t3013r1642b3054],
8	cumulative	JJ	O	cumulative	amod	9	SENT_279	[p18l1677t2995r2051b3055],
9	effect	NN	O	effect	dobj	6	SENT_279	[p18l14t3088r206b3147],
10	of	IN	O	of	_	0	SENT_279	[p18l254t3088r327b3147],
11	high-risk	JJ	O	high-risk	amod	12	SENT_279	[p18l368t3088r675b3164],
12	alleles	NNS	O	allele	prep_of	9	SENT_279	[p18l723t3088r954b3157],
13	,	,	O	,	_	0	SENT_279	[p18l723t3088r954b3157],
14	leading	VBG	O	lead	partmod	6	SENT_279	[p18l1005t3088r1252b3164],
15	to	TO	O	to	_	0	SENT_279	[p18l1301t3097r1364b3147],
16	a	DT	O	a	det	18	SENT_279	[p18l1414t3106r1449b3147],
17	younger	JJR	O	younger	amod	18	SENT_279	[p18l1496t3106r1774b3164],
18	age	NN	O	age	prep_to	14	SENT_279	[p18l1821t3106r1935b3164],
19	of	IN	O	of	_	0	SENT_279	[p18l1984t3088r2057b3147],
20	neovascular	JJ	O	neovascular	amod	22	SENT_279	[p18l14t3180r419b3239],
21	AMD	NNP	ORGANIZATION	AMD	nn	22	SENT_279	[p18l442t3180r637b3238],
22	onset	NN	O	onset	prep_of	18	SENT_279	[p18l665t3189r842b3239],
23	in	IN	O	in	_	0	SENT_279	[p18l866t3180r930b3238],
24	combination	NN	O	combination	prep_in	14	SENT_279	[p18l956t3180r1379b3239],
25	with	IN	O	with	_	0	SENT_279	[p18l1404t3180r1553b3239],
26	poor	JJ	O	poor	amod	28	SENT_279	[p18l1577t3198r1733b3256],
27	response	NN	O	response	nn	28	SENT_279	[p18l1756t3198r2051b3256],
28	rates	NNS	O	rate	prep_with	14	SENT_279	[p18l13t3281r170b3331],
29	to	TO	O	to	_	0	SENT_279	[p18l198t3281r261b3331],
30	intravitreal	JJ	O	intravitreal	amod	32	SENT_279	[p18l288t3272r659b3331],
31	ranibizumab	NN	O	ranibizumab	nn	32	SENT_279	[p18l684t3272r1107b3331],
32	treatment	NN	O	treatment	prep_to	14	SENT_279	[p18l1134t3281r1470b3331],
33	.	.	O	.	_	0	SENT_279	[p18l1134t3281r1470b3331],

1	Because	IN	O	because	mark	5	SENT_280	[p18l1501t3274r1781b3331],
2	genetic	JJ	O	genetic	amod	3	SENT_280	[p18l1809t3272r2050b3348],
3	variation	NN	O	variation	nsubj	5	SENT_280	[p18l14t3365r314b3425],
4	partially	RB	O	partially	advmod	5	SENT_280	[p18l350t3365r631b3443],
5	explains	VBZ	O	explain	advcl	17	SENT_280	[p18l670t3365r948b3443],
6	the	DT	O	the	det	8	SENT_280	[p18l987t3365r1088b3425],
7	wide	JJ	O	wide	amod	8	SENT_280	[p18l1126t3365r1288b3425],
8	range	NN	O	range	dobj	5	SENT_280	[p18l1325t3384r1512b3443],
9	of	IN	O	of	_	0	SENT_280	[p18l1550t3365r1624b3425],
10	response	NN	O	response	prep_of	8	SENT_280	[p18l1654t3384r1950b3442],
11	to	TO	O	to	_	0	SENT_280	[p18l1987t3374r2050b3425],
12	ranibizumab	NN	O	ranibizumab	nn	13	SENT_280	[p18l13t3456r435b3516],
13	treatment	NN	O	treatment	prep_to	5	SENT_280	[p18l470t3465r807b3527],
14	,	,	O	,	_	0	SENT_280	[p18l470t3465r807b3527],
15	genetic	JJ	O	genetic	amod	16	SENT_280	[p18l844t3456r1085b3534],
16	screening	NN	O	screening	nsubj	28	SENT_280	[p18l1123t3456r1442b3534],
17	has	VBZ	O	have	_	0	SENT_280	[p18l1476t3456r1586b3516],
18	the	DT	O	the	det	19	SENT_280	[p18l1621t3456r1723b3516],
19	potential	JJ	O	potential	dobj	17	SENT_280	[p18l1755t3456r2051b3534],
20	to	TO	O	to	aux	21	SENT_280	[p18l14t3559r76b3609],
21	identify	VB	O	identify	dep	19	SENT_280	[p18l122t3550r384b3627],
22	high-risk	JJ	O	high-risk	amod	23	SENT_280	[p18l429t3550r735b3627],
23	individuals	NNS	O	individual	dobj	21	SENT_280	[p18l779t3550r1152b3610],
24	and	CC	O	and	_	0	SENT_280	[p18l1200t3550r1320b3609],
25	in	IN	O	in	_	0	SENT_280	[p18l1364t3550r1428b3609],
26	future	NN	DATE	future	prep_in	28	SENT_280	[p18l1473t3549r1673b3609],
27	may	MD	O	may	aux	28	SENT_280	[p18l1718t3568r1861b3627],
28	help	VB	O	help	conj_and	17	SENT_280	[p18l1906t3550r2050b3627],
29	clinicians	NNS	O	clinician	nsubj	31	SENT_280	[p18l14t3644r335b3703],
30	to	TO	O	to	aux	31	SENT_280	[p18l368t3653r430b3703],
31	tailor	VB	O	tailor	xcomp	28	SENT_280	[p18l462t3644r641b3703],
32	medical	JJ	O	medical	amod	33	SENT_280	[p18l670t3644r936b3703],
33	care	NN	O	care	dobj	31	SENT_280	[p18l968t3662r1106b3703],
34	to	TO	O	to	_	0	SENT_280	[p18l1137t3653r1200b3703],
35	individual	JJ	O	individual	amod	36	SENT_280	[p18l1231t3644r1574b3703],
36	needs	NNS	O	need	prep_to	31	SENT_280	[p18l1604t3644r1813b3703],
37	.	.	O	.	_	0	SENT_280	[p18l1604t3644r1813b3703],

1	References	NNS	O	reference	_	0	SENT_281	[p19l14t94r514b172],

1	1	LS	NUMBER	1	_	0	SENT_282	[p19l59t365r103b418],
2	.	.	O	.	_	0	SENT_282	[p19l59t365r103b418],

1	Eye	NNP	O	Eye	nn	2	SENT_283	[p19l147t366r264b433],
2	Diseases	NNP	O	Diseases	_	0	SENT_283	[p19l289t365r553b418],
3	Prevalence	NN	O	prevalence	nn	5	SENT_283	[p19l579t365r912b418],
4	Research	NNP	O	Research	nn	5	SENT_283	[p19l938t365r1216b418],
5	Group	NNP	O	Group	dep	2	SENT_283	[p19l1242t365r1449b434],
6	.	.	O	.	_	0	SENT_283	[p19l1242t365r1449b434],

1	Prevalence	NN	O	prevalence	_	0	SENT_284	[p19l1478t365r1811b418],
2	of	IN	O	of	_	0	SENT_284	[p19l1837t365r1903b418],
3	agerelated	JJ	O	agerelated	amod	5	SENT_284	[p19l1924t381r2050b434, p19l147t448r354b502],
4	macular	JJ	O	macular	amod	5	SENT_284	[p19l378t449r624b502],
5	degeneration	NN	O	degeneration	prep_of	1	SENT_284	[p19l649t448r1041b517],
6	in	IN	O	in	_	0	SENT_284	[p19l1066t448r1123b501],
7	the	DT	O	the	det	9	SENT_284	[p19l1148t449r1239b502],
8	United	NNP	LOCATION	United	nn	9	SENT_284	[p19l1264t448r1472b502],
9	States	NNPS	LOCATION	States	prep_in	1	SENT_284	[p19l1498t449r1692b502],
10	.	.	O	.	_	0	SENT_284	[p19l1498t449r1692b502],

1	Arch	NNP	O	Arch	nn	2	SENT_285	[p19l1721t448r1872b502],
2	Ophthalmol	NNP	O	Ophthalmol	_	0	SENT_285	[p19l1898t448r2049b517, p19l147t532r379b585],
3	2004	CD	DATE	2004	num	2	SENT_285	[p19l408t533r575b595],
4	;	:	O	;	_	0	SENT_285	[p19l408t533r575b595],
5	122:564	CD	NUMBER	122:564	number	6	SENT_285	[p19l588t532r829b586],
6	-72	CD	NUMBER	-72	dep	2	SENT_285	[p19l839t533r969b586],
7	.	.	O	.	_	0	SENT_285	[p19l839t533r969b586],

1	2	LS	NUMBER	2	_	0	SENT_286	[p19l53t617r103b670],
2	.	.	O	.	_	0	SENT_286	[p19l53t617r103b670],

1	Klein	NNP	PERSON	Klein	nn	2	SENT_287	[p19l149t617r315b670],
2	R	NNP	PERSON	R	_	0	SENT_287	[p19l337t618r403b680],
3	,	,	O	,	_	0	SENT_287	[p19l337t618r403b680],
4	Klein	NNP	PERSON	Klein	nsubj	5	SENT_287	[p19l429t617r596b670],
5	BE	VBP	O	be	dep	2	SENT_287	[p19l618t618r730b680],
6	,	,	O	,	_	0	SENT_287	[p19l618t618r730b680],
7	Tomany	NNP	ORGANIZATION	Tomany	nn	8	SENT_287	[p19l755t618r1008b686],
8	SC	NNP	ORGANIZATION	SC	appos	2	SENT_287	[p19l1033t617r1138b680],
9	,	,	O	,	_	0	SENT_287	[p19l1033t617r1138b680],
10	et	FW	O	et	nn	11	SENT_287	[p19l1164t625r1218b670],
11	al.	FW	O	al.	appos	2	SENT_287	[p19l1241t617r1308b670],
12	.	.	O	.	_	0	SENT_287	[p19l1241t617r1308b670],

1	Ten-year	JJ	DURATION	ten-year	amod	2	SENT_288	[p19l1334t618r1609b686],
2	incidence	NN	O	incidence	_	0	SENT_288	[p19l1630t617r1921b670],
3	and	CC	O	and	_	0	SENT_288	[p19l1945t617r2052b670],
4	progression	NN	O	progression	conj_and	2	SENT_288	[p19l146t701r503b770],
5	of	IN	O	of	_	0	SENT_288	[p19l527t701r593b754],
6	age	NN	O	age	npadvmod	8	SENT_288	[p19l613t701r950b770],
7	—	CD	NUMBER	—	num	6	SENT_288	[p19l613t701r950b770],
8	related	JJ	O	related	amod	9	SENT_288	[p19l613t701r950b770],
9	maculopathy	NN	O	maculopathy	prep_of	2	SENT_288	[p19l973t701r1382b770],
10	:	:	O	:	_	0	SENT_288	[p19l973t701r1382b770],
11	the	DT	O	the	det	13	SENT_288	[p19l1411t701r1502b754],
12	Beaver	NNP	O	Beaver	nn	13	SENT_288	[p19l1526t702r1742b754],
13	Dam	NN	O	dam	dep	2	SENT_288	[p19l1764t702r1912b754],
14	Eye	NNP	O	Eye	nn	15	SENT_288	[p19l1934t702r2051b770],
15	Study	NNP	O	Study	dep	13	SENT_288	[p19l149t785r339b853],
16	.	.	O	.	_	0	SENT_288	[p19l149t785r339b853],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_289	[p19l372t784r848b853],
2	2002	CD	DATE	2002	num	1	SENT_289	[p19l877t785r1179b847],
3	;	:	O	;	_	0	SENT_289	[p19l877t785r1179b847],
4	l09	CD	NUMBER	l09	num	6	SENT_289	[p19l877t785r1179b847],
5	:	:	O	:	_	0	SENT_289	[p19l877t785r1179b847],
6	1767-79	CD	NUMBER	1767-79	dep	1	SENT_289	[p19l1194t784r1468b838],
7	.	.	O	.	_	0	SENT_289	[p19l1194t784r1468b838],

1	3	LS	NUMBER	3	_	0	SENT_290	[p19l54t869r103b922],
2	.	.	O	.	_	0	SENT_290	[p19l54t869r103b922],

1	Mitchell	NNP	PERSON	Mitchell	nn	2	SENT_291	[p19l147t868r404b921],
2	P	NN	PERSON	p	_	0	SENT_291	[p19l447t870r504b931],
3	,	,	O	,	_	0	SENT_291	[p19l447t870r504b931],
4	Smith	NNP	PERSON	Smith	nn	5	SENT_291	[p19l552t868r731b922],
5	W	NNP	PERSON	W	appos	2	SENT_291	[p19l773t870r860b931],
6	,	,	O	,	_	0	SENT_291	[p19l773t870r860b931],
7	Attebo	NNP	LOCATION	Attebo	nn	8	SENT_291	[p19l906t868r1111b921],
8	K	NNP	LOCATION	K	appos	2	SENT_291	[p19l1156t870r1225b931],
9	,	,	O	,	_	0	SENT_291	[p19l1156t870r1225b931],
10	Wang	NNP	PERSON	Wang	nn	11	SENT_291	[p19l1269t870r1450b937],
11	JJ	NN	PERSON	jj	appos	2	SENT_291	[p19l1494t870r1567b922],
12	.	.	O	.	_	0	SENT_291	[p19l1494t870r1567b922],

1	Prevalence	NN	O	prevalence	dep	6	SENT_292	[p19l1613t868r1947b922],
2	of	IN	O	of	_	0	SENT_292	[p19l1991t868r2057b921],
3	age	NN	O	age	prep_of	1	SENT_292	[p19l149t952r486b1021],
4	—	CD	NUMBER	—	dep	6	SENT_292	[p19l149t952r486b1021],
5	related	JJ	O	related	amod	6	SENT_292	[p19l149t952r486b1021],
6	maculopathy	NN	O	maculopathy	dep	14	SENT_292	[p19l505t952r898b1021],
7	in	IN	O	in	_	0	SENT_292	[p19l919t952r976b1005],
8	Australia	NNP	LOCATION	Australia	prep_in	6	SENT_292	[p19l995t952r1290b1005],
9	:	:	O	:	_	0	SENT_292	[p19l995t952r1290b1005],
10	the	DT	O	the	det	14	SENT_292	[p19l1315t952r1406b1005],
11	Blue	NNP	O	Blue	nn	14	SENT_292	[p19l1427t952r1569b1005],
12	Mountains	NNPS	O	Mountains	nn	14	SENT_292	[p19l1589t952r1913b1005],
13	Eye	NNP	O	Eye	nn	14	SENT_292	[p19l1934t953r2051b1021],
14	Study	NNP	O	Study	_	0	SENT_292	[p19l149t1037r339b1106],
15	.	.	O	.	_	0	SENT_292	[p19l149t1037r339b1106],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_293	[p19l372t1037r848b1106],
2	1995	CD	DATE	1995	num	1	SENT_293	[p19l883t1037r1024b1091],
3	;	:	O	;	_	0	SENT_293	[p19l1034t1037r1179b1100],
4	102	CD	NUMBER	102	num	6	SENT_293	[p19l1034t1037r1179b1100],
5	:	:	O	:	_	0	SENT_293	[p19l1034t1037r1179b1100],
6	1450-60	CD	NUMBER	1450-60	dep	1	SENT_293	[p19l1194t1037r1486b1090],
7	.	.	O	.	_	0	SENT_293	[p19l1194t1037r1486b1090],

1	4	LS	NUMBER	4	_	0	SENT_294	[p19l51t1121r103b1174],
2	.	.	O	.	_	0	SENT_294	[p19l51t1121r103b1174],

1	Ferrara	NNP	PERSON	Ferrara	nn	2	SENT_295	[p19l147t1122r367b1174],
2	N	NNP	O	N	_	0	SENT_295	[p19l389t1122r459b1183],
3	,	,	O	,	_	0	SENT_295	[p19l389t1122r459b1183],
4	Gerber	NNP	O	Gerber	nn	5	SENT_295	[p19l487t1121r698b1174],
5	HP	NNP	O	HP	appos	2	SENT_295	[p19l720t1122r832b1184],
6	,	,	O	,	_	0	SENT_295	[p19l720t1122r832b1184],
7	LeCouter	NNP	O	LeCouter	nn	10	SENT_295	[p19l858t1121r1147b1174],
8	J.	NNP	O	J.	nn	10	SENT_295	[p19l1169t1122r1212b1174],
9	The	NNP	O	The	nn	10	SENT_295	[p19l1240t1121r1357b1174],
10	biology	NN	O	biology	appos	2	SENT_295	[p19l1380t1121r1612b1190],
11	of	IN	O	of	_	0	SENT_295	[p19l1637t1121r1703b1174],
12	VEGF	NN	O	vegf	prep_of	10	SENT_295	[p19l1721t1121r1920b1174],
13	and	CC	O	and	_	0	SENT_295	[p19l1945t1121r2052b1174],
14	its	PRP$	O	its	poss	15	SENT_295	[p19l148t1204r216b1257],
15	receptors	NNS	O	receptor	conj_and	12	SENT_295	[p19l244t1212r539b1273],
16	.	.	O	.	_	0	SENT_295	[p19l244t1212r539b1273],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_296	[p19l570t1206r680b1258],
2	Med	NNP	O	Med	_	0	SENT_296	[p19l706t1204r845b1257],
3	2003	CD	DATE	2003	num	2	SENT_296	[p19l873t1204r1216b1267],
4	;	:	O	;	_	0	SENT_296	[p19l873t1204r1216b1267],
5	9:669	CD	NUMBER	9:669	number	6	SENT_296	[p19l873t1204r1216b1267],
6	-76	CD	NUMBER	-76	dep	2	SENT_296	[p19l1228t1204r1357b1258],
7	.	.	O	.	_	0	SENT_296	[p19l1228t1204r1357b1258],

1	5	CD	NUMBER	5	_	0	SENT_297	[p19l53t1288r103b1342],
2	.	.	O	.	_	0	SENT_297	[p19l53t1288r103b1342],

1	Frank	NNP	PERSON	Frank	nn	2	SENT_298	[p19l147t1288r325b1341],
2	RN	NNP	PERSON	RN	_	0	SENT_298	[p19l351t1290r471b1351],
3	,	,	O	,	_	0	SENT_298	[p19l351t1290r471b1351],
4	Amin	NNP	PERSON	Amin	nn	5	SENT_298	[p19l502t1288r674b1341],
5	RH	NNP	PERSON	RH	appos	2	SENT_298	[p19l701t1290r822b1351],
6	,	,	O	,	_	0	SENT_298	[p19l701t1290r822b1351],
7	Eliott	NNP	PERSON	Eliott	nn	8	SENT_298	[p19l851t1288r1021b1341],
8	D	NNP	O	D	appos	2	SENT_298	[p19l1047t1290r1117b1351],
9	,	,	O	,	_	0	SENT_298	[p19l1047t1290r1117b1351],
10	et	FW	O	et	nn	11	SENT_298	[p19l1148t1296r1202b1341],
11	al.	FW	O	al.	appos	2	SENT_298	[p19l1229t1288r1296b1341],
12	.	.	O	.	_	0	SENT_298	[p19l1229t1288r1296b1341],

1	Basic	JJ	O	basic	amod	4	SENT_299	[p19l1327t1288r1494b1341],
2	ﬁbroblast	NN	O	ﬁbroblast	nn	4	SENT_299	[p19l1524t1288r1811b1341],
3	growth	NN	O	growth	nn	4	SENT_299	[p19l1838t1288r2052b1357],
4	factor	NN	O	factor	nsubj	11	SENT_299	[p19l148t1373r325b1426],
5	and	CC	O	and	_	0	SENT_299	[p19l359t1373r466b1426],
6	vascular	JJ	O	vascular	amod	9	SENT_299	[p19l500t1373r754b1426],
7	endothelial	JJ	O	endothelial	amod	9	SENT_299	[p19l787t1373r1124b1426],
8	growth	NN	O	growth	nn	9	SENT_299	[p19l1159t1373r1373b1442],
9	factor	NN	O	factor	conj_and	4	SENT_299	[p19l1407t1373r1584b1426],
10	are	VBP	O	be	cop	11	SENT_299	[p19l1618t1389r1707b1426],
11	present	JJ	DATE	present	_	0	SENT_299	[p19l1741t1381r1962b1442],
12	in	IN	O	in	_	0	SENT_299	[p19l1995t1373r2052b1425],
13	epiretinal	JJ	O	epiretinal	amod	17	SENT_299	[p19l148t1456r434b1525],
14	and	CC	O	and	_	0	SENT_299	[p19l464t1457r571b1510],
15	choroidal	JJ	O	choroidal	conj_and	13	SENT_299	[p19l599t1456r885b1510],
16	neovascular	JJ	O	neovascular	amod	17	SENT_299	[p19l913t1457r1277b1510],
17	membranes	NNS	O	membrane	prep_in	11	SENT_299	[p19l1303t1457r1669b1510],
18	.	.	O	.	_	0	SENT_299	[p19l1303t1457r1669b1510],

1	Am	NNP	O	Am	nn	3	SENT_300	[p19l1701t1457r1815b1509],
2	J	NNP	O	J	nn	3	SENT_300	[p19l1841t1458r1869b1510],
3	Ophthalmol	NNP	O	Ophthalmol	_	0	SENT_300	[p19l1898t1456r2050b1525, p19l147t1540r379b1593],
4	1996	CD	DATE	1996	num	3	SENT_300	[p19l414t1540r1007b1603],
5	;	:	O	;	_	0	SENT_300	[p19l414t1540r1007b1603],
6	122:393	CD	NUMBER	122:393	number	7	SENT_300	[p19l414t1540r1007b1603],
7	-403	CD	NUMBER	-403	dep	3	SENT_300	[p19l414t1540r1007b1603],
8	.	.	O	.	_	0	SENT_300	[p19l414t1540r1007b1603],

1	6	CD	NUMBER	6	_	0	SENT_301	[p19l53t1625r103b1678],
2	.	.	O	.	_	0	SENT_301	[p19l53t1625r103b1678],

1	Kliffen	NN	O	kliffen	nn	2	SENT_302	[p19l149t1625r366b1678],
2	M	NN	O	m	_	0	SENT_302	[p19l387t1626r470b1688],
3	,	,	O	,	_	0	SENT_302	[p19l387t1626r470b1688],
4	Sharma	FW	ORGANIZATION	sharma	appos	2	SENT_302	[p19l497t1625r727b1678],
5	HS	NN	ORGANIZATION	h	dep	4	SENT_302	[p19l748t1625r860b1688],
6	,	,	O	,	_	0	SENT_302	[p19l748t1625r860b1688],
7	Mooy	NNP	PERSON	Mooy	nn	8	SENT_302	[p19l884t1626r1065b1694],
8	CM	NN	O	cm	appos	2	SENT_302	[p19l1088t1625r1220b1688],
9	,	,	O	,	_	0	SENT_302	[p19l1088t1625r1220b1688],
10	et	FW	O	et	nn	11	SENT_302	[p19l1245t1633r1299b1678],
11	al.	FW	O	al.	appos	2	SENT_302	[p19l1322t1625r1388b1678],
12	.	.	O	.	_	0	SENT_302	[p19l1322t1625r1388b1678],

1	Increased	VBN	O	increase	amod	2	SENT_303	[p19l1413t1625r1705b1678],
2	expression	NN	O	expression	_	0	SENT_303	[p19l1727t1625r2052b1694],
3	of	IN	O	of	_	0	SENT_303	[p19l148t1708r214b1762],
4	angiogenic	JJ	O	angiogenic	amod	6	SENT_303	[p19l233t1708r564b1777],
5	growth	NN	O	growth	nn	6	SENT_303	[p19l588t1708r802b1777],
6	factors	NNS	O	factor	prep_of	2	SENT_303	[p19l825t1708r1028b1762],
7	in	IN	O	in	_	0	SENT_303	[p19l1053t1708r1110b1761],
8	age	NN	O	age	npadvmod	10	SENT_303	[p19l1134t1708r1471b1777],
9	—	CD	NUMBER	—	num	8	SENT_303	[p19l1134t1708r1471b1777],
10	related	JJ	O	related	amod	11	SENT_303	[p19l1134t1708r1471b1777],
11	maculopathy	NN	O	maculopathy	prep_in	6	SENT_303	[p19l1493t1709r1901b1777],
12	.	.	O	.	_	0	SENT_303	[p19l1493t1709r1901b1777],

1	Br	NN	O	br	nn	3	SENT_304	[p19l1927t1710r2003b1761],
2	J	NN	O	j	nn	3	SENT_304	[p19l2023t1710r2051b1762],
3	Ophthalmol	NN	O	ophthalmol	_	0	SENT_304	[p19l149t1792r511b1861],
4	1997	CD	DATE	1997	num	6	SENT_304	[p19l546t1793r803b1855],
5	;	:	O	;	_	0	SENT_304	[p19l546t1793r803b1855],
6	81	CD	NUMBER	81	dep	3	SENT_304	[p19l546t1793r803b1855],
7	:	:	O	:	_	0	SENT_304	[p19l546t1793r803b1855],
8	154	CD	NUMBER	154	num	10	SENT_304	[p19l818t1792r922b1846],
9	-	:	O	-	_	0	SENT_304	[p19l933t1825r972b1830],
10	62	CD	DATE	62	dep	3	SENT_304	[p19l983t1792r1071b1846],
11	.	.	O	.	_	0	SENT_304	[p19l983t1792r1071b1846],

1	7	CD	NUMBER	7	_	0	SENT_305	[p19l52t1878r103b1930],
2	.	.	O	.	_	0	SENT_305	[p19l52t1878r103b1930],

1	Lopez	NNP	PERSON	Lopez	nn	2	SENT_306	[p19l147t1878r336b1946],
2	PF	NNP	O	PF	_	0	SENT_306	[p19l362t1878r462b1940],
3	,	,	O	,	_	0	SENT_306	[p19l362t1878r462b1940],
4	Sippy	NNP	O	Sippy	nn	5	SENT_306	[p19l492t1877r666b1946],
5	BD	NNP	O	BD	appos	2	SENT_306	[p19l692t1878r813b1940],
6	,	,	O	,	_	0	SENT_306	[p19l692t1878r813b1940],
7	Lambert	NNP	PERSON	Lambert	nn	8	SENT_306	[p19l841t1877r1100b1930],
8	HM	NNS	O	hm	appos	2	SENT_306	[p19l1125t1878r1262b1940],
9	,	,	O	,	_	0	SENT_306	[p19l1125t1878r1262b1940],
10	et	FW	O	et	nn	11	SENT_306	[p19l1291t1885r1345b1930],
11	al.	FW	O	al.	appos	2	SENT_306	[p19l1371t1877r1438b1930],
12	.	.	O	.	_	0	SENT_306	[p19l1371t1877r1438b1930],

1	T	NN	O	t	nsubj	2	SENT_307	[p19l1467t1878r1512b1929],
2	ransdifferentiated	VBD	O	ransdifferentiate	_	0	SENT_307	[p19l1513t1877r2052b1930],
3	retinal	JJ	O	retinal	amod	6	SENT_307	[p19l147t1961r341b2014],
4	pigment	NN	O	pigment	nn	6	SENT_307	[p19l364t1961r615b2030],
5	epithelial	JJ	O	epithelial	amod	6	SENT_307	[p19l639t1961r921b2030],
6	cells	NNS	O	cell	nsubj	8	SENT_307	[p19l946t1961r1081b2014],
7	are	VBP	O	be	cop	8	SENT_307	[p19l1109t1977r1199b2014],
8	immunoreactive	JJ	O	immunoreactive	ccomp	2	SENT_307	[p19l1224t1961r1718b2014],
9	for	IN	O	for	_	0	SENT_307	[p19l1743t1961r1832b2014],
10	vascular	JJ	O	vascular	amod	13	SENT_307	[p19l1855t1977r2050b2014, p19l148t2044r227b2097],
11	endothelial	JJ	O	endothelial	amod	13	SENT_307	[p19l252t2044r588b2097],
12	growth	NN	O	growth	nn	13	SENT_307	[p19l615t2044r829b2113],
13	factor	NN	O	factor	prep_for	8	SENT_307	[p19l853t2044r1031b2097],
14	in	IN	O	in	prep	13	SENT_307	[p19l1055t2044r1112b2097],
15	surgically	RB	O	surgically	pcomp	14	SENT_307	[p19l1140t2044r1436b2113],
16	excised	VBN	O	excise	partmod	13	SENT_307	[p19l1462t2044r1690b2097],
17	age	NN	O	age	nn	18	SENT_307	[p19l1715t2044r2052b2113],
18	—	NN	O	—	nsubj	19	SENT_307	[p19l1715t2044r2052b2113],
19	related	JJ	O	related	ccomp	16	SENT_307	[p19l1715t2044r2052b2113],
20	macular	JJ	O	macular	amod	22	SENT_307	[p19l147t2128r393b2181],
21	degeneration	NN	O	degeneration	nn	22	SENT_307	[p19l444t2128r1071b2197],
22	—	NN	O	—	iobj	19	SENT_307	[p19l444t2128r1071b2197],
23	related	JJ	O	related	amod	26	SENT_307	[p19l444t2128r1071b2197],
24	choroidal	JJ	O	choroidal	amod	26	SENT_307	[p19l1123t2128r1409b2181],
25	neovascular	JJ	O	neovascular	amod	26	SENT_307	[p19l1461t2128r1825b2182],
26	membranes	NNS	O	membrane	dobj	19	SENT_307	[p19l1876t2145r2050b2181, p19l146t2213r360b2266],
27	.	.	O	.	_	0	SENT_307	[p19l1876t2145r2050b2181, p19l146t2213r360b2266],

1	Invest	VB	O	invest	_	0	SENT_308	[p19l392t2214r578b2266],
2	Ophthalmol	NNP	O	Ophthalmol	nn	4	SENT_308	[p19l605t2213r967b2282],
3	Vis	NNP	O	Vis	nn	4	SENT_308	[p19l995t2213r1098b2266],
4	Sci	NNP	O	Sci	dobj	1	SENT_308	[p19l1129t2213r1222b2266],
5	1996	CD	DATE	1996	num	4	SENT_308	[p19l1257t2212r1774b2275],
6	;	:	O	;	_	0	SENT_308	[p19l1257t2212r1774b2275],
7	37:855	CD	NUMBER	37:855	num	8	SENT_308	[p19l1257t2212r1774b2275],
8	-68	CD	NUMBER	-68	dep	4	SENT_308	[p19l1257t2212r1774b2275],
9	.	.	O	.	_	0	SENT_308	[p19l1257t2212r1774b2275],

1	8	CD	NUMBER	8	_	0	SENT_309	[p19l55t2297r103b2350],
2	.	.	O	.	_	0	SENT_309	[p19l55t2297r103b2350],

1	Dugel	NNP	O	Dugel	_	0	SENT_310	[p19l147t2296r332b2365],
2	PU	NN	O	pu	dep	1	SENT_310	[p19l374t2298r485b2350],
3	.	.	O	.	_	0	SENT_310	[p19l374t2298r485b2350],

1	Ranibizumab	NN	O	ranibizumab	nn	2	SENT_311	[p19l530t2296r935b2350],
2	treatment	NN	O	treatment	_	0	SENT_311	[p19l978t2305r1266b2350],
3	of	IN	O	of	_	0	SENT_311	[p19l1307t2296r1373b2350],
4	patients	NNS	O	patient	prep_of	2	SENT_311	[p19l1408t2296r1643b2365],
5	with	IN	O	with	_	0	SENT_311	[p19l1687t2296r1822b2350],
6	ocular	JJ	O	ocular	amod	7	SENT_311	[p19l1864t2296r2053b2350],
7	diseases	NNS	O	disease	prep_with	2	SENT_311	[p19l148t2380r411b2433],
8	.	.	O	.	_	0	SENT_311	[p19l148t2380r411b2433],

1	Int	NNP	O	Int	nn	3	SENT_312	[p19l443t2382r527b2433],
2	Ophthalmol	NNP	O	Ophthalmol	nn	3	SENT_312	[p19l554t2380r916b2449],
3	Clin	NNP	O	Clin	_	0	SENT_312	[p19l945t2380r1074b2434],
4	2006	CD	DATE	2006	num	3	SENT_312	[p19l1102t2380r1625b2443],
5	;	:	O	;	_	0	SENT_312	[p19l1102t2380r1625b2443],
6	46:131	CD	NUMBER	46:131	number	7	SENT_312	[p19l1102t2380r1625b2443],
7	-40	CD	NUMBER	-40	dep	3	SENT_312	[p19l1102t2380r1625b2443],
8	.	.	O	.	_	0	SENT_312	[p19l1102t2380r1625b2443],

1	9	CD	NUMBER	9	_	0	SENT_313	[p19l53t2465r103b2519],
2	.	.	O	.	_	0	SENT_313	[p19l53t2465r103b2519],

1	Rosenfeld	NNP	PERSON	Rosenfeld	nn	2	SENT_314	[p19l147t2465r456b2518],
2	PJ	NNP	PERSON	PJ	_	0	SENT_314	[p19l487t2466r574b2528],
3	,	,	O	,	_	0	SENT_314	[p19l487t2466r574b2528],
4	Brown	NNP	PERSON	Brown	nn	5	SENT_314	[p19l609t2466r816b2518],
5	DM	NN	O	dm	appos	2	SENT_314	[p19l847t2466r985b2528],
6	,	,	O	,	_	0	SENT_314	[p19l847t2466r985b2528],
7	Heier	NNP	PERSON	Heier	nn	8	SENT_314	[p19l1021t2465r1190b2518],
8	JS	NNP	O	JS	appos	2	SENT_314	[p19l1220t2465r1307b2528],
9	,	,	O	,	_	0	SENT_314	[p19l1220t2465r1307b2528],
10	et	FW	O	et	nn	11	SENT_314	[p19l1343t2473r1396b2518],
11	al	FW	O	al	appos	2	SENT_314	[p19l1429t2465r1499b2528],
12	;	:	O	;	_	0	SENT_314	[p19l1429t2465r1499b2528],
13	MARINA	NNP	O	MARINA	nn	15	SENT_314	[p19l1534t2465r1843b2518],
14	Study	NNP	O	Study	nn	15	SENT_314	[p19l1877t2465r2051b2534],
15	Group	NNP	O	Group	dep	2	SENT_314	[p19l149t2549r356b2617],
16	.	.	O	.	_	0	SENT_314	[p19l149t2549r356b2617],

1	Ranibizumab	NNP	O	Ranibizumab	nsubj	6	SENT_315	[p19l386t2548r791b2602],
2	for	IN	O	for	_	0	SENT_315	[p19l819t2548r907b2602],
3	neovascular	JJ	O	neovascular	amod	5	SENT_315	[p19l932t2549r1296b2602],
4	age	NN	O	age	nn	5	SENT_315	[p19l1323t2548r1660b2617],
5	—	NN	O	—	prep_for	1	SENT_315	[p19l1323t2548r1660b2617],
6	related	JJ	O	related	_	0	SENT_315	[p19l1323t2548r1660b2617],
7	macular	JJ	O	macular	amod	8	SENT_315	[p19l1686t2548r1931b2602],
8	degeneration	NN	O	degeneration	dobj	6	SENT_315	[p19l1957t2548r2049b2602, p19l148t2632r483b2701],
9	.	.	O	.	_	0	SENT_315	[p19l1957t2548r2049b2602, p19l148t2632r483b2701],

1	N	NN	O	n	nn	3	SENT_316	[p19l515t2634r568b2686],
2	Engl	NNP	O	Engl	nn	3	SENT_316	[p19l595t2632r738b2701],
3	J	NNP	O	J	nsubj	4	SENT_316	[p19l765t2634r794b2686],
4	Med	VBD	O	med	_	0	SENT_316	[p19l820t2632r960b2685],
5	2006	CD	DATE	2006	dobj	4	SENT_316	[p19l988t2632r1587b2695],
6	;	:	O	;	_	0	SENT_316	[p19l988t2632r1587b2695],
7	355:1419	CD	NUMBER	355:1419	num	8	SENT_316	[p19l988t2632r1587b2695],
8	-31	CD	NUMBER	-31	dep	5	SENT_316	[p19l988t2632r1587b2695],
9	.	.	O	.	_	0	SENT_316	[p19l988t2632r1587b2695],

1	10	CD	NUMBER	10	_	0	SENT_317	[p19l21t2717r103b2770],
2	.	.	O	.	_	0	SENT_317	[p19l21t2717r103b2770],

1	Menghini	NNP	PERSON	Menghini	nn	2	SENT_318	[p19l147t2717r442b2786],
2	M	NNP	O	M	_	0	SENT_318	[p19l467t2718r549b2780],
3	,	,	O	,	_	0	SENT_318	[p19l467t2718r549b2780],
4	Kurz-Levin	NNP	O	Kurz-Levin	nn	5	SENT_318	[p19l577t2717r931b2770],
5	MM	NN	O	mm	appos	2	SENT_318	[p19l954t2718r1105b2780],
6	,	,	O	,	_	0	SENT_318	[p19l954t2718r1105b2780],
7	Amstutz	NNP	PERSON	Amstutz	nn	8	SENT_318	[p19l1132t2717r1389b2770],
8	C	NNP	O	C	appos	2	SENT_318	[p19l1414t2717r1479b2780],
9	,	,	O	,	_	0	SENT_318	[p19l1414t2717r1479b2780],
10	et	FW	O	et	nn	11	SENT_318	[p19l1506t2725r1560b2770],
11	al.	FW	O	al.	appos	2	SENT_318	[p19l1584t2717r1651b2770],
12	.	.	O	.	_	0	SENT_318	[p19l1584t2717r1651b2770],

1	Response	NN	O	response	_	0	SENT_319	[p19l1679t2718r1970b2786],
2	to	TO	O	to	_	0	SENT_319	[p19l1994t2725r2051b2770],
3	ranibizumab	NN	O	ranibizumab	nn	4	SENT_319	[p19l147t2801r526b2854],
4	therapy	NN	O	therapy	prep_to	1	SENT_319	[p19l561t2801r787b2870],
5	in	IN	O	in	_	0	SENT_319	[p19l821t2801r878b2853],
6	neovascular	JJ	O	neovascular	amod	7	SENT_319	[p19l911t2801r1276b2854],
7	AMD	NNP	O	AMD	prep_in	4	SENT_319	[p19l1307t2801r1499b2854],
8	:	:	O	:	_	0	SENT_319	[p19l1307t2801r1499b2854],
9	an	DT	O	a	det	10	SENT_319	[p19l1539t2817r1608b2854],
10	evaluation	NN	O	evaluation	dep	1	SENT_319	[p19l1641t2801r1957b2854],
11	of	IN	O	of	_	0	SENT_319	[p19l1991t2801r2057b2854],
12	good	JJ	O	good	amod	15	SENT_319	[p19l148t2884r299b2953],
13	and	CC	O	and	_	0	SENT_319	[p19l321t2884r429b2937],
14	bad	JJ	O	bad	conj_and	12	SENT_319	[p19l449t2884r559b2937],
15	responders	NNS	O	responder	prep_of	10	SENT_319	[p19l579t2884r924b2953],
16	.	.	O	.	_	0	SENT_319	[p19l579t2884r924b2953],

1	Klin	NNP	PERSON	Klin	nn	3	SENT_320	[p19l951t2884r1084b2937],
2	Monbl	NNP	O	Monbl	nn	3	SENT_320	[p19l1105t2884r1307b2937],
3	Augenheilkd	NNP	O	Augenheilkd	_	0	SENT_320	[p19l1329t2884r1723b2953],
4	2010	CD	DATE	2010	num	3	SENT_320	[p19l1745t2885r2047b2947],
5	;	:	O	;	_	0	SENT_320	[p19l1745t2885r2047b2947],
6	227	CD	NUMBER	227	num	8	SENT_320	[p19l1745t2885r2047b2947],
7	:	:	O	:	_	0	SENT_320	[p19l1745t2885r2047b2947],
8	244-8	CD	NUMBER	244-8	dep	3	SENT_320	[p19l148t2970r370b3024],
9	.	.	O	.	_	0	SENT_320	[p19l148t2970r370b3024],

1	11	CD	NUMBER	11	_	0	SENT_321	[p19l21t3054r103b3107],
2	.	.	O	.	_	0	SENT_321	[p19l21t3054r103b3107],

1	Chan	NNP	PERSON	Chan	nsubj	5	SENT_322	[p19l148t3054r307b3107],
2	IS	VBZ	O	be	cop	5	SENT_322	[p19l337t3054r419b3117],
3	,	,	O	,	_	0	SENT_322	[p19l337t3054r419b3117],
4	Ginsburg	NNP	PERSON	Ginsburg	nn	5	SENT_322	[p19l453t3054r733b3123],
5	GS	NN	O	g	_	0	SENT_322	[p19l765t3054r875b3107],
6	.	.	O	.	_	0	SENT_322	[p19l765t3054r875b3107],

1	Personalized	VBN	O	personalize	_	0	SENT_323	[p19l908t3054r1298b3107],
2	medicine	NN	O	medicine	dobj	1	SENT_323	[p19l1327t3054r1621b3107],
3	:	:	O	:	_	0	SENT_323	[p19l1327t3054r1621b3107],
4	progress	NN	O	progress	dep	2	SENT_323	[p19l1655t3070r1912b3123],
5	and	CC	O	and	_	0	SENT_323	[p19l1945t3054r2052b3107],
6	promise	NN	O	promise	dep	2	SENT_323	[p19l146t3137r407b3206],
7	.	.	O	.	_	0	SENT_323	[p19l146t3137r407b3206],

1	Annu	NNP	PERSON	Annu	nn	3	SENT_324	[p19l438t3138r606b3191],
2	Rev	NN	PERSON	rev	nn	3	SENT_324	[p19l634t3139r755b3191],
3	Genomics	NNS	PERSON	genomic	_	0	SENT_324	[p19l784t3137r1089b3191],
4	Hum	NNP	PERSON	Hum	nn	5	SENT_324	[p19l1119t3139r1270b3191],
5	Genet	NNP	PERSON	Genet	dep	3	SENT_324	[p19l1298t3138r1478b3191],
6	2011	CD	DATE	2011	num	5	SENT_324	[p19l1506t3138r2029b3200],
7	;	:	O	;	_	0	SENT_324	[p19l1506t3138r2029b3200],
8	12:217	CD	NUMBER	12:217	num	9	SENT_324	[p19l1506t3138r2029b3200],
9	-44	CD	NUMBER	-44	dep	3	SENT_324	[p19l1506t3138r2029b3200],
10	.	.	O	.	_	0	SENT_324	[p19l1506t3138r2029b3200],

1	12	CD	NUMBER	12	_	0	SENT_325	[p19l21t3222r103b3274],
2	.	.	O	.	_	0	SENT_325	[p19l21t3222r103b3274],

1	Ma	NNP	O	Ma	nn	2	SENT_326	[p19l147t3222r249b3274],
2	Q	NNP	O	Q	_	0	SENT_326	[p19l286t3222r355b3287],
3	,	,	O	,	_	0	SENT_326	[p19l286t3222r355b3287],
4	Lu	NNP	PERSON	Lu	nn	5	SENT_326	[p19l395t3223r478b3274],
5	AY	NNP	O	AY	appos	2	SENT_326	[p19l516t3222r640b3274],
6	.	.	O	.	_	0	SENT_326	[p19l516t3222r640b3274],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_327	[p19l682t3221r1253b3290],
2	,	,	O	,	_	0	SENT_327	[p19l682t3221r1253b3290],
3	pharmacogenomics	NNS	O	pharmacogenomic	appos	1	SENT_327	[p19l1292t3221r1902b3290],
4	,	,	O	,	_	0	SENT_327	[p19l1292t3221r1902b3290],
5	and	CC	O	and	_	0	SENT_327	[p19l1945t3221r2052b3274],
6	individualized	JJ	O	individualized	amod	7	SENT_327	[p19l147t3306r584b3359],
7	medicine	NN	O	medicine	appos	1	SENT_327	[p19l611t3306r904b3359],
8	.	.	O	.	_	0	SENT_327	[p19l611t3306r904b3359],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_328	[p19l935t3306r1261b3359],
2	Rev	NN	O	rev	_	0	SENT_328	[p19l1288t3307r1409b3359],
3	2011	CD	DATE	2011	num	2	SENT_328	[p19l1438t3306r1952b3369],
4	;	:	O	;	_	0	SENT_328	[p19l1438t3306r1952b3369],
5	63:437	CD	NUMBER	63:437	number	6	SENT_328	[p19l1438t3306r1952b3369],
6	-59	CD	NUMBER	-59	dep	2	SENT_328	[p19l1438t3306r1952b3369],
7	.	.	O	.	_	0	SENT_328	[p19l1438t3306r1952b3369],

1	Number	NN	O	number	_	0	SENT_329	[p19l6t3638r316b3712],
2	11	CD	NUMBER	11	num	1	SENT_329	[p19l358t3642r468b3725],
3	,	,	O	,	_	0	SENT_329	[p19l358t3642r468b3725],
4	November	NNP	DATE	November	appos	1	SENT_329	[p19l510t3638r896b3712],
5	2012	CD	DATE	2012	num	4	SENT_329	[p19l931t3642r1118b3712],

1	Edwards	NNP	ORGANIZATION	Edwards	_	0	SENT_330	[p20l158t86r434b142],
2	AO	JJ	ORGANIZATION	ao	dep	1	SENT_330	[p20l463t87r593b152],
3	,	,	O	,	_	0	SENT_330	[p20l463t87r593b152],
4	Ritter	NNP	PERSON	Ritter	nn	6	SENT_330	[p20l622t86r804b141],
5	R	NNP	PERSON	R	nn	6	SENT_330	[p20l828t88r881b141],
6	III	NNP	PERSON	III	appos	2	SENT_330	[p20l906t88r1001b152],
7	,	,	O	,	_	0	SENT_330	[p20l906t88r1001b152],
8	Abel	NNP	PERSON	Abel	nn	10	SENT_330	[p20l1030t86r1183b141],
9	K	NNP	O	K	nn	10	SENT_330	[p20l1211t88r1313b152],
10	]	NNP	O	]	appos	2	SENT_330	[p20l1211t88r1313b152],
11	,	,	O	,	_	0	SENT_330	[p20l1211t88r1313b152],
12	et	FW	O	et	nn	13	SENT_330	[p20l1343t94r1399b141],
13	al.	FW	O	al.	appos	2	SENT_330	[p20l1426t86r1496b141],
14	.	.	O	.	_	0	SENT_330	[p20l1426t86r1496b141],

1	Complement	NN	O	complement	nn	2	SENT_331	[p20l1528t86r1938b158],
2	factor	NN	O	factor	_	0	SENT_331	[p20l1964t86r2149b141],
3	H	NN	O	h	nn	4	SENT_331	[p20l159t175r214b228],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_331	[p20l245t173r711b245],
5	and	CC	O	and	_	0	SENT_331	[p20l744t174r856b229],
6	age-related	JJ	O	age-related	amod	8	SENT_331	[p20l889t173r1240b245],
7	macular	JJ	O	macular	amod	8	SENT_331	[p20l1271t174r1528b229],
8	degeneration	NN	O	degeneration	dep	2	SENT_331	[p20l1560t173r1985b245],
9	.	.	O	.	_	0	SENT_331	[p20l1560t173r1985b245],

1	Science	NNP	O	Science	_	0	SENT_332	[p20l2023t173r2145b229, p20l159t279r303b317],
2	2005	CD	DATE	2005	num	1	SENT_332	[p20l333t261r879b327],
3	;	:	O	;	_	0	SENT_332	[p20l333t261r879b327],
4	308:421	CD	NUMBER	308:421	number	5	SENT_332	[p20l333t261r879b327],
5	—	CD	NUMBER	—	dep	1	SENT_332	[p20l333t261r879b327],
6	4	CD	NUMBER	4	dep	5	SENT_332	[p20l333t261r879b327],
7	.	.	O	.	_	0	SENT_332	[p20l333t261r879b327],

1	Klein	NNP	PERSON	Klein	nn	2	SENT_333	[p20l160t347r334b402],
2	RJ	NN	PERSON	rj	nsubj	7	SENT_333	[p20l372t349r472b413],
3	,	,	O	,	_	0	SENT_333	[p20l372t349r472b413],
4	Zeiss	NNP	ORGANIZATION	Zeiss	nn	5	SENT_333	[p20l513t347r678b402],
5	C	NNP	ORGANIZATION	C	appos	2	SENT_333	[p20l719t347r786b413],
6	,	,	O	,	_	0	SENT_333	[p20l719t347r786b413],
7	Chew	VB	O	chew	_	0	SENT_333	[p20l828t347r1011b403],
8	EY	NN	O	ey	dobj	7	SENT_333	[p20l1049t349r1171b413],
9	,	,	O	,	_	0	SENT_333	[p20l1049t349r1171b413],
10	et	FW	O	et	nn	11	SENT_333	[p20l1213t355r1269b402],
11	al.	FW	O	al.	dobj	7	SENT_333	[p20l1308t347r1378b402],
12	.	.	O	.	_	0	SENT_333	[p20l1308t347r1378b402],

1	Complement	NN	O	complement	nn	4	SENT_334	[p20l1421t347r1832b419],
2	factor	NN	O	factor	nn	4	SENT_334	[p20l1869t347r2055b402],
3	H	NN	O	h	nn	4	SENT_334	[p20l2092t349r2147b402],
4	polymorphism	NN	O	polymorphism	_	0	SENT_334	[p20l158t434r624b506],
5	in	IN	O	in	_	0	SENT_334	[p20l659t434r719b489],
6	age-related	JJ	O	age-related	amod	8	SENT_334	[p20l757t435r1108b506],
7	macular	JJ	O	macular	amod	8	SENT_334	[p20l1143t434r1400b490],
8	degeneration	NN	O	degeneration	prep_in	4	SENT_334	[p20l1435t434r1861b506],
9	.	.	O	.	_	0	SENT_334	[p20l1435t434r1861b506],

1	Science	NNP	O	Science	_	0	SENT_335	[p20l1903t434r2147b490],
2	2005	CD	DATE	2005	num	1	SENT_335	[p20l160t521r696b587],
3	;	:	O	;	_	0	SENT_335	[p20l160t521r696b587],
4	308:385	CD	NUMBER	308:385	number	5	SENT_335	[p20l160t521r696b587],
5	—	CD	NUMBER	—	dep	1	SENT_335	[p20l160t521r696b587],
6	9	CD	NUMBER	9	dep	5	SENT_335	[p20l160t521r696b587],
7	.	.	O	.	_	0	SENT_335	[p20l160t521r696b587],

1	Weeks	NNS	DURATION	week	nn	2	SENT_336	[p20l158t608r360b663],
2	DE	NN	O	de	_	0	SENT_336	[p20l383t610r498b674],
3	,	,	O	,	_	0	SENT_336	[p20l383t610r498b674],
4	Conley	NNP	PERSON	Conley	nn	5	SENT_336	[p20l524t608r736b680],
5	YP	NNP	O	YP	appos	2	SENT_336	[p20l759t609r869b674],
6	,	,	O	,	_	0	SENT_336	[p20l759t609r869b674],
7	Tsai	NNP	PERSON	Tsai	nn	8	SENT_336	[p20l894t608r1019b663],
8	HJ	NNP	PERSON	HJ	appos	2	SENT_336	[p20l1041t610r1138b674],
9	,	,	O	,	_	0	SENT_336	[p20l1041t610r1138b674],
10	et	FW	O	et	nn	11	SENT_336	[p20l1164t616r1217b663],
11	al.	FW	O	al.	appos	2	SENT_336	[p20l1240t608r1303b663],
12	.	.	O	.	_	0	SENT_336	[p20l1240t608r1303b663],

1	Age	NNP	O	Age	_	0	SENT_337	[p20l1329t608r1673b680],
2	—	RB	O	—	advmod	3	SENT_337	[p20l1329t608r1673b680],
3	related	JJ	O	related	amod	4	SENT_337	[p20l1329t608r1673b680],
4	maculopathy	NN	O	maculopathy	dep	1	SENT_337	[p20l1694t608r2086b680],
5	:	:	O	:	_	0	SENT_337	[p20l1694t608r2086b680],
6	a	DT	O	a	det	7	SENT_337	[p20l2116t626r2148b663],
7	genomewide	JJ	O	genomewide	nsubj	8	SENT_337	[p20l160t695r536b767],
8	scan	VB	O	scan	dep	1	SENT_337	[p20l575t713r703b751],
9	with	IN	O	with	_	0	SENT_337	[p20l739t695r869b751],
10	continued	JJ	O	continued	amod	11	SENT_337	[p20l906t695r1193b751],
11	evidence	NN	O	evidence	prep_with	8	SENT_337	[p20l1229t695r1487b751],
12	of	IN	O	of	_	0	SENT_337	[p20l1525t695r1590b751],
13	susceptibility	NN	O	susceptibility	nn	14	SENT_337	[p20l1623t695r2003b767],
14	loci	NNS	O	locus	prep_of	11	SENT_337	[p20l2039t695r2147b751],
15	within	IN	O	within	_	0	SENT_337	[p20l159t783r346b838],
16	the	DT	O	the	det	17	SENT_337	[p20l380t783r469b838],
17	1q31	NN	O	1q31	prep_within	8	SENT_337	[p20l513t783r666b855],
18	,	,	O	,	_	0	SENT_337	[p20l513t783r666b855],
19	10q26	NN	O	10q26	prep_within	8	SENT_337	[p20l713t783r904b855],
20	,	,	O	,	_	0	SENT_337	[p20l713t783r904b855],
21	and	CC	O	and	_	0	SENT_337	[p20l943t783r1050b838],
22	17q25	NN	O	17q25	nn	23	SENT_337	[p20l1092t782r1265b855],
23	regions	NNS	O	region	prep_within	8	SENT_337	[p20l1303t783r1531b855],
24	.	.	O	.	_	0	SENT_337	[p20l1303t783r1531b855],

1	Am	VBP	O	be	dep	4	SENT_338	[p20l1570t783r1686b837],
2	J	NN	O	j	nn	4	SENT_338	[p20l1719t784r1749b838],
3	Hum	NNP	O	Hum	nn	4	SENT_338	[p20l1784t784r1937b838],
4	Genet	NNP	O	Genet	_	0	SENT_338	[p20l1972t783r2148b838],
5	2004	CD	DATE	2004	num	4	SENT_338	[p20l160t869r671b935],
6	;	:	O	;	_	0	SENT_338	[p20l160t869r671b935],
7	75:174	CD	NUMBER	75:174	dep	4	SENT_338	[p20l160t869r671b935],
8	—	CD	NUMBER	—	num	9	SENT_338	[p20l160t869r671b935],
9	89	CD	NUMBER	89	dep	7	SENT_338	[p20l160t869r671b935],
10	.	.	O	.	_	0	SENT_338	[p20l160t869r671b935],

1	Kloeckener-Gruissem	NNP	O	Kloeckener-Gruissem	nn	2	SENT_339	[p20l160t956r859b1013],
2	B	NNP	O	B	_	0	SENT_339	[p20l881t958r950b1022],
3	,	,	O	,	_	0	SENT_339	[p20l881t958r950b1022],
4	Barthelmes	NNP	ORGANIZATION	Barthelmes	nn	5	SENT_339	[p20l976t957r1336b1012],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_339	[p20l1362t958r1434b1022],
6	,	,	O	,	_	0	SENT_339	[p20l1362t958r1434b1022],
7	Labs	NNPS	O	Labs	appos	2	SENT_339	[p20l1460t957r1612b1012],
8	S	NN	O	s	dep	7	SENT_339	[p20l1639t957r1696b1022],
9	,	,	O	,	_	0	SENT_339	[p20l1639t957r1696b1022],
10	et	FW	O	et	nn	11	SENT_339	[p20l1724t965r1780b1012],
11	al.	FW	O	al.	appos	2	SENT_339	[p20l1804t957r1874b1012],
12	.	.	O	.	_	0	SENT_339	[p20l1804t957r1874b1012],

1	Genetic	JJ	O	genetic	amod	2	SENT_340	[p20l1903t956r2146b1013],
2	association	NN	O	association	_	0	SENT_340	[p20l160t1044r512b1099],
3	with	IN	O	with	_	0	SENT_340	[p20l548t1044r689b1099],
4	response	NN	O	response	prep_with	2	SENT_340	[p20l723t1061r1001b1116],
5	to	TO	O	to	_	0	SENT_340	[p20l1038t1052r1097b1099],
6	intravitreal	JJ	O	intravitreal	amod	7	SENT_340	[p20l1134t1044r1482b1099],
7	ranibizumab	NN	O	ranibizumab	prep_to	2	SENT_340	[p20l1517t1044r1914b1099],
8	in	IN	O	in	_	0	SENT_340	[p20l1951t1044r2012b1098],
9	patients	NNS	O	patient	prep_in	2	SENT_340	[p20l2047t1061r2145b1116, p20l159t1130r328b1185],
10	with	IN	O	with	_	0	SENT_340	[p20l375t1130r515b1186],
11	neovascular	JJ	O	neovascular	amod	12	SENT_340	[p20l559t1130r940b1185],
12	AMD	NNP	O	AMD	prep_with	9	SENT_340	[p20l983t1131r1183b1185],
13	.	.	O	.	_	0	SENT_340	[p20l983t1131r1183b1185],

1	Invest	VB	O	invest	_	0	SENT_341	[p20l1232t1132r1427b1185],
2	Ophthalmol	NNP	O	Ophthalmol	nn	4	SENT_341	[p20l1471t1130r1849b1202],
3	Vis	NNP	O	Vis	nn	4	SENT_341	[p20l1894t1130r2001b1185],
4	Sci	NNP	O	Sci	dobj	1	SENT_341	[p20l2050t1130r2147b1186],
5	201	CD	NUMBER	201	number	6	SENT_341	[p20l160t1218r269b1274],
6	1	CD	NUMBER	1	dep	4	SENT_341	[p20l286t1217r600b1283],
7	;	:	O	;	_	0	SENT_341	[p20l286t1217r600b1283],
8	52:4694	CD	NUMBER	52:4694	num	9	SENT_341	[p20l286t1217r600b1283],
9	-702	CD	NUMBER	-702	dep	4	SENT_341	[p20l611t1218r786b1274],
10	.	.	O	.	_	0	SENT_341	[p20l611t1218r786b1274],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_342	[p20l158t1306r276b1360],
2	AY	NNP	O	AY	_	0	SENT_342	[p20l311t1305r441b1370],
3	,	,	O	,	_	0	SENT_342	[p20l311t1305r441b1370],
4	Raya	NNP	ORGANIZATION	Raya	nn	5	SENT_342	[p20l479t1306r642b1376],
5	AK	NNP	ORGANIZATION	AK	appos	2	SENT_342	[p20l675t1305r805b1370],
6	,	,	O	,	_	0	SENT_342	[p20l675t1305r805b1370],
7	Kymes	NNP	O	Kymes	nn	8	SENT_342	[p20l844t1306r1065b1377],
8	SM	NNP	O	SM	appos	2	SENT_342	[p20l1104t1305r1232b1370],
9	,	,	O	,	_	0	SENT_342	[p20l1104t1305r1232b1370],
10	et	FW	O	et	nn	11	SENT_342	[p20l1270t1313r1326b1360],
11	al.	FW	O	al.	appos	2	SENT_342	[p20l1361t1305r1431b1360],
12	.	.	O	.	_	0	SENT_342	[p20l1361t1305r1431b1360],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_343	[p20l1469t1305r2046b1377],
2	of	IN	O	of	_	0	SENT_343	[p20l2084t1305r2152b1360],
3	complement	NN	O	complement	nn	8	SENT_343	[p20l159t1391r553b1463],
4	factor	NN	O	factor	nn	8	SENT_343	[p20l593t1391r778b1446],
5	H	NN	O	h	nn	8	SENT_343	[p20l817t1393r872b1446],
6	(	CD	NUMBER	(	num	8	SENT_343	[p20l916t1391r1197b1460],
7	Y402H	NN	O	y402h	nn	8	SENT_343	[p20l916t1391r1197b1460],
8	)	NN	O	)	prep_of	1	SENT_343	[p20l916t1391r1197b1460],
9	and	CC	O	and	_	0	SENT_343	[p20l1242t1391r1354b1446],
10	treatment	NN	O	treatment	prep_of	1	SENT_343	[p20l1394t1399r1695b1446],
11	of	IN	O	of	_	0	SENT_343	[p20l1735t1391r1804b1446],
12	exudative	JJ	O	exudative	amod	15	SENT_343	[p20l1840t1391r2147b1447],
13	age-related	JJ	O	age-related	amod	15	SENT_343	[p20l160t1478r512b1550],
14	macular	JJ	O	macular	amod	15	SENT_343	[p20l545t1478r801b1534],
15	degeneration	NN	O	degeneration	prep_of	1	SENT_343	[p20l833t1478r1243b1550],
16	with	IN	O	with	_	0	SENT_343	[p20l1275t1478r1415b1534],
17	ranibizumab	NN	O	ranibizumab	prep_with	15	SENT_343	[p20l1447t1478r1844b1534],
18	80	CD	NUMBER	80	num	17	SENT_343	[p20l1881t1479r1971b1534],
19	.	.	O	.	_	0	SENT_343	[p20l1881t1479r1971b1534],

1	Br	NN	O	br	nn	3	SENT_344	[p20l2008t1480r2087b1533],
2	J	NN	O	j	nn	3	SENT_344	[p20l2118t1480r2148b1534],
3	Ophthalmol	NN	O	ophthalmol	_	0	SENT_344	[p20l160t1566r539b1638],
4	2009	CD	DATE	2009	dep	3	SENT_344	[p20l568t1566r1074b1631],
5	;	:	O	;	_	0	SENT_344	[p20l568t1566r1074b1631],
6	93:610	CD	NUMBER	93:610	number	7	SENT_344	[p20l568t1566r1074b1631],
7	—	CD	NUMBER	—	dep	3	SENT_344	[p20l568t1566r1074b1631],
8	3	CD	NUMBER	3	dep	7	SENT_344	[p20l568t1566r1074b1631],
9	.	.	O	.	_	0	SENT_344	[p20l568t1566r1074b1631],

1	McKibbin	NN	PERSON	mckibbin	nn	2	SENT_345	[p20l158t1652r485b1708],
2	M	NN	O	m	_	0	SENT_345	[p20l507t1654r593b1718],
3	,	,	O	,	_	0	SENT_345	[p20l507t1654r593b1718],
4	Ali	NNP	PERSON	Ali	nn	5	SENT_345	[p20l618t1652r718b1707],
5	M	NNP	O	M	appos	2	SENT_345	[p20l741t1654r827b1718],
6	,	,	O	,	_	0	SENT_345	[p20l741t1654r827b1718],
7	Bansal	NNP	PERSON	Bansal	nn	8	SENT_345	[p20l852t1652r1067b1708],
8	S	NNP	O	S	appos	2	SENT_345	[p20l1092t1652r1149b1718],
9	,	,	O	,	_	0	SENT_345	[p20l1092t1652r1149b1718],
10	et	FW	O	et	nn	11	SENT_345	[p20l1175t1660r1231b1708],
11	al.	FW	O	al.	appos	2	SENT_345	[p20l1254t1652r1324b1708],
12	.	.	O	.	_	0	SENT_345	[p20l1254t1652r1324b1708],

1	CFH	NNP	O	CFH	nsubj	9	SENT_346	[p20l1354t1653r1520b1717],
2	,	,	O	,	_	0	SENT_346	[p20l1354t1653r1520b1717],
3	VEGF	NNP	O	VEGF	nsubj	9	SENT_346	[p20l1555t1653r1756b1709],
4	and	CC	O	and	_	0	SENT_346	[p20l1776t1652r1888b1708],
5	HTRA1	NN	O	htra1	nn	7	SENT_346	[p20l1908t1653r2141b1707],
6	promoter	NN	O	promoter	nn	7	SENT_346	[p20l158t1747r451b1811],
7	genotype	NN	O	genotype	conj_and	1	SENT_346	[p20l479t1747r769b1811],
8	may	MD	O	may	aux	9	SENT_346	[p20l797t1757r933b1811],
9	inﬂuence	VB	O	inﬂuence	_	0	SENT_346	[p20l961t1739r1251b1795],
10	the	DT	O	the	det	11	SENT_346	[p20l1281t1739r1376b1795],
11	response	NN	O	response	dobj	9	SENT_346	[p20l1404t1757r1681b1811],
12	to	TO	O	to	_	0	SENT_346	[p20l1711t1748r1770b1795],
13	intravitreal	JJ	O	intravitreal	amod	15	SENT_346	[p20l1799t1739r2147b1795],
14	ranibizumab	NN	O	ranibizumab	nn	15	SENT_346	[p20l158t1827r555b1882],
15	therapy	NN	O	therapy	prep_to	9	SENT_346	[p20l585t1827r822b1899],
16	for	IN	O	for	_	0	SENT_346	[p20l852t1827r945b1882],
17	neovascular	JJ	O	neovascular	amod	20	SENT_346	[p20l973t1827r1353b1882],
18	age-related	JJ	O	age-related	amod	20	SENT_346	[p20l1383t1827r1735b1899],
19	macular	JJ	O	macular	amod	20	SENT_346	[p20l1763t1827r2020b1882],
20	degeneration	NN	O	degeneration	prep_for	15	SENT_346	[p20l2049t1827r2146b1882, p20l160t1913r510b1985],
21	.	.	O	.	_	0	SENT_346	[p20l2049t1827r2146b1882, p20l160t1913r510b1985],

1	Br	NN	O	br	nn	3	SENT_347	[p20l543t1915r622b1968],
2	J	NN	O	j	nn	3	SENT_347	[p20l649t1915r678b1969],
3	Ophthalmol	NN	O	ophthalmol	_	0	SENT_347	[p20l708t1913r1086b1985],
4	2012	CD	DATE	2012	dep	3	SENT_347	[p20l1116t1913r1662b1979],
5	;	:	O	;	_	0	SENT_347	[p20l1116t1913r1662b1979],
6	96:208	CD	NUMBER	96:208	number	7	SENT_347	[p20l1116t1913r1662b1979],
7	—	CD	NUMBER	—	dep	3	SENT_347	[p20l1116t1913r1662b1979],
8	12	CD	NUMBER	12	dep	7	SENT_347	[p20l1116t1913r1662b1979],
9	.	.	O	.	_	0	SENT_347	[p20l1116t1913r1662b1979],

1	Teper	NNP	PERSON	Teper	nn	2	SENT_348	[p20l159t2002r345b2072],
2	SJ	NNP	O	SJ	_	0	SENT_348	[p20l374t2001r463b2066],
3	,	,	O	,	_	0	SENT_348	[p20l374t2001r463b2066],
4	Nowinska	NNP	O	Nowinska	nn	5	SENT_348	[p20l495t2000r819b2056],
5	A	NNP	O	A	appos	2	SENT_348	[p20l846t2001r919b2066],
6	,	,	O	,	_	0	SENT_348	[p20l846t2001r919b2066],
7	Pilat	NNP	PERSON	Pilat	nn	8	SENT_348	[p20l951t2000r1097b2056],
8	J	NNP	O	J	appos	2	SENT_348	[p20l1125t2002r1171b2066],
9	,	,	O	,	_	0	SENT_348	[p20l1125t2002r1171b2066],
10	et	FW	O	et	nn	11	SENT_348	[p20l1204t2009r1261b2056],
11	al.	FW	O	al.	appos	2	SENT_348	[p20l1290t2000r1360b2056],
12	.	.	O	.	_	0	SENT_348	[p20l1290t2000r1360b2056],

1	Involvement	NN	O	involvement	_	0	SENT_349	[p20l1394t2000r1796b2056],
2	of	IN	O	of	_	0	SENT_349	[p20l1826t2000r1894b2056],
3	genetic	JJ	O	genetic	amod	4	SENT_349	[p20l1920t2000r2146b2072],
4	factors	NNS	O	factor	prep_of	1	SENT_349	[p20l159t2088r372b2143],
5	in	IN	O	in	_	0	SENT_349	[p20l398t2088r458b2142],
6	the	DT	O	the	det	7	SENT_349	[p20l481t2088r577b2143],
7	response	NN	O	response	prep_in	1	SENT_349	[p20l599t2105r877b2160],
8	to	TO	O	to	_	0	SENT_349	[p20l901t2096r960b2143],
9	a	DT	O	a	det	13	SENT_349	[p20l987t2105r1020b2143],
10	variable-dosing	JJ	O	variable-dosing	amod	13	SENT_349	[p20l1042t2088r1536b2160],
11	ranibizumab	NN	O	ranibizumab	nn	13	SENT_349	[p20l1559t2088r1956b2143],
12	treatment	NN	O	treatment	nn	13	SENT_349	[p20l1981t2096r2145b2143, p20l159t2183r318b2230],
13	regimen	NN	O	regimen	prep_to	7	SENT_349	[p20l344t2175r606b2247],
14	for	IN	O	for	_	0	SENT_349	[p20l634t2175r726b2230],
15	age-related	JJ	O	age-related	amod	17	SENT_349	[p20l756t2175r1107b2247],
16	macular	JJ	O	macular	amod	17	SENT_349	[p20l1135t2175r1392b2230],
17	degeneration	NN	O	degeneration	prep_for	1	SENT_349	[p20l1420t2175r1846b2247],
18	.	.	O	.	_	0	SENT_349	[p20l1420t2175r1846b2247],

1	Mol	NNP	O	Mol	nn	2	SENT_350	[p20l1878t2175r2010b2230],
2	Vis	NNP	O	Vis	_	0	SENT_350	[p20l2039t2175r2146b2230],
3	[	CD	NUMBER	[	dep	2	SENT_350	[p20l165t2261r356b2328],
4	serial	JJ	O	serial	amod	2	SENT_350	[p20l165t2261r356b2328],
5	online	NN	O	online	prep	2	SENT_350	[p20l389t2261r607b2328],
6	]	CD	NUMBER	]	num	7	SENT_350	[p20l389t2261r607b2328],
7	2010	CD	DATE	2010	dep	5	SENT_350	[p20l645t2261r1280b2327],
8	;	:	O	;	_	0	SENT_350	[p20l645t2261r1280b2327],
9	16:2598	CD	NUMBER	16:2598	num	10	SENT_350	[p20l645t2261r1280b2327],
10	—	NN	O	—	dep	2	SENT_350	[p20l645t2261r1280b2327],
11	604	CD	NUMBER	604	dep	10	SENT_350	[p20l645t2261r1280b2327],
12	.	.	O	.	_	0	SENT_350	[p20l645t2261r1280b2327],

1	Available	JJ	O	available	_	0	SENT_351	[p20l1316t2261r1624b2317],
2	at	IN	O	at	advmod	1	SENT_351	[p20l1658t2270r1728b2317],
3	:	:	O	:	_	0	SENT_351	[p20l1658t2270r1728b2317],
4	http://www	NN	O	http://www	dep	1	SENT_351	[p20l1765t2261r2143b2333],
5	.	.	O	.	_	0	SENT_351	[p20l1765t2261r2143b2333],

1	molvis.org/molvis/v16/a278/	NN	O	molvis.org/molvis/v16/a278/	_	0	SENT_352	[p20l159t2349r1098b2420],
2	.	.	O	.	_	0	SENT_352	[p20l159t2349r1098b2420],

1	Accessed	VBN	O	access	_	0	SENT_353	[p20l1130t2349r1431b2404],
2	May	NNP	DATE	May	tmod	1	SENT_353	[p20l1458t2350r1603b2420],
3	19	CD	DATE	19	num	2	SENT_353	[p20l1640t2349r1727b2414],
4	,	,	DATE	,	_	0	SENT_353	[p20l1640t2349r1727b2414],
5	2012	CD	DATE	2012	num	2	SENT_353	[p20l1760t2349r1932b2404],
6	.	.	O	.	_	0	SENT_353	[p20l1760t2349r1932b2404],

1	Yannuzzi	NNP	ORGANIZATION	Yannuzzi	nn	2	SENT_354	[p20l159t2436r462b2491],
2	LA	NNP	ORGANIZATION	LA	_	0	SENT_354	[p20l497t2436r619b2501],
3	,	,	O	,	_	0	SENT_354	[p20l497t2436r619b2501],
4	Negrao	NNP	PERSON	Negrao	nn	5	SENT_354	[p20l656t2437r888b2508],
5	S	NNP	PERSON	S	appos	2	SENT_354	[p20l926t2436r983b2502],
6	,	,	O	,	_	0	SENT_354	[p20l926t2436r983b2502],
7	Iida	NNP	PERSON	Iida	nn	8	SENT_354	[p20l1020t2436r1144b2491],
8	T	NN	O	t	appos	2	SENT_354	[p20l1177t2437r1240b2502],
9	,	,	O	,	_	0	SENT_354	[p20l1177t2437r1240b2502],
10	et	FW	O	et	nn	11	SENT_354	[p20l1279t2444r1335b2491],
11	al.	FW	O	al.	appos	2	SENT_354	[p20l1370t2436r1439b2491],
12	.	.	O	.	_	0	SENT_354	[p20l1370t2436r1439b2491],

1	Retinal	JJ	O	retinal	amod	3	SENT_355	[p20l1478t2436r1707b2491],
2	angiomatous	JJ	O	angiomatous	amod	3	SENT_355	[p20l1743t2436r2145b2508],
3	proliferation	NN	O	proliferation	_	0	SENT_355	[p20l158t2522r556b2594],
4	in	IN	O	in	_	0	SENT_355	[p20l614t2522r674b2577],
5	age-related	JJ	O	age-related	amod	7	SENT_355	[p20l733t2522r1084b2594],
6	macular	JJ	O	macular	amod	7	SENT_355	[p20l1141t2522r1398b2578],
7	degeneration	NN	O	degeneration	prep_in	3	SENT_355	[p20l1454t2522r1880b2594],
8	.	.	O	.	_	0	SENT_355	[p20l1454t2522r1880b2594],

1	Retina	NNP	O	Retina	_	0	SENT_356	[p20l1941t2522r2149b2578],
2	2001	CD	DATE	2001	num	1	SENT_356	[p20l160t2610r706b2675],
3	;	:	O	;	_	0	SENT_356	[p20l160t2610r706b2675],
4	21:416	CD	NUMBER	21:416	number	5	SENT_356	[p20l160t2610r706b2675],
5	—	CD	NUMBER	—	dep	1	SENT_356	[p20l160t2610r706b2675],
6	34	CD	NUMBER	34	dep	5	SENT_356	[p20l160t2610r706b2675],
7	.	.	O	.	_	0	SENT_356	[p20l160t2610r706b2675],

1	Wolf	NNP	O	Wolf	nn	3	SENT_357	[p20l158t2697r326b2752],
2	S.	NNP	O	S.	nn	3	SENT_357	[p20l365t2697r420b2752],
3	Current	NNP	DATE	Current	_	0	SENT_357	[p20l467t2697r709b2752],
4	status	NN	O	status	dep	3	SENT_357	[p20l752t2705r927b2752],
5	of	IN	O	of	_	0	SENT_357	[p20l972t2697r1041b2752],
6	anti	JJ	O	anti	amod	7	SENT_357	[p20l1078t2697r1489b2752],
7	—	NN	O	—	prep_of	4	SENT_357	[p20l1078t2697r1489b2752],
8	vascular	JJ	O	vascular	amod	12	SENT_357	[p20l1078t2697r1489b2752],
9	endothelial	JJ	O	endothelial	amod	12	SENT_357	[p20l1530t2697r1882b2752],
10	growth	NN	O	growth	nn	12	SENT_357	[p20l1924t2697r2148b2769],
11	factor	NN	O	factor	nn	12	SENT_357	[p20l159t2783r345b2839],
12	therapy	NN	O	therapy	dep	3	SENT_357	[p20l372t2783r609b2855],
13	in	IN	O	in	_	0	SENT_357	[p20l638t2783r698b2838],
14	Europe	NNP	LOCATION	Europe	prep_in	12	SENT_357	[p20l726t2785r971b2855],
15	.	.	O	.	_	0	SENT_357	[p20l726t2785r971b2855],

1	Jpn	NN	O	jpn	nn	3	SENT_358	[p20l1004t2785r1113b2855],
2	J	NN	O	j	nn	3	SENT_358	[p20l1141t2785r1170b2839],
3	Ophthalmol	NN	O	ophthalmol	_	0	SENT_358	[p20l1201t2783r1578b2855],
4	2008	CD	DATE	2008	dep	3	SENT_358	[p20l1609t2783r2105b2849],
5	;	:	O	;	_	0	SENT_358	[p20l1609t2783r2105b2849],
6	52:433	CD	NUMBER	52:433	number	7	SENT_358	[p20l1609t2783r2105b2849],
7	—	CD	NUMBER	—	dep	3	SENT_358	[p20l1609t2783r2105b2849],
8	9	CD	NUMBER	9	dep	7	SENT_358	[p20l1609t2783r2105b2849],
9	.	.	O	.	_	0	SENT_358	[p20l1609t2783r2105b2849],

1	CATT	NNP	ORGANIZATION	CATT	nn	3	SENT_359	[p20l160t2871r365b2926],
2	Research	NNP	ORGANIZATION	Research	nn	3	SENT_359	[p20l402t2871r693b2926],
3	Group	NNP	ORGANIZATION	Group	_	0	SENT_359	[p20l731t2871r948b2942],
4	.	.	O	.	_	0	SENT_359	[p20l731t2871r948b2942],

1	Ranibizumab	NNP	O	Ranibizumab	_	0	SENT_360	[p20l989t2870r1412b2926],
2	and	CC	O	and	_	0	SENT_360	[p20l1451t2871r1564b2926],
3	bevacizumab	NNP	O	bevacizumab	conj_and	1	SENT_360	[p20l1599t2870r2018b2926],
4	for	IN	O	for	_	0	SENT_360	[p20l2057t2870r2149b2926],
5	neovascular	JJ	O	neovascular	amod	8	SENT_360	[p20l159t2958r540b3013],
6	age-related	JJ	O	age-related	amod	8	SENT_360	[p20l567t2958r919b3030],
7	macular	JJ	O	macular	amod	8	SENT_360	[p20l946t2958r1203b3013],
8	degeneration	NN	O	degeneration	prep_for	1	SENT_360	[p20l1230t2958r1655b3030],
9	.	.	O	.	_	0	SENT_360	[p20l1230t2958r1655b3030],

1	N	NN	O	n	nn	3	SENT_361	[p20l1686t2959r1743b3013],
2	Engl	NNP	O	Engl	nn	3	SENT_361	[p20l1770t2958r1919b3030],
3	J	NNP	O	J	nsubj	4	SENT_361	[p20l1946t2959r1975b3013],
4	Med	VBD	O	med	_	0	SENT_361	[p20l2003t2958r2148b3013],
5	201	CD	NUMBER	201	number	6	SENT_361	[p20l160t3045r269b3100],
6	1	CD	NUMBER	1	dobj	4	SENT_361	[p20l286t3044r475b3110],
7	;	:	O	;	_	0	SENT_361	[p20l286t3044r475b3110],
8	364	CD	NUMBER	364	dep	6	SENT_361	[p20l286t3044r475b3110],
9	:	:	O	:	_	0	SENT_361	[p20l286t3044r475b3110],
10	1897-908	CD	NUMBER	1897-908	dep	8	SENT_361	[p20l491t3045r816b3101],
11	.	.	O	.	_	0	SENT_361	[p20l491t3045r816b3101],

1	Immonen	NNP	PERSON	Immonen	nn	2	SENT_362	[p20l159t3133r463b3187],
2	I	NNP	O	I	_	0	SENT_362	[p20l488t3133r530b3197],
3	,	,	O	,	_	0	SENT_362	[p20l488t3133r530b3197],
4	Seitsonen	NNP	O	Seitsonen	nn	5	SENT_362	[p20l560t3131r866b3188],
5	S	NNP	O	S	appos	2	SENT_362	[p20l894t3132r951b3197],
6	,	,	O	,	_	0	SENT_362	[p20l894t3132r951b3197],
7	Tommila	NNP	O	Tommila	nn	8	SENT_362	[p20l979t3131r1271b3187],
8	P	NN	O	p	appos	2	SENT_362	[p20l1294t3133r1354b3197],
9	,	,	O	,	_	0	SENT_362	[p20l1294t3133r1354b3197],
10	et	FW	O	et	nn	11	SENT_362	[p20l1383t3140r1439b3187],
11	al.	FW	O	al.	appos	2	SENT_362	[p20l1464t3131r1534b3187],
12	.	.	O	.	_	0	SENT_362	[p20l1464t3131r1534b3187],

1	Vascular	JJ	O	vascular	_	0	SENT_363	[p20l1563t3132r1847b3188],
2	endothelial	JJ	O	endothelial	dep	1	SENT_363	[p20l1871t3131r2145b3187, p21l159t18r259b73],

1	growth	NN	O	growth	nn	2	SENT_364	[p21l293t18r517b90],
2	factor	NN	O	factor	_	0	SENT_364	[p21l549t18r735b73],
3	gene	NN	O	gene	nn	4	SENT_364	[p21l767t36r914b90],
4	variation	NN	O	variation	dep	2	SENT_364	[p21l948t18r1230b73],
5	and	CC	O	and	_	0	SENT_364	[p21l1265t18r1377b73],
6	the	DT	O	the	det	7	SENT_364	[p21l1409t18r1504b73],
7	response	NN	O	response	dep	2	SENT_364	[p21l1536t36r1815b90],
8	to	TO	O	to	_	0	SENT_364	[p21l1848t26r1907b73],
9	photodynamic	JJ	O	photodynamic	amod	10	SENT_364	[p21l1940t18r2145b90, p21l160t104r430b176],
10	therapy	NN	O	therapy	prep_to	2	SENT_364	[p21l468t104r705b176],
11	in	IN	O	in	_	0	SENT_364	[p21l742t104r802b159],
12	age-related	JJ	O	age-related	amod	14	SENT_364	[p21l840t104r1192b176],
13	macular	JJ	O	macular	amod	14	SENT_364	[p21l1227t104r1484b160],
14	degeneration	NN	O	degeneration	prep_in	10	SENT_364	[p21l1519t104r1945b176],
15	.	.	O	.	_	0	SENT_364	[p21l1519t104r1945b176],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_365	[p21l1987t104r2145b176, p21l159t191r520b263],
2	2010	CD	DATE	2010	num	1	SENT_365	[p21l550t192r1097b257],
3	;	:	O	;	_	0	SENT_365	[p21l550t192r1097b257],
4	117:103	CD	NUMBER	117:103	number	5	SENT_365	[p21l550t192r1097b257],
5	-8	CD	NUMBER	-8	dep	1	SENT_365	[p21l550t192r1097b257],
6	.	.	O	.	_	0	SENT_365	[p21l550t192r1097b257],

1	Seddon	NNP	PERSON	Seddon	nn	2	SENT_366	[p21l161t279r397b334],
2	JM	NN	O	jm	_	0	SENT_366	[p21l424t280r542b345],
3	,	,	O	,	_	0	SENT_366	[p21l424t280r542b345],
4	Francis	NNP	PERSON	Francis	nn	5	SENT_366	[p21l572t279r804b334],
5	PJ	NNP	PERSON	PJ	appos	2	SENT_366	[p21l833t280r924b344],
6	,	,	O	,	_	0	SENT_366	[p21l833t280r924b344],
7	George	NNP	PERSON	George	nn	8	SENT_366	[p21l956t279r1187b351],
8	S	NNP	PERSON	S	appos	2	SENT_366	[p21l1218t279r1276b345],
9	,	,	O	,	_	0	SENT_366	[p21l1218t279r1276b345],
10	et	FW	O	et	nn	11	SENT_366	[p21l1307t287r1363b334],
11	al.	FW	O	al.	appos	2	SENT_366	[p21l1392t279r1461b334],
12	.	.	O	.	_	0	SENT_366	[p21l1392t279r1461b334],

1	Association	NNP	O	Association	_	0	SENT_367	[p21l1494t279r1869b334],
2	of	IN	O	of	_	0	SENT_367	[p21l1898t279r1967b334],
3	CFH	NNP	O	CFH	nn	4	SENT_367	[p21l1993t280r2152b335],
4	Y402H	NN	O	y402h	prep_of	1	SENT_367	[p21l164t365r383b420],
5	and	CC	O	and	_	0	SENT_367	[p21l404t365r517b420],
6	LOC3877I5	NN	O	loc3877i5	nn	7	SENT_367	[p21l538t366r934b421],
7	A69S	NN	O	a69	prep_of	1	SENT_367	[p21l951t365r1125b421],
8	with	IN	O	with	_	0	SENT_367	[p21l1148t365r1288b421],
9	progression	NN	O	progression	prep_with	4	SENT_367	[p21l1311t365r1682b437],
10	of	IN	O	of	_	0	SENT_367	[p21l1707t365r1776b420],
11	age-related	JJ	O	age-related	amod	13	SENT_367	[p21l1796t365r2148b437],
12	macular	JJ	O	macular	amod	13	SENT_367	[p21l159t453r416b508],
13	degeneration	NN	O	degeneration	prep_of	1	SENT_367	[p21l444t452r869b524],
14	.	.	O	.	_	0	SENT_367	[p21l444t452r869b524],

1	JAMA	NNP	O	JAMA	_	0	SENT_368	[p21l901t453r1118b508],
2	2007	CD	DATE	2007	num	1	SENT_368	[p21l1147t453r1669b518],
3	;	:	O	;	_	0	SENT_368	[p21l1147t453r1669b518],
4	297:1793	CD	NUMBER	297:1793	num	6	SENT_368	[p21l1147t453r1669b518],
5	-	:	O	-	_	0	SENT_368	[p21l1147t453r1669b518],
6	800	CD	NUMBER	800	dep	1	SENT_368	[p21l1682t453r1813b508],
7	.	.	O	.	_	0	SENT_368	[p21l1682t453r1813b508],

1	Scholl	NN	ORGANIZATION	scholl	_	0	SENT_369	[p21l161t540r361b595],
2	HP	NNP	ORGANIZATION	HP	dep	1	SENT_369	[p21l386t541r502b605],
3	,	,	O	,	_	0	SENT_369	[p21l386t541r502b605],
4	Charbel	NNP	PERSON	Charbel	nn	6	SENT_369	[p21l531t540r781b595],
5	Issa	NNP	PERSON	Issa	nn	6	SENT_369	[p21l806t541r929b595],
6	P	NN	PERSON	p	appos	2	SENT_369	[p21l952t541r1011b606],
7	,	,	O	,	_	0	SENT_369	[p21l952t541r1011b606],
8	Walier	NNP	O	Walier	nn	9	SENT_369	[p21l1038t540r1255b595],
9	M	NNP	O	M	appos	2	SENT_369	[p21l1278t541r1365b606],
10	,	,	O	,	_	0	SENT_369	[p21l1278t541r1365b606],
11	et	FW	O	et	nn	12	SENT_369	[p21l1393t548r1449b595],
12	al.	FW	O	al.	appos	2	SENT_369	[p21l1474t540r1544b595],
13	.	.	O	.	_	0	SENT_369	[p21l1474t540r1544b595],

1	Systemic	JJ	MISC	systemic	amod	3	SENT_370	[p21l1575t540r1862b612],
2	complement	NN	O	complement	nn	3	SENT_370	[p21l1889t540r2145b612, p21l159t634r318b681],
3	activation	NN	O	activation	_	0	SENT_370	[p21l359t626r671b682],
4	in	IN	O	in	_	0	SENT_370	[p21l711t626r771b681],
5	age-related	JJ	O	age-related	amod	7	SENT_370	[p21l813t626r1165b698],
6	macular	JJ	O	macular	amod	7	SENT_370	[p21l1205t626r1462b681],
7	degeneration	NN	O	degeneration	prep_in	3	SENT_370	[p21l1502t626r1927b698],
8	.	.	O	.	_	0	SENT_370	[p21l1502t626r1927b698],

1	PLoS	NNP	O	PLoS	_	0	SENT_371	[p21l1972t626r2144b682],
2	One	CD	NUMBER	one	num	4	SENT_371	[p21l160t714r289b769],
3	[	NN	O	[	nn	4	SENT_371	[p21l331t713r522b781],
4	serial	NN	O	serial	dep	1	SENT_371	[p21l331t713r522b781],
5	online	NN	O	online	prep	4	SENT_371	[p21l559t713r776b781],
6	]	CD	NUMBER	]	num	7	SENT_371	[p21l559t713r776b781],
7	2008	CD	DATE	2008	dep	5	SENT_371	[p21l818t713r1270b779],
8	;	:	O	;	_	0	SENT_371	[p21l818t713r1270b779],
9	3	CD	NUMBER	3	dep	1	SENT_371	[p21l818t713r1270b779],
10	:	:	O	:	_	0	SENT_371	[p21l818t713r1270b779],
11	e2593	NN	O	e2593	dep	9	SENT_371	[p21l818t713r1270b779],
12	.	.	O	.	_	0	SENT_371	[p21l818t713r1270b779],

1	Available	JJ	O	available	_	0	SENT_372	[p21l1309t713r1617b769],
2	at	IN	O	at	advmod	1	SENT_372	[p21l1654t722r1725b769],
3	:	:	O	:	_	0	SENT_372	[p21l1654t722r1725b769],
4	http://www	NN	O	http://www	dep	1	SENT_372	[p21l1765t713r2143b785],
5	.	.	O	.	_	0	SENT_372	[p21l1765t713r2143b785],

1	molvis.org/molvis/Vl6/a278/	NN	O	molvis.org/molvis/vl6/a278/	_	0	SENT_373	[p21l159t801r1098b873],
2	.	.	O	.	_	0	SENT_373	[p21l159t801r1098b873],

1	Accessed	VBN	O	access	_	0	SENT_374	[p21l1130t801r1431b856],
2	May	NNP	DATE	May	tmod	1	SENT_374	[p21l1458t802r1603b873],
3	19	CD	DATE	19	num	2	SENT_374	[p21l1640t801r1727b866],
4	,	,	DATE	,	_	0	SENT_374	[p21l1640t801r1727b866],
5	2012	CD	DATE	2012	num	2	SENT_374	[p21l1760t801r1932b856],
6	.	.	O	.	_	0	SENT_374	[p21l1760t801r1932b856],

1	Smailhodzic	JJ	O	smailhodzic	amod	2	SENT_375	[p21l161t887r555b943],
2	D	NN	O	d	_	0	SENT_375	[p21l578t889r651b953],
3	,	,	O	,	_	0	SENT_375	[p21l578t889r651b953],
4	Klaver	NNP	ORGANIZATION	Klaver	nn	5	SENT_375	[p21l677t887r892b943],
5	CC	NN	ORGANIZATION	cc	appos	2	SENT_375	[p21l914t887r1034b953],
6	,	,	O	,	_	0	SENT_375	[p21l914t887r1034b953],
7	Klevering	VBG	ORGANIZATION	klever	partmod	2	SENT_375	[p21l1060t887r1376b959],
8	BJ	NNP	ORGANIZATION	BJ	dobj	7	SENT_375	[p21l1398t888r1497b953],
9	,	,	O	,	_	0	SENT_375	[p21l1398t888r1497b953],
10	et	FW	O	et	nn	11	SENT_375	[p21l1523t895r1579b942],
11	al.	FW	O	al.	appos	8	SENT_375	[p21l1602t887r1672b942],
12	.	.	O	.	_	0	SENT_375	[p21l1602t887r1672b942],

1	Risk	NN	O	risk	nn	2	SENT_376	[p21l1697t887r1843b942],
2	alleles	NNS	O	allele	nsubjpass	9	SENT_376	[p21l1865t887r2064b942],
3	in	IN	O	in	_	0	SENT_376	[p21l2088t887r2148b942],
4	CFH	NNP	O	CFH	prep_in	2	SENT_376	[p21l163t976r322b1030],
5	and	CC	O	and	_	0	SENT_376	[p21l345t975r457b1030],
6	ARMS2	NNP	O	ARMS2	prep_in	2	SENT_376	[p21l478t975r723b1030],
7	are	VBP	O	be	auxpass	9	SENT_376	[p21l753t992r847b1030],
8	independently	RB	O	independently	advmod	9	SENT_376	[p21l874t974r1324b1046],
9	associated	VBN	O	associate	_	0	SENT_376	[p21l1352t974r1678b1030],
10	with	IN	O	with	_	0	SENT_376	[p21l1704t974r1844b1030],
11	systemic	JJ	O	systemic	amod	13	SENT_376	[p21l1873t974r2146b1046],
12	complement	NN	O	complement	nn	13	SENT_376	[p21l160t1062r553b1133],
13	activation	NN	O	activation	prep_with	9	SENT_376	[p21l591t1062r902b1117],
14	in	IN	O	in	_	0	SENT_376	[p21l939t1062r999b1116],
15	age-related	JJ	O	age-related	amod	17	SENT_376	[p21l1037t1062r1389b1134],
16	macular	JJ	O	macular	amod	17	SENT_376	[p21l1425t1062r1682b1117],
17	degeneration	NN	O	degeneration	prep_in	13	SENT_376	[p21l1718t1062r2144b1134],
18	.	.	O	.	_	0	SENT_376	[p21l1718t1062r2144b1134],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_377	[p21l160t1148r658b1220],
2	2012	CD	DATE	2012	num	1	SENT_377	[p21l688t1148r1284b1214],
3	;	:	O	;	_	0	SENT_377	[p21l688t1148r1284b1214],
4	119:339	CD	NUMBER	119:339	number	5	SENT_377	[p21l688t1148r1284b1214],
5	-46	CD	NUMBER	-46	dep	1	SENT_377	[p21l688t1148r1284b1214],
6	.	.	O	.	_	0	SENT_377	[p21l688t1148r1284b1214],

1	Nozaki	NNP	PERSON	Nozaki	nn	2	SENT_378	[p21l159t1235r387b1291],
2	M	NNP	PERSON	M	_	0	SENT_378	[p21l419t1237r505b1301],
3	,	,	O	,	_	0	SENT_378	[p21l419t1237r505b1301],
4	Raisler	NNP	ORGANIZATION	Raisler	nn	5	SENT_378	[p21l539t1235r765b1291],
5	BJ	NNP	ORGANIZATION	BJ	appos	2	SENT_378	[p21l795t1237r894b1301],
6	,	,	O	,	_	0	SENT_378	[p21l795t1237r894b1301],
7	Sakurai	NNP	PERSON	Sakurai	nn	8	SENT_378	[p21l931t1235r1170b1291],
8	E	NNP	O	E	appos	2	SENT_378	[p21l1202t1237r1266b1301],
9	,	,	O	,	_	0	SENT_378	[p21l1202t1237r1266b1301],
10	et	FW	O	et	nn	11	SENT_378	[p21l1301t1244r1357b1291],
11	al.	FW	O	al.	appos	2	SENT_378	[p21l1389t1236r1459b1291],
12	.	.	O	.	_	0	SENT_378	[p21l1389t1236r1459b1291],

1	Drusen	JJ	PERSON	drusen	amod	4	SENT_379	[p21l1495t1237r1724b1291],
2	complement	NN	O	complement	nn	4	SENT_379	[p21l1755t1236r2149b1307],
3	components	NNS	O	component	nn	4	SENT_379	[p21l160t1331r541b1395],
4	C3a	NN	O	c3a	nsubj	7	SENT_379	[p21l573t1323r700b1378],
5	and	CC	O	and	_	0	SENT_379	[p21l730t1323r842b1378],
6	C5a	NN	O	c5a	conj_and	4	SENT_379	[p21l872t1322r999b1378],
7	promote	VBP	O	promote	_	0	SENT_379	[p21l1025t1331r1290b1395],
8	choroidal	JJ	O	choroidal	amod	9	SENT_379	[p21l1321t1323r1620b1378],
9	neovascularization	NN	O	neovascularization	dobj	7	SENT_379	[p21l1649t1323r2146b1378, p21l159t1409r297b1465],
10	.	.	O	.	_	0	SENT_379	[p21l1649t1323r2146b1378, p21l159t1409r297b1465],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_380	[p21l330t1411r473b1465],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_380	[p21l503t1409r638b1465],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_380	[p21l667t1409r835b1465],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_380	[p21l864t1409r961b1465],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_380	[p21l991t1411r1047b1465],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_380	[p21l1077t1410r1114b1465],
7	A	NNP	O	A	_	0	SENT_380	[p21l1146t1410r1202b1464],
8	2006	CD	DATE	2006	num	7	SENT_380	[p21l1232t1409r1709b1475],
9	;	:	O	;	_	0	SENT_380	[p21l1232t1409r1709b1475],
10	103:2328	CD	NUMBER	103:2328	number	11	SENT_380	[p21l1232t1409r1709b1475],
11	-33	CD	NUMBER	-33	dep	7	SENT_380	[p21l1723t1410r1857b1465],
12	.	.	O	.	_	0	SENT_380	[p21l1723t1410r1857b1465],

1	Rohrer	NNP	PERSON	Rohrer	nn	2	SENT_381	[p21l159t1496r380b1552],
2	B	NNP	O	B	_	0	SENT_381	[p21l407t1498r475b1562],
3	,	,	O	,	_	0	SENT_381	[p21l407t1498r475b1562],
4	Long	NNP	O	Long	nn	5	SENT_381	[p21l506t1498r672b1568],
5	Q	NNP	O	Q	appos	2	SENT_381	[p21l702t1497r773b1565],
6	,	,	O	,	_	0	SENT_381	[p21l702t1497r773b1565],
7	Coughlin	NNP	PERSON	Coughlin	nn	8	SENT_381	[p21l806t1496r1100b1568],
8	B	NNP	O	B	appos	2	SENT_381	[p21l1128t1498r1196b1562],
9	,	,	O	,	_	0	SENT_381	[p21l1128t1498r1196b1562],
10	et	FW	O	et	nn	11	SENT_381	[p21l1228t1505r1284b1552],
11	al.	FW	O	al.	appos	2	SENT_381	[p21l1313t1497r1382b1552],
12	.	.	O	.	_	0	SENT_381	[p21l1313t1497r1382b1552],

1	A	DT	O	a	det	3	SENT_382	[p21l1415t1497r1470b1551],
2	targeted	VBN	O	target	amod	3	SENT_382	[p21l1498t1496r1754b1568],
3	inhibitor	NN	O	inhibitor	nsubj	9	SENT_382	[p21l1781t1496r2056b1552],
4	of	IN	O	of	_	0	SENT_382	[p21l2084t1496r2152b1552],
5	the	DT	O	the	det	8	SENT_382	[p21l159t1584r254b1639],
6	alternative	JJ	O	alternative	amod	8	SENT_382	[p21l278t1584r611b1639],
7	complement	NN	O	complement	nn	8	SENT_382	[p21l633t1584r1027b1655],
8	pathway	NN	O	pathway	prep_of	3	SENT_382	[p21l1046t1584r1315b1656],
9	reduces	VBZ	O	reduce	_	0	SENT_382	[p21l1336t1584r1577b1639],
10	angiogenesis	NN	O	angiogenesis	dobj	9	SENT_382	[p21l1602t1584r2009b1656],
11	in	IN	O	in	_	0	SENT_382	[p21l2032t1584r2094b1638],
12	a	DT	O	a	det	14	SENT_382	[p21l2116t1601r2149b1639],
13	mouse	NN	O	mouse	nn	14	SENT_382	[p21l159t1688r365b1725],
14	model	NN	O	model	prep_in	9	SENT_382	[p21l414t1670r611b1725],
15	of	IN	O	of	_	0	SENT_382	[p21l661t1670r729b1725],
16	age-related	JJ	O	age-related	amod	18	SENT_382	[p21l774t1670r1125b1742],
17	macular	JJ	O	macular	amod	18	SENT_382	[p21l1173t1670r1429b1725],
18	degeneration	NN	O	degeneration	prep_of	14	SENT_382	[p21l1477t1670r1902b1742],
19	.	.	O	.	_	0	SENT_382	[p21l1477t1670r1902b1742],

1	Invest	VB	O	invest	_	0	SENT_383	[p21l1955t1671r2149b1726],
2	Ophthalmol	NNP	O	Ophthalmol	nn	4	SENT_383	[p21l160t1757r538b1829],
3	Vis	NNP	O	Vis	nn	4	SENT_383	[p21l567t1757r674b1813],
4	Sci	NNP	O	Sci	dobj	1	SENT_383	[p21l707t1757r804b1813],
5	2009	CD	DATE	2009	num	4	SENT_383	[p21l835t1757r1430b1823],
6	;	:	O	;	_	0	SENT_383	[p21l835t1757r1430b1823],
7	50:3056	CD	NUMBER	50:3056	num	8	SENT_383	[p21l835t1757r1430b1823],
8	-64	CD	NUMBER	-64	dep	4	SENT_383	[p21l835t1757r1430b1823],
9	.	.	O	.	_	0	SENT_383	[p21l835t1757r1430b1823],

1	Shahbazi	NNP	PERSON	Shahbazi	nn	2	SENT_384	[p21l161t1845r449b1900],
2	M	NNP	O	M	_	0	SENT_384	[p21l474t1846r561b1910],
3	,	,	O	,	_	0	SENT_384	[p21l474t1846r561b1910],
4	Fryer	NNP	ORGANIZATION	Fryer	nn	5	SENT_384	[p21l588t1846r761b1916],
5	AA	NNP	ORGANIZATION	AA	appos	2	SENT_384	[p21l784t1845r915b1910],
6	,	,	O	,	_	0	SENT_384	[p21l784t1845r915b1910],
7	Pravica	NNP	O	Pravica	nn	8	SENT_384	[p21l943t1845r1182b1900],
8	V	NNP	O	V	appos	2	SENT_384	[p21l1206t1846r1278b1910],
9	,	,	O	,	_	0	SENT_384	[p21l1206t1846r1278b1910],
10	et	FW	O	et	nn	11	SENT_384	[p21l1307t1853r1363b1900],
11	al.	FW	O	al.	appos	2	SENT_384	[p21l1389t1845r1459b1900],
12	.	.	O	.	_	0	SENT_384	[p21l1389t1845r1459b1900],

1	Vascular	JJ	O	vascular	amod	6	SENT_385	[p21l1488t1845r1771b1900],
2	endothelial	JJ	O	endothelial	amod	6	SENT_385	[p21l1795t1845r2148b1900],
3	growth	NN	O	growth	nn	6	SENT_385	[p21l160t1931r384b2003],
4	factor	NN	O	factor	nn	6	SENT_385	[p21l414t1931r599b1986],
5	gene	NN	O	gene	nn	6	SENT_385	[p21l628t1949r775b2003],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_385	[p21l805t1931r1299b2003],
7	are	VBP	O	be	auxpass	8	SENT_385	[p21l1332t1949r1425b1986],
8	associated	VBN	O	associate	_	0	SENT_385	[p21l1457t1931r1783b1986],
9	with	IN	O	with	_	0	SENT_385	[p21l1812t1931r1952b1986],
10	acute	JJ	O	acute	amod	13	SENT_385	[p21l1983t1939r2147b1986],
11	renal	JJ	O	renal	amod	13	SENT_385	[p21l158t2018r316b2074],
12	allograft	NN	O	allograft	nn	13	SENT_385	[p21l347t2018r615b2090],
13	rejection	NN	O	rejection	prep_with	8	SENT_385	[p21l642t2018r936b2090],
14	.	.	O	.	_	0	SENT_385	[p21l642t2018r936b2090],

1	J	NNP	O	J	nn	4	SENT_386	[p21l968t2020r998b2074],
2	Am	NNP	O	Am	nn	4	SENT_386	[p21l1026t2019r1145b2073],
3	Soc	NNP	O	Soc	nn	4	SENT_386	[p21l1175t2019r1289b2074],
4	Nephrol	NNP	O	Nephrol	_	0	SENT_386	[p21l1319t2018r1578b2090],
5	2002	CD	DATE	2002	num	4	SENT_386	[p21l1609t2018r2124b2084],
6	;	:	O	;	_	0	SENT_386	[p21l1609t2018r2124b2084],
7	l3	CD	NUMBER	l3	num	8	SENT_386	[p21l1609t2018r2124b2084],
8	:260	CD	NUMBER	:260	dep	4	SENT_386	[p21l1609t2018r2124b2084],
9	—	NN	O	—	dep	8	SENT_386	[p21l1609t2018r2124b2084],
10	4	CD	NUMBER	4	num	9	SENT_386	[p21l1609t2018r2124b2084],
11	.	.	O	.	_	0	SENT_386	[p21l1609t2018r2124b2084],

1	Leveziel	NNP	PERSON	Leveziel	nn	2	SENT_387	[p21l158t2106r432b2161],
2	N	NNP	PERSON	N	_	0	SENT_387	[p21l465t2107r538b2171],
3	,	,	O	,	_	0	SENT_387	[p21l465t2107r538b2171],
4	Zerbib	NNP	PERSON	Zerbib	nn	5	SENT_387	[p21l574t2106r784b2161],
5	J	NNP	O	J	appos	2	SENT_387	[p21l819t2107r865b2171],
6	,	,	O	,	_	0	SENT_387	[p21l819t2107r865b2171],
7	Richard	NNP	PERSON	Richard	nn	8	SENT_387	[p21l901t2106r1153b2161],
8	F	NN	PERSON	f	appos	2	SENT_387	[p21l1186t2107r1245b2171],
9	,	,	O	,	_	0	SENT_387	[p21l1186t2107r1245b2171],
10	et	FW	O	et	nn	11	SENT_387	[p21l1283t2114r1339b2161],
11	al.	FW	O	al.	appos	2	SENT_387	[p21l1373t2106r1442b2161],
12	.	.	O	.	_	0	SENT_387	[p21l1373t2106r1442b2161],

1	Genotype-phenotype	JJ	O	genotype-phenotype	amod	2	SENT_388	[p21l1481t2106r2147b2178],
2	correlations	NNS	O	correlation	nsubj	8	SENT_388	[p21l160t2192r532b2247],
3	for	IN	O	for	_	0	SENT_388	[p21l574t2192r666b2247],
4	exudative	JJ	O	exudative	amod	7	SENT_388	[p21l704t2192r1011b2247],
5	age-related	JJ	O	age-related	amod	7	SENT_388	[p21l1053t2192r1404b2264],
6	macular	JJ	O	macular	amod	7	SENT_388	[p21l1443t2192r1700b2247],
7	degeneration	NN	O	degeneration	prep_for	2	SENT_388	[p21l1738t2192r2148b2264],
8	associated	VBN	O	associate	_	0	SENT_388	[p21l161t2279r486b2335],
9	with	IN	O	with	_	0	SENT_388	[p21l528t2279r668b2335],
10	homozygous	JJ	O	homozygous	amod	11	SENT_388	[p21l709t2279r1114b2351],
11	HTRA1	NN	O	htra1	prep_with	8	SENT_388	[p21l1158t2280r1406b2334],
12	and	CC	O	and	_	0	SENT_388	[p21l1457t2279r1569b2335],
13	CFH	NN	O	cfh	nn	14	SENT_388	[p21l1612t2280r1763b2335],
14	genotypes	NNS	O	genotype	prep_with	8	SENT_388	[p21l1807t2288r2144b2351],
15	.	.	O	.	_	0	SENT_388	[p21l1807t2288r2144b2351],

1	Invest	VB	O	invest	_	0	SENT_389	[p21l159t2368r353b2422],
2	Ophthalmol	NNP	O	Ophthalmol	nn	4	SENT_389	[p21l382t2367r760b2439],
3	Vis	NNP	O	Vis	nn	4	SENT_389	[p21l789t2367r896b2422],
4	Sci	NNP	O	Sci	dobj	1	SENT_389	[p21l929t2367r1026b2422],
5	2008	CD	DATE	2008	num	4	SENT_389	[p21l1056t2367r1612b2432],
6	;	:	O	;	_	0	SENT_389	[p21l1056t2367r1612b2432],
7	49:3090	CD	NUMBER	49:3090	number	8	SENT_389	[p21l1056t2367r1612b2432],
8	—	CD	NUMBER	—	dep	4	SENT_389	[p21l1056t2367r1612b2432],
9	4	CD	NUMBER	4	dep	8	SENT_389	[p21l1056t2367r1612b2432],
10	.	.	O	.	_	0	SENT_389	[p21l1056t2367r1612b2432],

1	Rosenfeld	NNP	PERSON	Rosenfeld	nn	2	SENT_390	[p21l159t2454r481b2509],
2	PJ	NNP	PERSON	PJ	_	0	SENT_390	[p21l518t2455r609b2520],
3	,	,	O	,	_	0	SENT_390	[p21l518t2455r609b2520],
4	Shapiro	NNP	PERSON	Shapiro	nn	5	SENT_390	[p21l651t2454r894b2526],
5	H	NNP	O	H	appos	2	SENT_390	[p21l932t2455r1005b2519],
6	,	,	O	,	_	0	SENT_390	[p21l932t2455r1005b2519],
7	Tuomi	NNP	O	Tuomi	nn	8	SENT_390	[p21l1045t2454r1255b2509],
8	L	NNP	O	L	appos	2	SENT_390	[p21l1292t2455r1357b2520],
9	,	,	O	,	_	0	SENT_390	[p21l1292t2455r1357b2520],
10	et	FW	O	et	nn	11	SENT_390	[p21l1398t2462r1453b2509],
11	al	FW	O	al	appos	2	SENT_390	[p21l1491t2454r1564b2519],
12	;	:	O	;	_	0	SENT_390	[p21l1491t2454r1564b2519],
13	MARINA	NNP	ORGANIZATION	MARINA	nn	15	SENT_390	[p21l1604t2454r1926b2509],
14	Study	NNP	ORGANIZATION	Study	nn	15	SENT_390	[p21l1965t2454r2147b2526],
15	Group	NNP	ORGANIZATION	Group	dep	2	SENT_390	[p21l160t2541r380b2612],
16	;	:	O	;	_	0	SENT_390	[p21l160t2541r380b2612],
17	ANCHOR	NNP	O	ANCHOR	nn	19	SENT_390	[p21l423t2541r759b2596],
18	Study	NNP	O	Study	nn	19	SENT_390	[p21l800t2540r982b2612],
19	Group	NNP	O	Group	dep	15	SENT_390	[p21l1024t2541r1240b2612],
20	.	.	O	.	_	0	SENT_390	[p21l1024t2541r1240b2612],

1	Characteristics	NNS	O	characteristic	_	0	SENT_391	[p21l1285t2540r1755b2596],
2	of	IN	O	of	_	0	SENT_391	[p21l1797t2540r1867b2596],
3	patients	NNS	O	patient	prep_of	1	SENT_391	[p21l1900t2540r2146b2612],

1	Smailhodzic	JJ	MISC	smailhodzic	_	0	SENT_392	[p21l468t2687r670b2726],
2	et	FW	MISC	et	dep	1	SENT_392	[p21l686t2698r716b2722],
3	al	FW	MISC	al	nn	4	SENT_392	[p21l732t2687r762b2722],
4	°	FW	MISC	°	amod	6	SENT_392	[p21l788t2702r796b2709],
5	Risk	NN	MISC	risk	nn	6	SENT_392	[p21l823t2687r904b2722],
6	Alleles	NNS	MISC	allele	dep	1	SENT_392	[p21l919t2687r1047b2722],
7	on	IN	O	on	_	0	SENT_392	[p21l1065t2701r1112b2722],
8	Treatment	NN	O	treatment	nn	9	SENT_392	[p21l1128t2689r1326b2722],
9	Response	NN	O	response	prep_on	6	SENT_392	[p21l1342t2689r1513b2731],
10	in	IN	O	in	_	0	SENT_392	[p21l1532t2692r1568b2722],
11	AMD	NNP	ORGANIZATION	AMD	prep_in	9	SENT_392	[p21l1584t2688r1692b2722],

1	losing	VBG	O	lose	_	0	SENT_393	[p21l147t2860r341b2933],
2	vision	NN	O	vision	dobj	1	SENT_393	[p21l369t2860r564b2916],
3	after	IN	O	after	_	0	SENT_393	[p21l593t2860r737b2916],
4	2	CD	DURATION	2	num	5	SENT_393	[p21l765t2860r801b2915],
5	years	NNS	NUMBER	year	prep_after	1	SENT_393	[p21l829t2877r995b2932],
6	of	IN	O	of	_	0	SENT_393	[p21l1025t2860r1094b2916],
7	monthly	JJ	SET	monthly	amod	8	SENT_393	[p21l1116t2860r1382b2933],
8	dosing	NN	O	dosing	prep_of	5	SENT_393	[p21l1411t2860r1621b2933],
9	in	IN	O	in	_	0	SENT_393	[p21l1650t2860r1710b2915],
10	the	DT	O	the	det	13	SENT_393	[p21l1738t2860r1834b2916],
11	phase	NN	O	phase	nn	13	SENT_393	[p21l1860t2860r2042b2933],
12	III	CD	NUMBER	iii	num	13	SENT_393	[p21l2070t2861r2148b2915],
13	ranibizumab	NN	O	ranibizumab	prep_in	8	SENT_393	[p21l146t2947r545b3003],
14	clinical	JJ	O	clinical	amod	15	SENT_393	[p21l573t2947r806b3003],
15	trials	NNS	O	trial	dep	13	SENT_393	[p21l831t2947r1006b3003],
16	.	.	O	.	_	0	SENT_393	[p21l831t2947r1006b3003],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_394	[p21l1037t2947r1537b3020],
2	2011	CD	DATE	2011	num	1	SENT_394	[p21l1564t2947r2144b3014],
3	;	:	O	;	_	0	SENT_394	[p21l1564t2947r2144b3014],
4	118:523	CD	NUMBER	118:523	number	5	SENT_394	[p21l1564t2947r2144b3014],
5	-30	CD	NUMBER	-30	dep	1	SENT_394	[p21l1564t2947r2144b3014],
6	.	.	O	.	_	0	SENT_394	[p21l1564t2947r2144b3014],

1	Andreoli	NNP	PERSON	Andreoli	nn	2	SENT_395	[p21l147t3035r430b3092],
2	MT	NNP	O	MT	_	0	SENT_395	[p21l462t3037r598b3102],
3	,	,	O	,	_	0	SENT_395	[p21l462t3037r598b3102],
4	Morrison	NNP	PERSON	Morrison	nn	5	SENT_395	[p21l633t3035r931b3092],
5	MA	NNP	PERSON	MA	appos	2	SENT_395	[p21l962t3036r1107b3102],
6	,	,	O	,	_	0	SENT_395	[p21l962t3036r1107b3102],
7	Kim	NNP	PERSON	Kim	nn	9	SENT_395	[p21l1143t3035r1284b3091],
8	B	NNP	O	B	nn	9	SENT_395	[p21l1315t3037r1415b3102],
9	]	NN	O	]	appos	2	SENT_395	[p21l1315t3037r1415b3102],
10	,	,	O	,	_	0	SENT_395	[p21l1315t3037r1415b3102],
11	et	FW	O	et	nn	12	SENT_395	[p21l1451t3044r1507b3092],
12	al.	FW	O	al.	appos	2	SENT_395	[p21l1539t3035r1610b3092],
13	.	.	O	.	_	0	SENT_395	[p21l1539t3035r1610b3092],

1	Comprehensive	JJ	O	comprehensive	amod	2	SENT_396	[p21l1647t3035r2148b3108],
2	analysis	NN	O	analysis	_	0	SENT_396	[p21l149t3124r402b3197],
3	of	IN	O	of	_	0	SENT_396	[p21l445t3124r514b3180],
4	complement	NN	O	complement	nn	6	SENT_396	[p21l550t3124r946b3197],
5	factor	NN	O	factor	nn	6	SENT_396	[p21l986t3124r1172b3180],
6	H	NN	O	h	prep_of	2	SENT_396	[p21l1212t3125r1267b3179],
7	and	CC	O	and	_	0	SENT_396	[p21l1310t3124r1423b3180],
8	LOC387715/ARMS2	NN	O	loc387715/arms2	prep_of	2	SENT_396	[p21l1460t3124r2151b3180],
9	/	:	O	/	punct	2	SENT_396	[p21l1460t3124r2151b3180],
10	HTRAI	NN	O	htraus	nn	11	SENT_396	[p21l145t3212r380b3267],
11	variants	NNS	O	variant	dep	2	SENT_396	[p21l418t3211r668b3267],
12	with	IN	O	with	_	0	SENT_396	[p21l702t3211r843b3268],
13	respect	NN	O	respect	_	0	SENT_396	[p21l873t3219r1101b3284],
14	to	TO	O	to	_	0	SENT_396	[p21l1131t3219r1191b3267],
15	phenotype	NN	O	phenotype	prep_with_respect_to	11	SENT_396	[p21l1222t3211r1555b3284],
16	in	IN	O	in	_	0	SENT_396	[p21l1587t3211r1648b3267],
17	advanced	JJ	O	advanced	amod	20	SENT_396	[p21l1681t3211r1981b3267],
18	agerelated	JJ	O	agerelated	amod	20	SENT_396	[p21l2014t3229r2146b3284, p21l146t3299r364b3356],
19	macular	JJ	O	macular	amod	20	SENT_396	[p21l404t3299r662b3355],
20	degeneration	NN	O	degeneration	prep_in	11	SENT_396	[p21l702t3299r1130b3372],
21	.	.	O	.	_	0	SENT_396	[p21l702t3299r1130b3372],

1	Am	NNP	O	Am	nn	3	SENT_397	[p21l1174t3300r1294b3355],
2	J	NNP	O	J	nn	3	SENT_397	[p21l1333t3301r1362b3356],
3	Ophthalmol	NNP	O	Ophthalmol	_	0	SENT_397	[p21l1404t3299r1784b3372],
4	2009	CD	DATE	2009	num	3	SENT_397	[p21l1826t3300r2143b3366],
5	;	:	O	;	_	0	SENT_397	[p21l1826t3300r2143b3366],
6	148	CD	NUMBER	148	dep	3	SENT_397	[p21l1826t3300r2143b3366],
7	:	:	O	:	_	0	SENT_397	[p21l1826t3300r2143b3366],
8	869	CD	NUMBER	869	num	9	SENT_397	[p21l150t3388r263b3445],
9	-74	CD	NUMBER	-74	dep	6	SENT_397	[p21l276t3388r411b3444],
10	.	.	O	.	_	0	SENT_397	[p21l276t3388r411b3444],

1	33	CD	NUMBER	33	_	0	SENT_398	[p22l9t21r100b78],
2	.	.	O	.	_	0	SENT_398	[p22l9t21r100b78],

1	Bessho	NNP	PERSON	Bessho	nn	2	SENT_399	[p22l147t21r376b77],
2	H	NNP	PERSON	H	_	0	SENT_399	[p22l413t22r485b88],
3	,	,	O	,	_	0	SENT_399	[p22l413t22r485b88],
4	Honda	NNP	ORGANIZATION	Honda	nn	5	SENT_399	[p22l524t21r737b77],
5	S	NNP	O	S	appos	2	SENT_399	[p22l774t22r831b88],
6	,	,	O	,	_	0	SENT_399	[p22l774t22r831b88],
7	Kondo	NNP	PERSON	Kondo	nn	8	SENT_399	[p22l871t21r1085b77],
8	N	NNP	O	N	appos	2	SENT_399	[p22l1121t23r1195b88],
9	,	,	O	,	_	0	SENT_399	[p22l1121t23r1195b88],
10	Negi	NNP	PERSON	Negi	nn	12	SENT_399	[p22l1233t21r1387b94],
11	A.	NNP	O	A.	nn	12	SENT_399	[p22l1423t22r1495b77],
12	The	NNP	O	The	appos	8	SENT_399	[p22l1534t21r1657b77],
13	association	NN	O	association	dep	2	SENT_399	[p22l1694t21r2048b77],
14	of	IN	O	of	_	0	SENT_399	[p22l2084t21r2153b77],
15	age	NN	O	age	nn	19	SENT_399	[p22l149t109r503b182],
16	—	CD	NUMBER	—	num	19	SENT_399	[p22l149t109r503b182],
17	related	JJ	O	related	amod	19	SENT_399	[p22l149t109r503b182],
18	maculopathy	NN	O	maculopathy	nn	19	SENT_399	[p22l528t109r941b182],
19	susceptibility	NN	O	susceptibility	prep_of	13	SENT_399	[p22l970t109r1393b182],
20	2	CD	NUMBER	2	num	21	SENT_399	[p22l1421t110r1457b165],
21	polymorphisms	NNS	O	polymorphism	dep	2	SENT_399	[p22l1483t109r1980b182],
22	with	IN	O	with	_	0	SENT_399	[p22l2008t109r2149b166],
23	phenotype	NN	O	phenotype	prep_with	21	SENT_399	[p22l146t198r480b271],
24	in	IN	O	in	_	0	SENT_399	[p22l510t198r571b253],
25	typical	JJ	O	typical	amod	28	SENT_399	[p22l601t198r817b271],
26	neovascular	JJ	O	neovascular	amod	28	SENT_399	[p22l847t198r1231b254],
27	age	NN	O	age	nn	28	SENT_399	[p22l1261t198r1615b271],
28	—	NN	O	—	prep_in	23	SENT_399	[p22l1261t198r1615b271],
29	related	JJ	O	related	amod	31	SENT_399	[p22l1261t198r1615b271],
30	macular	JJ	O	macular	amod	31	SENT_399	[p22l1645t198r1903b254],
31	degeneration	NN	O	degeneration	dep	2	SENT_399	[p22l1932t198r2146b271, p22l148t285r368b341],
32	and	CC	O	and	_	0	SENT_399	[p22l390t285r503b341],
33	polypoidal	JJ	O	polypoidal	amod	35	SENT_399	[p22l521t285r864b358],
34	choroidal	JJ	O	choroidal	amod	35	SENT_399	[p22l885t285r1185b341],
35	vasculopathy	NN	O	vasculopathy	dep	2	SENT_399	[p22l1206t285r1644b358],
36	.	.	O	.	_	0	SENT_399	[p22l1206t285r1644b358],

1	Mol	NNP	O	Mol	nn	2	SENT_400	[p22l1667t285r1799b341],
2	Vis	NNP	O	Vis	_	0	SENT_400	[p22l1819t285r1927b341],
3	[	CD	NUMBER	[	dep	2	SENT_400	[p22l1955t285r2148b353],
4	serial	JJ	O	serial	amod	2	SENT_400	[p22l1955t285r2148b353],
5	online	NN	O	online	prep	2	SENT_400	[p22l148t373r348b441],
6	]	CD	NUMBER	]	num	7	SENT_400	[p22l148t373r348b441],
7	2011	CD	DATE	2011	dep	5	SENT_400	[p22l415t374r825b440],
8	;	:	O	;	_	0	SENT_400	[p22l415t374r825b440],
9	17:977	CD	NUMBER	17:977	number	10	SENT_400	[p22l415t374r825b440],
10	—	CD	NUMBER	—	dep	2	SENT_400	[p22l415t374r825b440],
11	82	CD	NUMBER	82	dep	10	SENT_400	[p22l835t374r920b430],
12	.	.	O	.	_	0	SENT_400	[p22l835t374r920b430],

1	Available	JJ	O	available	_	0	SENT_401	[p22l985t373r1269b430],
2	at	IN	O	at	dep	1	SENT_401	[p22l1332t382r1396b430],
3	:	:	O	:	_	0	SENT_401	[p22l1332t382r1396b430],
4	http://wwW.molvis.org/	NN	O	http://www.molvis.org/	nn	5	SENT_401	[p22l1463t373r2150b446],
5	molvis/v17/a108	NN	O	molvis/v17/a108	dep	2	SENT_401	[p22l147t462r672b518],
6	/	:	O	/	punct	5	SENT_401	[p22l147t462r672b518],
7	.	.	O	.	_	0	SENT_401	[p22l147t462r672b518],

1	Accessed	VBN	O	access	_	0	SENT_402	[p22l699t462r978b518],
2	May	NNP	DATE	May	tmod	1	SENT_402	[p22l1000t463r1139b535],
3	19	CD	DATE	19	num	2	SENT_402	[p22l1170t462r1251b528],
4	,	,	DATE	,	_	0	SENT_402	[p22l1170t462r1251b528],
5	2012	CD	DATE	2012	num	2	SENT_402	[p22l1277t462r1438b518],
6	.	.	O	.	_	0	SENT_402	[p22l1277t462r1438b518],

1	34	CD	NUMBER	34	_	0	SENT_403	[p22l9t550r101b606],
2	.	.	O	.	_	0	SENT_403	[p22l9t550r101b606],

1	Brantley	NNP	PERSON	Brantley	nn	3	SENT_404	[p22l147t550r432b623],
2	MA	NNP	PERSON	MA	nn	3	SENT_404	[p22l463t550r593b605],
3	Jr	NNP	PERSON	Jr	_	0	SENT_404	[p22l623t551r700b616],
4	,	,	O	,	_	0	SENT_404	[p22l623t551r700b616],
5	Fang	NNP	ORGANIZATION	Fang	nn	6	SENT_404	[p22l733t551r896b623],
6	AM	NNP	ORGANIZATION	AM	appos	3	SENT_404	[p22l928t550r1076b617],
7	,	,	O	,	_	0	SENT_404	[p22l928t550r1076b617],
8	King	NNP	O	King	nn	9	SENT_404	[p22l1111t550r1272b623],
9	JM	NN	O	jm	appos	3	SENT_404	[p22l1304t551r1425b616],
10	,	,	O	,	_	0	SENT_404	[p22l1304t551r1425b616],
11	et	FW	O	et	nn	12	SENT_404	[p22l1459t558r1517b606],
12	al.	FW	O	al.	appos	3	SENT_404	[p22l1549t550r1622b606],
13	.	.	O	.	_	0	SENT_404	[p22l1549t550r1622b606],

1	Association	NNP	O	Association	_	0	SENT_405	[p22l1657t550r2051b606],
2	of	IN	O	of	_	0	SENT_405	[p22l2083t550r2153b606],
3	complement	NN	O	complement	nn	5	SENT_405	[p22l148t637r558b710],
4	factor	NN	O	factor	nn	5	SENT_405	[p22l591t637r786b694],
5	H	NN	O	h	prep_of	1	SENT_405	[p22l819t639r874b693],
6	and	CC	O	and	_	0	SENT_405	[p22l910t637r1026b693],
7	LOC387715	NN	O	loc387715	nn	8	SENT_405	[p22l1060t637r1469b694],
8	genotypes	NNS	O	genotype	prep_of	1	SENT_405	[p22l1508t646r1842b710],
9	with	IN	O	with	_	0	SENT_405	[p22l1878t637r2024b694],
10	response	NN	O	response	prep_with	1	SENT_405	[p22l2057t655r2146b693, p22l150t743r371b799],
11	of	IN	O	of	_	0	SENT_405	[p22l437t726r507b782],
12	exudative	JJ	O	exudative	amod	14	SENT_405	[p22l566t726r888b782],
13	age	NN	O	age	nn	14	SENT_405	[p22l954t726r1324b799],
14	—	NN	O	—	prep_of	10	SENT_405	[p22l954t726r1324b799],
15	related	JJ	O	related	amod	17	SENT_405	[p22l954t726r1324b799],
16	macular	JJ	O	macular	amod	17	SENT_405	[p22l1387t726r1655b782],
17	degeneration	NN	O	degeneration	dep	1	SENT_405	[p22l1719t726r2149b799],

1	Footnotes	NNS	O	footnote	_	0	SENT_406	[p22l6t938r473b1015],
2	and	CC	O	and	_	0	SENT_406	[p22l514t932r689b1015],
3	Financial	JJ	MISC	financial	amod	4	SENT_406	[p22l727t932r1168b1015],
4	Disclosures	NNS	MISC	disclosure	conj_and	1	SENT_406	[p22l1203t932r1741b1015],
5	to	TO	O	to	_	0	SENT_406	[p22l145t1184r206b1232],
6	intravitreal	JJ	O	intravitreal	amod	7	SENT_406	[p22l271t1176r640b1232],
7	bevacizumab	NN	O	bevacizumab	prep_to	1	SENT_406	[p22l702t1176r1161b1232],
8	.	.	O	.	_	0	SENT_406	[p22l702t1176r1161b1232],

1	Ophthalmology	NNP	O	Ophthalmology	_	0	SENT_407	[p22l1229t1176r1751b1249],
2	2007	CD	DATE	2007	num	1	SENT_407	[p22l1816t1176r2147b1242],
3	;	:	O	;	_	0	SENT_407	[p22l1816t1176r2147b1242],
4	1l4	CD	NUMBER	1l4	num	6	SENT_407	[p22l1816t1176r2147b1242],
5	:	:	O	:	_	0	SENT_407	[p22l1816t1176r2147b1242],
6	2168-73	CD	NUMBER	2168-73	dep	1	SENT_407	[p22l146t1264r462b1320],
7	.	.	O	.	_	0	SENT_407	[p22l146t1264r462b1320],

1	35	CD	NUMBER	35	_	0	SENT_408	[p22l7t1351r99b1408],
2	.	.	O	.	_	0	SENT_408	[p22l7t1351r99b1408],

1	Seitsonen	NNP	PERSON	Seitsonen	nn	2	SENT_409	[p22l148t1351r457b1408],
2	S	NNP	PERSON	S	_	0	SENT_409	[p22l494t1352r552b1418],
3	,	,	O	,	_	0	SENT_409	[p22l494t1352r552b1418],
4	Jarvela	NNP	PERSON	Jarvela	nn	8	SENT_409	[p22l591t1351r818b1408],
5	I	PRP	O	I	dep	8	SENT_409	[p22l853t1353r894b1418],
6	,	,	O	,	_	0	SENT_409	[p22l853t1353r894b1418],
7	Meri	NNP	PERSON	Meri	dep	8	SENT_409	[p22l933t1351r1087b1407],
8	S	NNP	O	S	appos	2	SENT_409	[p22l1125t1352r1183b1418],
9	,	,	O	,	_	0	SENT_409	[p22l1125t1352r1183b1418],
10	et	FW	O	et	nn	11	SENT_409	[p22l1222t1360r1279b1407],
11	al.	FW	O	al.	appos	8	SENT_409	[p22l1315t1351r1385b1408],
12	.	.	O	.	_	0	SENT_409	[p22l1315t1351r1385b1408],

1	Complement	NN	O	complement	nn	3	SENT_410	[p22l1426t1351r1841b1424],
2	factor	NN	O	factor	nn	3	SENT_410	[p22l1875t1351r2063b1408],
3	H	NN	O	h	_	0	SENT_410	[p22l2097t1353r2153b1407],
4	Y402H	NN	O	y402h	nn	5	SENT_410	[p22l146t1440r380b1496],
5	polymorphism	NN	O	polymorphism	dep	3	SENT_410	[p22l416t1439r886b1512],
6	and	CC	O	and	_	0	SENT_410	[p22l923t1440r1036b1496],
7	characteristics	NNS	O	characteristic	dep	3	SENT_410	[p22l1072t1439r1529b1496],
8	of	IN	O	of	_	0	SENT_410	[p22l1568t1439r1637b1496],
9	exudative	JJ	O	exudative	amod	10	SENT_410	[p22l1669t1439r1979b1496],
10	agerelated	JJ	O	agerelated	amod	13	SENT_410	[p22l2017t1457r2150b1512, p22l144t1528r363b1584],
11	macular	JJ	O	macular	amod	13	SENT_410	[p22l390t1528r649b1584],
12	degeneration	NN	O	degeneration	nn	13	SENT_410	[p22l675t1528r1089b1601],
13	lesions	NNS	O	lesion	prep_of	5	SENT_410	[p22l1115t1528r1353b1584],
14	.	.	O	.	_	0	SENT_410	[p22l1115t1528r1353b1584],

1	Acta	NNP	O	Acta	nn	2	SENT_411	[p22l1384t1528r1536b1584],
2	Ophthalmol	NNP	O	Ophthalmol	_	0	SENT_411	[p22l1562t1528r1944b1601],
3	2008	CD	DATE	2008	num	2	SENT_411	[p22l1972t1528r2149b1594],
4	;	:	O	;	_	0	SENT_411	[p22l1972t1528r2149b1594],
5	86:390	CD	NUMBER	86:390	number	6	SENT_411	[p22l149t1615r483b1672],
6	—	CD	NUMBER	—	dep	2	SENT_411	[p22l149t1615r483b1672],
7	4	CD	NUMBER	4	dep	6	SENT_411	[p22l149t1615r483b1672],
8	.	.	O	.	_	0	SENT_411	[p22l149t1615r483b1672],

1	36	CD	NUMBER	36	_	0	SENT_412	[p22l6t1703r99b1760],
2	.	.	O	.	_	0	SENT_412	[p22l6t1703r99b1760],

1	Age-Related	JJ	O	age-related	amod	6	SENT_413	[p22l145t1703r551b1776],
2	Eye	NNP	O	Eye	nn	6	SENT_413	[p22l579t1705r702b1776],
3	Disease	NNP	O	Disease	nn	6	SENT_413	[p22l731t1703r979b1760],
4	Study	NNP	O	Study	nn	6	SENT_413	[p22l1010t1703r1193b1776],
5	Research	NNP	O	Research	nn	6	SENT_413	[p22l1223t1704r1516b1760],
6	Group	NNP	O	Group	_	0	SENT_413	[p22l1545t1704r1764b1776],
7	.	.	O	.	_	0	SENT_413	[p22l1545t1704r1764b1776],

1	A	DT	O	a	nsubj	35	SENT_414	[p22l1797t1704r1853b1759],
2	randomized	VBN	O	randomize	dep	1	SENT_414	[p22l1881t1704r2150b1760, p22l145t1792r294b1858],
3	,	,	O	,	_	0	SENT_414	[p22l1881t1704r2150b1760, p22l145t1792r294b1858],
4	placebo-controlled	JJ	O	placebo-controlled	amod	7	SENT_414	[p22l339t1792r960b1865],
5	,	,	O	,	_	0	SENT_414	[p22l339t1792r960b1865],
6	clinical	JJ	O	clinical	amod	7	SENT_414	[p22l1006t1792r1240b1848],
7	trial	NN	O	trial	dobj	2	SENT_414	[p22l1282t1792r1410b1848],
8	of	IN	O	of	_	0	SENT_414	[p22l1453t1792r1522b1848],
9	high	JJ	O	high	amod	12	SENT_414	[p22l1558t1792r1875b1865],
10	—	NN	O	—	nn	12	SENT_414	[p22l1558t1792r1875b1865],
11	dose	NN	O	dose	nn	12	SENT_414	[p22l1558t1792r1875b1865],
12	supplementation	NN	O	supplementation	prep_of	7	SENT_414	[p22l1920t1792r2150b1865, p22l146t1880r466b1937],
13	with	IN	O	with	_	0	SENT_414	[p22l494t1880r635b1937],
14	vitamins	NNS	O	vitamin	nn	15	SENT_414	[p22l662t1880r936b1937],
15	C	NN	O	c	prep_with	12	SENT_414	[p22l966t1881r1015b1937],
16	and	CC	O	and	_	0	SENT_414	[p22l1046t1880r1159b1937],
17	E	NN	O	e	conj_and	15	SENT_414	[p22l1186t1882r1250b1947],
18	,	,	O	,	_	0	SENT_414	[p22l1186t1882r1250b1947],
19	beta	NN	O	beta	nn	20	SENT_414	[p22l1280t1880r1415b1937],
20	carotene	NN	O	carotene	appos	15	SENT_414	[p22l1441t1889r1729b1947],
21	,	,	O	,	_	0	SENT_414	[p22l1441t1889r1729b1947],
22	and	CC	O	and	_	0	SENT_414	[p22l1761t1880r1874b1937],
23	zinc	NN	O	zinc	dep	1	SENT_414	[p22l1902t1880r2032b1937],
24	for	IN	O	for	_	0	SENT_414	[p22l2061t1880r2154b1937],
25	age	NN	O	age	prep_for	23	SENT_414	[p22l147t1968r502b2041],
26	—	CD	NUMBER	—	num	29	SENT_414	[p22l147t1968r502b2041],
27	related	JJ	O	related	amod	29	SENT_414	[p22l147t1968r502b2041],
28	macular	JJ	O	macular	amod	29	SENT_414	[p22l545t1969r804b2025],
29	degeneration	NN	O	degeneration	dep	25	SENT_414	[p22l847t1968r1261b2041],
30	and	CC	O	and	_	0	SENT_414	[p22l1306t1969r1419b2025],
31	vision	NN	O	vision	nn	32	SENT_414	[p22l1463t1968r1657b2025],
32	loss	NN	O	loss	dep	25	SENT_414	[p22l1701t1969r1841b2025],
33	:	:	O	:	_	0	SENT_414	[p22l1701t1969r1841b2025],
34	AREDS	NN	O	ared	dep	25	SENT_414	[p22l1890t1969r2149b2025],
35	report	NN	O	report	_	0	SENT_414	[p22l144t2066r337b2130],
36	no.	NN	O	no.	dobj	35	SENT_414	[p22l365t2075r459b2113],
37	8	CD	NUMBER	8	num	36	SENT_414	[p22l495t2057r547b2113],
38	.	.	O	.	_	0	SENT_414	[p22l495t2057r547b2113],

1	Arch	NNP	O	Arch	nn	3	SENT_415	[p22l580t2057r739b2113],
2	Ophthalmol	NNP	O	Ophthalmol	nn	3	SENT_415	[p22l769t2057r1150b2130],
3	200l	NN	O	200l	_	0	SENT_415	[p22l1181t2057r1803b2123],
4	;	:	O	;	_	0	SENT_415	[p22l1181t2057r1803b2123],
5	ll9	NN	O	ll9	dep	3	SENT_415	[p22l1181t2057r1803b2123],
6	:	:	O	:	_	0	SENT_415	[p22l1181t2057r1803b2123],
7	l4l7	CD	NUMBER	l4l7	dep	5	SENT_415	[p22l1181t2057r1803b2123],
8	—	CD	NUMBER	—	number	9	SENT_415	[p22l1181t2057r1803b2123],
9	36	CD	NUMBER	36	dep	7	SENT_415	[p22l1181t2057r1803b2123],
10	.	.	O	.	_	0	SENT_415	[p22l1181t2057r1803b2123],

1	37	CD	NUMBER	37	_	0	SENT_416	[p22l6t2145r99b2201],
2	.	.	O	.	_	0	SENT_416	[p22l6t2145r99b2201],

1	Charbel	NNP	PERSON	Charbel	nn	3	SENT_417	[p22l146t2144r398b2201],
2	Issa	NNP	PERSON	Issa	nn	3	SENT_417	[p22l421t2146r546b2200],
3	P	NN	PERSON	p	_	0	SENT_417	[p22l567t2146r627b2211],
4	,	,	O	,	_	0	SENT_417	[p22l567t2146r627b2211],
5	Chong	NNP	ORGANIZATION	Chong	nn	6	SENT_417	[p22l654t2144r865b2217],
6	NV	NNP	ORGANIZATION	NV	appos	3	SENT_417	[p22l888t2146r1020b2211],
7	,	,	O	,	_	0	SENT_417	[p22l888t2146r1020b2211],
8	Scholl	NN	PERSON	scholl	appos	3	SENT_417	[p22l1048t2144r1249b2201],
9	HP	NNP	O	HP	dep	8	SENT_417	[p22l1272t2146r1390b2200],
10	.	.	O	.	_	0	SENT_417	[p22l1272t2146r1390b2200],

1	The	DT	O	the	det	2	SENT_418	[p22l1416t2144r1539b2200],
2	signiﬁcance	NN	O	signiﬁcance	nsubj	13	SENT_418	[p22l1565t2144r1945b2217],
3	of	IN	O	of	_	0	SENT_418	[p22l1969t2144r2038b2200],
4	the	DT	O	the	det	6	SENT_418	[p22l2056t2144r2152b2200],
5	complement	NN	O	complement	nn	6	SENT_418	[p22l146t2232r543b2305],
6	system	NN	O	system	prep_of	2	SENT_418	[p22l574t2241r794b2305],
7	for	IN	O	for	_	0	SENT_418	[p22l823t2232r916b2289],
8	the	DT	O	the	det	9	SENT_418	[p22l944t2232r1040b2289],
9	pathogenesis	NN	O	pathogenesis	prep_for	6	SENT_418	[p22l1069t2232r1482b2305],
10	of	IN	O	of	_	0	SENT_418	[p22l1515t2232r1584b2289],
11	age	NN	O	age	prep_of	9	SENT_418	[p22l1610t2232r1965b2305],
12	—	CD	NUMBER	—	num	11	SENT_418	[p22l1610t2232r1965b2305],
13	related	JJ	O	related	_	0	SENT_418	[p22l1610t2232r1965b2305],
14	macular	JJ	O	macular	amod	18	SENT_418	[p22l1994t2250r2150b2289, p22l145t2321r270b2377],
15	degeneration	NN	O	degeneration	nn	18	SENT_418	[p22l294t2321r789b2394],
16	—	NN	O	—	nn	18	SENT_418	[p22l294t2321r789b2394],
17	current	JJ	DATE	current	amod	18	SENT_418	[p22l800t2329r1027b2377],
18	evidence	NN	O	evidence	dobj	13	SENT_418	[p22l1051t2321r1334b2377],
19	and	CC	O	and	_	0	SENT_418	[p22l1360t2321r1474b2377],
20	translation	NN	O	translation	conj_and	18	SENT_418	[p22l1497t2321r1836b2377],
21	into	IN	O	into	_	0	SENT_418	[p22l1859t2321r1982b2377],
22	clinical	JJ	O	clinical	amod	23	SENT_418	[p22l2008t2321r2151b2377, p22l145t2408r259b2464],
23	application	NN	O	application	prep_into	13	SENT_418	[p22l301t2408r672b2481],
24	.	.	O	.	_	0	SENT_418	[p22l301t2408r672b2481],

1	Graefes	NNP	O	Graefes	nn	5	SENT_419	[p22l717t2408r963b2465],
2	Arch	NNP	O	Arch	nn	5	SENT_419	[p22l1004t2408r1164b2464],
3	Clin	NNP	O	Clin	nn	5	SENT_419	[p22l1204t2408r1340b2465],
4	Exp	NNP	O	Exp	nn	5	SENT_419	[p22l1380t2410r1507b2481],
5	Ophthalmol	NNP	O	Ophthalmol	_	0	SENT_419	[p22l1549t2408r1930b2481],
6	2011	CD	DATE	2011	num	5	SENT_419	[p22l1972t2409r2149b2475],
7	;	:	O	;	_	0	SENT_419	[p22l1972t2409r2149b2475],
8	249:163	CD	NUMBER	249:163	number	9	SENT_419	[p22l147t2496r545b2554],
9	—	CD	NUMBER	—	dep	5	SENT_419	[p22l147t2496r545b2554],
10	74	CD	NUMBER	74	dep	9	SENT_419	[p22l147t2496r545b2554],
11	.	.	O	.	_	0	SENT_419	[p22l147t2496r545b2554],

1	Originally	RB	O	originally	_	0	SENT_420	[p22l8t2691r299b2755],
2	received	VBN	O	receive	partmod	1	SENT_420	[p22l325t2691r581b2741],
3	:	:	O	:	_	0	SENT_420	[p22l325t2691r581b2741],
4	February	NNP	DATE	February	dep	1	SENT_420	[p22l611t2691r867b2755],
5	7	CD	DATE	7	num	4	SENT_420	[p22l894t2692r943b2750],
6	,	,	DATE	,	_	0	SENT_420	[p22l894t2692r943b2750],
7	2012	CD	DATE	2012	appos	4	SENT_420	[p22l972t2691r1127b2741],
8	.	.	O	.	_	0	SENT_420	[p22l972t2691r1127b2741],

1	Final	JJ	O	final	amod	2	SENT_421	[p22l7t2778r152b2828],
2	revision	NN	O	revision	_	0	SENT_421	[p22l177t2778r422b2828],
3	:	:	O	:	_	0	SENT_421	[p22l177t2778r422b2828],
4	April	NNP	DATE	April	dep	2	SENT_421	[p22l452t2778r602b2842],
5	13	CD	DATE	13	num	4	SENT_421	[p22l635t2779r712b2837],
6	,	,	DATE	,	_	0	SENT_421	[p22l635t2779r712b2837],
7	2012	CD	DATE	2012	num	4	SENT_421	[p22l741t2779r896b2828],
8	.	.	O	.	_	0	SENT_421	[p22l741t2779r896b2828],

1	Accepted	JJ	O	accepted	_	0	SENT_422	[p22l7t2867r291b2931],
2	:	:	O	:	_	0	SENT_422	[p22l7t2867r291b2931],
3	May	NNP	DATE	May	dep	1	SENT_422	[p22l320t2868r450b2931],
4	23	CD	DATE	23	num	3	SENT_422	[p22l477t2867r561b2925],
5	,	,	DATE	,	_	0	SENT_422	[p22l477t2867r561b2925],
6	2012	CD	DATE	2012	num	3	SENT_422	[p22l591t2867r745b2916],
7	.	.	O	.	_	0	SENT_422	[p22l591t2867r745b2916],

1	Available	JJ	O	available	amod	2	SENT_423	[p22l7t2954r283b3004],
2	online	NN	O	online	_	0	SENT_423	[p22l310t2954r501b3003],
3	:	:	O	:	_	0	SENT_423	[p22l310t2954r501b3003],
4	July	NNP	DATE	July	dep	2	SENT_423	[p22l532t2954r649b3018],
5	26	CD	DATE	26	num	4	SENT_423	[p22l676t2954r760b3013],
6	,	,	DATE	,	_	0	SENT_423	[p22l676t2954r760b3013],
7	2012	CD	DATE	2012	num	4	SENT_423	[p22l789t2954r944b3004],
8	.	.	O	.	_	0	SENT_423	[p22l789t2954r944b3004],

1	Manuscript	NN	O	manuscript	nsubj	3	SENT_424	[p22l1399t2954r1725b3018],
2	no.	SYM	O	no.	dep	3	SENT_424	[p22l1749t2970r1833b3004],
3	2012-175	CD	NUMBER	2012-175	_	0	SENT_424	[p22l1863t2954r2149b3004],
4	.	.	O	.	_	0	SENT_424	[p22l1863t2954r2149b3004],

1	1	CD	NUMBER	1	num	2	SENT_425	[p22l12t3032r28b3062],
2	Department	NNP	ORGANIZATION	Department	_	0	SENT_425	[p22l52t3043r389b3107],
3	of	IN	ORGANIZATION	of	_	0	SENT_425	[p22l418t3042r479b3092],
4	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	prep_of	2	SENT_425	[p22l504t3042r966b3107],
5	,	,	O	,	_	0	SENT_425	[p22l504t3042r966b3107],
6	Radboud	NNP	ORGANIZATION	Radboud	nn	10	SENT_425	[p22l997t3042r1254b3092],
7	University	NNP	ORGANIZATION	University	nn	10	SENT_425	[p22l1282t3042r1582b3107],
8	Nijmegen	NNP	ORGANIZATION	Nijmegen	nn	10	SENT_425	[p22l1611t3042r1892b3107],
9	Medical	NNP	ORGANIZATION	Medical	nn	10	SENT_425	[p22l1920t3042r2153b3092],
10	Center	NNP	ORGANIZATION	Center	appos	2	SENT_425	[p22l8t3130r211b3188],
11	,	,	O	,	_	0	SENT_425	[p22l8t3130r211b3188],
12	Nijmegen	NNP	MISC	Nijmegen	appos	2	SENT_425	[p22l239t3129r535b3194],
13	,	,	O	,	_	0	SENT_425	[p22l239t3129r535b3194],
14	The	DT	LOCATION	the	det	15	SENT_425	[p22l564t3130r673b3179],
15	Netherlands	NNP	LOCATION	Netherlands	appos	2	SENT_425	[p22l698t3130r1057b3179],
16	.	.	O	.	_	0	SENT_425	[p22l698t3130r1057b3179],

1	2	CD	NUMBER	2	num	2	SENT_426	[p22l8t3206r32b3237],
2	Department	NNP	O	Department	_	0	SENT_426	[p22l52t3218r389b3281],
3	of	IN	O	of	_	0	SENT_426	[p22l450t3217r512b3266],
4	Ophthalmology	NNP	O	Ophthalmology	prep_of	2	SENT_426	[p22l569t3217r1030b3281],
5	,	,	O	,	_	0	SENT_426	[p22l569t3217r1030b3281],
6	University	NNP	ORGANIZATION	University	appos	2	SENT_426	[p22l1094t3217r1394b3281],
7	of	IN	ORGANIZATION	of	_	0	SENT_426	[p22l1456t3217r1518b3266],
8	Cologne	NNP	ORGANIZATION	Cologne	prep_of	6	SENT_426	[p22l1575t3217r1830b3281],
9	,	,	O	,	_	0	SENT_426	[p22l1575t3217r1830b3281],
10	Cologne	NNP	LOCATION	Cologne	appos	2	SENT_426	[p22l1895t3217r2150b3281],
11	,	,	O	,	_	0	SENT_426	[p22l1895t3217r2150b3281],
12	Germany	NNP	LOCATION	Germany	appos	2	SENT_426	[p22l8t3306r286b3370],
13	.	.	O	.	_	0	SENT_426	[p22l8t3306r286b3370],

1	3	CD	NUMBER	3	num	2	SENT_427	[p22l8t3383r30b3414],
2	Department	NNP	O	Department	_	0	SENT_427	[p22l52t3395r389b3458],
3	of	IN	O	of	_	0	SENT_427	[p22l415t3393r477b3443],
4	Ophthalmology	NNP	O	Ophthalmology	prep_of	2	SENT_427	[p22l499t3393r961b3458],
5	,	,	O	,	_	0	SENT_427	[p22l499t3393r961b3458],
6	McGill	NNP	ORGANIZATION	McGill	nn	9	SENT_427	[p22l989t3393r1194b3443],
7	University	NNP	ORGANIZATION	University	nn	9	SENT_427	[p22l1221t3393r1521b3458],
8	Health	NNP	ORGANIZATION	Health	nn	9	SENT_427	[p22l1547t3393r1737b3443],
9	Centre	NNP	ORGANIZATION	Centre	appos	2	SENT_427	[p22l1763t3394r1966b3452],
10	,	,	O	,	_	0	SENT_427	[p22l1763t3394r1966b3452],
11	Montreal	NNP	LOCATION	Montreal	appos	2	SENT_427	[p22l1995t3395r2151b3443, p22l7t3481r148b3540],
12	,	,	O	,	_	0	SENT_427	[p22l1995t3395r2151b3443, p22l7t3481r148b3540],
13	Canada	NNP	LOCATION	Canada	appos	2	SENT_427	[p22l177t3481r403b3531],
14	.	.	O	.	_	0	SENT_427	[p22l177t3481r403b3531],

1	4	CD	NUMBER	4	num	2	SENT_428	[p22l7t3558r32b3589],
2	Department	NNP	ORGANIZATION	Department	_	0	SENT_428	[p22l52t3571r389b3634],
3	of	IN	ORGANIZATION	of	_	0	SENT_428	[p22l412t3569r474b3619],
4	Human	JJ	ORGANIZATION	human	amod	5	SENT_428	[p22l492t3571r701b3619],
5	Genetics	NNP	ORGANIZATION	Genetics	prep_of	2	SENT_428	[p22l725t3569r987b3628],
6	,	,	O	,	_	0	SENT_428	[p22l725t3569r987b3628],
7	Radboud	NNP	ORGANIZATION	Radboud	nn	11	SENT_428	[p22l1014t3569r1271b3619],
8	University	NNP	ORGANIZATION	University	nn	11	SENT_428	[p22l1293t3569r1593b3634],
9	Nijmegen	NNP	ORGANIZATION	Nijmegen	nn	11	SENT_428	[p22l1616t3569r1898b3634],
10	Medical	NNP	ORGANIZATION	Medical	nn	11	SENT_428	[p22l1920t3569r2153b3619],
11	Center	NNP	ORGANIZATION	Center	appos	2	SENT_428	[p22l8t3657r211b3715],
12	,	,	O	,	_	0	SENT_428	[p22l8t3657r211b3715],
13	Nijmegen	NNP	MISC	Nijmegen	appos	2	SENT_428	[p22l239t3656r535b3721],
14	,	,	O	,	_	0	SENT_428	[p22l239t3656r535b3721],
15	The	DT	LOCATION	the	det	16	SENT_428	[p22l564t3657r673b3706],
16	Netherlands	NNP	LOCATION	Netherlands	appos	2	SENT_428	[p22l698t3657r1057b3706],
17	.	.	O	.	_	0	SENT_428	[p22l698t3657r1057b3706],

1	Financial	NNP	O	Financial	nn	3	SENT_429	[p22l7t3744r271b3794],
2	Disclosure	NNP	O	Disclosure	nn	3	SENT_429	[p22l298t3744r692b3806],
3	(	NN	O	(	nsubj	5	SENT_429	[p22l298t3744r692b3806],
4	s	VBZ	O	s	cop	5	SENT_429	[p22l298t3744r692b3806],
5	)	CD	NUMBER	)	_	0	SENT_429	[p22l298t3744r692b3806],
6	:	:	O	:	_	0	SENT_429	[p22l298t3744r692b3806],

1	The	DT	O	the	det	2	SENT_430	[p23l7t20r116b69],
2	author	NN	O	author	nsubj	6	SENT_430	[p23l142t20r395b81],
3	(	CD	NUMBER	(	num	4	SENT_430	[p23l142t20r395b81],
4	s	NNS	O	s	dep	2	SENT_430	[p23l142t20r395b81],
5	)	CD	NUMBER	)	dep	2	SENT_430	[p23l142t20r395b81],
6	have	VBP	O	have	_	0	SENT_430	[p23l421t20r555b70],
7	no	DT	O	no	det	11	SENT_430	[p23l579t36r648b69],
8	proprietary	NN	O	proprietary	nn	11	SENT_430	[p23l672t20r988b84],
9	or	CC	O	or	_	0	SENT_430	[p23l1014t36r1072b69],
10	commercial	JJ	O	commercial	nn	11	SENT_430	[p23l1096t20r1431b69],
11	interest	NN	O	interest	dobj	6	SENT_430	[p23l1455t20r1665b69],
12	in	IN	O	in	_	0	SENT_430	[p23l1688t20r1742b69],
13	any	DT	O	any	det	14	SENT_430	[p23l1768t36r1867b84],
14	materials	NNS	O	material	prep_in	11	SENT_430	[p23l1892t20r2151b69],
15	discussed	VBN	O	discuss	partmod	14	SENT_430	[p23l8t107r280b157],
16	in	IN	O	in	_	0	SENT_430	[p23l305t107r359b156],
17	this	DT	O	this	det	18	SENT_430	[p23l385t107r485b157],
18	article	NN	O	article	prep_in	15	SENT_430	[p23l514t107r703b157],
19	.	.	O	.	_	0	SENT_430	[p23l514t107r703b157],

1	Supported	VBN	O	support	dep	138	SENT_431	[p23l8t195r299b259],
2	by	IN	O	by	dep	138	SENT_431	[p23l328t195r398b259],
3	the	DT	O	the	dep	138	SENT_431	[p23l429t195r515b244],
4	Netherlands	NNP	ORGANIZATION	Netherlands	dep	138	SENT_431	[p23l545t195r888b245],
5	Organization	NNP	ORGANIZATION	Organization	dep	138	SENT_431	[p23l921t195r1292b259],
6	for	IN	ORGANIZATION	for	dep	138	SENT_431	[p23l1323t195r1405b244],
7	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	dep	138	SENT_431	[p23l1437t195r1702b245],
8	Research	NNP	ORGANIZATION	Research	dep	138	SENT_431	[p23l1734t195r2009b254],
9	,	,	O	,	_	0	SENT_431	[p23l1734t195r2009b254],
10	The	DT	O	the	dep	138	SENT_431	[p23l2042t195r2152b244],
11	Hague	NNP	O	Hague	dep	138	SENT_431	[p23l6t284r206b347],
12	,	,	O	,	_	0	SENT_431	[p23l6t284r206b347],
13	the	DT	O	the	dep	138	SENT_431	[p23l235t282r320b332],
14	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l346t282r689b332],
15	(	CD	NUMBER	(	dep	138	SENT_431	[p23l719t283r887b347],
16	grant	NN	O	grant	dep	138	SENT_431	[p23l719t283r887b347],
17	no.	NN	O	no.	dep	138	SENT_431	[p23l913t298r996b332],
18	0l6	CD	NUMBER	0l6	dep	138	SENT_431	[p23l1027t282r1423b344],
19	.096.309	CD	NUMBER	.096.309	dep	138	SENT_431	[p23l1027t282r1423b344],
20	)	NN	O	)	dep	138	SENT_431	[p23l1027t282r1423b344],
21	;	:	O	;	_	0	SENT_431	[p23l1027t282r1423b344],
22	the	DT	O	the	dep	138	SENT_431	[p23l1452t282r1537b332],
23	MD	NNP	ORGANIZATION	MD	dep	138	SENT_431	[p23l1563t284r1676b331],
24	Fonds	NNP	ORGANIZATION	Fonds	dep	138	SENT_431	[p23l1703t282r1892b341],
25	,	,	O	,	_	0	SENT_431	[p23l1703t282r1892b341],
26	Utrecht	NNP	ORGANIZATION	Utrecht	dep	138	SENT_431	[p23l1921t282r2149b341],
27	,	,	O	,	_	0	SENT_431	[p23l1921t282r2149b341],
28	the	DT	O	the	dep	138	SENT_431	[p23l6t370r91b419],
29	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l114t370r475b428],
30	;	:	O	;	_	0	SENT_431	[p23l114t370r475b428],
31	Oogfonds	NNP	LOCATION	Oogfonds	dep	138	SENT_431	[p23l502t369r796b434],
32	,	,	O	,	_	0	SENT_431	[p23l502t369r796b434],
33	Utrecht	NNP	ORGANIZATION	Utrecht	dep	138	SENT_431	[p23l821t370r1049b428],
34	,	,	O	,	_	0	SENT_431	[p23l821t370r1049b428],
35	the	DT	O	the	dep	138	SENT_431	[p23l1074t370r1159b419],
36	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l1181t370r1543b428],
37	;	:	O	;	_	0	SENT_431	[p23l1181t370r1543b428],
38	Landelijke	NNP	ORGANIZATION	Landelijke	dep	138	SENT_431	[p23l1568t370r1872b434],
39	Stichting	NNP	ORGANIZATION	Stichting	dep	138	SENT_431	[p23l1897t370r2151b434],
40	Voor	NNP	ORGANIZATION	Voor	dep	138	SENT_431	[p23l7t473r137b507],
41	Blinden	NNP	ORGANIZATION	Blinden	dep	138	SENT_431	[p23l160t457r385b507],
42	en	IN	O	en	dep	138	SENT_431	[p23l410t473r475b506],
43	Slechtzienden	NNP	O	Slechtzienden	dep	138	SENT_431	[p23l501t457r914b516],
44	,	,	O	,	_	0	SENT_431	[p23l501t457r914b516],
45	Utrecht	NNP	ORGANIZATION	Utrecht	dep	138	SENT_431	[p23l941t457r1169b516],
46	,	,	O	,	_	0	SENT_431	[p23l941t457r1169b516],
47	the	DT	O	the	dep	138	SENT_431	[p23l1196t457r1281b506],
48	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l1306t457r1667b516],
49	;	:	O	;	_	0	SENT_431	[p23l1306t457r1667b516],
50	Algemene	NNP	ORGANIZATION	Algemene	dep	138	SENT_431	[p23l1694t457r1986b521],
51	Nederlandse	NNP	ORGANIZATION	Nederlandse	dep	138	SENT_431	[p23l2010t457r2150b507, p23l7t544r242b594],
52	Vereniging	NNP	ORGANIZATION	Vereniging	dep	138	SENT_431	[p23l274t544r593b609],
53	ter	NN	O	ter	dep	138	SENT_431	[p23l625t552r701b594],
54	Voorkoming	NNP	PERSON	Voorkoming	dep	138	SENT_431	[p23l730t544r1094b609],
55	Van	NNP	PERSON	Van	dep	138	SENT_431	[p23l1126t560r1228b594],
56	Blindheid	NNP	PERSON	Blindheid	dep	138	SENT_431	[p23l1258t544r1554b603],
57	,	,	O	,	_	0	SENT_431	[p23l1258t544r1554b603],
58	Doorn	NNP	PERSON	Doorn	dep	138	SENT_431	[p23l1588t546r1784b603],
59	,	,	O	,	_	0	SENT_431	[p23l1588t546r1784b603],
60	the	DT	O	the	dep	138	SENT_431	[p23l1818t544r1903b594],
61	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l1935t544r2150b594, p23l7t631r173b690],
62	;	:	O	;	_	0	SENT_431	[p23l1935t544r2150b594, p23l7t631r173b690],
63	Stichting	NNP	PERSON	Stichting	dep	138	SENT_431	[p23l208t632r461b696],
64	A.F.	NNP	PERSON	A.F.	dep	138	SENT_431	[p23l492t632r615b681],
65	Deutman	NNP	PERSON	Deutman	dep	138	SENT_431	[p23l649t633r909b681],
66	Oogheelkunde	NNP	PERSON	Oogheelkunde	dep	138	SENT_431	[p23l941t631r1355b696],
67	Researchfonds	NNP	PERSON	Researchfonds	dep	138	SENT_431	[p23l1385t631r1820b690],
68	,	,	O	,	_	0	SENT_431	[p23l1385t631r1820b690],
69	Nijmegen	NNP	LOCATION	Nijmegen	dep	138	SENT_431	[p23l1853t632r2149b696],
70	,	,	O	,	_	0	SENT_431	[p23l1853t632r2149b696],
71	the	DT	O	the	dep	138	SENT_431	[p23l6t719r91b768],
72	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l115t719r477b778],
73	;	:	O	;	_	0	SENT_431	[p23l115t719r477b778],
74	Stichting	NNP	ORGANIZATION	Stichting	dep	138	SENT_431	[p23l506t719r760b783],
75	Nederlands	NNP	ORGANIZATION	Nederlands	dep	138	SENT_431	[p23l784t719r1107b769],
76	Oogheelkundig	NNP	ORGANIZATION	Oogheelkundig	dep	138	SENT_431	[p23l1134t719r1571b783],
77	Onderzoek	NNP	ORGANIZATION	Onderzoek	dep	138	SENT_431	[p23l1598t719r1924b778],
78	,	,	O	,	_	0	SENT_431	[p23l1598t719r1924b778],
79	Rotterdam	NNP	LOCATION	Rotterdam	dep	138	SENT_431	[p23l1951t720r2149b768, p23l7t806r143b865],
80	,	,	O	,	_	0	SENT_431	[p23l1951t720r2149b768, p23l7t806r143b865],
81	the	DT	O	the	dep	138	SENT_431	[p23l170t806r255b856],
82	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l280t806r641b865],
83	;	:	O	;	_	0	SENT_431	[p23l280t806r641b865],
84	Stichting	VBG	PERSON	sticht	dep	138	SENT_431	[p23l670t806r924b871],
85	Blindenhulp	NNP	PERSON	Blindenhulp	dep	138	SENT_431	[p23l950t806r1317b871],
86	,	,	O	,	_	0	SENT_431	[p23l950t806r1317b871],
87	Den	NNP	PERSON	Den	dep	138	SENT_431	[p23l1344t808r1462b856],
88	Haag	NNP	PERSON	Haag	dep	138	SENT_431	[p23l1486t808r1651b871],
89	,	,	O	,	_	0	SENT_431	[p23l1486t808r1651b871],
90	the	DT	O	the	dep	138	SENT_431	[p23l1677t806r1763b856],
91	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l1788t806r2149b865],
92	;	:	O	;	_	0	SENT_431	[p23l1788t806r2149b865],
93	the	DT	O	the	dep	138	SENT_431	[p23l6t894r91b943],
94	Gelderse	NNP	PERSON	Gelderse	dep	138	SENT_431	[p23l136t894r387b943],
95	Blindenstichting	NNP	PERSON	Blindenstichting	dep	138	SENT_431	[p23l430t894r916b958],
96	,	,	O	,	_	0	SENT_431	[p23l430t894r916b958],
97	Velp	NNP	O	Velp	dep	138	SENT_431	[p23l962t894r1114b958],
98	,	,	O	,	_	0	SENT_431	[p23l962t894r1114b958],
99	the	DT	O	the	dep	138	SENT_431	[p23l1160t893r1245b943],
100	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l1288t894r1649b952],
101	;	:	O	;	_	0	SENT_431	[p23l1288t894r1649b952],
102	Nijmeegse	NNP	ORGANIZATION	Nijmeegse	dep	138	SENT_431	[p23l1694t894r1999b958],
103	Oogonderzoek	NNP	ORGANIZATION	Oogonderzoek	dep	138	SENT_431	[p23l2043t894r2149b943, p23l7t981r340b1045],
104	Stichting	NNP	ORGANIZATION	Stichting	dep	138	SENT_431	[p23l360t981r630b1045],
105	,	,	O	,	_	0	SENT_431	[p23l360t981r630b1045],
106	Nijmegen	NNP	LOCATION	Nijmegen	dep	138	SENT_431	[p23l652t981r949b1045],
107	,	,	O	,	_	0	SENT_431	[p23l652t981r949b1045],
108	the	DT	O	the	dep	138	SENT_431	[p23l971t981r1056b1030],
109	Netherlands	NNP	LOCATION	Netherlands	dep	138	SENT_431	[p23l1076t981r1438b1040],
110	;	:	O	;	_	0	SENT_431	[p23l1076t981r1438b1040],
111	the	DT	O	the	dep	138	SENT_431	[p23l1460t981r1546b1030],
112	Foundation	NNP	ORGANIZATION	Foundation	dep	138	SENT_431	[p23l1566t981r1890b1031],
113	Fighting	NN	ORGANIZATION	fighting	dep	138	SENT_431	[p23l1910t981r2150b1045],
114	Blindness	NNP	ORGANIZATION	Blindness	dep	138	SENT_431	[p23l6t1068r285b1118],
115	Canada	NNP	ORGANIZATION	Canada	dep	138	SENT_431	[p23l314t1068r541b1127],
116	,	,	O	,	_	0	SENT_431	[p23l314t1068r541b1127],
117	Toronto	NNP	LOCATION	Toronto	dep	138	SENT_431	[p23l571t1070r815b1127],
118	,	,	O	,	_	0	SENT_431	[p23l571t1070r815b1127],
119	Canada	NNP	LOCATION	Canada	dep	138	SENT_431	[p23l844t1068r1073b1127],
120	;	:	O	;	_	0	SENT_431	[p23l844t1068r1073b1127],
121	and	CC	O	and	dep	138	SENT_431	[p23l1105t1068r1205b1118],
122	by	IN	O	by	dep	138	SENT_431	[p23l1231t1068r1301b1133],
123	the	DT	O	the	dep	138	SENT_431	[p23l1327t1068r1413b1118],
124	Koeln	NNP	O	Koeln	dep	138	SENT_431	[p23l1441t1068r1613b1118],
125	Fortune	NNP	O	Fortune	dep	138	SENT_431	[p23l1639t1070r1860b1118],
126	Program	NNP	O	Program	dep	138	SENT_431	[p23l1887t1069r2153b1133],
127	/	:	O	/	dep	138	SENT_431	[p23l1887t1069r2153b1133],
128	Faculty	NNP	O	Faculty	dep	138	SENT_431	[p23l6t1156r219b1220],
129	of	IN	O	of	dep	138	SENT_431	[p23l246t1155r308b1205],
130	Medicine	NNP	O	Medicine	dep	138	SENT_431	[p23l328t1156r612b1214],
131	,	,	O	,	_	0	SENT_431	[p23l328t1156r612b1214],
132	University	NNP	ORGANIZATION	University	dep	138	SENT_431	[p23l640t1156r940b1220],
133	of	IN	ORGANIZATION	of	dep	138	SENT_431	[p23l967t1155r1029b1205],
134	Cologne	NNP	ORGANIZATION	Cologne	dep	138	SENT_431	[p23l1050t1156r1306b1220],
135	,	,	O	,	_	0	SENT_431	[p23l1050t1156r1306b1220],
136	Cologne	NNP	LOCATION	Cologne	dep	138	SENT_431	[p23l1335t1156r1590b1220],
137	,	,	O	,	_	0	SENT_431	[p23l1335t1156r1590b1220],
138	Germany	NNP	LOCATION	Germany	_	0	SENT_431	[p23l1619t1156r1897b1220],
139	.	.	O	.	_	0	SENT_431	[p23l1619t1156r1897b1220],

1	Correspondence	NN	O	correspondence	_	0	SENT_432	[p23l7t1242r484b1307],
2	:	:	O	:	_	0	SENT_432	[p23l7t1242r484b1307],
3	Anneke	NNP	PERSON	Anneke	nn	6	SENT_432	[p23l6t1330r220b1379],
4	I.	NNP	PERSON	I.	nn	6	SENT_432	[p23l238t1331r272b1379],
5	den	NN	PERSON	den	nn	6	SENT_432	[p23l295t1330r393b1379],
6	Hollander	NNP	PERSON	Hollander	dep	1	SENT_432	[p23l410t1330r697b1388],
7	,	,	O	,	_	0	SENT_432	[p23l410t1330r697b1388],
8	Department	NNP	ORGANIZATION	Department	appos	1	SENT_432	[p23l718t1331r1042b1394],
9	of	IN	ORGANIZATION	of	_	0	SENT_432	[p23l1060t1329r1120b1379],
10	Ophthalmology	NNP	ORGANIZATION	Ophthalmology	prep_of	8	SENT_432	[p23l1134t1330r1578b1394],
11	,	,	O	,	_	0	SENT_432	[p23l1134t1330r1578b1394],
12	Radboud	NNP	ORGANIZATION	Radboud	nn	16	SENT_432	[p23l1598t1330r1846b1379],
13	University	NNP	ORGANIZATION	University	nn	16	SENT_432	[p23l1863t1330r2151b1394],
14	Nijmegen	NNP	ORGANIZATION	Nijmegen	nn	16	SENT_432	[p23l6t1417r277b1481],
15	Medical	NNP	ORGANIZATION	Medical	nn	16	SENT_432	[p23l304t1417r528b1466],
16	Center	NNP	ORGANIZATION	Center	appos	1	SENT_432	[p23l556t1417r751b1476],
17	,	,	O	,	_	0	SENT_432	[p23l556t1417r751b1476],
18	Philips	NNP	ORGANIZATION	Philips	nn	19	SENT_432	[p23l781t1417r968b1481],
19	Van	NNP	ORGANIZATION	Van	appos	1	SENT_432	[p23l997t1433r1096b1467],
20	Leydenlaan	NNP	ORGANIZATION	Leydenlaan	dep	19	SENT_432	[p23l1122t1417r1442b1481],
21	15	CD	NUMBER	15	num	20	SENT_432	[p23l1476t1417r1551b1476],
22	,	,	O	,	_	0	SENT_432	[p23l1476t1417r1551b1476],
23	6525	CD	NUMBER	6525	num	20	SENT_432	[p23l1582t1417r1715b1467],
24	EX	NNP	MISC	EX	nn	25	SENT_432	[p23l1745t1418r1837b1466],
25	Nijmegen	NNP	MISC	Nijmegen	dep	1	SENT_432	[p23l1864t1417r2149b1481],
26	,	,	O	,	_	0	SENT_432	[p23l1864t1417r2149b1481],
27	The	DT	LOCATION	the	det	28	SENT_432	[p23l6t1504r112b1554],
28	Netherlands	NNP	LOCATION	Netherlands	appos	25	SENT_432	[p23l136t1504r691b1554],
29	.	.	O	.	_	0	SENT_432	[p23l136t1504r691b1554],

1	E	NN	O	e	nn	3	SENT_433	[p23l136t1504r691b1554],
2	—	CD	NUMBER	—	num	3	SENT_433	[p23l136t1504r691b1554],
3	mail	NN	O	mail	_	0	SENT_433	[p23l136t1504r691b1554],
4	:	:	O	:	_	0	SENT_433	[p23l136t1504r691b1554],
5	A.denHollander@ohk.umcn.nl	NN	O	a.denhollander@ohk.umcn.nl	dep	3	SENT_433	[p23l721t1504r1616b1554],
6	.	.	O	.	_	0	SENT_433	[p23l721t1504r1616b1554],

